rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
GACTCGGCCATGTATCGCTGTGCCAGCAGCGAACCCCGGCCGGACAGTTATCAGCCCCAGCATTTTGGTGAT	CASSEPRPDSYQPQHF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	5	5	11	2	18	30	47	41	49														CASSEPRPDSYQPQHF+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAAGGGACAGTTATGAAAAACTGTTTTTTGGCAGT	CASSLRDSYEKLFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	5	6	1	2	18	33	41	34	43														CASSLRDSYEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCCGAGCGTACCACAGATACGCAGTATTTTGGCCCA	CASSPERTTDTQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	6	2	4	3	18	30	38	34	41						01,02								CASSPERTTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGTCGACTAGTGGGTCGATTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	11	2.4953269331978296E-5		41	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	8	9	2	9	18	29	37	31	46						01,02								X+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCGCTAGCGGGAGTTGGGATGAGCAGTTCTTCGGGCCA	CASSASGSWDEQFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	2	8	1	5	18	30	41	31	46														CASSASGSWDEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAAACCAGGGACCCACAGATACGCAGTATTTTGGCCCA	CASSLNQGPTDTQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-03	01	2	0	7	2	5	1	18	33	43	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNQGPTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGCGCCGGGAGTCACAGATACGCAGTATTTTGGCCCA	CASSLAPGVTDTQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	8	2	2	2	1	18	35	43	37	44														CASSLAPGVTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAAACGCGTACCAAGAGACCCAGTACTTCGGGCCA	CASSLNAYQETQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	7	6	0	3	1	18	33	39	36	40						01,02								CASSLNAYQETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGACAGGACTAATGAAAAACTGTTTTTTGGCAGT	CASSLDRTNEKLFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	4	2	0	0	18	-1	-1	32	39														CASSLDRTNEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCGCCCAGAGGGCCGGGGGCACTGAAGCTTTCTTTGGACAA	CASSAQRAGGTEAFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	2	4	11	0	18	30	-1	41	47														CASSAQRAGGTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCTAGCAGCTTACAAACATCGGGACAGCGGGAGCCATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	3.629566448287752E-5		56	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	6	2	3	13	4	18	33	54	46	58														X+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAACGTCAAGGGGGACGGGTCGGGTGAGCAGTTCTTCGGGCCA	CASNVKGDGSGEQFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	5	1	9	6	10	18	28	40	34	50														CASNVKGDGSGEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCCACCGGGGGGGCAAGGCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	17	3.8564143513057367E-5		46	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	8	0	7	5	5	18	30	43	35	48														X+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCTAGCAGAACTCAGAGCGATCTTCTCGGGCTAGCGGGATGTAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	17	3.8564143513057367E-5		62	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	4	3	5	22	3	18	29	60	51	63														X+TCRBV07-06+TCRBJ02-04	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCGGGGGGACAGGGGAGACCACCGGGGAGCTGTTTTTTGGAGAA	CAGGTGETTGELFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	11	0	2	4	3	4	18	24	37	27	41														CAGGTGETTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAAGGAATGGCGGAGGGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	4.5369580603596903E-5		49	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	10	0	4	9	1	18	33	48	42	49														X+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCACCCGGGACAGGCGCTTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTRDRRFSSYNEQFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	51	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	4	0	3	8	18	28	39	31	47														CASTRDRRFSSYNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGAGGGGCTAGCGGGAACCTACGAGCAGTACTTCGGGCCG	CASSLEGLAGTYEQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	4	3	2	5	1	18	34	48	39	49														CASSLEGLAGTYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGAAGCTTGCCCCAGGGGGACAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	26	5.898045478467597E-5		46	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	1	2	4	3	18	32	43	36	46														X+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGCCAGACAGGGAAAGACGAGCAGTACTTCGGGCCG	CASSLGQTGKDEQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	3	5	4	4	18	34	45	38	49														CASSLGQTGKDEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCGTGTTTCCTCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSRVSSQSRANVLTF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	51	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	6	5	11	5	18	30	44	41	49														CASSRVSSQSRANVLTF+TCRBV07-06+TCRBJ02-06	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGCCGGTGGGCCCAGTGGCTATGGCTACACCTTCGGTTCG	CASSLAGGPSGYGYTF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	8	0	4	7	7	18	32	43	39	50														CASSLAGGPSGYGYTF+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCCCTCGGGCCCCACACTGAAGCTTTCTTTGGACAA	CASSSLGPHTEAFF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	42	TCRBV07	TCRBV07-06	01				TCRBJ01	TCRBJ01-01	01	4	8	0	3	5	3	18	31	40	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSLGPHTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTTATAGGACTAGCGGGAGATACGCAGTATTTTGGCCCA	CASSFIGLAGDTQYF	In	VDJ	2	49	1.1115547247881241E-4	1.4267453608937832E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	1	4	5	4	0	18	32	-1	36	47						01,02								CASSFIGLAGDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCTCATGGGCAGCTGGGGGCCAGGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	59	1.3384026278061086E-4		56	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	6	0	1	13	4	18	30	49	43	53														X+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCGAGGGGGGAGGGGGCTAGGGAATGAGCAGTTCTTCGGGCCA	CASSRGGRGLGNEQFF	In	VDJ	2	68	1.5425657405222947E-4	1.9799731538934135E-4	48	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-01	01	5	5	0	7	9	5	18	30	46	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGGRGLGNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGGAGGACTAGCGGGAGAGTCCGAGCAGTACTTCGGGCCG	CASSLGGLAGESEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	1	2	6	2	4	19	35	50	37	54														CASSLGGLAGESEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGGAGCTAGCGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLGASGYNEQFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	5	3	3	0	19	35	-1	38	45						01,02								CASSLGASGYNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCTGTGTATCTCTGTGCCAGAAGCACCGGGACCCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	12	2.722174836215814E-5		41	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-01	01	4	0	7	5	3	4	19	31	39	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCGCGACTAGCGGGAGTCCCTACGAGCAGTACTTCGGGCCG	CASATSGSPYEQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	2	2	2	3	2	19	27	42	30	44														CASATSGSPYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCTTAAAGCATATCTCGCGAAAGACCTATGGCTACACCTTCGGTTCG	CASLKHISRKTYGYTF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	48	TCRBV07	TCRBV07-05	01				TCRBJ01	TCRBJ01-02	01	8	2	7	4	21	0	19	27	-1	48	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASLKHISRKTYGYTF+TCRBV07-05+TCRBJ01-02	TCRBV07-05*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCAGGATGGACAGAACTATGGCTACACCTTCGGTTCG	CASSQDGQNYGYTF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	5	2	6	0	19	31	-1	37	43														CASSQDGQNYGYTF+TCRBV07-05+TCRBJ01-02	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCGTAGCGGGATCCCTCACAGTACAGATACGCAGTATTTTGGCCCA	CASSRSGIPHSTDTQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	51	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	5	3	3	2	11	19	31	41	33	52														CASSRSGIPHSTDTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCTGTGTATCTCTGTGCTAGCAGCTTGAGCGGGAGCGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSLSGSGGNEQFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	6	2	6	7	0	19	33	-1	40	48						01,02								CASSLSGSGGNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCCGAGCGGGGCCCATACGGGAATGAGCAGTTCTTCGGGCCA	CASSSERGPYGNEQFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	6	3	7	3	10	19	32	42	35	52														CASSSERGPYGNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCAGGGGCCCTACCTCCTACGAGCAGTACTTCGGGCCG	CASSRGPTSYEQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	5	2	0	0	6	19	-1	36	31	42														CASSRGPTSYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCATCAAACCCCAAGGACAGGGGACCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	6.805437090539536E-5		53	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	2	2	12	3	19	31	52	43	55														X+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTGGGGGATGACTTTAGCGGTCCCCGGTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	31	7.032284993557519E-5		59	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	5	5	1	12	8	19	32	50	44	58						01,02								X+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCCCTTCGGCGCGGGAGGGACCGATGAGCAGTTCTTCGGGCCA	CASSPFGAGGTDEQFF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	7	0	8	9	4	19	31	49	40	53														CASSPFGAGGTDEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGAGGACAGCCATACGAGCAGTACTTCGGGCCG	CASRGQPYEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	36	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	5	4	1	3	23	34	41	35	44			01,02										Vb 1	CASRGQPYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCCTTTCAAAGGGGTTGAGGTATGGCTACACCTTCGGTTCG	CASSPLSKGLRYGYTF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	5	2	5	10	6	23	35	50	45	56			01,02										Vb 1	CASSPLSKGLRYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTAGACTAGCGGGAGTGGGGTGGAATGAGCAGTTCTTCGGGCCA	CASSRLAGVGWNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	2	2	7	2	8	23	34	48	36	56			01,02										Vb 1	CASSRLAGVGWNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCTCTCCGGGGGGCCGAACCGGGGAGCTGTTTTTTGGAGAA	CASSPGGRTGELFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	8	1	5	4	4	23	32	43	36	47			01,02										Vb 1	CASSPGGRTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ACGTTTGGTGGAACCCGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAACCCACGCCCAAAACACTGAAGCTTTCTTTGGACAA	CASSVTHAQNTEAFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	1	3	7	2	0	10	36	-1	53	51	63			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVTHAQNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAGCCACGTTTGGTGCTGGGGGACTCAGCTTTGATTTCTGTGCCAGCTTGAGAGGACAGGAGGTGGGCGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	2.2684790301798452E-5		41	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	22	1	4	8	20	8	40	34	61	54	69			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAGCCACGTTTGGTGCTGGGGGACTCAGTTTGTATTTCTGTGCCAGCTTGAGAGGACAGGAGGTGGGCGAAGCTTTCTTTGGACAA	CASLRGQEVGEAFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	1	4	8	6	8	39	48	61	54	69			01,02										Vb 1	CASLRGQEVGEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCRTTGGACAGGGTGACATTCAGTACTTCGGCGCC	CASSXGQGDIQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	1	3	8	1	2	23	37	46	38	48			01,02										Vb 1	CASSXGQGDIQYF+TCRBV09-01+TCRBJ02-04	TCRBV09-01	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGGGACTAGCAGGCAATGAGCAGTTCTTCGGGCCA	CASSVGGLAGNEQFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	7	6	1	3	23	39	49	40	52			01,02			01,02							Vb 1	CASSVGGLAGNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAAGGTGGCAGGGCCTATGGCTACACCTTCGGTTCG	CASSEGGRAYGYTF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	4	9	1	23	34	48	43	49			01,02										Vb 1	CASSEGGRAYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTCGGACCTCTAATTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPRTSNSYNEQFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	48	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	4	1	7	1	4	7	23	35	43	39	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSPRTSNSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGAGGGGCTAATGAGCAGTTCTTCGGGCCA	CASSVGGANEQFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	39	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	0	5	2	7	1	2	23	39	45	40	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGGANEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGTTGGCAATGAGCAGTTCTTCGGGCCA	CASSVVGNEQFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	36	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	0	0	10	6	2	0	23	39	-1	41	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVVGNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTTGGATCCGCCTTAAGCACAGATACGCAGTATTTTGGCCCA	CASSVGSALSTDTQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	48	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	2	1	8	0	1	9	23	37	41	38	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGSALSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCCGCTTAGGAAACACTGAAGCTTTCTTTGGACAA	CASSARLGNTEAFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	3	1	8	2	8	0	23	36	-1	44	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSARLGNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGGGGACTGAAGCTTTCTTTGGACAA	CASSVGGTEAFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	36	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	0	6	1	5	0	0	23	-1	-1	39	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGGTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGATTAGGGGTATTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	15	3.402718545269768E-5		46	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	5	2	0	5	3	23	34	44	39	47			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCGATGGCCGGGACTCGACGGTTCTTCGGGCCA	CASSAMAGTRRFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	10	15	8	5	23	36	50	44	55			01,02			01,02							Vb 1	CASSAMAGTRRFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCCGGGGATCAGCCCCAGCATTTTGGTGAT	CASSSGDQPQHF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	36	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	4	8	3	5	2	0	23	35	-1	37	42			01,02										Vb 1	CASSSGDQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGGGAGACAGGGGGCGGTTACGAGCAGTACTTCGGGCCG	CASSGETGGGYEQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	0	4	4	3	23	36	50	40	53			01,02										Vb 1	CASSGETGGGYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCGGACCAGTGGGCAGGGACAGCAGCCCCAGCATTTTGGTGAT	CASSRTSGQGQQPQHF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	5	7	14	0	23	35	-1	49	56			01,02										Vb 1	CASSRTSGQGQQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCTAGCAGCCGGGGGACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRGTSGANVLTF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	4	8	2	0	0	2	23	-1	41	35	43			01,02										Vb 1	CASSRGTSGANVLTF+TCRBV09-01+TCRBJ02-06	TCRBV09-01	TCRBD02-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAAGTCAAGGGCAGGGTGAGGTCAAATTACAATGAGCAGTTCTTCGGGCCA	CASSEVKGRVRSNYNEQFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	57	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	4	12	11	23	34	51	46	62			01,02										Vb 1	CASSEVKGRVRSNYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCCGCCGAAACACTGAAGCTTTCTTTGGACAA	CASSARRNTEAFF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	3	2	8	2	6	0	23	36	-1	42	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSARRNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGTGGAGGGCGAGCGAGTGGCTACACCTTCGGTTCG	CASSVGGGRASGYTF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	10	0	7	2	8	23	39	47	41	55			01,02										Vb 1	CASSVGGGRASGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGTAGATCCAGATACGCAGTATTTTGGCCCA	CASSVVDPDTQYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	5	8	4	0	3	23	-1	42	39	45			01,02			01,02							Vb 1	CASSVVDPDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCGCGTGGGCGGGACAACAATGAGCAGTTCTTCGGGCCA	CASSPRGRDNNEQFF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	4	0	6	5	10	0	23	35	-1	45	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSPRGRDNNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATGGGACTTACAATGAGCAGTTCTTCGGGCCA	CASSVDGTYNEQFF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	10	4	2	0	23	39	-1	41	47			01,02			01,02							Vb 1	CASSVDGTYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGAGGGGACAGGGGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASRGDRGNTGELFF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	2	2	2	1	23	34	46	36	47			01,02										Vb 1	CASRGDRGNTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCTAACAGGTTACAACAATGAGCAGTTCTTCGGGCCA	CASSLTGYNNEQFF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	4	5	3	5	23	35	43	38	48			01,02										Vb 1	CASSLTGYNNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCGGTTCGGCTGTAGATACGCAGTATTTTGGCCCA	CASGSAVDTQYF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	36	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	7	9	0	5	5	3	23	32	40	37	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASGSAVDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGGATAGACCTAACCGGGGAGCTGTTTTTTGGAGAA	CASRIDLTGELFF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	39	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-02	01	5	2	7	5	4	3	23	34	41	38	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASRIDLTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTCTAAGGGGGGACTCCGAGGAAGAGACCCAGTACTTCGGGCCA	CASSLRGDSEEETQYF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	48	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-05	01	5	5	1	3	4	10	23	34	44	38	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSLRGDSEEETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTGACATCCAACTCCTACGAGCAGTACTTCGGGCCG	CASSLTSNSYEQYF	In	VDJ	1	42	9.527611926755349E-5	1.222924595051814E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	6	0	2	5	23	35	41	37	46			01,02										Vb 1	CASSLTSNSYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGTCTAAGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSVSKGSGNTIYF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	45	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-03	01	2	5	3	0	5	0	23	37	-1	42	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVSKGSGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAAGGAGACAGTCTCTGGAAACACCATATATTTTGGAGAG	CASKETVSGNTIYF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	5	0	4	1	23	33	42	37	43			01,02										Vb 1	CASKETVSGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGTCAGGGGTGAGCAGTTCTTCGGGCCA	CASSVVRGEQFF	In	VDJ	2	49	1.1115547247881241E-4	1.4267453608937832E-4	36	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	9	1	0	23	39	-1	40	46			01,02										Vb 1	CASSVVRGEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATTTTCTTAGCGGGAGTAGGGGTGAGCAGTTCTTCGGGCCA	CASSVDFLSGSRGEQFF	In	VDJ	2	67	1.5198809502204962E-4	1.950855901630275E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	5	2	9	7	6	23	39	55	46	61			01,02										Vb 1	CASSVDFLSGSRGEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCAGTGTCCTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSVLGANVLTF	In	VDJ	4	117	2.6541204653104185E-4	3.4067185147871964E-4	42	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-06	01	4	5	5	3	0	6	23	-1	37	35	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSSVLGANVLTF+TCRBV09-01+TCRBJ02-06	TCRBV09-01		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTAGTGGGCGGGTTCAGCACAGATACGCAGTATTTTGGCCCA	CASSLVGGFSTDTQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	7	4	0	3	3	19	35	43	38	46						01,02								CASSLVGGFSTDTQYF+TCRBV11-01+TCRBJ02-03	TCRBV11-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGTAGGACGGTGAATGCTGGAAACACCATATATTTTGGAGAG	CASSRTVNAGNTIYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	TCRBV11	TCRBV11-01	01				TCRBJ01	TCRBJ01-03	01	6	1	7	2	2	8	19	30	36	32	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTVNAGNTIYF+TCRBV11-01+TCRBJ01-03	TCRBV11-01*01		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTTGGGACAGGCCCGTACAATGAGCAGTTCTTCGGGCCA	CASSFGTGPYNEQFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	45	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	4	4	1	4	19	33	42	34	46														CASSFGTGPYNEQFF+TCRBV11-01+TCRBJ02-01	TCRBV11-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACGTTTGGTGGCAGAACTGGAGGATTCTGGGAGTTTATTTCTGTGCCAGCAGCATGGTGGGCACAGATACGCAGTATTTTGGCCCA	CASSMVGTDTQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	39	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	5	0	10	1	2	3	42	54	58	56	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSMVGTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGTTTGGTGGCAGAACTGGAGGATTCTGGAGTTATTTCTGTGCCAGCAGCCAAGAGAGGGATTGTCCACGAGCAGTACTTCGGGCCG	VPAAKRGIVHEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	23	11	0	5	22	7	39	33	60	55	67													Vb 16	VPAAKRGIVHEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGCAGAACTGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCCTGTGGGACTCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	2.2684790301798452E-5		50	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	10	2	6	1	31	48	60	54	61						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTAGTGACAAGGTACGAGCAGTACTTCGGGCCG	CASSLVTRYEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	6	4	4	3	29	42	50	46	53													Vb 16	CASSLVTRYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCGGGGGACAGGGGACGGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	11	2.4953269331978296E-5		41	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	0	2	6	2	4	29	38	50	40	54													Vb 16	X+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCCACGTTTGGTGGCAGAACTGGAGGATTCTGRGTTTATTTCTGTGCCAGCAGCATGGTGGGCACAGATACGCAGTATTTTGGCCCA	CASSMVGTDTQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	39	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	5	0	10	1	2	3	42	54	58	56	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSMVGTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGTCTGGGACAGGGCGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	2.9490227392337985E-5		44	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	3	6	4	2	29	43	56	47	58													Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCTAGCAGCCAAGCGCCGGGGCCTTATCCCGACGGCTACACCTTCGGTTCG	CASSQAPGPYPDGYTF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	48	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	1	7	0	8	4	11	29	45	54	49	65				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQAPGPYPDGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACGTTTGGTGGCAGAACTGGAGGGATTCTGGAGTTTATTTCTGTGCCAGCAGCATGGTGGGCACAGATACGCAGTATTTTGGCCCA	CASSMVGTDTQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	5	0	10	1	2	3	42	54	58	56	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSMVGTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGTAGGACAGGGGGCTTACGAGCAGTACTTCGGGCCG	CASSVGQGAYEQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	0	4	3	1	29	41	55	44	56													Vb 16	CASSVGQGAYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTTGGTGGCAGAACTGGAGGATTCTGGAGTTTATTCTGTGCCAGCAGCCAGCGGCAGGGGGACTATTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	3.175870642251783E-5		44	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	19	4	1	4	19	5	37	35	61	54	66				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCCCCCCGGGACAAGGTAAGCGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	15	3.402718545269768E-5		53	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	6	2	7	9	28	41	54	48	63													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCACGCCGTTCTAGGGTAGGGATCAGCCCCAGCATTTTGGTGAT	CATPF*GRDQPQHF	Stop	VDJ	1	16	3.629566448287752E-5		42	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-05	01	10	5	3	5	9	5	29	36	49	45	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CATPF*GRDQPQHF+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCATAGTGGGCACAGATATGCAGTATTTTGGCCCA	CASSIVGTDMQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	5	11	9	4	29	41	54	50	58													Vb 16	CASSIVGTDMQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCCCCCGGGACAGGGTAAGCGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	18	4.083262254323721E-5		52	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	2	6	6	29	42	57	48	63													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCCACGTTTGGTGGCAGAACTGGAGGATCTGGAGTTTATTTCTGTGCCAGCAGCATGGTGGGCACAGATACGCAGTATTTTGGCCCA	CASSMVGTDTQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	39	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	5	0	10	1	2	3	42	54	58	56	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSMVGTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGCCTTCCATGATCTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRLP*SSGANVLTF	Stop	VDJ	1	19	4.3101101573417056E-5		51	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-06	01	4	2	8	1	9	3	29	42	53	51	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSRLP*SSGANVLTF+TCRBV14-01+TCRBJ02-06	TCRBV14-01*01		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAAAGGGACAGGAGAGGGGTACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	20	4.5369580603596903E-5		53	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	4	0	2	8	28	43	53	45	61													Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGAGGTGGGACCCCTACGAGCAGTACTTCGGGCCG	CASSQERWDPYEQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	45	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	0	0	7	2	5	1	29	46	56	51	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQERWDPYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGCGTTGGCAGGAAAAACTGTTTTTTGGCAGT	CASSQERWQEKLFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	42	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-04	01	0	4	5	8	7	0	29	46	-1	53	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQERWQEKLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGATCCAGGCTTGGCTACACCTTCGGTTCG	CASSQGSRLGYTF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	4	7	4	2	29	45	53	49	55													Vb 16	CASSQGSRLGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGCCCGGGACAGCCTTTGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQARDSLWNTGELFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	54	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	0	5	1	3	6	27	43	53	46	59													Vb 16	CASSQARDSLWNTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGTAGCTGACTACGAGCAGTACTTCGGGCCG	CASSQDVADYEQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	5	7	3	2	3	29	46	52	48	55						01,02							Vb 16	CASSQDVADYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCCTATCGTGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	5.2175017694136434E-5		34	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	9	7	2	4	29	42	47	44	51						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGTGGCAGAACGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCATGGTGGGCACAGATACGCAGTATTTTGGCCCA	CASSMVGTDTQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	39	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	5	0	10	1	2	3	34	46	50	48	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSMVGTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGCGGGACAGGGGGATCAGATACGCAGTATTTTGGCCCA	CASSRGTGGSDTQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	1	4	2	2	29	42	55	44	57													Vb 16	CASSRGTGGSDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACTTGTAGTATCTGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	26	5.898045478467597E-5		55	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	2	6	5	12	5	26	40	56	52	61													Vb 16	X+TCRBV14-01+TCRBJ02-06	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGAGTGAGTACGAGCAGTACTTCGGGCCG	CASSQESEYEQYF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	2	4	0	4	29	-1	49	46	53													Vb 16	CASSQESEYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTCGGGGTCAATGAGCAGTTCTTCGGGCCA	CASSQVGVNEQFF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	3	6	1	1	29	45	51	46	52													Vb 16	CASSQVGVNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATAGGTGGGGGGTTCAGAACACTGAAGCTTTCTTTGGACAA	CASSQDRWGVQNTEAFF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	51	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	9	1	1	5	4	29	46	57	51	61													Vb 16	CASSQDRWGVQNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACCCGGGACAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQPGTTNTGELFF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	6	0	3	1	29	44	53	47	54													Vb 16	CASSQPGTTNTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCGGGGATCGACTATGGCTACACCTTCGGTTCG	CASSPGIDYGYTF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	8	3	3	0	4	29	-1	47	42	51													Vb 16	CASSPGIDYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD02-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCCGAGCCCTCAGGGGGGTCGGGGGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	33	7.485980799593489E-5		50	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	8	4	1	4	8	9	29	38	53	46	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGYCAGCAGCCAAGTACTTAGCGGGAGGGGAGCAGTATTTTGGCCCA		Out	VDJ	1	33	7.485980799593489E-5		43	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	5	0	11	4	2	29	45	60	49	62													Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGCGACAGGGGCAGGGGTGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	34	7.712828702611473E-5		46	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	2	6	2	8	29	42	52	44	60													Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTCCTTGGCCGCAGTCTCCTACGAGCAGTACTTCGGGCCG	CASSSLAAVSYEQYF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	5	0	10	1	29	41	54	51	55													Vb 16	CASSSLAAVSYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGCCCCGGACTAGCGGGAGGAGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	36	8.166524508647442E-5		52	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	1	1	3	5	2	29	43	62	48	64													Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAATACATACGTACGAGCAGTACTTCGGGCCG	CASSQIHTYEQYF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	6	4	2	4	29	44	49	46	53													Vb 16	CASSQIHTYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCCAAGATATGGCTACACCTTCGGTTCG	CASSQDPRYGYTF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	39	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	0	2	8	5	5	0	29	46	-1	51	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQDPRYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAACTACACGACGGGACTAATAGACAGATACGCAGTATTTTGGCCCA	CASSQTTRRD**TDTQYF	Stop	VDJ	1	39	8.847068217701396E-5		54	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	0	9	3	10	4	27	42	59	52	63						01,02							Vb 16	CASSQTTRRD**TDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGAGATACGGGGGCCCGGACGAAGCTTTCTTTGGACAA	CASSQGRYGGPDEAFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	48	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-01	01	1	6	0	8	8	6	29	45	59	53	65				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQGRYGGPDEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGAGGGACCAGGGGGACCCAGTACTTCGGGCCA	CASSQGGTRGTQYF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	2	7	7	0	29	45	-1	52	58													Vb 16	CASSQGGTRGTQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTATTGAGGGACTAAGGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	42	9.527611926755349E-5		49	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	0	9	6	6	3	29	45	58	51	61						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGCCAGGGTTTCTACGAGCAGTACTTCGGGCCG	CASSQGQGFYEQYF	In	VDJ	1	44	9.981307732791318E-5	1.281159099578091E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	3	3	2	3	29	45	52	47	55													Vb 16	CASSQGQGFYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGTCAGGGCAGTTCCCCCTACGAGCAGTACTTCGGGCCG	CASSRQGSSPYEQYF	In	VDJ	1	44	9.981307732791318E-5	1.281159099578091E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	2	2	8	29	42	49	44	57													Vb 16	CASSRQGSSPYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTTGACAGGGTGACTGAAGCTTTCTTTGGACAA	CASSLDRVTEAFF	In	VDJ	1	44	9.981307732791318E-5	1.281159099578091E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	5	2	2	29	42	51	44	53													Vb 16	CASSLDRVTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGATATACGAGCAGTACTTCGGGCCG	CASSQGIYEQYF	In	VDJ	2	46	1.0435003538827287E-4	1.3393936041043678E-4	36	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	1	1	8	4	0	2	29	-1	48	45	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQGIYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCACGATAGGGGTGGGTGAGCAGTTCTTCGGGCCA	CASSPTIGVGEQFF	In	VDJ	2	48	1.0888699344863256E-4	1.3976281086306447E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	5	2	9	7	4	29	42	54	49	58													Vb 16	CASSPTIGVGEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTAAAACAACAGGGAAAAACTGGAAACACCATATATTTTGGAGAG	CASSLKQQGKTGNTIYF	In	VDJ	2	48	1.0888699344863256E-4	1.3976281086306447E-4	51	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	3	2	7	5	29	42	55	49	60													Vb 16	CASSLKQQGKTGNTIYF+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGACCGGGACTAGCGGGAGTTCCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	49	1.1115547247881241E-4		50	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	0	2	6	4	3	29	41	59	45	62													Vb 16	X+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTAGCCCGCATGAACACTGAAGCTTTCTTTGGACAA	CASSLARMNTEAFF	In	VDJ	2	50	1.1342395150899225E-4	1.4558626131569216E-4	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	5	7	0	0	5	29	-1	46	42	51						01,02							Vb 16	CASSLARMNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTTATTTCTGTGCCAGCAGCCGGCGCCTCGGGGGGGGTTCTTGACCGGAGCACCCGGCGAGCAGTACTTCGGGCCG		Out	VDJ	2	52	1.1796090956935194E-4		62	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	0	6	7	21	8	21	36	28	57													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACTAACGCCCGGGGCTGAGCAGTACTTCGGGCCG	CASSQLTPGAEQYF	In	VDJ	2	55	1.2476634665989147E-4	1.6014488744726138E-4	42	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	2	7	0	7	9	1	29	44	58	53	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQLTPGAEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGCACAGGGGCCTGGAAACACCATATATTTTGGAGAG	CASSQAQGPGNTIYF	In	VDJ	2	63	1.4291417890133023E-4	1.8343868925777213E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	3	2	2	3	1	29	43	53	46	54													Vb 16	CASSQAQGPGNTIYF+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGTACGGGGGGTTCAGCGCTGAGACCCAGTACTTCGGGCCA	CASSQYGGFSAETQYF	In	VDJ	2	63	1.4291417890133023E-4	1.8343868925777213E-4	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	1	5	3	9	29	43	53	46	62													Vb 16	CASSQYGGFSAETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGCAGAACTGGAGGATTCTGGAGTTATTTCTGTGCCAGCAGCCAAGATCCTGTGGGACTCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	68	1.5425657405222947E-4		49	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	23	0	10	2	28	1	32	26	60	54	61						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGACAGGGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	72	1.6333049017294883E-4		43	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	3	2	1	1	29	46	54	47	55													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGCCTCGGGACAGGGGCTTTGGACGACCCAGTACTTCGGGCCA	CASSQGASGQGLWTTQYF	In	VDJ	2	73	1.6559896920312868E-4	2.1255594152091057E-4	54	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	2	7	7	8	27	43	60	50	68													Vb 16	CASSQGASGQGLWTTQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGTAGCCAAGATCCTGTGGGACTTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	75	1.7013592726348837E-4		50	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	10	1	6	0	29	46	-1	52	58						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCAGGACTAGCGGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	84	1.9055223853510698E-4		50	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	1	5	3	3	0	29	46	-1	49	59						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAATTTCGGGGAGGGCAAGAGACCCAGTACTTCGGGCCA	CASSQEFRGGQETQYF	In	VDJ	3	85	1.9282071756528683E-4	2.474966442366767E-4	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	9	0	2	6	0	29	46	-1	52	59													Vb 16	CASSQEFRGGQETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCGACAGTTTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	94	2.1323702883690543E-4		40	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	5	4	1	3	29	42	48	43	51													Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCACTGAACCTGGGGGGATTGATGGCTACACCTTCGGTTCG	CASSTEPGGIDGYTF	In	VDJ	3	103	2.3365334010852403E-4	2.999076983103259E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	9	1	6	9	4	29	41	56	50	60													Vb 16	CASSTEPGGIDGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD02-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGTCAGGGTAGTTGGACTGAAGCTTTCTTTGGACAA	CASSQGQGSWTEAFF	In	VDJ	4	108	2.4499573525942325E-4	3.1446632444189507E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	5	2	7	29	45	52	47	59													Vb 16	CASSQGQGSWTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCCACGTTTGGTGGCAGAACTGGAGGATTCTGGAGTTWWTTCTGTGCCAGCAGCATGGTGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	4	108	2.4499573525942325E-4		38	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	23	4	5	1	10	11	43	37	50	47	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCACTTTAGCGGGAGGGCGAGATACGCAGTATTTTGGCCCA	CASSTLAGGRDTQYF	In	VDJ	4	112	2.5406965138014264E-4	3.2611322534715044E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	0	5	4	2	29	41	56	45	58													Vb 16	CASSTLAGGRDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGTCGAGGGTGGGTGTCCTACGAGCAGTACTTCGGGCCG	CASSRRGWVSYEQYF	In	VDJ	4	132	2.9943923198373954E-4	3.843477298734273E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	11	0	1	3	6	29	42	50	45	56													Vb 16	CASSRRGWVSYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCCCCCCGGGACAGGGTAAGCGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	5	143	3.2439250131571784E-4		53	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	2	7	6	28	41	57	48	63													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCGGTGGGAGGGCACCCACAATGAGCAGTTCTTCGGGCCA	CASSQDRWEGTHNEQFF	In	VDJ	7	196	4.4462188991524964E-4	5.706981443575133E-4	51	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	0	5	5	5	29	46	58	51	63													Vb 16	CASSQDRWEGTHNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCCCGGGGTAGAGCAGTACTTCGGGCCG	CASSQDPGVEQYF	In	VDJ	7	201	4.5596428506614886E-4	5.852567704890825E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	3	7	3	2	29	46	54	49	56													Vb 16	CASSQDPGVEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTAACCAGGGCGGTAATTGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	10	282	6.397110865107163E-4		52	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	1	4	8	29	42	51	46	59													Vb 16	X+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCGTCCCTTAGGCGGGCAGATACGCAGTATTTTGGCCCA	CASSPSLRRADTQYF	In	VDJ	10	298	6.760067509935939E-4	8.676941174415253E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	7	4	4	10	0	29	42	-1	52	57						01,02							Vb 16	CASSPSLRRADTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGAGGTAGCCAGGATTTCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	11	337	7.644774331706077E-4		49	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	4	4	4	0	8	4	29	42	54	50	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATTTAGCACACTCTGGAAACACCATATATTTTGGAGAG	CASSQDLAHSGNTIYF	In	VDJ	13	388	8.801698637097799E-4	0.0011297493878097713	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	0	5	7	0	2	3	29	46	52	48	55						01,02							Vb 16	CASSQDLAHSGNTIYF+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01	TCRBD02-01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCAAGGAAAGGTGGGAGCGGAACACTGAAGCTTTCTTTGGACAA	CASSKERWERNTEAFF	In	VDJ	15	438	9.935938152187721E-4	0.0012753356491254633	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	2	1	10	2	29	41	56	51	58													Vb 16	CASSKERWERNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGAGGGATTGTCCACGAGCAGTACTTCGGGCCG		Out	VDJ	22	652	0.001479048327677259		43	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	0	5	0	7	29	-1	51	46	58													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGAAGGTCCCGATGAGCAGTTCTTCGGGCCA	CASSQDEGPDEQFF	In	VDJ	29	873	0.001980382193347005	0.002541936122571985	42	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	0	5	4	8	3	5	29	46	52	49	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQDEGPDEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGCGGCAGGGGGACTATTACGAGCAGTACTTCGGGCCG	CASSQRQGDYYEQYF	In	VDJ	35	1039	0.002356949712356859	0.003025282510140083	45	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	3	4	1	4	4	5	29	43	54	47	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQRQGDYYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCCTGTGGGACTCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	148	4369	0.009910984882855743		50	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	10	2	6	1	29	46	58	52	59						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCATGGTGGGCACAGATACGCAGTATTTTGGCCCA	CASSMVGTDTQYF	In	VDJ	264	7807	0.01771001578861405	0.022731838841832174	39	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	5	0	10	1	2	3	29	41	45	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSMVGTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGATCCAGACAGGCGGGAAACACCATATATTTTGGAGAG	CASRSRQAGNTIYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	4	4	5	2	24	35	46	40	48														CASRSRQAGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAACTTCGACTAGCGGGAGATCGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	9	2.0416311271618604E-5		52	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	2	2	5	4	5	24	39	55	43	60														X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCCACAGGGGGGGAAAAACTGTTTTTTGGCAGT	CASSATGGEKLFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	1	8	3	1	24	36	47	39	48														CASSATGGEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGCCCACAGGGGAGTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSGPQGSGANVLTF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	2	3	5	2	24	36	48	41	50														CASSGPQGSGANVLTF+TCRBV21-or09_02+TCRBJ02-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGATGAATTGGGTTGGAACATTCAATACTTCGGCGCC	CASSVDELGWNIQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-04	01	5	0	9	16	11	13	24	36	50	47	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVDELGWNIQYF+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01		TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCTTAGCGGACACTACAATGAGCAGTTCTTCGGGCCA	CASSLSGHYNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	5	5	3	3	3	24	35	44	38	47						01,02								CASSLSGHYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGACCCGGACGAGAAAGAGACCCAGTACTTCGGGCCA	CASSDPDEKETQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-05	01	6	1	7	3	6	4	24	35	45	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDPDEKETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGGTCAGGAGAACAGCACGGTATTTCTGTGCCAGCTTGAGAGGACAGGAGGTGGGCGAAGCTTTCTTTGGACAA	CASLRGQEVGEAFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	1	4	8	8	8	39	46	61	54	69														CASLRGQEVGEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGGTCAGGAGACACAGCACGTATTTCTGTGCCAGCTTGAGAGGACAGGAGGTGGGCGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	2.2684790301798452E-5		41	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	24	1	4	8	21	8	40	33	61	54	69														X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGCAAGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSVGKGSGNTIYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-03	01	5	5	3	0	7	0	24	36	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGKGSGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTATGGAGCACGGGTGCCGGGGACTATGGCTACACCTTCGGTTCG	CASSLWSTGAGDYGYTF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	3	3	17	0	24	36	-1	53	58														CASSLWSTGAGDYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCCGGGCAGGGGCTCGGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRAGARDSNQPQHF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	4	2	0	6	7	24	31	43	37	50														CASRAGARDSNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAACTCATCAGGGGGTTGGGATCAGCCCCAGCATTTTGGTGAT	CANSSGGWDQPQHF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	4	1	5	4	5	24	33	44	37	49														CANSSGGWDQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAATCGAACACGGACAGGACCTTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	2.722174836215814E-5		50	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	4	4	8	5	24	38	53	46	58														X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCCCCGGGACGTGGAGGTAACTATGGCTACACCTTCGGTTCG	CASSVAPGRGGNYGYTF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	51	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	5	0	7	1	8	7	24	36	49	44	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVAPGRGGNYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGAAACGGGAGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSETGGSYNEQFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	0	1	5	0	24	35	-1	40	48														CASSETGGSYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTCCCGGGACAGGGCCTCCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	12	2.722174836215814E-5		46	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	6	5	4	24	35	49	40	53														X+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAACCAGACTAACCGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	2.9490227392337985E-5		41	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	2	9	5	3	4	24	39	47	42	51						01,02								X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCACCCCTAGGGGGGCGGGGTTCTTGTACGAGCAGTACTTCGGGCCG	CASSTPRGAGFLYEQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	51	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	4	5	1	4	5	12	24	37	48	42	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTPRGAGFLYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCGTGGGGACAGGGGGTCCAAGAGACCCAGTACTTCGGGCCA	CASSPWGQGVQETQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	1	1	5	1	24	36	52	41	53														CASSPWGQGVQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCTAGACGTAGAGGAGGGACTAATGAAAAACTGTTTTTTGGCAGT	CASSVARRRGGTNEKLFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	54	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	10	0	2	15	0	24	36	-1	51	57														CASSVARRRGGTNEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGGGAGGGACTAATGAAAAACTGTTTTTTGGCAGT	CASSVGGGTNEKLFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	9	0	2	5	0	24	36	-1	41	48														CASSVGGGTNEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTCTTGTCGGCTCCCTACAATGAGCAGTTCTTCGGGCCA	CASSVLSAPYNEQFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	5	9	0	2	8	2	24	36	47	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVLSAPYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAGACGGTTCGGGACAGGGGGACTCGGGCCG		Out	VDJ	1	14	3.175870642251783E-5		38	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	1	17	7	2	24	40	58	47	60														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCATGGTTGGCGAGCACAGATACGCAGTATTTTGGCCCA	CASSPWLASTDTQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	5	9	0	0	8	1	24	36	47	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPWLASTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCCACCCGGGGGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSATRGGSYNEQFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	0	1	6	1	24	36	50	42	51														CASSATRGGSYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCGGGCCCCAATGAGCAGTTCTTCGGGCCA	CASSAGPNEQFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	7	4	6	0	3	24	-1	41	36	44						01,02								CASSAGPNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCTTAAGGGACCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASLRDLAKNIQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-04	01	10	0	7	0	6	2	24	31	42	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASLRDLAKNIQYF+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01		TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACAGCACGGTATTTCTGTGCCAGCAGCTCCTTCCTCTAGCGGAAACTCTGGCGGGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	15	3.402718545269768E-5		61	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	4	5	1	8	13	20	32	47	40	60						01,02								X+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGAAGACAGGGGTCAATTAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	15	3.402718545269768E-5		38	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	2	2	8	3	6	24	31	42	34	48														X+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAACAAAACGGGACAGGACAAACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	3.402718545269768E-5		50	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	4	3	6	5	24	39	53	45	58														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTGGCGGGAGACTACGAGCAGTACTTCGGGCCG	CASSVAGDYEQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	2	3	3	1	24	36	46	39	47														CASSVAGDYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCGCGGGGCAGGGGGTCGACCGGGGAGCTGTTTTTTGGAGAA	CASSSRGRGSTGELFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	1	5	8	3	24	36	51	44	54														CASSSRGRGSTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGGTCAGGAGACACAGCACGGTWTTCTGTGCCAGCTTGAGAGGACAGGAGGTGGGCGAAGCTTTCTTTGGACAA		Out	VDJ	1	16	3.629566448287752E-5		41	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	22	1	4	8	19	8	40	35	61	54	69														X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCATCAGGGAGGACACTGAAGCTTTCTTTGGACAA	CASSIREDTEAFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	9	1	3	3	0	24	37	-1	40	46														CASSIREDTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTGAGGGCCAGTCCTACGAGCAGTACTTCGGGCCG	CASSPEGQSYEQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	11	0	1	3	4	24	36	44	39	48														CASSPEGQSYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGATGTCAGTAACTATGGCTACACCTTCGGTTCG	CASSVDVSNYGYTF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	5	4	5	1	8	0	24	36	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVDVSNYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCACAACGAAAGGATTAGCAGATACGCAGTATTTTGGCCCA	CASSTTKGLADTQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	4	1	8	4	8	4	24	37	48	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTTKGLADTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCCGTGAAAAGAGTGAGGTGGAGACCCAGTACTTCGGGCCA	CASSPREKSEVETQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	11	1	5	15	2	24	36	55	51	57														CASSPREKSEVETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTTAAACTAGCGGGAGTGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	19	4.3101101573417056E-5		47	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	3	2	4	5	3	24	36	52	41	55														X+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCCGGTGGGAGGGCCGATAAGCAGTTCTTCGGGCCA	CASSVAGGRADKQFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	0	11	9	6	24	36	52	45	58														CASSVAGGRADKQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGGTTGGTCCTTCTATGGCTACACCTTCGGTTCG	CASGWSFYGYTF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	10	7	5	4	0	9	24	-1	35	31	44						01,02								CASGWSFYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCCCGGAACCAAAACTAGCGGAGTTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	4.7638059633776745E-5		56	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	5	0	13	4	24	36	57	49	61						01,02								X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGGCCGCGGGCAGGGAGATACGCAGTATTTTGGCCCA	CASGRGQGDTQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	10	4	3	5	11	0	24	31	-1	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGRGQGDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAGTAAACCCGAGCGGAATCTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	22	4.990653866395659E-5		53	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	6	5	2	8	5	24	40	53	48	58						01,02								X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTGGGGCTGGGTGGCGTATGAACACTGAAGCTTTCTTTGGACAA	CASSPGAGWRMNTEAFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	51	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	7	0	0	3	11	24	36	44	39	55														CASSPGAGWRMNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGCAACTCAGATACGCAGTATTTTGGCCCA	CASSVGNSDTQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	5	5	4	4	2	5	24	36	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGNSDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGTAAGAAAGGACCTCTGAATGAGCAGTTCTTCGGGCCA	CASKKGPLNEQFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	10	1	7	7	8	5	24	31	43	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKKGPLNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCGGGACAGGGTAACACTGAAGCTTTCTTTGGACAA	CASSSGQGNTEAFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	2	2	1	24	36	47	38	48														CASSSGQGNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGAAGGAAACGTGATGCGTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	24	5.444349672431628E-5		55	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	1	8	4	2	23	24	35	40	37	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAGCCAGGACGGAGGGAACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	5.671197575449612E-5		50	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	0	2	8	2	24	38	52	46	54														X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGTACGGGTATAACACGATGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	25	5.671197575449612E-5		41	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	10	8	4	5	3	12	24	31	38	34	50						01,02								X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCCAAGGGTTCGGGTGTCGAGCAGTACTTCGGGCCG	CASSVAKGSGVEQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	5	5	3	6	7	9	24	36	47	43	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVAKGSGVEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGCGGCGGGAGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVGGGSSYNEQFF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	7	2	1	7	1	24	36	50	43	51														CASSVGGGSSYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCCAGCAGGGCAGGAAGACCCAGTACTTCGGGCCA		Out	VDJ	1	26	5.898045478467597E-5		40	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	3	6	5	5	24	35	45	40	50														X+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGGTTTAGGACTAGGGGAGGGGTACATTCAGTACTTCGGCGCC	CASSGLGLGEGYIQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	6	1	8	8	7	9	24	35	49	42	58						01,02								CASSGLGLGEGYIQYF+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCATAGCGGAAGCGGAGCCCAATACAATGAGCAGTTCTTCGGGCCA	CASSHSGSGAQYNEQFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	5	5	4	3	13	24	35	44	38	57						01,02								CASSHSGSGAQYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCATCCGGACTAGCGGACGCACAGATACGCAGTATTTTGGCCCA	CASSIRTSGRTDTQYF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	5	1	3	2	24	37	50	40	52						01,02								CASSIRTSGRTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCTTAAAAGGACAGGAGGTGGGCGAAGCTTTCTTTGGACAA	CASLKGQEVGEAFF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	1	4	8	8	8	24	31	46	39	54														CASLKGQEVGEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTCACAAGGGAGTGGGYACCGGGGAGCTGTTTTTTGGAGAA	CASSPHKGVGTGELFF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	9	2	5	8	5	24	36	49	44	54														CASSPHKGVGTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCGGCGACTAGCGGGACTCAAGAGACCCAGTACTTCGGGCCA	CASSSATSGTQETQYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	2	3	2	5	2	24	36	52	41	54														CASSSATSGTQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTGACTCGGAGCGGGGTCATAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLTRSGVIAKNIQYF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	54	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	5	6	3	0	9	4	24	36	52	45	56														CASSLTRSGVIAKNIQYF+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAACTAGCGACTACAATGAGCAGTTCTTCGGGCCA	CASSVTSDYNEQFF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	6	3	3	1	24	36	46	39	47						01,02								CASSVTSDYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCGTACCTGGACAGGATTGAATGGCTACACCTTCGGTTCG	CASSRTWTGLNGYTF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	4	6	7	5	24	36	50	43	55														CASSRTWTGLNGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTGTCGGGGGGTGAAAAACTGTTTTTTGGCAGT	CASSVSGGEKLFF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	1	7	4	0	24	36	-1	40	47														CASSVSGGEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAACAGGGGGCGCAGGGATGAAAAACTGTTTTTTGGCAGT	CASSNRGRRDEKLFF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	0	6	0	6	24	-1	46	38	52														CASSNRGRRDEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTGTTAGCGGGAGTCCGCGAGCAGTACTTCGGGCCG	CASSVLAGVREQYF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	5	2	6	4	4	24	36	49	40	53														CASSVLAGVREQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAACCCGGACGGTCAACTATGGCTACACCTTCGGTTCG	CASSLTRTVNYGYTF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	5	1	7	2	7	4	24	36	47	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTRTVNYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGACGAGGGGTAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	44	9.981307732791318E-5		46	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	5	5	2	0	4	3	24	36	45	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTGGACGGCTAAGGATGAGTGAAAGACCTATGGCTACACCTTCGGTTCG	CASSWTAKDE*KTYGYTF	Stop	VDJ	2	45	1.0208155635809302E-4		54	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	5	1	7	4	1	21	24	36	41	37	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWTAKDE*KTYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCACATGAGGGTTGGTTGGACTATGGCTACACCTTCGGTTCG	CASSAHEGWLDYGYTF	In	VDJ	2	50	1.1342395150899225E-4	1.4558626131569216E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	11	0	3	6	8	24	36	47	42	55														CASSAHEGWLDYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCGAGGACAGGGGCGGATACGCAGTATTTTGGCCCA	CASSSRTGADTQYF	In	VDJ	2	50	1.1342395150899225E-4	1.4558626131569216E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	2	6	4	2	24	36	49	40	51														CASSSRTGADTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCGAGGAGCGGGAGGAGCTACAATGAGCAGTTCTTCGGGCCA	CASSARSGRSYNEQFF	In	VDJ	2	55	1.2476634665989147E-4	1.6014488744726138E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	1	3	6	2	24	36	51	42	53														CASSARSGRSYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTATCAGGAGGGTACGAGCAGTACTTCGGGCCG	CASSVSGGYEQYF	In	VDJ	2	57	1.2930330472025117E-4	1.6596833789988907E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	0	4	6	0	24	36	-1	42	48														CASSVSGGYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCCGGGACCGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	59	1.3384026278061086E-4		44	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	5	0	7	0	3	2	24	36	44	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTAGGTTCGGGGACAGTGTCTGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGSGTVSGSNQPQHF	In	VDJ	2	73	1.6559896920312868E-4	2.1255594152091057E-4	57	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	5	1	10	8	24	35	52	45	60														CASSLGSGTVSGSNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTACAGGGAGTCCAAGAGACCCAGTACTTCGGGCCA	CASSLQGVQETQYF	In	VDJ	3	77	1.7467288532384807E-4	2.2420284242616594E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	3	1	2	3	24	36	44	38	47														CASSLQGVQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCCCTAGGGGGCAGGCCAAGCACAGATACGCAGTATTTTGGCCCA	CASSALGGRPSTDTQYF	In	VDJ	3	91	2.0643159174636589E-4	2.6496699559455975E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	5	0	0	5	6	24	36	48	41	54														CASSALGGRPSTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTGGCGGAGAGGGCAGATACGCAGTATTTTGGCCCA	CASSVVAERADTQYF	In	VDJ	3	96	2.1777398689726513E-4	2.7952562172612894E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	11	0	4	11	0	24	36	-1	47	52														CASSVVAERADTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCCTTTTGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	99	2.2457942398780467E-4		38	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	5	0	10	5	7	0	24	36	-1	43	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAACACGGACAGTGGAGAGACCCAGTACTTCGGGCCA	CASSNTDSGETQYF	In	VDJ	3	100	2.268479030179845E-4	2.911725226313843E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	5	4	3	3	24	38	47	41	50														CASSNTDSGETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCCGAGTACTACGAGCAGTACTTCGGGCCG	CASSVAEYYEQYF	In	VDJ	4	115	2.6087508847068215E-4	3.3484840102609195E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	7	3	1	6	24	36	41	37	47						01,02								CASSVAEYYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTCTCTTGGGCCAATCAGCCCCAGCATTTTGGTGAT	CASSVSWANQPQHF	In	VDJ	4	123	2.7902292071212094E-4	3.581422028366027E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	8	0	3	7	0	24	36	-1	43	47														CASSVSWANQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCTGGGGGGGAATGAGCAGTTCTTCGGGCCA	CASSLGGNEQFF	In	VDJ	5	157	3.5615120773823566E-4	4.571408605312734E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	9	0	7	2	0	24	36	-1	38	45														CASSLGGNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCTCCGGGACTGCATACCGGGGAGCTGTTTTTTGGAGAA	CASSAPGLHTGELFF	In	VDJ	6	171	3.8790991416075347E-4	4.979050136996671E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	10	5	5	4	24	36	47	41	51						01,02								CASSAPGLHTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCACCCCGGGTAGTCCGTTACGAGCAGTACTTCGGGCCG		Out	VDJ	6	178	4.0378926737201244E-4		37	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	10	8	4	4	3	8	24	31	38	34	46						01,02								X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTCCAACAGGGGCCAGCACGGAAGCTTTCTTTGGACAA	CASSPPTGASTEAFF	In	VDJ	15	438	9.935938152187721E-4	0.0012753356491254633	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	2	8	6	8	24	36	49	42	57														CASSPPTGASTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTATCAGAACCGTCGGGAGGCCCCTCCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	16	470	0.0010661851441845273		58	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	8	1	0	13	6	23	35	55	48	61														X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCTTCTTGACTCGTACAATGAGCAGTTCTTCGGGCCA	CASSLLDSYNEQFF	In	VDJ	21	624	0.0014155309148322233	0.001816916541219838	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	10	4	6	2	24	36	46	42	48						01,02								CASSLLDSYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAACGACAGGGGCTACGAGCAGTACTTCGGGCCG	CASSNDRGYEQYF	In	VDJ	26	767	0.0017399234161479412	0.0022332932485827177	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	2	3	1	0	24	38	-1	39	47														CASSNDRGYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCTAGTATTGGACAGGTACGCAATGAGCAGTTCTTCGGGCCA	CASSEASIGQVRNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	51	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	4	6	7	4	23	40	54	47	58														CASSEASIGQVRNEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGACTATTTGGGGAACTGAAGCTTTCTTTGGACAA	CASSEGTIWGTEAFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	1	9	5	0	8	23	-1	45	39	53						01,02								CASSEGTIWGTEAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTAAGAACTAGCCCCTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSEVRTSPSNTGELFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	54	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	3	7	0	5	4	23	39	50	44	54						01,02								CASSEVRTSPSNTGELFF+TCRBV06-01+TCRBJ02-02	TCRBV06-01*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAGGGCAGCCCTATGGCTACACCTTCGGTTCG	CASSEGQPYGYTF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-02	01	1	4	5	4	2	2	24	40	45	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGQPYGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCTCGGGCCTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSEARAFSGANVLTF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	51	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-06	01	0	8	0	0	2	3	23	40	46	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEARAFSGANVLTF+TCRBV06-01+TCRBJ02-06	TCRBV06-01*01		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGATGGGGGGCGAGCTACGAGCAGTACTTCGGGCCG	CASSEGWGASYEQYF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	45	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-07	01	1	6	0	3	4	3	23	39	49	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGWGASYEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGCCGCTACTGGAGACCCAGTACTTCGGGCCA	CASSEGPLLETQYF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	42	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-05	01	1	9	0	5	0	8	23	-1	42	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGPLLETQYF+TCRBV06-01+TCRBJ02-05	TCRBV06-01*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCACGGAAGAGGAACCTATGGCTACACCTTCGGTTCG	CASSEAHGRGTYGYTF	In	VDJ	2	49	1.1115547247881241E-4	1.4267453608937832E-4	48	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	11	1	4	8	3	23	40	52	48	55														CASSEAHGRGTYGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCTGTAACAGGCTACTCTAACTATGGCTACACCTTCGGTTCG	CASSEAVTGYSNYGYTF	In	VDJ	2	58	1.3157178375043101E-4	1.688800631262029E-4	51	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	4	0	4	5	23	40	49	44	54														CASSEAVTGYSNYGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCGACAGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSDRGGTGELFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	2	4	0	3	22	-1	42	34	45														CASSDRGGTGELFF+TCRBV07-04+TCRBJ02-02	TCRBV07-04*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTCCCCTTGGGCAGGGGGTCTGGAGATACGCAGTATTTTGGCCCA	CASSFPLGRGSGDTQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	51	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	1	5	9	5	22	36	52	45	57														CASSFPLGRGSGDTQYF+TCRBV07-04+TCRBJ02-03	TCRBV07-04*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTGCCCAGGGACTAGAGGACAGACCCAGTACTTCGGGCCA		Out	VDJ	1	15	3.402718545269768E-5		46	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	0	8	6	5	5	22	36	49	41	54						01,02								X+TCRBV07-04+TCRBJ02-05	TCRBV07-04*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGTACAGGGGCCGCTAATGAAAAACTGTTTTTTGGCAGT	CASSTGAANEKLFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	42	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	2	3	1	3	22	33	41	34	44														CASSTGAANEKLFF+TCRBV07-04+TCRBJ01-04	TCRBV07-04*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTGGTCGCGGGAGCAATAGATGAGCAGTTCTTCGGGCCA	CASSLVAGAIDEQFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	45	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	2	8	4	6	22	36	47	40	53														CASSLVAGAIDEQFF+TCRBV07-04+TCRBJ02-01	TCRBV07-04*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCCCCCCCATTTCCCTCGGAAGGCTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	30	6.805437090539536E-5		50	TCRBV07	TCRBV07-04	01				TCRBJ01	TCRBJ01-04	01	5	1	8	7	15	4	22	34	52	49	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-04+TCRBJ01-04	TCRBV07-04*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTATGGCCGGGACTTCCGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	5	155	3.5161424967787596E-4		49	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	0	10	1	5	3	22	37	48	42	51						01,02								X+TCRBV07-04+TCRBJ02-03	TCRBV07-04*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCCACGTTTGGTGCTCCTCAGTGACTCTGGCTCTATCTCTGTGCCTGGAGCCGCGGGAGTTGGTACAATGAGCAGTTCTTCGGGCCA	CAWSRGSWYNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV30	TCRBV30-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	2	4	2	4	39	50	59	52	63			01,02										Vb 20	CAWSRGSWYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCCACGTTTGGTGCTTCTCAGTGACCTGGCTTCTATCTCTGTGCCTGGAGCCGCGGGAGTTGGTACAATGAGCAGTTCTTCGGGCCA	CAWSRGSWYNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV30	TCRBV30-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	2	4	2	4	39	50	59	52	63			01,02										Vb 20	CAWSRGSWYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACAGTTTCTGAGACCCAGTACTTCGGGCCA	CAWTVSETQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	5	5	0	5	26	-1	39	36	44													Vb 20	CAWTVSETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCTCGGGACGCTCACTTTGGGTTCCGGGGAGCTGTTTTTTGGAGAA	CAWSLGTLTLGSGELFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	51	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-02	01	3	0	7	6	4	14	26	37	46	41	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSLGTLTLGSGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGCCGTGCGGGGCAGCCCCAGCATTTTGGTGAT	CAWGRAGQPQHF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	7	3	7	6	0	26	35	-1	41	47													Vb 20	CAWGRAGQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAACAGACTTAGAGACCCAGTACTTCGGGCCA	CAWSVTDLETQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	0	3	5	4	1	4	26	40	45	41	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVTDLETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATATACAAAGGAAACACCATATATTTTGGAGAG	CAWIYKGNTIYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	6	4	3	2	26	36	42	39	44													Vb 20	CAWIYKGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCATGCTGGACAGCATACTACAGTTCTTCGGGCCA	CACMLDSILQFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	5	13	6	7	26	34	46	40	53													Vb 20	CACMLDSILQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGACTAGCGGGTGGTCCTACGAGCAGTACTTCGGGCCG	CAWRTSGWSYEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	2	4	1	0	3	26	-1	47	37	50						01,02							Vb 20	CAWRTSGWSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCACACCGACCGGCTATGGCTACACCTTCGGTTCG	CATPTGYGYTF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	33	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	8	2	7	4	5	3	26	32	40	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CATPTGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCAGGGGACAGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	11	2.4953269331978296E-5		37	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	5	5	0	26	36	-1	41	48			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGTGGGGGGCTAGAGAGACCCAGTACTTCGGGCCA	CAWSGWGARETQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	1	6	0	4	4	3	26	39	49	43	52			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSGWGARETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTGCCCGCCGGAGCACGAGAGCAGTTCTTCGGGCCA	CAWSLPAGAREQFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	10	2	10	9	5	26	38	51	47	56													Vb 20	CAWSLPAGAREQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATATGGGGGTTCGGGACAATCAGCCCCAGCATTTTGGTGAT	CAWNMGVRDNQPQHF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV30	TCRBV30-01	01	unresolved			TCRBJ01	TCRBJ01-05	01	4	0	6	14	12	9	26	36	54	48	63				TCRBD01,TCRBD02									Vb 20	CAWNMGVRDNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	unresolved	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGGCTGGACAGAGAACACTGAAGCTTTCTTTGGACAA	CAWSVGWTENTEAFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	5	1	5	1	26	40	51	45	52													Vb 20	CAWSVGWTENTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTCAATGGGCGGGACAGGGGGTCGACGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	2.722174836215814E-5		49	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	1	3	9	6	26	33	53	42	59													Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATATGGGGGTTCGGGACAATCAGCCCTAGCATTTTGGTGAT	CAWNMGVRDNQP*HF	Stop	VDJ	1	13	2.9490227392337985E-5		45	TCRBV30	TCRBV30-01	01	unresolved			TCRBJ01	TCRBJ01-05	01	4	0	6	14	12	9	26	36	54	48	63				TCRBD01,TCRBD02									Vb 20	CAWNMGVRDNQP*HF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	unresolved	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCATCGGACTCGTAGCTCCTACGAGCAGTACTTCGGGCCG	CAWHRTRSSYEQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	10	0	4	5	26	35	44	39	49						01,02							Vb 20	CAWHRTRSSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCCACGTTTGGTGCTTCTCAGTGATCTGGCTTCTATCTCTGTGCCTGGAGCCGCGGGAGTTGGTACAATGAGCAGTTCTTCGGGCCA	CAWSRGSWYNEQFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV30	TCRBV30-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	2	4	2	4	39	50	59	52	63			01,02										Vb 20	CAWSRGSWYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGCAGGACAGGGGGCCATGGCTACACCTTCGGTTCG	CAWSSRTGGHGYTF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	0	6	4	1	26	38	53	42	54													Vb 20	CAWSSRTGGHGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCACGGGGGGCTAGCCGGCAATGAGCAGTTCTTCGGGCCA	CAWSHGGLAGNEQFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	1	6	2	8	26	38	47	40	55			unresolved										Vb 20	CAWSHGGLAGNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCACTAGCGGCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	3.175870642251783E-5		43	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	3	5	2	3	1	26	38	49	41	50						01,02							Vb 20	X+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTTGGAGCGGAGCAGTTCTTCGGGCCA	CAWSVLGAEQFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	6	6	10	6	0	26	40	-1	46	50			unresolved			01,02							Vb 20	CAWSVLGAEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTCGGGTCTTCGGCCGGCCGTTTCGTTCAGCCCCAGCATTTTGGTGAT	CAFGSSAGRFVQPQHF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	8	4	6	1	20	26	33	38	34	58			unresolved			01,02							Vb 20	CAFGSSAGRFVQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCCACGTTTGGTGCTCCTCAGTGACTCTGGCTTCTATTCTGTGCCTGGAGCCGCGGGAGTTGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	15	3.402718545269768E-5		41	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	17	7	2	4	15	4	40	37	59	52	63													Vb 20	X+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGACAGGGGCGTTTTCGGCGGCACTGAAGCTTTCTTTGGACAA	CAWDRGVFGGTEAFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	4	0	12	26	-1	43	35	55													Vb 20	CAWDRGVFGGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTTCCGGCTCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	15	3.402718545269768E-5		40	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	5	9	0	0	4	2	26	35	42	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAGCGGGGGTTGGACTGAAGCTTTCTTTGGACAA	CAWSVSGGWTEAFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	6	2	5	1	4	26	40	49	41	53													Vb 20	CAWSVSGGWTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGGGCCAGATACGCAGTATTTTGGCCCA	CAWSVGPDTQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	36	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-03	01	0	5	3	4	0	1	26	-1	44	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVGPDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACGACAGGGGATTTTGGCTACACCTTCGGTTCG	CAWSTTGDFGYTF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	2	7	2	4	26	38	48	40	52			unresolved										Vb 20	CAWSTTGDFGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTCCGGACAGGAATTAATGAAAAACTGTTTTTTGGCAGT	CAWSLRTGINEKLFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	1	4	4	4	3	26	38	49	42	52			unresolved										Vb 20	CAWSLRTGINEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGATAGGCCCGAAATCGGGGAGCTGTTTTTTGGAGAA	CAWSDRPEIGELFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-02	01	1	5	4	7	2	8	26	39	44	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSDRPEIGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCCACGTTTGGTGCTTCTCAGTGACTCTGGCTTCTTCTCTGTGCCTGGAGCCGCGGGAGTTGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	3.8564143513057367E-5		41	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	19	7	2	4	17	4	40	35	59	52	63													Vb 20	X+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGAACTGGAAACACCATATATTTTGGAGAG	CAWSGTGNTIYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	36	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-03	01	1	2	8	2	0	1	26	-1	41	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSGTGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*02		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAACAGGACTACACTGAAGCTTTCTTTGGACAA	CAWKQDYTEAFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	4	3	4	3	1	3	26	36	42	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKQDYTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCCTAAGCCCTCCGGGACTGGGTCCTACGAGCAGTACTTCGGGCCG	CAWSPKPSGTGSYEQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	51	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	10	1	13	3	26	37	56	50	59						01,02							Vb 20	CAWSPKPSGTGSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGAGACTAGTAAAGAGGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	18	4.083262254323721E-5		40	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	8	5	1	9	26	34	41	35	50						01,02							Vb 20	X+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTAGCGGGAGGGGAGACGAGCAGTACTTCGGGCCG	CAWTSGRGDEQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	4	0	5	0	3	26	-1	48	36	51			unresolved										Vb 20	CAWTSGRGDEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCGGGGTCGATTACAATGAGCAGTTCTTCGGGCCA	CAWSPGVDYNEQFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	3	4	2	5	26	38	45	40	50													Vb 20	CAWSPGVDYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTCGCAGAGAACACTGAAGCTTTCTTTGGACAA	CAWSLAENTEAFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	5	1	4	1	26	38	45	42	46													Vb 20	CAWSLAENTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGGGGGCCAATCAGCCCCAGCATTTTGGTGAT	CAWSGGANQPQHF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	1	6	0	3	1	0	26	39	-1	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSGGANQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCGGACAATGAGCAGTTCTTCGGGCCA	CAWSSDNEQFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	8	5	5	1	0	26	38	-1	39	42			unresolved			01,02							Vb 20	CAWSSDNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAAGGGGCCTCCTACGAGCAGTACTTCGGGCCG	CAWSEGASYEQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	5	2	0	1	1	26	39	45	40	46			unresolved										Vb 20	CAWSEGASYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTGAGGGGAACACTGAAGCTTTCTTTGGACAA	CAWSVEGNTEAFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	11	0	1	1	0	26	40	-1	41	46			unresolved										Vb 20	CAWSVEGNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAGTTTCCTCTGGAAACACCATATATTTTGGAGAG	CAWRVSSGNTIYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	3	5	5	0	0	4	26	-1	39	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWRVSSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTGGCTAGCGGGAAACGACGAGCAGTACTTCGGGCCG	CAWSWLAGNDEQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	4	3	5	3	4	26	38	50	41	54													Vb 20	CAWSWLAGNDEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGACAGGCGACAAGAGACCCAGTACTTCGGGCCA	CAWSVDRRQETQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	2	4	2	1	3	26	40	47	41	50													Vb 20	CAWSVDRRQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATCTTACCTGGAAACACCATATATTTTGGAGAG	CAWSILPGNTIYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-03	01	2	3	7	2	5	0	26	38	-1	43	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSILPGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*02		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACCCCGGGAGGGGCACTGAAGCTTTCTTTGGACAA	CAWNPGRGTEAFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	8	0	4	4	1	26	36	48	40	49			unresolved										Vb 20	CAWNPGRGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAGTCAGGACACTGAAGCTTTCTTTGGACAA	CAWSVSQDTEAFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	4	3	4	0	26	40	-1	44	48													Vb 20	CAWSVSQDTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATATCCGCATCCTACGAGCAGTACTTCGGGCCG	CAWSISASYEQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	2	4	6	1	7	0	26	38	-1	45	47			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSISASYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCTCAGTGGGGGTTAACTGGAAACACCATATATTTTGGAGAG	CAWSPQWGLTGNTIYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	48	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	2	6	1	2	7	4	26	38	50	45	54			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPQWGLTGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGTCAGGCACGATTGGCTATGGCTACACCTTCGGTTCG	CAWSVSGTIGYGYTF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	4	4	2	9	26	40	46	42	55			unresolved										Vb 20	CAWSVSGTIGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTTCCCCCGACCGCGCAGGGGCTGAAGCTTTCTTTGGACAA	CAWSVSPDRAGAEAFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	2	6	14	0	26	40	-1	54	60													Vb 20	CAWSVSPDRAGAEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTTTCGACTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAFSTSSYNEQFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	2	8	0	4	0	26	33	-1	37	43			unresolved			01,02							Vb 20	CAFSTSSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCAGGACAGGGTAGGATTTTTAGTCAGCCCCAGCATTTTGGTGAT	CAWSPGQGRIFSQPQHF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	51	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	1	3	6	3	12	26	38	49	41	61													Vb 20	CAWSPGQGRIFSQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCTCCCGGGCGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	25	5.671197575449612E-5		46	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-06	01	3	8	0	0	5	1	26	37	46	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ02-06	TCRBV30-01*02		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCACCGCTACCGAGCAGTACTTCGGGCCG	CAWSPTATEQYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	9	6	7	1	26	38	48	45	49						01,02							Vb 20	CAWSPTATEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAAGGGTTGCGAGTGGTAGCTTTCTTTGGACAA	CAWSEGLRVVAFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	1	5	3	10	1	11	26	39	44	40	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSEGLRVVAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCAGGGTGGCTGAAGCTTTCTTTGGACAA	CAWTRVAEAFF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	6	1	3	26	36	42	37	45													Vb 20	CAWTRVAEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCGGCGGGAGGGCCGGATACGAGCAGTTCTTCGGGCCA	CAWTGGRAGYEQFF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	7	0	10	3	8	26	36	48	39	56													Vb 20	CAWTGGRAGYEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTAAACAGGGTTCGGGAAACACCATATATTTTGGAGAG	CAWTKQGSGNTIYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	3	4	4	4	26	36	46	40	50													Vb 20	CAWTKQGSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATTGGGATGGGTGGCTACACCTTCGGTTCG	CAWIGMGGYTF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	33	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	4	0	8	7	2	4	26	36	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWIGMGGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCCCTCCGGGCGGGAGCAGATACGCAGTATTTTGGCCCA	CAWALRAGADTQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	7	2	4	9	0	26	35	-1	44	51													Vb 20	CAWALRAGADTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTTTTGATGAACACTGAAGCTTTCTTTGGACAA	CAWSLLMNTEAFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	2	2	8	0	5	0	26	38	-1	43	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSLLMNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGACAGGGTTGGAAACACCATATATTTTGGAGAG	CAWDRVGNTIYF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	3	3	0	1	26	-1	42	35	43													Vb 20	CAWDRVGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGGGGGCAGGGGGCAAGAGACCCAGTACTTCGGGCCA	CAWSVGGRGQETQYF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	1	2	6	0	26	40	-1	46	53													Vb 20	CAWSVGGRGQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAGGCCAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CAWEARNTGELFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	11	1	1	0	4	26	-1	39	35	43													Vb 20	CAWEARNTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTATCCGGGACAGGGTTGGCCGGGGAGCTGTTTTTTGGAGAA	CALSGTGLAGELFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	0	3	6	5	4	26	33	47	38	51													Vb 20	CALSGTGLAGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGTGGGACCCATGAACACTGAAGCTTTCTTTGGACAA	CAWRVGPMNTEAFF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	3	0	7	0	3	3	26	37	45	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWRVGPMNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCCGGGACAGGGTATGGCTACACCTTCGGTTCG	CAWSSGTGYGYTF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	3	5	3	0	26	38	-1	41	50			unresolved										Vb 20	CAWSSGTGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTGGAATAGGGAGACCCAGTACTTCGGGCCA	CAWSWNRETQYF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	2	1	8	5	1	5	26	38	42	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSWNRETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGTTCCCCCGGTGGTGAAGCTTTCTTTGGACAA	CACSPGGEAFF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	33	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	5	7	6	3	26	34	43	40	46						01,02							Vb 20	CACSPGGEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATAGCGGGAGGGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	31	7.032284993557519E-5		40	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	5	0	1	0	0	26	-1	-1	36	47													Vb 20	X+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGCCTCGGTGGAAGCTTTCTTTGGACAA	CAWSASVEAFF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	33	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	8	5	8	5	2	26	37	45	42	47						01,02							Vb 20	CAWSASVEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTAGAGGGAGGGATGTCGGGGAGCTGTTTTTTGGAGAA	CAWTRGRDVGELFF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	9	0	7	5	4	26	36	48	41	52													Vb 20	CAWTRGRDVGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAGGAATCGGAGCGGGAGAGCCCTACGAGCAGTACTTCGGGCCG	CAWRGIGAGEPYEQYF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	6	2	2	9	3	26	37	54	46	57													Vb 20	CAWRGIGAGEPYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCGGGACAGGGTTCAGCCCCAGCATTTTGGTGAT	CAWSRDRVQPQHF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	3	6	2	1	26	37	48	39	49													Vb 20	CAWSRDRVQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTGAGGCGTCTGCCCCTTAATGAAAAACTGTTTTTTGGCAGT	CAWSLRRLPLNEKLFF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	11	1	4	2	11	26	38	44	40	55			unresolved										Vb 20	CAWSLRRLPLNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATTGTGGGATATACGCAGTATTTTGGCCCA	CAWIVGYTQYF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	33	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-03	01	0	0	8	7	0	1	26	-1	44	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWIVGYTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGACCGGAATAGCGTGAATGAGCAGTTCTTCGGGCCA	CAWDRNSVNEQFF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	6	7	8	2	26	35	48	43	50						01,02							Vb 20	CAWDRNSVNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCATTACCGGACGATCGAGACTGAAGCTTTCTTTGGACAA	CAWSHYRTIETEAFF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	45	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	2	1	7	5	7	7	26	38	49	45	56			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSHYRTIETEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTACAAAACGGGACTAGCGGGAGAAAGGTCCTACGAGCAGTACTTCGGGCCG	CAYKTGLAGERSYEQYF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	51	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	0	2	1	7	5	26	33	54	40	59													Vb 20	CAYKTGLAGERSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCAGAGGGGGAGTATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	35	7.939676605629458E-5		41	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	5	1	5	3	3	26	38	47	41	50													Vb 20	X+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCCACGTTTGGTGCTYCTCAGTGACTCTGGCTTTATCTCTGTGCCTGGAGCCGCGGGAGTTGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	37	8.393372411665426E-5		41	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	21	7	2	4	19	4	40	33	59	52	63			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCGAGTAGGGACGGCTATGAAGCTTTCTTTGGACAA	CASSRDGYEAFF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	36	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	2	0	7	7	1	5	26	38	44	39	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CASSRDGYEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAACCCCTACAAGGTACGCAAGGGACTGGGGCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	38	8.620220314683411E-5		58	TCRBV30	TCRBV30-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	10	5	20	5	23	33	59	53	64			01,02			01,02							Vb 20	X+TCRBV30-01+TCRBJ02-01	TCRBV30-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGGATCTCGAGGGGGTTACACAGATACGCAGTATTTTGGCCCA	CGSRGGYTDTQYF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	5	1	2	7	3	26	30	43	37	46													Vb 20	CGSRGGYTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCACAGGGAACACTGAAGCTTTCTTTGGACAA	CAWTTGNTEAFF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	4	1	2	0	26	36	-1	38	43			unresolved										Vb 20	CAWTTGNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAGTGATCCGGGACAGGGGGTACGAGCAGTACTTCGGGCCG	CAWRVIRDRGYEQYF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	1	4	8	0	26	37	-1	45	56			unresolved										Vb 20	CAWRVIRDRGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTCAATTCTAGCGGGAGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAWSILAGGSYNEQFF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	48	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	1	0	6	0	26	35	-1	41	52													Vb 20	CAWSILAGGSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAACTGTAATGATAGCGGGGGCCTACGAGCAGTACTTCGGGCCG	CAWRTVMIAGAYEQYF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	5	2	2	11	0	26	37	-1	48	57			unresolved										Vb 20	CAWRTVMIAGAYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCCTTGAGAGGTCCTAGGGAGACCCAGTACTTCGGGCCA	CAWALRGPRETQYF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	4	8	5	13	1	26	35	52	48	53			unresolved			01,02							Vb 20	CAWALRGPRETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATCCGGGGGTCGCAGTATTTTGGCCCA	CAWSIRGSQYF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	8	2	10	3	1	26	38	47	41	48													Vb 20	CAWSIRGSQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACGGGGGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAWSTGVSGANVLTF	In	VDJ	2	49	1.1115547247881241E-4	1.4267453608937832E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	2	8	2	0	1	1	26	38	45	39	46													Vb 20	CAWSTGVSGANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGCGGGTAATCAGCCCCAGCATTTTGGTGAT	CAWSAGNQPQHF	In	VDJ	2	50	1.1342395150899225E-4	1.4558626131569216E-4	36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	7	4	4	1	1	26	37	43	38	44						01,02							Vb 20	CAWSAGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCCACGTTTGGTGCTTCTCAGTGACTCTGGCTCTATCTCTGTGCCTGGAGCCGCGGGAGTTGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	51	1.1569243053917209E-4		41	TCRBV30	TCRBV30-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	22	7	2	4	20	4	40	32	59	52	63			01,02										Vb 20	X+TCRBV30-01+TCRBJ02-01	TCRBV30-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACCTTTTAAGGGAGGGCTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	54	1.2249786762971162E-4		52	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	9	0	3	9	2	26	40	56	49	58													Vb 20	X+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTGGGTCTCCTGGAATGAGCAGTTCTTCGGGCCA	CAWSWVSWNEQFF	In	VDJ	2	56	1.2703482569007132E-4	1.6305661267357522E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	2	0	9	7	1	8	26	38	42	39	50			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSWVSWNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTGCCACGGACAGGGGGGACTGAAGCTTTCTTTGGACAA	CAWSLPRTGGTEAFF	In	VDJ	2	57	1.2930330472025117E-4	1.6596833789988907E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	1	5	7	1	26	38	55	45	56			unresolved										Vb 20	CAWSLPRTGGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGTGCGGTGGGTACGCAGTATTTTGGCCCA	CAWSGAVGTQYF	In	VDJ	2	58	1.3157178375043101E-4	1.688800631262029E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	7	5	8	2	4	26	39	45	41	49			unresolved			01,02							Vb 20	CAWSGAVGTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGGTGGCAGGGTGGCAATCAGCCCCAGCATTTTGGTGAT	CAWSVRWQGGNQPQHF	In	VDJ	2	61	1.3837722084097056E-4	1.7761523880514444E-4	48	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	2	7	2	26	40	52	47	54			unresolved										Vb 20	CAWSVRWQGGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACCGGTACTAGCGGACCCTCCAGATACGCAGTATTTTGGCCCA	CAWSVPVLADPPDTQYF	In	VDJ	2	62	1.4064569987115038E-4	1.8052696403145828E-4	51	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	3	5	4	6	6	26	40	54	46	60			unresolved			01,02							Vb 20	CAWSVPVLADPPDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACGCAGGGAAACTACGAGCAGTACTTCGGGCCG	CAWSTQGNYEQYF	In	VDJ	2	63	1.4291417890133023E-4	1.8343868925777213E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	3	3	3	26	38	46	41	49			unresolved										Vb 20	CAWSTQGNYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGGGCGAGCGGGGGCGGAGGCTACACCTTCGGTTCG	CAWSVRASGGGGYTF	In	VDJ	3	75	1.7013592726348837E-4	2.1837939197353825E-4	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	6	2	8	7	4	26	40	55	47	59			unresolved										Vb 20	CAWSVRASGGGGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGACAGGACCTGAACACCGGGGAGCTGTTTTTTGGAGAA	CAWSRQDLNTGELFF	In	VDJ	3	79	1.7920984338420777E-4	2.300262928787936E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	2	4	1	1	4	26	38	45	39	49													Vb 20	CAWSRQDLNTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTGGACTGGATGAAAAACTGTTTTTTGGCAGT	CAWTGLDEKLFF	In	VDJ	3	81	1.8374680144456743E-4	2.358497433314213E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	1	10	6	2	2	26	36	43	38	45						01,02							Vb 20	CAWTGLDEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD02-01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTGGCCGGGGGGGATACTCTGAAGCTTTCTTTGGACAA	CAWSVGRGGYSEAFF	In	VDJ	3	85	1.9282071756528683E-4	2.474966442366767E-4	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	0	6	4	5	26	40	52	44	57			unresolved										Vb 20	CAWSVGRGGYSEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAATTAGGGGGCGGCTAGGCATGGCTACACCTTCGGTTCG		Out	VDJ	3	91	2.0643159174636589E-4		47	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	0	6	4	8	26	40	51	44	59			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTATTCAGGGGGGAGAAGTAGGCCGAGCAGTACTTCGGGCCG	CAWSVFRGEK*AEQYF	Stop	VDJ	3	93	2.1096854980672558E-4		48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	1	6	3	11	26	40	50	43	61													Vb 20	CAWSVFRGEK*AEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGATATACGGGAGAGGGCGGGTCGAGCAGTACTTCGGGCCG		Out	VDJ	3	95	2.1550550786708528E-4		41	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	8	2	6	5	9	26	34	45	39	54													Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTAGGGGGAACTAGGTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	95	2.1550550786708528E-4		43	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	5	1	1	1	8	26	35	42	36	50													Vb 20	X+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGTAGCGGGAGCCATACGAGCAGTACTTCGGGCCG		Out	VDJ	5	138	3.1305010616481863E-4		41	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	5	2	4	2	3	26	38	49	40	52			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGCCGGGGAGGGTGGCTACACCTTCGGTTCG	CAWSVAGEGGYTF	In	VDJ	5	138	3.1305010616481863E-4	4.018180812313104E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	9	0	7	5	0	26	40	-1	45	52			unresolved										Vb 20	CAWSVAGEGGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCAGGACAGGGCCCCCCGTATGGCTACACCTTCGGTTCG	CASGQGPPYGYTF	In	VDJ	5	158	3.5841968676841553E-4	4.600525857575872E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	3	5	2	7	26	33	43	35	50													Vb 20	CASGQGPPYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCCAGGACAGGGGTCTACGAGCAGTACTTCGGGCCG	CASRTGVYEQYF	In	VDJ	6	163	3.6976208191931474E-4	4.7461121188915645E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	2	3	3	1	26	33	45	36	46													Vb 20	CASRTGVYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACATCGACTAGCGGGAGTAGAGAGACCCAGTACTTCGGGCCA	CAWTSTSGSRETQYF	In	VDJ	6	166	3.7656751900985426E-4	4.8334638756809795E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	2	2	4	4	3	26	36	52	40	55													Vb 20	CAWTSTSGSRETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGCGGGAACCCGCTACGAGCAGTACTTCGGGCCG	CAWSAGTRYEQYF	In	VDJ	26	769	0.0017444603742083008	0.0022391166990353454	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	3	3	1	5	26	37	44	38	49			unresolved										Vb 20	CAWSAGTRYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGATAGCGGGAGTGACACCGGGGAGCTGTTTTTTGGAGAA	CAWSDSGSDTGELFF	In	VDJ	31	932	0.0021142224561276155	0.002713727910924502	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	5	2	3	1	2	26	39	49	40	51			unresolved										Vb 20	CAWSDSGSDTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCGCGGGAGTTGGTACAATGAGCAGTTCTTCGGGCCA	CAWSRGSWYNEQFF	In	VDJ	450	13308	0.030188918933633378	0.038749239311784624	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	2	4	2	4	26	37	46	39	50			unresolved										Vb 20	CAWSRGSWYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATTGGAGGGGCTACACCTTCGGTTCG	CASSQDWRGYTF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	36	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	10	1	8	2	0	23	40	-1	42	47														CASSQDWRGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGCTAAAGACAGGGGCGAGCAGTACTTCGGGCCG	CASSQAKDRGEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	2	6	5	0	23	39	-1	44	52														CASSQAKDRGEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCTTGGGGCTAGCGGGAGAGGGTTTGGTGAGCAGTTCTTCGGGCCA	CASSQDLGASGRGFGEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	57	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	4	2	9	8	9	23	40	58	48	67														CASSQDLGASGRGFGEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAACAGGCAATGGATGAAAAACTGTTTTTTGGCAGT	CASSQQAMDEKLFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	4	6	0	6	23	-1	42	38	48														CASSQQAMDEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGTGAGCCCGGGGACTAGCGGGGCATACGAGCAGTACTTCGGGCCG	CASSQVSPGTSGAYEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	54	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	4	10	2	23	37	60	47	62														CASSQVSPGTSGAYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGGGGACTAATTACAATGAGCAGTTCTTCGGGCCA	CASSQEGTNYNEQFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	9	4	1	2	23	40	48	41	50						01,02								CASSQEGTNYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGCAAGGGACGATAGCTTTCTTTGGACAA	CASSQGQGTIAFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	39	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-01	01	1	0	7	10	5	3	23	39	49	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGQGTIAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCTTACAGAATTACAGGGGACCCTGGAAACACCATATATTTTGGAGAG	CASSPYRITGDPGNTIYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	54	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	2	2	11	3	23	36	54	47	57														CASSPYRITGDPGNTIYF+TCRBV01-01+TCRBJ01-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAAACCTCGGGCGGCTACGAGCAGTACTTCGGGCCG	CASSQETSGGYEQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-07	01	0	8	0	3	6	2	23	40	50	46	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQETSGGYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCAGACCGACAGATTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSRPTDSTNEKLFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	5	0	5	3	23	35	45	40	48														CASSRPTDSTNEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAACTGGGACGCACACTGAAGCTTTCTTTGGACAA	CASSQTGTHTEAFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	42	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-01	01	2	0	7	3	3	2	23	38	46	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTGTHTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCATGGCGGGGGGCAGGACCTTTCCTATGGCTACACCTTCGGTTCG	CASSHGGGQDLSYGYTF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	7	1	4	2	11	23	37	47	39	58														CASSHGGGQDLSYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGAACGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASSRTTGNTEAFF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	4	1	4	0	23	36	-1	40	46														CASSRTTGNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGACAGGGGTTTGGGGAATGAGCAGTTCTTCGGGCCA	CASSQDRGLGNEQFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	7	0	7	23	-1	46	40	53														CASSQDRGLGNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCTAGCAGCCAAGGGGAGACTAACGAGCAGTACTTTGGGCCG	CASSQGETNEQYF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	2	9	19	4	14	23	39	48	43	62						01,02								CASSQGETNEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTGGGACAGGGAATGGCAGATACGCAGTATTTTGGCCCA	CASSLGQGMADTQYF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	3	4	1	5	23	36	46	37	51														CASSLGQGMADTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGATCAGCACTAACGAAAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CTSSQDQH*RKSSYNEQFF	Stop	VDJ	1	30	6.805437090539536E-5		57	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	3	9	0	5	9	23	40	49	45	58						01,02								CTSSQDQH*RKSSYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGAAATTCCTCCCCGCCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	33	7.485980799593489E-5		53	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-03	01	0	10	0	0	11	2	23	40	53	51	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCCGTACGCCCCCGAATGAAAAACTGTTTTTTGGCAGT	CTRTPPNEKLFF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	36	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-04	01	11	3	7	5	3	7	23	29	34	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTRTPPNEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGTCATACTAGCGGCAATGAGCAGTTCTTCGGGCCA	CASSHTSGNEQFF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	5	6	4	0	23	34	-1	38	46						01,02								CASSHTSGNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCTAGTAGCCAAGATCTTGGGACAGGGGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	37	8.393372411665426E-5		52	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	1	0	4	0	23	40	-1	44	55														X+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCTACGCGGACCAGAGAGAGCAGTTCTTCGGGCCA	CASSPYADQREQFF	In	VDJ	2	48	1.0888699344863256E-4	1.3976281086306447E-4	42	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-01	01	4	1	7	10	7	6	23	36	47	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPYADQREQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCGGACGGACTAGCGGGATTCAAGAGACCCAGTACTTCGGGCCA	CASSGRTSGIQETQYF	In	VDJ	2	57	1.2930330472025117E-4	1.6596833789988907E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	1	3	2	4	2	23	35	51	39	53														CASSGRTSGIQETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGAGGACAGGGGCAGCAATCAGCCCCAGCATTTTGGTGAT	CTSSQEDRGSNQPQHF	In	VDJ	2	66	1.4971961599186977E-4	1.9217386493671366E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	2	1	0	1	23	-1	49	40	50														CTSSQEDRGSNQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCTATGACTCAGATACGCAGTATTTTGGCCCA	CASSYDSDTQYF	In	VDJ	3	89	2.0189463368600622E-4	2.5914354514193207E-4	36	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	10	4	3	0	23	35	-1	38	42						01,02								CASSYDSDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGTGGGTAGCGACCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	92	2.0870007077654573E-4		50	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	5	6	0	4	2	23	39	48	43	50						01,02								X+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAACTGGGACAGGGATCCGAAAAGCAGTACTTCGGGCCG	CASSQLGQGSEKQYF	In	VDJ	5	148	3.3573489646661705E-4	4.309353334944488E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	8	2	8	23	38	49	40	57														CASSQLGQGSEKQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCCTGGGGTAACAAGCGGGCAGTACTTCGGGCCG	CASSQDPGVTSGQYF	In	VDJ	5	162	3.6749360288913487E-4	4.716994866628426E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	6	5	9	13	0	23	40	-1	53	58						01,02								CASSQDPGVTSGQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCTAAACAGTCGGACAGCGAACACTGAAGCTTTCTTTGGACAA	CASSQDLNSRTANTEAFF	In	VDJ	6	163	3.6976208191931474E-4	4.7461121188915645E-4	54	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	5	1	11	1	23	40	57	51	58														CASSQDLNSRTANTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGTTAGAAAACAGATACGAGCAGTACTTCGGGCCG	CASSQLENRYEQYF	In	VDJ	10	283	6.419795655408961E-4	8.240182390468176E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	5	4	8	1	23	37	49	45	50														CASSQLENRYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCCTAGGATTTACTCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	25	735	0.001667332087182186		44	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	8	2	0	10	23	-1	40	36	50						01,02								X+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCACCGGAGACAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	27	804	0.0018238571402645954		43	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	10	2	2	2	2	23	37	43	39	45														X+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCACAGGGACGGTCAACACTGAAGCTTTCTTTGGACAA	CASSTGTVNTEAFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	2	0	6	19	-1	37	31	43													Vb 5.1	CASSTGTVNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCGAACAGCTCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	9	2.0416311271618604E-5		40	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	5	4	4	3	19	32	40	36	43													Vb 5.1	X+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGGTCGGGAGAGAGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	9	2.0416311271618604E-5		44	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	2	6	4	5	19	32	42	36	47													Vb 5.1	X+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCCCAGCGGAAATGGCCTACGAGCAGTACTTCGGGCCG	CASSLAPAEMAYEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	6	5	2	4	6	19	35	44	39	50						01,02							Vb 5.1	CASSLAPAEMAYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSLGQGNTEAFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	3	1	0	0	19	-1	-1	35	42													Vb 5.1	CASSLGQGNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGGTGGCGAACACTGAAGCTTTCTTTGGACAA	CASSLGVANTEAFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	0	0	9	1	0	4	19	-1	38	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLGVANTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTAACAAGCGGGGTCAAGAGACCCAGTACTTCGGGCCA	CASSFNKRGQETQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	6	3	2	5	1	19	33	45	38	46													Vb 5.1	CASSFNKRGQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCACCGGACAGGGGAGTTTGTATGGCTACACCTTCGGTTCG	CASSTGQGSLYGYTF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	2	5	3	6	19	31	43	34	49													Vb 5.1	CASSTGQGSLYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGTAGCGGGAGGGTACAATGAGCAGTTCTTCGGGCCA	CASSPVAGGYNEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	0	4	4	0	19	31	-1	35	46													Vb 5.1	CASSPVAGGYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCTATTAATGACAGGGCATCTGAAGCTTTCTTTGGACAA	CASSPINDRASEAFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	6	9	3	19	31	47	40	50													Vb 5.1	CASSPINDRASEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCAAAGCTAAATATTATTAAATCCTACAATGAGCAGTTCTTCGGGCCA	CASSLAKLNIIKSYNEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	57	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	9	1	5	12	19	35	43	40	55						01,02							Vb 5.1	CASSLAKLNIIKSYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCATCCCAGGACAGAGGGGCACAGATACGCAGTATTTTGGCCCA	CASIPGQRGTDTQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	5	1	5	4	19	29	40	34	44													Vb 5.1	CASIPGQRGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTGGGGGAGGCCTCTTTTAACTATGGCTACACCTTCGGTTCG	CASSLGEASFNYGYTF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	9	1	1	0	7	19	-1	41	35	48													Vb 5.1	CASSLGEASFNYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCAGGAGCGGGAGGCACGAGCACAGATACGCAGTATTTTGGCCCA	CASSSGAGGTSTDTQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	6	1	0	4	4	19	32	45	36	49													Vb 5.1	CASSSGAGGTSTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGAGGACTAGCGGGAGCTATGAGCAGTTCTTCGGGCCA	CASSSRTSGSYEQFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	1	2	8	3	2	19	32	48	35	50													Vb 5.1	CASSSRTSGSYEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGATACCGGGACAGCTTAGCGAGCAGTACTTCGGGCCG	CASSWIPGQLSEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	5	6	7	5	19	32	46	39	51													Vb 5.1	CASSWIPGQLSEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAAGGTCGGCTCCCTACGAGCAGTACTTCGGGCCG	CASSLRSAPYEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	2	5	4	2	1	7	19	33	37	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLRSAPYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCACAGGGGATTTCTACGAGCAGTACTTCGGGCCG	CASSFTGDFYEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	2	3	1	4	19	33	41	34	45													Vb 5.1	CASSFTGDFYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGAGGGAGGGCCTGGGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSLGGRAWGAKNIQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	54	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	9	0	1	2	8	19	35	44	37	52													Vb 5.1	CASSLGGRAWGAKNIQYF+TCRBV05-01+TCRBJ02-04	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGGGGTAGTCGGGACAGGGATGAGGCTTTCTTTGGACAA	CASRGSRDRDEAFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	11	8	5	19	30	47	38	52													Vb 5.1	CASRGSRDRDEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTCTTGGCACACTGGAGGATGAAAAACTGTTTTTTGGCAGT	CASSLGTLEDEKLFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	10	1	6	12	0	19	30	-1	42	47													Vb 5.1	CASSLGTLEDEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGGGGTAGGGTGGGGAGTCAACAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	12	2.722174836215814E-5		49	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-05	01	3	6	1	7	0	16	19	-1	37	32	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTGAGGTCGGACAGACCTCTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	12	2.722174836215814E-5		58	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	5	0	7	7	19	35	48	42	55													Vb 5.1	X+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTCTACAGGTCAATACGGGGGAGCTGTTTTTTGGAGAA	CASSFLQVNTGELFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	3	4	8	3	8	19	33	41	36	49													Vb 5.1	CASSFLQVNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGGCCGACAGGGGCAGGATTAACTGAAGCTTTCTTTGGACAA	CASRPTGAGLTEAFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	5	3	8	19	30	41	33	49													Vb 5.1	CASRPTGAGLTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAACCCAGGCCAAGACTAACTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	13	2.9490227392337985E-5		46	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	9	2	9	0	11	1	19	26	42	37	43						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCACCGCCCTCTCGGTCCGGGACAGATACGCAGTATTTTGGCCCA	CASSPPPSRSGTDTQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	8	4	3	17	0	19	31	-1	48	52						01,02							Vb 5.1	CASSPPPSRSGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCCCGGCGTCACGAGCGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	13	2.9490227392337985E-5		47	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	6	6	3	13	0	19	32	-1	45	49						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD02-01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGACGACGAGATTCCCGGGACTAATGAAAAACTGTTTTTTGGCAGT	CASSLDDEIPGTNEKLFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	54	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	8	4	2	13	0	19	35	-1	48	52						01,02							Vb 5.1	CASSLDDEIPGTNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCATACAGGGGGTCGGGACACAGATACGCAGTATTTTGGCCCA	CASSHTGGRDTDTQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	1	2	3	6	19	31	42	34	48													Vb 5.1	CASSHTGGRDTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTAAGACAGGGCGGAAGGAACACTGAAGCTTTCTTTGGACAA	CASSLRQGGRNTEAFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	1	4	6	19	31	42	35	48													Vb 5.1	CASSLRQGGRNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTACGGACTAGCGGAAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSYGLAESSYNEQFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	5	0	2	4	19	32	44	34	48						01,02							Vb 5.1	CASSYGLAESSYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTGTCAGCCCAAGAGACCCAGTACTTCGGGCCA	CASSLVSAQETQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-05	01	0	4	5	1	3	1	19	35	41	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLVSAQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCTTTCCGGGACAGTACAGCACAGATACGCAGTATTTTGGCCCA	CASFPGQYSTDTQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	5	0	5	3	19	28	40	33	43													Vb 5.1	CASFPGQYSTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGGACCCCGTTCGAAGAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	15	3.402718545269768E-5		53	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-03	01	4	1	7	0	2	13	19	31	37	33	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTCGGGGGGCGGGAGCTTGGGGAGCAGTTCTTCGGGCCA	CASSLGGRELGEQFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	8	1	10	2	12	19	31	40	33	52						01,02							Vb 5.1	CASSLGGRELGEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTCGCCACAGGGCAGCTATGGCTACACCTTCGGTTCG	CASSLSPQGSYGYTF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	3	4	5	3	19	34	45	39	48													Vb 5.1	CASSLSPQGSYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAAGGGATTGGGTCGACAGGGGACTACGAGCAGTACTTCGGGCCG	CASSQGIGSTGDYEQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	2	3	14	1	19	31	53	45	54													Vb 5.1	CASSQGIGSTGDYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCTTCCGGGACAGGGGGGATCTATGAGCAGTTCTTCGGGCCA	CASSPSGTGGIYEQFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	1	8	6	5	19	31	48	37	53													Vb 5.1	CASSPSGTGGIYEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGAGGGGAGAGGGAATGAAAAACTGTTTTTTGGCAGT	CASSEGRGNEKLFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	4	5	2	5	1	6	19	31	37	32	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSEGRGNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGTTCGTCGGGGGGAAACACCATATATTTTGGAGAG	CASSLGSSGGNTIYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	0	8	3	4	6	0	19	35	-1	41	46													Vb 5.1	CASSLGSSGGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCCAGGGAGGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFQGGNTGELFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	9	1	2	3	1	19	33	42	36	43													Vb 5.1	CASSFQGGNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTTTCCCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VJ	1	17	3.8564143513057367E-5		44	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	0	0	0	0	0	5	19	-1	35	-1	40													Vb 5.1	X+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGAGGTGGACGCCACTAGCACAGATACGCAGTATTTTGGCCCA	CASSEVDATSTDTQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	4	1	7	0	5	6	19	31	40	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSEVDATSTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGTGCCGGGACGGTTCTACGAGCAGTACTTCGGGCCG	CASSVPGRFYEQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	4	0	7	3	5	4	19	31	41	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSVPGRFYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTACCGTCTCGAATCGGATACGCAGTATTTTGGCCCA	CASSYRLESDTQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	3	2	8	6	8	4	19	32	42	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSYRLESDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTGGCTAGCGCGGACAATGAGCAGTTCTTCGGGCCA	CASSLVASADNEQFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	6	5	3	3	19	35	44	38	47						01,02							Vb 5.1	CASSLVASADNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTGAGGGCCGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSEGRVNTEAFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	0	0	1	5	19	30	36	31	41													Vb 5.1	CASSEGRVNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGTACCCGGGATACACTGAACACTGAAGCTTTCTTTGGACAA	CASTRDTLNTEAFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	8	3	0	4	5	19	27	36	31	41													Vb 5.1	CASTRDTLNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCAGTCAGGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSQGSGANVLTF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	4	2	1	3	0	19	31	-1	34	40													Vb 5.1	CASSSQGSGANVLTF+TCRBV05-01+TCRBJ02-06	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCATAGCGGGAGGGCCAAATGAGCAGTTCTTCGGGCCA	CASSSIAGGPNEQFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	5	0	7	3	3	19	32	46	35	49													Vb 5.1	CASSSIAGGPNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGATACCTCGGGGACTAGCGGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	23	5.2175017694136434E-5		49	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	4	3	8	0	19	30	-1	38	50						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCGGGCTAGCGGGAGGGGGTCAGTTCTTCGGGCCA	CASSLAGLAGGGQFF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	4	0	13	5	3	19	35	52	40	55													Vb 5.1	CASSLAGLAGGGQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTATACAGGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	25	5.671197575449612E-5		41	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	3	1	2	1	19	32	40	34	41													Vb 5.1	X+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCCCCACTGAAGGGGTGCCGGGACAGACTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	5.671197575449612E-5		52	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	0	5	3	17	3	19	25	49	42	52													Vb 5.1	X+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAATAGACCCGGGCACAGATACGCAGTATTTTGGCCCA	CASSLIDPGTDTQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	2	2	7	1	4	4	19	33	40	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLIDPGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCAGGGGACAGGTTGCTGAGACCCAGTACTTCGGGCCA	CASSRGQVAETQYF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	4	5	2	5	19	31	41	33	46													Vb 5.1	CASSRGQVAETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAACCCAGGCCGGGACTAACTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	30	6.805437090539536E-5		46	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	9	0	9	0	9	1	19	26	42	35	43						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCGGGACAGGGCTAAACACCATATATTTTGGAGAG	CASSSGTGLNTIYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	3	6	2	2	19	32	43	34	45													Vb 5.1	CASSSGTGLNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTACAAGGGAGAGGGGAGACCCAGTACTTCGGGCCA	CASSLQGRGETQYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	9	2	5	4	4	19	33	42	37	46													Vb 5.1	CASSLQGRGETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGGCGGGACTAGCTCACAATGAGCAGTTCTTCGGGCCA	CASSWAGLAHNEQFF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	7	5	4	2	19	32	45	36	47						01,02							Vb 5.1	CASSWAGLAHNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTACTAACGGGGGAGGTCACTGAAGCTTTCTTTGGACAA	CASSLLTGEVTEAFF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	8	2	4	7	4	19	31	44	38	48						01,02							Vb 5.1	CASSLLTGEVTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCTGGACGGTCTGTAGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPGRSVGTNEKLFF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	51	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	4	1	7	1	3	10	19	31	38	34	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSPGRSVGTNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTGGCAAGCCACGTTTGGTGGGGACTCGGCCTTTATCTTTGCGCCAGCAGCTTGGAATTGGACTACTACGAGCAGTACTTCGGGCCG	CASSLELDYYEQYF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	1	9	3	4	0	39	55	-1	59	65						01,02							Vb 5.1	CASSLELDYYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCGGACTAGTCGGTGAGACCCAGTACTTCGGGCCA	CASSLAGLVGETQYF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	1	8	5	2	5	19	35	44	37	49						01,02							Vb 5.1	CASSLAGLVGETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGACCGGGACCCACATTGGGGATACGCAGTATTTTGGCCCA	CASSLTGTHIGDTQYF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	1	0	7	6	3	10	19	34	42	37	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLTGTHIGDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGACAGGGCCGGGCAATGAGCAGTTCTTCGGGCCA	CASSWTGPGNEQFF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	3	6	0	5	19	-1	40	32	45													Vb 5.1	CASSWTGPGNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTATGGGACCGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSYGTATNEKLFF	In	VDJ	2	48	1.0888699344863256E-4	1.3976281086306447E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	3	0	7	0	2	2	19	32	39	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSYGTATNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGATTCTTGGGGTCCCTACGAGCAGTACTTCGGGCCG	CASSLDSWGPYEQYF	In	VDJ	2	48	1.0888699344863256E-4	1.3976281086306447E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	0	6	2	2	6	2	19	35	45	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLDSWGPYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTATCGCGGTTTCCAGAATGAGCAGTTCTTCGGGCCA	CASSYRGFQNEQFF	In	VDJ	2	49	1.1115547247881241E-4	1.4267453608937832E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	7	5	7	3	7	19	32	39	35	46						01,02							Vb 5.1	CASSYRGFQNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCGTGACTAGCGGGAGTCCGGGGAGCTGTTTTTTGGAGAA	CASSRD*RESGELFF	Stop	VDJ	2	50	1.1342395150899225E-4		45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	2	2	6	3	1	19	31	46	34	47													Vb 5.1	CASSRD*RESGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTCCGGGACTATAACAGATACGCAGTATTTTGGCCCA	CASSLSGTITDTQYF	In	VDJ	2	63	1.4291417890133023E-4	1.8343868925777213E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	0	9	3	3	2	19	34	44	37	46						01,02							Vb 5.1	CASSLSGTITDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCGGGAGCAGGGGGCAAAAACATTCAGTACTTCGGCGCC	CASSLAGAGGKNIQYF	In	VDJ	3	85	1.9282071756528683E-4	2.474966442366767E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	1	3	6	0	19	35	-1	41	48													Vb 5.1	CASSLAGAGGKNIQYF+TCRBV05-01+TCRBJ02-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAGACTGGGGACATCTGGAAACACCATATATTTTGGAGAG	CASSLRLGTSGNTIYF	In	VDJ	3	91	2.0643159174636589E-4	2.6496699559455975E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	0	6	1	6	0	19	34	-1	40	46													Vb 5.1	CASSLRLGTSGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTCGACATCCCATCGGAGATACGCAGTATTTTGGCCCA	CASSFRHPIGDTQYF	In	VDJ	3	94	2.1323702883690543E-4	2.7370217127350126E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	6	5	2	9	19	33	39	35	48													Vb 5.1	CASSFRHPIGDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGGGGGGAAACAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRGETGNTGELFF	In	VDJ	5	155	3.5161424967787596E-4	4.513174100786457E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	5	3	4	1	7	0	19	30	-1	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASRGETGNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAATTGGACTACTACGAGCAGTACTTCGGGCCG	CASSLELDYYEQYF	In	VDJ	172	5079	0.011521604994283433	0.014788652424448009	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	1	9	3	4	0	19	35	-1	39	45						01,02							Vb 5.1	CASSLELDYYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCTCTGCGAGTTCTGGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	35	7.939676605629458E-5		46	TCRBV17	TCRBV17-01	01				TCRBJ01	TCRBJ01-02	01	5	0	8	4	12	5	22	31	47	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV17-01+TCRBJ01-02	TCRBV17-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCCCCCCGGCCCTGGGGAGGGATTCCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	124	2.8129139974230076E-4		53	TCRBV17	TCRBV17-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	11	9	0	2	18	5	22	25	50	43	55														X+TCRBV17-01+TCRBJ02-01	TCRBV17-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCTCCGGGTAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASTPPGSGGTDTQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	5	3	1	10	0	25	35	-1	45	53													Vb 3	CASTPPGSGGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCCCGGGACGGCGACCTACGAGCAGTACTTCGGGCCG	CASRPGTATYEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	6	0	7	2	4	5	25	36	45	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRPGTATYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGGGGGTGGCAATCAGCCCCAGCATTTTGGTGAT	CASRGGGNQPQHF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	9	1	2	0	2	25	-1	42	36	44													Vb 3	CASRGGGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGGGAACAGGGAATAGGGCCCCGCTCCTACGAGCAGTACTTCGGGCCG	CASSGEQGIGPRSYEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	0	5	12	25	37	48	42	60													Vb 3	CASSGEQGIGPRSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGAGTGCAAGGGGCCCAGTACTTCGGGCCA	CASSLGVQGAQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	3	5	2	9	9	0	25	39	-1	48	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGVQGAQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCTAGCGGGAGGGCCCTTCTACGAGCAGTACTTCGGGCCG	CASSFLAGGPFYEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	4	0	3	1	5	25	39	52	40	57													Vb 3	CASSFLAGGPFYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGACAGGGGGTATGACTAGCGGGCGAAGCGAGACCCAGTACTTCGGGCCA		Out	VDDJ	1	9	2.0416311271618604E-5		58	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	2	4	5	3	6	23	47	60	50	66						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCAAGCCACGTTTGGTGGCACCAACCAGACACTATGTACCTCTGTGCCACCCAGTTTAGGGGGAATCAGCCCCAGCATTTTGGTGAT	CATQFRGNQPQHF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	5	1	4	8	0	42	49	-1	57	63													Vb 3	CATQFRGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCTATGTACCTCTGTGCCAGCAGCGAACGGGACTAGCGGGAGTTTCTCCCGCTTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	9	2.0416311271618604E-5		62	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	0	2	3	5	12	12	23	42	28	54													Vb 3	X+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCCACGTTTGGTGGCACCAACCAGACATCTATGTACTCTGTGCCAGCAGTGAATATTCGGGGGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	10	2.2684790301798452E-5		41	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	20	8	2	3	21	1	40	37	64	58	65													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAACTCCAGGGAGTTTGGACTGAAGCTTTCTTTGGACAA	CASKLQGVWTEAFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	7	4	3	5	5	7	25	35	45	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASKLQGVWTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACGGGGTTCCAGAAATCGGAGCAGTTCTTCGGGCCA	CASTGFQKSEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	8	3	10	0	12	25	-1	40	35	52													Vb 3	CASTGFQKSEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCAAGGGGGGACCCACAGATACGCAGTATTTTGGCCCA	CASSKGGPTDTQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	6	5	1	2	2	4	25	36	44	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSKGGPTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGTCAGGGGGCCGAACCGGGGAGCTGTTTTTTGGAGAA	CASRSGGRTGELFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	0	5	2	3	25	36	46	38	49													Vb 3	CASRSGGRTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCGACCAGCTGGAAAGCACCATATATTTTGGAGAG	CASSLDQLESTIYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-03	01	5	1	8	9	11	3	25	37	51	48	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLDQLESTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCAGCCGGGACAGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSSAGTGYTGELFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	3	3	5	1	25	38	52	43	53													Vb 3	CASSSAGTGYTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCAGGTATTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLSGISNQPQHF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	4	0	0	3	25	-1	45	41	48													Vb 3	CASSLSGISNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCCCATGACTAGCGGGGACTACAATGAGCAGTTCTTCGGGCCA	CASSFPMTSGDYNEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	2	3	3	6	1	25	39	56	45	57													Vb 3	CASSFPMTSGDYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGGGGACACAGGAACACTGAAGCTTTCTTTGGACAA	CASSLGGHRNTEAFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	3	0	6	1	3	3	25	39	48	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGGHRNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTAACAGGGTGAGCCACGAGCAGTACTTCGGGCCG	CASSFNRVSHEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	3	5	2	6	25	39	47	41	53													Vb 3	CASSFNRVSHEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGCCGGGGGAGGCGAAAAACTGTTTTTTGGCAGT	CASAGGGEKLFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	8	8	2	8	2	4	25	34	42	36	46						01,02							Vb 3	CASAGGGEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCAAGCCACGTTTGGTGGCACCAACCAGCATCTATGTACCTCTGTGCCACCCAGTTTAGGGGGAATCAGCCCCAGCATTTTGGTGAT	CATQFRGNQPQHF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	5	1	4	8	0	42	49	-1	57	63													Vb 3	CATQFRGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCAGACATCTATGTACCTCTGTGCCAACAGTTTCGGGGTCAGGGGCATTTTCACCAACTCCTACAATGAGCAGTTCTTCGGGCCA	CANSFGVRGIFTNSYNEQFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	60	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	2	0	6	12	21	35	47	41	59													Vb 3	CANSFGVRGIFTNSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCCACGTTTGGTGGCACCAACCAGAATCTATGTACCTCTGTGCCAGCAGTGAATATTCGGGGGACTACGAGCAGTACTTCGGGCCG	CASSEYSGDYEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	2	3	7	1	39	51	64	58	65													Vb 3	CASSEYSGDYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAACAGTCTTCCTCTCGACAGGGCCCTAAATCAGCCCCAGCATTTTGGTGAT	CANSLPLDRALNQPQHF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	3	4	9	5	25	37	53	46	58													Vb 3	CANSLPLDRALNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTATCAAGACGGTAGTGAAGCTTTCTTTGGACAA	CASSYQDGSEAFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	6	2	7	7	7	5	25	36	46	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSYQDGSEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACCCCAGGTTACGGAAACACCATATATTTTGGAGAG	CASSTPGYGNTIYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	4	4	4	4	25	37	45	41	49													Vb 3	CASSTPGYGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGGGTAGAGAGGACACTGAAGCTTTCTTTGGACAA	CASSWGREDTEAFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	4	6	2	3	0	8	25	-1	42	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSWGREDTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGAGGGGGCGTCGCGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	11	2.4953269331978296E-5		44	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	0	5	0	5	25	-1	49	42	54													Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTTCCCGGCCACGGAGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	11	2.4953269331978296E-5		47	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	10	2	3	11	0	25	41	-1	52	56													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGCAGGGGGCAACGGTCAGCCCCAGCATTTTGGTGAT	CASSLAGGNGQPQHF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	0	6	2	5	25	39	49	41	54													Vb 3	CASSLAGGNGQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGCTGGGGGGCGAGCGGGATATCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	11	2.4953269331978296E-5		49	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	6	3	2	11	3	25	34	52	45	55													Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCCACGTTTGGTGGCACCACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACAAACAGAAAACAATGAGCAGTTCTTCGGGCCA	CASSLQTENNEQFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	5	5	3	3	39	54	61	57	64													Vb 3	CASSLQTENNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCCCCGGGACAAGAGACTCAGTACTTCGGGCCA	CASTPPGQETQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	0	6	11	7	7	25	35	48	42	55													Vb 3	CASTPPGQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCTAGGGGGGGTAAGCAATCAGCCCCAGCATTTTGGTGAT	CASRLGGVSNQPQHF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	9	0	1	4	2	25	36	47	40	49													Vb 3	CASRLGGVSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTAGCGGGACTAGCGGGAGTAGAGACCCAGTACTTCGGGCCA	CASSLAGLAGVETQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	0	2	4	5	1	25	37	56	42	57													Vb 3	CASSLAGLAGVETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCCTAGGGACCACTGGCGAGCAGTACTTCGGGCCG	CASSLLGTTGEQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	5	0	7	6	6	6	25	37	48	43	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLLGTTGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCGTAACAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	12	2.722174836215814E-5		34	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	4	10	7	0	5	25	-1	39	37	44						01,02							Vb 3	X+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTATAGCGGATGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSYSGWAKNIQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	4	5	5	1	1	4	25	38	45	39	49						01,02							Vb 3	CASSYSGWAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACAGCGGGAGAGTATGTACTTCGGGCCG	CASSLQRESMYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	6	2	12	1	5	25	40	49	41	54													Vb 3	CASSLQRESMYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGTCCGGCCAGTCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	2.722174836215814E-5		44	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	2	4	5	2	7	2	25	40	50	47	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCGAATGGGAAAACAGGGGGCAGGAACGAGCAGTACTTCGGGCCG	CASSLSNGKTGGRNEQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	0	5	11	4	25	41	61	52	65													Vb 3	CASSLSNGKTGGRNEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCGGCGGCGACCCGGGACGAGAGACACCATATATTTTGGAGAG		Out	VDJ	1	12	2.722174836215814E-5		41	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-03	01	11	0	7	8	11	5	25	31	47	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCCACGTTTGGTGGCACCAMCAGACATCTATGTACCTCTGTGCCAGCAGTGAATATTCGGGGGACTACGAGCAGTACTTCGGGCCG	CASSEYSGDYEQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	2	3	7	1	39	51	64	58	65													Vb 3	CASSEYSGDYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCCGGGACTACACTATTTTATGAGCAGTTCTTCGGGCCA	CASSSGTTLFYEQFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	9	8	4	9	25	36	47	40	56						01,02							Vb 3	CASSSGTTLFYEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCAAACCTATACAGGGGGCGCGATTGATAATGAGCAGTTCTTCGGGCCA	CASSQTYTGGAIDNEQFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	0	7	9	9	25	37	55	46	64													Vb 3	CASSQTYTGGAIDNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGAAGAAAAAGAGACCCAGTACTTCGGGCCA	CASSPEEKETQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	5	2	8	3	3	5	25	37	42	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPEEKETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCCGCCGGACACAGGGGATACGAGCAGTACTTCGGGCCG	CASSAAGHRGYEQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	2	4	10	1	25	37	54	47	55													Vb 3	CASSAAGHRGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGGACTCTGAGACCCAGTACTTCGGGCCA	CASSLGDSETQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	0	10	5	1	2	25	40	47	41	49						01,02							Vb 3	CASSLGDSETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGACTAGCGGGGCCCGCATCGGCAGATACGCAGTATTTTGGCCCA	CASSLGLAGPASADTQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	0	3	4	0	10	25	-1	52	39	62													Vb 3	CASSLGLAGPASADTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGCAACTCAGACTAGCGGGAGTGGCGATGAGCAGTTCTTCGGGCCA	CASATQTSGSGDEQFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	2	2	8	8	5	25	34	54	42	59													Vb 3	CASATQTSGSGDEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGAACGGATTCCTACGAGCAGTACTTCGGGCCG	CASGTDSYEQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	8	1	8	1	0	6	25	-1	37	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASGTDSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAACCAGACATCTATGTACCTCTGTGCCAGCAGACTTGAACTGGGACTAGCGGGCGAGGATGGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	13	2.9490227392337985E-5		58	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	4	4	9	10	23	34	55	43	65						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCGACTAGCGGTAAGAGCAGTTCTTCGGGCCA	CASTD*R*EQFF	Stop	VDJ	1	14	3.175870642251783E-5		36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	2	5	10	2	3	25	35	46	37	49						01,02							Vb 3	CASTD*R*EQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACGAGGGGCTTTTTGACTAATTCACCCCTCCACTTTGGGAAC	CASTRGFLTNSPLHF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-06	01	7	5	2	6	2	9	25	35	42	37	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASTRGFLTNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01		TCRBJ01-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAGGGGACCGGACAGGCAACTAGCGGGGCCAACGCAGTATTTTGGCCCA		Out	VDJ	1	14	3.175870642251783E-5		53	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	3	3	9	17	3	25	36	63	53	66													Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCATGATTTGCCCGGGGAGCTGTTTTTTGGAGAA	CASSPHDLPGELFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-02	01	5	2	8	6	6	5	25	37	45	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPHDLPGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCTCGCGGGAAAAGTTGATAACGAACACTGAAGCTTTCTTTGGACAA	CASSPSREKLITNTEAFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	7	3	1	5	12	25	37	48	42	60													Vb 3	CASSPSREKLITNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTAGAAACCGGGGGGGTTTCACAGTGAACACTGAAGCTTTCTTTGGACAA	CASRNRGGFTVNTEAFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	9	8	0	0	7	8	25	33	48	40	56													Vb 3	CASRNRGGFTVNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCTTTGACCTAAACACTGAAGCTTTCTTTGGACAA	CATFDLNTEAFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	10	2	7	2	5	3	25	32	40	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CATFDLNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACTCCTCCGGGACAGGGATTGGGCTATGGCTACACCTTCGGTTCG	CASTPPGQGLGYGYTF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	3	4	7	6	25	35	51	42	57													Vb 3	CASTPPGQGLGYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCACTATTACCGCCTCGGTAGGGAACACTGAAGCTTTCTTTGGACAA	CASSTITASVGNTEAFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	3	9	1	1	16	25	36	41	37	57						01,02							Vb 3	CASSTITASVGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACGTACACAACAGGGCAGAATCAGCCCCAGCATTTTGGTGAT	CASSTYTTGQNQPQHF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	4	9	3	25	37	52	46	55													Vb 3	CASSTYTTGQNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCATAGCGGGCCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	3.402718545269768E-5		41	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	4	2	2	3	25	37	46	39	49						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTACAGAGGAACAGAAGCTTTCTTTGGACAA	CASSYRGTEAFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	4	3	5	8	0	7	25	-1	42	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSYRGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCATCTGTCAGGATGGTCCAAAGGGGTCAGATACGCAGTATTTTGGCCCA	CAICQDGPKGSDTQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	5	2	4	18	1	25	32	55	50	56													Vb 3	CAICQDGPKGSDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCCCTTTGGGGCGGGAGGAGGGAGACAAGAGACCCAGTACTTCGGGCCA	CASSPPFGAGGGRQETQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	57	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	7	1	2	12	7	24	36	56	48	63													Vb 3	CASSPPFGAGGGRQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAACAGTCCCCGGACAGGGAGGACTAGCACAGATACGCAGTATTTTGGCCCA	CANSPRTGRTSTDTQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	3	0	4	6	25	37	49	41	55													Vb 3	CANSPRTGRTSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCATCCAGGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	16	3.629566448287752E-5		38	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	4	4	5	6	0	25	35	-1	41	45													Vb 3	X+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCGGACAGGGACCTACGAGCAGTACTTCGGGCCG	CASTRTGTYEQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	3	2	3	1	25	35	46	38	47													Vb 3	CASTRTGTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGTAAGAAAGCGGGCAAGCACAGATACGCAGTATTTTGGCCCA	CASSVRKRASTDTQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	6	4	0	8	2	25	36	50	44	52						01,02							Vb 3	CASSVRKRASTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAAGACTAGCGGGTTCACCGGGGAGCTGTTTTTTGGAGAA	CASSKTSGFTGELFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	2	4	4	2	2	25	37	49	39	51						01,02							Vb 3	CASSKTSGFTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACTAGCGGGGGCGCCGGCAATGAGCAGTTCTTCGGGCCA	CASSTSGGAGNEQFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	3	2	6	0	6	25	-1	48	37	54													Vb 3	CASSTSGGAGNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTATATTTACTGGGTTCGGGCAGCCCCAGCATTTTGGTGAT	CASSIFTGFGQPQHF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	8	4	7	10	0	25	41	-1	51	55						01,02							Vb 3	CASSIFTGFGQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCCCGTAGTCTACGAGCAGTACTTCGGGCCG	CASSPPVVYEQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	3	7	1	25	37	47	44	48						01,02							Vb 3	CASSPPVVYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGAAAAAGACTACATCAATGAGCAGTTCTTCGGGCCA	CASSLEKDYINEQFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	2	9	6	7	3	25	39	51	46	54						01,02							Vb 3	CASSLEKDYINEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCCCCCCGACAGATCGAAAATGAACACTGAAGCTTTCTTTGGACAA	CASPPDRSKMNTEAFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	2	5	0	6	8	25	34	45	40	53													Vb 3	CASPPDRSKMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCAAGCCACGTTTGGTGGCACCAACCAGACATCTATGTACTCTGTGCCACCCAGTTTAGGGGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	16	3.629566448287752E-5		38	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	20	5	1	4	17	0	43	40	-1	57	63													Vb 3	X+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAACTCAGGACAGGGTGAGGATCGATGGCTACACCTTCGGTTCG	CASRTQDRVRIDGYTF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	6	6	9	25	36	50	42	59													Vb 3	CASRTQDRVRIDGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGTTTTCGGGGGCGCCTGAAGCTTTCTTTGGACAA	CASRFSGAPEAFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	6	6	0	6	6	2	25	36	48	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRFSGAPEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGCCGGGAGCGGGAGAGTACGAGCAGTACTTCGGGCCG	CASSLPGAGEYEQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	6	2	4	6	2	25	39	53	45	55													Vb 3	CASSLPGAGEYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTTGGGGCTCAGGGGCACAGATACGCAGTATTTTGGCCCA	CASLGLRGTDTQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	4	3	1	8	0	25	34	-1	42	47													Vb 3	CASLGLRGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAATAGCGATTCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	4.083262254323721E-5		43	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	5	6	0	2	3	25	36	43	38	46						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAGAACACGAACTTCCACTGAAGCTTTCTTTGGACAA	CASSRTRTSTEAFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	5	3	6	4	3	8	25	37	43	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSRTRTSTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGAACGGGACGGGGTCGGCAACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	4.083262254323721E-5		46	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	5	0	7	5	5	10	25	37	47	42	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGGAGACTAGCTTACCATGAGCAGTTCTTCGGGCCA	CASSGRLAYHEQFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	7	8	4	5	25	37	48	41	53						01,02							Vb 3	CASSGRLAYHEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCAGACAGGGAACTATGGCTACACCTTCGGTTCG	CASSSQTGNYGYTF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	2	4	0	25	38	-1	42	49													Vb 3	CASSSQTGNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCATGACAATCAGCCCCAGCATTTTGGTGAT	CASSSHDNQPQHF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	4	2	8	3	5	0	25	38	-1	43	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSHDNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTAGGGGGTCCGCTCTACGAGCAGTACTTCGGGCCG	CASSLLGGPLYEQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	5	1	3	1	6	25	41	48	42	54													Vb 3	CASSLLGGPLYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATCCACCGGACAGGGCAAGGAAACACCATATATTTTGGAGAG	CASIHRTGQGNTIYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	1	3	4	6	3	25	35	49	41	52													Vb 3	CASIHRTGQGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCAGAAGGACTAGCGGAAAGGGGGACGCAGTATTTTGGCCCA		Out	VDJ	1	19	4.3101101573417056E-5		47	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	1	5	9	6	8	25	36	52	42	60						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAACCCCGGGGGAGCAGGAGCGCCCGAGCAGTACTTCGGGCCG	CASSNPGGAGAPEQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	2	6	5	12	25	37	48	42	60													Vb 3	CASSNPGGAGAPEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCAAGGGRGCACGCTGAAGCTTTCTTTGGACAA	CASSSRXHAEAFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	39	TCRBV28	TCRBV28-01	01	unresolved			TCRBJ01	TCRBJ01-01	01	4	5	0	6	2	3	25	38	47	40	50				TCRBD01,TCRBD02									Vb 3	CASSSRXHAEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	unresolved	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGGGACATAGCACAGATACGCAGTATTTTGGCCCA	CASSWGHSTDTQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	6	0	1	1	25	38	45	39	46													Vb 3	CASSWGHSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACTCCGGACAGAAACGAACTATGGCTACACCTTCGGTTCG	CASSLLRTETNYGYTF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	5	2	4	5	25	40	50	44	55													Vb 3	CASSLLRTETNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGAGGGCGGAGGGGGTTTATACCGTACCAAAAACATTCAGTACTTCGGCGCC	CASSEGGGGLYRTKNIQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	57	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-04	01	5	5	1	2	8	11	24	36	50	44	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSEGGGGLYRTKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01		TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCACGCGCGAGGGCGATGACAGATACGCAGTATTTTGGCCCA	CASSPRARAMTDTQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	11	0	3	9	5	25	36	50	45	55													Vb 3	CASSPRARAMTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAACCCAGCAGATACGCAGTATTTTGGCCCA	CASSNPADTQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	5	4	4	0	25	37	-1	41	44													Vb 3	CASSNPADTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGTACTAGCGGGAGACGAGCAGTACTTCGGGCCG	CASSLVLAGDEQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	3	2	5	2	0	25	40	-1	42	53													Vb 3	CASSLVLAGDEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGCATATGGGGCCGGGGGGGGACATTCAGTACTTCGGCGCC		Out	VDJ	1	20	4.5369580603596903E-5		50	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	0	8	0	8	10	1	25	42	60	52	61													Vb 3	X+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGCGACTAGCGGGAGGTCCCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	4.5369580603596903E-5		53	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	2	1	2	1	5	25	42	56	43	61													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTGGGGACTCTAAGCGCAGTTCTTCGGGCCA	CASSFWGL*AQFF	Stop	VDJ	1	20	4.5369580603596903E-5		39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	10	12	3	6	25	39	48	42	54						01,02							Vb 3	CASSFWGL*AQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACACGGAACGACAGAGAACTCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	21	4.7638059633776745E-5		49	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	5	0	8	6	25	35	48	43	54													Vb 3	X+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACGGGGGCGGCGGGATTGGGAAATGAGCAGTTCTTCGGGCCA	CASTGAAGLGNEQFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	7	6	0	7	1	13	25	35	42	36	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASTGAAGLGNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGACCGGGACTCACACAGATACGCAGTATTTTGGCCCA	CASRTGTHTDTQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	10	2	4	2	25	36	46	40	48						01,02							Vb 3	CASRTGTHTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCGGCGACAGGGCATGGCTACACCTTCGGTTCG	CASSLSATGHGYTF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	3	6	4	1	25	41	52	45	53													Vb 3	CASSLSATGHGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTACAGTCACTACGAGCAGTACTTCGGGCCG	CASSFYSHYEQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	5	3	2	3	25	39	45	41	48													Vb 3	CASSFYSHYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCTTAGGGCAGGGAACACTGAAGCTTTCTTTGGACAA	CASLRAGNTEAFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	8	4	4	1	7	0	25	34	-1	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASLRAGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAACTCAGGACAGGGTGGGGATCGATGGCTACACCTTCGGTTCG	CASRTQDRVGIDGYTF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	6	6	9	25	36	50	42	59													Vb 3	CASRTQDRVGIDGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCGACAGGACCTACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	22	4.990653866395659E-5		46	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	4	0	2	5	25	36	44	38	49													Vb 3	X+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCACAGGTTCCCGCTACAATGAGCAGTTCTTCGGGCCA	CASSSTGSRYNEQFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	4	3	2	6	25	38	45	40	51													Vb 3	CASSSTGSRYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCCTGGGGGGTCTCTCCTACAATGAGCAGTTCTTCGGGCCA	CALGGLSYNEQFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	11	9	1	0	2	3	25	31	39	33	42													Vb 3	CALGGLSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTTGGGGCCTATGAGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGAYESGANVLTF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	7	0	1	4	7	25	36	45	40	52													Vb 3	CASSLGAYESGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGAGGGGGGAGCTAACTATGGCTACACCTTCGGTTCG	CASREGGANYGYTF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	6	5	1	0	2	3	25	36	44	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASREGGANYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCCAATGAAAAACTGTTTTTTGGCAGT	CASSLPNEKLFF	In	VJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	2	0	0	5	0	3	25	-1	40	-1	43													Vb 3	CASSLPNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGGACTAGGCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSRTRLAKNIQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	6	1	8	0	2	3	25	36	45	38	48						01,02							Vb 3	CASSRTRLAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCCTCCGGGACAGGGAGACACCGGGGAGCTGTTTTTTGGAGAA	CASRPPGQGDTGELFF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	3	6	2	25	36	51	42	53													Vb 3	CASRPPGQGDTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATATCCAGGACAGACTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASISRTDYSGANVLTF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	1	5	0	6	4	25	35	47	41	51													Vb 3	CASISRTDYSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCAACCGGGACTAGCGGGGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPTGTSGGSSYNEQFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	57	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	0	6	3	24	36	56	42	59													Vb 3	CASSPTGTSGGSSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAGGGCGGGACTAGCGGGAGCAGGGCAGTACTTCGGGCCG	CASSRAGLAGAGQYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	0	2	9	5	4	25	37	56	42	60													Vb 3	CASSRAGLAGAGQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGACAGGGAACTGAAGCTTTCTTTGGACAA	CASSRQGTEAFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	5	1	1	25	37	45	38	46													Vb 3	CASSRQGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGGGGACTAGCGGGGGAGAGACCCAGTACTTCGGGCCA	CASSWGTSGGETQYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	0	2	4	2	0	25	38	-1	40	54													Vb 3	CASSWGTSGGETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACTCATTCGGGGAAGTGGAAAGATACGCAGTATTTTGGCCCA	CASTHSGKWKDTQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	8	3	5	6	8	25	35	46	41	54													Vb 3	CASTHSGKWKDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGTTGGACAGCCCAAGAGACCCAGTACTTCGGGCCA	CASSRWTAQETQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	5	1	5	1	25	36	47	41	48													Vb 3	CASSRWTAQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTCACCGGGGCCCAAGCCTACGAGCAGTACTTCGGGCCG	CASSFTGAQAYEQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	6	7	0	2	7	5	25	36	48	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFTGAQAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGGACTAGCGGAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	26	5.898045478467597E-5		47	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	1	5	2	1	2	25	40	51	41	53						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCAGACCCCAATCGTCTCTATGGCTACACCTTCGGTTCG	CASSLPDPNRLYGYTF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	48	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	2	2	7	4	3	11	25	40	46	43	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLPDPNRLYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTGGGACATTAGCACAGATACGCAGTATTTTGGCCCA	CASWDISTDTQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	0	6	0	1	2	25	34	41	35	43													Vb 3	CASWDISTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAACAGTTTAAGGCCGGCAGGGGGCACCATAAACACTGAAGCTTTCTTTGGACAA	CANSLRPAGGTINTEAFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	0	2	7	6	25	40	55	47	61													Vb 3	CANSLRPAGGTINTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCAACTAGCGGGAGGGGATTTCGGTATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	27	6.124893381485581E-5		46	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	3	0	8	3	9	25	32	48	35	57													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGAGCCCAGGGGCCTAGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSEPRGLGTGELFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	2	5	5	7	25	37	48	42	55													Vb 3	CASSEPRGLGTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGAATCTAACACTGAAGCTTTCTTTGGACAA	CASSLESNTEAFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	3	1	8	2	0	4	25	-1	42	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLESNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTCCAGGGTTCACTGAAGCTTTCTTTGGACAA	CASSSPGFTEAFF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	4	3	2	25	38	46	41	48													Vb 3	CASSSPGFTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTCGGGGGACGGCGAGCGAAAAACTGTTTTTTGGCAGT	CASSSRGTASEKLFF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	4	8	2	8	2	9	25	38	46	40	55													Vb 3	CASSSRGTASEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAATTTGGACAACACTAACTATGGCTACACCTTCGGTTCG	CASNLDNTNYGYTF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	6	0	0	3	25	-1	44	39	47													Vb 3	CASNLDNTNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCAATTTGGGCTCCTGATCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	29	6.578589187521551E-5		49	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	8	0	1	8	6	25	35	47	43	53													Vb 3	X+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGAGGCCGGGAGGAACATTCAGTACTTCGGCGCC	CASEAGRNIQYF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	8	8	1	7	5	0	25	34	-1	39	46													Vb 3	CASEAGRNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTCTGCCCCGCGGGTTTGGAACAATGAGCAGTTCTTCGGGCCA	CASSAPRVWNNEQFF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	7	4	5	8	6	25	34	47	42	53						01,02							Vb 3	CASSAPRVWNNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCATTAGTGGCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	30	6.805437090539536E-5		40	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	6	9	0	1	7	0	25	36	-1	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGGGACGGGCTATGGCTACACCTTCGGTTCG	CASSGTGYGYTF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	6	0	7	4	1	3	25	36	42	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSGTGYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGAACAGCAATCAGCCCCAGCATTTTGGTGAT	CASSWNSNQPQHF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	4	1	8	1	0	2	25	-1	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSWNSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTCGGGACTAGGCCTAGAGCAGTTCTTCGGGCCA	CASSGLGLEQFF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	0	8	10	2	5	25	34	44	36	49						01,02							Vb 3	CASSGLGLEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACCGGCTACCCCAAGAAGGGCCAGTACTTCGGGCCA	CASSTGYPKKGQYF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	5	5	3	10	16	0	25	37	-1	53	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSTGYPKKGQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGACAGGGGTGCGCACTGAAGCTTTCTTTGGACAA	CASSSTGVRTEAFF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	2	4	1	4	25	38	47	39	51													Vb 3	CASSSTGVRTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACAACAACGAACTTATGGCTACACCTTCGGTTCG	CASSLQQRTYGYTF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	2	3	6	5	2	7	25	40	45	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLQQRTYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCGGGAGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFRESYNEQFF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	2	1	1	0	25	39	-1	40	46													Vb 3	CASSFRESYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCGAGCGGGAGAAGGGTACGAGCAGTACTTCGGGCCG	CASRRAGEGYEQYF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	6	2	4	3	5	25	36	47	39	52													Vb 3	CASRRAGEGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAAGGGGCCCTATGGCTACACCTTCGGTTCG	CASSKGPYGYTF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	5	2	4	1	2	25	37	43	38	45													Vb 3	CASSKGPYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCGAATTCCGGGACCTTTGGTGTCAGCCCCAGCATTTTGGTGAT	CASTEFRDLWCQPQHF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	48	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	7	0	7	6	9	8	25	35	49	44	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASTEFRDLWCQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCAAGCTCCCGGGGCTACACCTTCGGTTCG	CASSSSSRGYTF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	6	7	8	2	6	25	38	43	40	49						01,02							Vb 3	CASSSSSRGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTTGGGTAGCGGGAGCTTACGAGCAGTACTTCGGGCCG	CASSSWVAGAYEQYF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	5	2	4	6	2	25	38	53	44	55													Vb 3	CASSSWVAGAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCGGACAGACTAATTCCTACGAGCAGTACTTCGGGCCG	CAGQTNSYEQYF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	1	5	1	0	6	25	-1	37	31	43													Vb 3	CAGQTNSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATATAGGAACACTGAAGCTTTCTTTGGACAA	CASSLYRNTEAFF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	5	8	1	1	0	25	41	-1	42	45						01,02							Vb 3	CASSLYRNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCATAGCGGGAGGGTACAATGAGCAGTTCTTCGGGCCA	CASSFIAGGYNEQFF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	5	0	4	2	0	25	39	-1	41	52													Vb 3	CASSFIAGGYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGTAGCGGGATTGGGGGAAATGAGCAGTTCTTCGGGCCA	CASSRSGIGGNEQFF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	3	7	3	8	25	36	47	39	55													Vb 3	CASSRSGIGGNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCCGGGAGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRPGGSYNEQFF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	1	0	2	0	25	36	-1	38	45													Vb 3	CASRPGGSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTACTATGAGGGGCTGATGGGGAATGAAAAACTGTTTTTTGGCAGT	CASSYYEGLMGNEKLFF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	51	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	4	5	2	5	6	9	25	38	49	44	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSYYEGLMGNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGCGGCAGGGGGTCAGCCCCAGCATTTTGGTGAT	CASSFAAGGQPQHF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	1	6	5	0	25	39	-1	44	51													Vb 3	CASSFAAGGQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGAATGGCCTCCAAGAGACCCAGTACTTCGGGCCA	CASSLNGLQETQYF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	9	0	1	4	2	25	39	46	43	48													Vb 3	CASSLNGLQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGGCTTAACACAGATACGCAGTATTTTGGCCCA	CASSLGLNTDTQYF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	7	0	2	0	4	25	-1	44	39	48													Vb 3	CASSLGLNTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACTAGAATTTGGACAGGGGGGTACCAAGAGACCCAGTACTTCGGGCCA	CATRIWTGGYQETQYF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	1	1	0	9	2	25	32	51	41	53													Vb 3	CATRIWTGGYQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGATAGGGGACTAATGAAAAACTGTTTTTTGGCAGT	CASSR*GTNEKLFF	Stop	VDJ	1	39	8.847068217701396E-5		42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	5	2	2	4	0	25	37	-1	41	46													Vb 3	CASSR*GTNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTCTCAAGATTCAGTGGGGAATCAGCCCCAGCATTTTGGTGAT	CASSFSQDSVGNQPQHF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	51	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	3	6	2	4	15	0	25	39	-1	54	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFSQDSVGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCAGGAGTCTTAATGAAAAACTGTTTTTTGGCAGT	CASTRSLNEKLFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	7	4	4	4	1	5	25	35	40	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASTRSLNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCACCGGGGGCCTGAACACTGAAGCTTTCTTTGGACAA	CASSTGGLNTEAFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	6	6	0	0	4	1	25	36	46	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSTGGLNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCTGATTCGTGGACCCAGTACTTCGGGCCA	CASSPDSWTQYF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	6	2	8	7	4	6	25	36	42	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPDSWTQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGGTAGAATACAACCTAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSWVEYNLANTGELFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	4	8	0	14	0	25	38	-1	52	56						01,02							Vb 3	CASSWVEYNLANTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACTAGCGGGACCCTACAATGAGCAGTTCTTCGGGCCA	CASSLLAGPYNEQFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	4	3	2	0	1	25	-1	49	40	50													Vb 3	CASSLLAGPYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCTGGCTAGCGATCCCATGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSFLASDPMGTGELFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	4	6	5	5	11	25	39	50	44	61						01,02							Vb 3	CASSFLASDPMGTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGGACAGGGCAATGGATACGCAGTATTTTGGCCCA	CASSWDRAMDTQYF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	3	6	0	5	25	-1	47	38	52													Vb 3	CASSWDRAMDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGCTTCACGTGGACAGGGACCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	42	9.527611926755349E-5		52	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	3	2	8	2	25	42	58	50	60													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCGCCCCAGGGGCACTTCTATGGCTACACCTTCGGTTCG	CASSPPQGHFYGYTF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	2	4	7	5	25	36	49	43	54													Vb 3	CASSPPQGHFYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGGACTACCAACCCACAGATACGCAGTATTTTGGCCCA	CASSLWDYQPTDTQYF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	1	9	2	0	6	25	-1	48	42	54						01,02							Vb 3	CASSLWDYQPTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGGAGGGGTGGCTGAGCAGTTCTTCGGGCCA	CASSFGGVAEQFF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	0	9	1	5	25	39	46	40	51													Vb 3	CASSFGGVAEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAACCAGACATCTATGTACCTCTGTGCCAGCAGTATCCGGGACTAGCGGGAGGGCATAAGGTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	43	9.754459829773334E-5		58	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	0	0	3	4	8	23	35	55	39	63													Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTTGGACAGGGAATATCTCAGCCCCAGCATTTTGGTGAT	CASSLGQGISQPQHF	In	VDJ	1	44	9.981307732791318E-5	1.281159099578091E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	3	6	4	6	25	36	48	40	54													Vb 3	CASSLGQGISQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTAGGGGGATAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	44	9.981307732791318E-5		46	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	5	1	0	2	2	25	39	47	41	49													Vb 3	X+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAGAATCGACAGCCTACACAGATACGCAGTATTTTGGCCCA	CASRESTAYTDTQYF	In	VDJ	2	46	1.0435003538827287E-4	1.3393936041043678E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	5	2	6	4	25	36	47	42	51													Vb 3	CASRESTAYTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAAGGGAACAAGAACTCTCCTACGAGCAGTACTTCGGGCCG	CASRREQELSYEQYF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	6	0	8	0	2	9	25	36	42	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRREQELSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGGATGGGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSPGWGMNTEAFF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	5	6	1	0	7	1	25	37	49	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPGWGMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGAAATGGACAGGGCCATGGCTACACCTTCGGTTCG		Out	VDJ	2	51	1.1569243053917209E-4		41	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	6	5	2	25	37	50	42	52													Vb 3	X+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGTCGACTCTCTTGACGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	2	53	1.2022938859953179E-4		50	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	2	10	4	3	15	25	37	44	40	59						01,02							Vb 3	X+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCTAGCGTACACAGAGACCCAGTACTTCGGGCCA	CASRLAYTETQYF	In	VDJ	2	58	1.3157178375043101E-4	1.688800631262029E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	4	6	4	1	5	25	36	43	37	48						01,02							Vb 3	CASRLAYTETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTCTAACGTCACGGGCGGACCACACCGGGGAGCTGTTTTTTGGAGAA	CASSSLTSRADHTGELFF	In	VDJ	2	59	1.3384026278061086E-4	1.7179178835251675E-4	54	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-02	01	4	1	7	3	16	1	25	38	58	54	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSLTSRADHTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCAAAGGACCGCGGACTAGCGGTTACGAGCAGTACTTCGGGCCG	CASSKGPRTSGYEQYF	In	VDJ	2	60	1.361087418107907E-4	1.747035135788306E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	1	5	4	11	1	25	36	57	47	58						01,02							Vb 3	CASSKGPRTSGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCCGACTAGCGGAGAATACAATGAGCAGTTCTTCGGGCCA	CASRPTSGEYNEQFF	In	VDJ	2	60	1.361087418107907E-4	1.747035135788306E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	5	4	3	4	25	36	48	39	52						01,02							Vb 3	CASRPTSGEYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAGAAATCGACGGGTACAATGAGCAGTTCTTCGGGCCA	CASREIDGYNEQFF	In	VDJ	2	61	1.3837722084097056E-4	1.7761523880514444E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	8	4	4	9	0	25	36	-1	45	49						01,02							Vb 3	CASREIDGYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGACAGGGGGCGGGAGACCCAGTACTTCGGGCCA	CASSDRGRETQYF	In	VDJ	2	63	1.4291417890133023E-4	1.8343868925777213E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	0	5	0	2	25	-1	47	37	49													Vb 3	CASSDRGRETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCGAGGGTCAGTAGACCTCACCGGGGAGCTGTTTTTTGGAGAA	CASRGSVDLTGELFF	In	VDJ	2	64	1.4518265793151007E-4	1.8635041448408597E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	11	0	4	1	11	25	34	40	35	51													Vb 3	CASRGSVDLTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCAGGGGGGAGAACATTCAGTACTTCGGCGCC	CASSRGENIQYF	In	VDJ	2	66	1.4971961599186977E-4	1.9217386493671366E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	4	1	7	0	3	25	-1	43	36	46													Vb 3	CASSRGENIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCGACTTCATATGAGCAGTTCTTCGGGCCA	CASSPTSYEQFF	In	VDJ	2	66	1.4971961599186977E-4	1.9217386493671366E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	10	8	3	4	25	36	43	39	47						01,02							Vb 3	CASSPTSYEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCATCGGACTCTCTGGAAACACCATATATTTTGGAGAG	CASSIGLSGNTIYF	In	VDJ	2	70	1.5879353211258916E-4	2.0382076584196903E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	1	10	0	4	0	25	36	-1	40	45						01,02							Vb 3	CASSIGLSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGAGGGACTTAAGCGGGAGCTATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	83	1.8828375950492713E-4		43	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	6	2	8	10	2	25	34	52	44	54													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACCTTAGCGGGATCGGCCTACGAGCAGTACTTCGGGCCG	CASSTLAGSAYEQYF	In	VDJ	3	85	1.9282071756528683E-4	2.474966442366767E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	5	3	2	4	4	25	37	49	41	53													Vb 3	CASSTLAGSAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCATCCAAGCCCGTTGGAAACACCATATATTTTGGAGAG	CASSSSKPVGNTIYF	In	VDJ	3	86	1.9508919659546667E-4	2.504083694629905E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	6	7	3	6	4	25	38	47	44	51						01,02							Vb 3	CASSSSKPVGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCATGGGGGTCGGACGGGATCAGCCCCAGCATTTTGGTGAT	CASSFMGVGRDQPQHF	In	VDJ	3	100	2.268479030179845E-4	2.911725226313843E-4	48	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	3	6	1	5	3	9	25	39	47	42	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFMGVGRDQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTAGGGCCTTACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	103	2.3365334010852403E-4		40	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	5	5	3	2	2	5	25	37	43	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGGAGGACCCTGCTTGGCGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSWEDPAWRGSYNEQFF	In	VDJ	4	106	2.4045877719906358E-4	3.086428739892674E-4	57	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	7	3	0	16	0	24	37	-1	53	59						01,02							Vb 3	CASSWEDPAWRGSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGGGAACAGGGAGTGAGACCCAGTACTTCGGGCCA	CASSSGTGSETQYF	In	VDJ	4	107	2.4272725622924343E-4	3.115545992155812E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	3	5	5	3	25	38	49	43	52													Vb 3	CASSSGTGSETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCAGACTAGCGCTTAGCACAGATACGCAGTATTTTGGCCCA	CASSRLALSTDTQYF	In	VDJ	4	113	2.563381304103225E-4	3.2902495057346426E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	6	0	2	3	25	36	46	38	49						01,02							Vb 3	CASSRLALSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACAAATGTTCCGGACAGGGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSTNVPDRGSTDTQYF	In	VDJ	4	113	2.563381304103225E-4	3.2902495057346426E-4	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	2	0	11	1	25	37	57	48	58													Vb 3	CASSTNVPDRGSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAACCAGACATCTATGTACCTCTGTGCCAGCAAACCTCAACCGGGACTAGCGGGTTAGACGGGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	115	2.6087508847068215E-4		58	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	4	7	10	11	23	33	55	43	66						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCTCGACAGGATACCTGTCTGATGGCTACACCTTCGGTTCG	CASSPSTGYLSDGYTF	In	VDJ	4	123	2.7902292071212094E-4	3.581422028366027E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	4	6	5	11	25	37	48	42	59													Vb 3	CASSPSTGYLSDGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCGACAGGGGGGAGAGATACGCAGTATTTTGGCCCA		Out	VDJ	4	124	2.8129139974230076E-4		41	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	1	5	2	3	25	36	47	38	50													Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGATCTCAGGGGTATACTGAAGCTTTCTTTGGACAA	CASRSQGYTEAFF	In	VDJ	5	144	3.2666098034589766E-4	4.1928843258919344E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	5	4	3	25	36	46	40	49													Vb 3	CASRSQGYTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGCCCCCGAGAGGAGACCCAGTACTTCGGGCCA	CASSLSPREETQYF	In	VDJ	5	147	3.3346641743643723E-4	4.2802360826813495E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	6	7	5	0	9	25	-1	43	40	52						01,02							Vb 3	CASSLSPREETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCATCAGCGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPISGSSYNEQFF	In	VDJ	5	151	3.425403335571566E-4	4.396705091733903E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	6	2	0	7	0	25	36	-1	43	51													Vb 3	CASSPISGSSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAACCTCTACAACGAGCAGTACTTCGGGCCG	CASSLNLYNEQYF	In	VDJ	5	151	3.425403335571566E-4	4.396705091733903E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	2	3	6	5	7	0	25	40	-1	47	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLNLYNEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCCGGGATGGGGGACTACGAGCAGTACTTCGGGCCG	CASSLSGMGDYEQYF	In	VDJ	5	153	3.4707729161751627E-4	4.45493959626018E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	1	6	1	3	7	1	25	41	53	48	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLSGMGDYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCCGGGACTAGCGGGAGGTCTATTCGGGCCG		Out	VDJ	5	158	3.5841968676841553E-4		40	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	0	1	16	3	4	25	40	58	43	62													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTCTGGGGCCTAGCGGGAGGTTAAGGGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	6	165	3.7429903997967444E-4		52	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	4	1	6	8	7	25	34	53	42	60													Vb 3	X+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATAGCGATCTGGGGGGACAAGGCAGACTATGGCTACACCTTCGGTTCG	CASIAIWGDKADYGYTF	In	VDJ	6	173	3.9244687222111317E-4	5.037284641522949E-4	51	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	7	0	6	3	12	6	25	35	53	47	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASIAIWGDKADYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCCAATGGAGGGGAAATCAGCCCCAGCATTTTGGTGAT	CATQWRGNQPQHF	In	VDJ	6	192	4.3554797379453025E-4	5.590512434522579E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	10	10	0	4	6	2	25	32	44	38	46													Vb 3	CATQWRGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGGGTGTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	7	212	4.8091755439812715E-4		44	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-06	01	3	0	9	1	1	2	25	39	43	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCAGGGGGCGGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	7	222	5.036023446999256E-4		41	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	0	4	3	3	25	36	47	39	50													Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGAGTGCAGGTGCGGTTGGCTACACCTTCGGTTCG	CASSLGSAGAVGYTF	In	VDJ	8	238	5.398980091828031E-4	6.929906038626946E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	9	2	7	0	12	25	-1	45	40	57													Vb 3	CASSLGSAGAVGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCACCCTCGGTCAGGCTAGAAGGATGCGGGAGACCCAGTACTTCGGGCCA	CASSPTLGQARRMRETQYF	In	VDJ	9	263	5.966099849372993E-4	7.657837345205408E-4	57	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	6	4	4	5	13	14	24	35	52	48	66				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPTLGQARRMRETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCGGACGCCCCTACGAGCAGTACTTCGGGCCG	CASSLGRPYEQYF	In	VDJ	9	280	6.351741284503566E-4	8.152830633678761E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	5	1	7	2	3	3	25	37	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGRPYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCCCTACAGGGGCGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLSLQGRNTGELFF	In	VDJ	10	298	6.760067509935939E-4	8.676941174415253E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	3	2	1	4	2	25	41	52	45	54													Vb 3	CASSLSLQGRNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTGGGGCGGGACAGAGCTTTACGAGCAGTACTTCGGGCCG	CASSWGGTELYEQYF	In	VDJ	11	313	7.100339364462915E-4	9.113699958362329E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	4	7	5	25	36	50	43	55													Vb 3	CASSWGGTELYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACAATCGCCGGGACAGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASRQSPGQGYTGELFF	In	VDJ	12	370	8.393372411665427E-4	0.001077338333736122	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	2	3	9	1	25	36	55	45	56													Vb 3	CASRQSPGQGYTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCCCCCGGGAGGCGCTGGATACGCAGTATTTTGGCCCA	CASSPPREALDTQYF	In	VDJ	13	393	8.915122588606791E-4	0.0011443080139413404	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	8	1	6	7	5	25	36	50	43	55													Vb 3	CASSPPREALDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACTGTTGATGGGACAGTAGAGACCCAGTACTTCGGGCCA	CASSTVDGTVETQYF	In	VDJ	19	553	0.0012544689036894543	0.0016101840501515554	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	5	4	9	1	25	37	53	46	54													Vb 3	CASSTVDGTVETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACGTCCGGGACGGATAACAATGAGCAGTTCTTCGGGCCA	CASTSGTDNNEQFF	In	VDJ	30	879	0.0019939930675280837	0.002559406473929868	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	7	0	7	5	5	5	25	35	45	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASTSGTDNNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCTGTGCCAGCAGTTTAGGCGGAATGAGGGCAATCCGGACTAGCGGGACCCCCGGAACCCAGTACTTCGGGCCA	CASSLGGMRAIRTSGTPGTQYF	In	VDJ	38	1118	0.0025361595557410665	0.003255308803018877	66	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	1	3	8	19	8	2	17	48	36	56													Vb 3	CASSLGGMRAIRTSGTPGTQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGCCCGGGGCGGGAGGCCTCTACGAGCAGTACTTCGGGCCG	CASSPPGAGGLYEQYF	In	VDJ	69	2033	0.004611817868355625	0.0059195373850960435	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	1	3	9	3	25	37	54	46	57													Vb 3	CASSPPGAGGLYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACAAACAGAAAACAATGAGCAGTTCTTCGGGCCA	CASSLQTENNEQFF	In	VDJ	86	2535	0.005750594341505907	0.007381223448705593	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	5	5	3	3	25	40	47	43	50													Vb 3	CASSLQTENNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCCAGTTTAGGGGGAATCAGCCCCAGCATTTTGGTGAT	CATQFRGNQPQHF	In	VDJ	109	3230	0.007327187267480899	0.009404872480993713	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	5	1	4	8	0	25	32	-1	40	46													Vb 3	CATQFRGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTACAGGGCCCTAGCGGGGATTCTAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	9	2.0416311271618604E-5		56	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	2	8	5	18	31	48	39	53														X+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGTAGGAACCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	9	2.0416311271618604E-5		44	TCRBV12	TCRBV12-02	01				TCRBJ01	TCRBJ01-01	01	1	1	8	0	2	3	18	34	39	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-02+TCRBJ01-01	TCRBV12-02*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTCCTCTGACCTTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	9	2.0416311271618604E-5		43	TCRBV12	TCRBV12-02	01				TCRBJ01	TCRBJ01-02	01	3	2	7	1	5	2	18	32	40	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-02+TCRBJ01-02	TCRBV12-02*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCGGTTTTTACTGACTAGCGGGATTGAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	11	2.4953269331978296E-5		52	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	2	3	7	10	4	18	30	51	40	55														X+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCAAGTCGCTTAGTCGGTTGGGTTGGGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	14	3.175870642251783E-5		52	TCRBV12	TCRBV12-02	01				TCRBJ02	TCRBJ02-02	01	1	0	9	1	6	5	18	34	43	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTCCTCCCCGGGACATGGATGGACGACTAATGAAAAACTGTTTTTTGGCAGT	CASRSSPGHGWTTNEKLFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	57	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	6	2	7	10	18	31	44	38	54														CASRSSPGHGWTTNEKLFF+TCRBV12-02+TCRBJ01-04	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCCTCCCCCCACCAGGACTAGCGTTTAACACCGGGGAGCTGTTTTTTGGAGAA	CASRLPPPGLAFNTGELFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	57	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	1	6	2	12	3	18	30	51	42	54						01,02								CASRLPPPGLAFNTGELFF+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGTAGTCCATCCCCGGGACTGGCCCTAAGCGGGGAGCTGTTTTTTGGAGAA	CASSPSPGLALSGELFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	51	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	0	10	7	11	9	18	27	44	38	53						01,02								CASSPSPGLALSGELFF+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCGACGGACTAGCTGTGCGATACAATGAGCAGTTCTTCGGGCCA	CASRDGLAVRYNEQFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	48	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	7	4	3	7	18	30	41	33	48						01,02								CASRDGLAVRYNEQFF+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCGGTCCCGTACTAGCGGGGACCAATGAGCAGTTCTTCGGGCCA	CAGPVLAGTNEQFF	In	VDJ	2	53	1.2022938859953179E-4	1.543214369946337E-4	42	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	12	3	3	6	9	2	18	23	42	32	44														CAGPVLAGTNEQFF+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTGTACAGTAACAGGGGACACTATTCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRCTVTGDTIPNTGELFF	In	VDJ	5	144	3.2666098034589766E-4	4.1928843258919344E-4	60	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	2	0	8	9	18	31	46	39	55														CASRCTVTGDTIPNTGELFF+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCGAATAGAGGGGCCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	9	2.0416311271618604E-5		37	TCRBV27	TCRBV27-01	01				TCRBJ01	TCRBJ01-01	01	8	5	2	4	6	1	23	32	43	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	X+TCRBV27-01+TCRBJ01-01	TCRBV27-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCACCAGTGATCCTTTGGCGAGACTAGCGGGCGCAGATACGCAGTATTTTGGCCCA	CATSDPLARLAGADTQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	54	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	4	4	13	2	23	35	58	48	60						01,02							Vb 14	CATSDPLARLAGADTQYF+TCRBV27-01+TCRBJ02-03	TCRBV27-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGCCCCGGACAGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	12	2.722174836215814E-5		47	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	2	0	4	0	23	34	-1	38	47													Vb 14	X+TCRBV27-01+TCRBJ02-02	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCACCAGTGCCCTGGTGGGGGAACCGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	16	3.629566448287752E-5		49	TCRBV27	TCRBV27-01	01				TCRBJ01	TCRBJ01-05	01	5	6	1	2	8	4	23	35	48	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	X+TCRBV27-01+TCRBJ01-05	TCRBV27-01*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTAACTATGAATCAGCCCCAGCATTTTGGTGAT	CASSLTMNQPQHF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	3	9	4	0	2	23	-1	42	38	44						01,02							Vb 14	CASSLTMNQPQHF+TCRBV27-01+TCRBJ01-05	TCRBV27-01*01	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTAGGACAGGCTCCTTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	19	4.3101101573417056E-5		46	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	1	4	3	0	5	23	-1	45	38	50													Vb 14	X+TCRBV27-01+TCRBJ01-03	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCACCAGTGCGACTGGTCCTTTCAACAATGAGCAGTTCTTCGGGCCA	CATSATGPFNNEQFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	45	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	10	5	2	10	23	35	41	37	51						01,02							Vb 14	CATSATGPFNNEQFF+TCRBV27-01+TCRBJ02-01	TCRBV27-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTAGGGAGGGCGTCAGATACGCAGTATTTTGGCCCA	CASSLGRASDTQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	42	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	9	0	4	0	3	23	-1	45	38	48													Vb 14	CASSLGRASDTQYF+TCRBV27-01+TCRBJ02-03	TCRBV27-01*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTACAGGGGGGGAGCACTGAAGCTTTCTTTGGACAA	CASSLQGGSTEAFF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	42	TCRBV27	TCRBV27-01	01				TCRBJ01	TCRBJ01-01	01	2	4	1	4	0	4	23	-1	45	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	CASSLQGGSTEAFF+TCRBV27-01+TCRBJ01-01	TCRBV27-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTCCGAGGGGAGGGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSFRGEGANTEAFF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	48	TCRBV27	TCRBV27-01	01				TCRBJ01	TCRBJ01-01	01	3	5	0	1	8	0	23	37	-1	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	CASSFRGEGANTEAFF+TCRBV27-01+TCRBJ01-01	TCRBV27-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGACTCCCGGGACCGATCACCGGGGAGCTGTTTTTTGGAGAA	CASRLPGPITGELFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	45	TCRBV27	TCRBV27-01	01				TCRBJ02	TCRBJ02-02	01	6	0	7	4	6	4	23	34	45	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	CASRLPGPITGELFF+TCRBV27-01+TCRBJ02-02	TCRBV27-01*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTAGCGGCTAGATACACCGGGGAGCTGTTTTTTGGAGAA	CASSLAARYTGELFF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	45	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	4	8	3	4	2	23	38	46	42	48						01,02							Vb 14	CASSLAARYTGELFF+TCRBV27-01+TCRBJ02-02	TCRBV27-01*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATTGGTACGGGGGCCTGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CSVELVRGPGGNQPQHF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	51	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	2	6	0	2	7	6	25	37	50	44	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVELVRGPGGNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTAGGGTTGGAAGGTAAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	9	2.0416311271618604E-5		44	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	4	5	3	4	1	11	25	35	40	36	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGTGTGGACTGGCCCTAGTAATGAGCAGTACTTCGGGCCG	CSVVWTGPSNEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	1	10	7	5	12	25	33	43	38	55						01,02							Vb 4	CSVVWTGPSNEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCACGGGAGGAATTGAGCAGTTCTTCGGGCCA	CSVATGGIEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	1	9	3	3	25	35	45	38	48													Vb 4	CSVATGGIEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCGGCCAGGGGAGGTGTGGCTACACCTTCGGTTCG	CSVVGQGRCGYTF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	4	4	2	7	5	5	25	35	46	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVGQGRCGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCCGGGACAGGGGGCTTTCGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	10	2.2684790301798452E-5		43	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	0	5	3	4	25	34	49	37	53													Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTGGCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCAATATCTCTGCAGCGTTGAAACCGGAAGGGGGACCCAGTACTTCGGGCCA	CSVETGRGTQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	5	2	7	6	0	45	57	-1	63	68													Vb 4	CSVETGRGTQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGTGACCGGGACAGGGTATGGCTACACCTTCGGTTCG	CSVGVTGTGYGYTF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	5	8	0	25	35	-1	43	52													Vb 4	CSVGVTGTGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGGAGGAGAGAACACTTGGACTGAAGCTTTCTTTGGACAA	CSVGGENTWTEAFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	1	5	1	13	25	33	39	34	52													Vb 4	CSVGGENTWTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGACCGGACAGGGGGTTATTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVTGQGVISGANVLTF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	1	1	1	4	5	25	33	47	37	52													Vb 4	CSVTGQGVISGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCGGCAGGGGGATGGGATCAGCCCCAGCATTTTGGTGAT	CSVSAGGWDQPQHF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	1	5	4	5	25	34	45	38	50													Vb 4	CSVSAGGWDQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCCGGGAGAACTATGGCTACACCTTCGGTTCG	CSVVRENYGYTF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	8	2	2	2	0	25	35	-1	37	43													Vb 4	CSVVRENYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCATATATTCTGCAGCGGACTAGCGGGAGATGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	14	3.175870642251783E-5		38	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	17	1	2	5	8	5	43	40	61	48	66													Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACGCAGCATATATCTCTGCAGCGGACTAGCGGGAGATGGGGAGACCCAGTACTTCGGGCCA	CSGLAGDGETQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	2	2	5	0	5	42	-1	61	49	66													Vb 4	CSGLAGDGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCAAGCCACGTTTGGTGGCCCTGAAGCAGCAGCATATATCTCTGCAGCGGACTAGCGGGAGATGGGGAGACCCAGTACTTCGGGCCA	CSGLAGDGETQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	2	2	5	0	5	42	-1	61	49	66													Vb 4	CSGLAGDGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGGGGGATAACTAGCACAGATACGCAGTATTTTGGCCCA	CSVGGITSTDTQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	9	0	0	0	6	25	-1	40	33	46													Vb 4	CSVGGITSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCTGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CSVAGSYNEQFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	4	0	9	1	2	0	25	35	-1	37	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVAGSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGGCCCTGAAAGACAGCAGCATATATCTCTGCAGCGGACTAGCGGGAGATGGGGAGACCCAGTACTTCGGGCCA	CSGLAGDGETQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	2	2	5	0	5	42	-1	61	49	66													Vb 4	CSGLAGDGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCTCGACAGGGGGCGGTCAGCCCCAGCATTTTGGTGAT	CSVSTGGGQPQHF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	0	6	3	2	25	33	46	36	48													Vb 4	CSVSTGGGQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGCATGGAGGGGGCGCCTTATGCAGATACGCAGTATTTTGGCCCA	CSVEGMEGAPYADTQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	5	0	4	6	8	25	38	51	44	59													Vb 4	CSVEGMEGAPYADTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTATAAGTGGGGGCACTGAAGCTTTCTTTGGACAA	CSAISGGTEAFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	7	6	1	4	8	0	25	32	-1	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAISGGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCATATWCTCTGCAGCGGACTAGCGGGAGATGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	17	3.8564143513057367E-5		38	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	19	1	2	5	10	5	43	38	61	48	66													Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTGGTGTCTAGCGGGAGAGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	4.083262254323721E-5		44	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	4	2	5	7	3	25	32	49	39	52													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGGACTAGCTCTAGCACAGATACGCAGTATTTTGGCCCA	CSVRTSSSTDTQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	7	0	1	3	25	34	43	35	46						01,02							Vb 4	CSVRTSSSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCCTCGCGACAGGGCGTCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	4.083262254323721E-5		50	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	3	2	7	5	25	39	53	46	58													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACCACAGGGGGGTTGAAGCTTTCTTTGGACAA	CSVDHRGVEAFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	1	7	2	2	25	36	46	38	48													Vb 4	CSVDHRGVEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCGGGGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSVAGGSSYNEQFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	2	0	1	3	25	35	42	36	45													Vb 4	CSVAGGSSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCGGGTCAGTGGGTGCCATCTACAATGAGCAGTTCTTCGGGCCA	CSVAGSVGAIYNEQFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	8	4	3	1	14	25	35	40	36	54						01,02							Vb 4	CSVAGSVGAIYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGCAGGGGGGCCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	4.083262254323721E-5		40	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	1	1	1	3	25	35	43	36	46													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGTACGGCGGGAACTAATGAAAAACTGTTTTTTGGCAGT	CSVGTAGTNEKLFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	7	4	1	5	0	25	35	-1	40	45						01,02							Vb 4	CSVGTAGTNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD02-01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGACGGAGGGGAGGGTGGCTACACCTTCGGTTCG	CSDGGEGGYTF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	33	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	9	0	7	6	0	25	32	-1	38	45													Vb 4	CSDGGEGGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGCAACCCGGGACTACCACAGATACGCAGTATTTTGGCCCA	CSVQPGTTTDTQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	9	2	7	1	25	33	47	40	48						01,02							Vb 4	CSVQPGTTTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCAGGCTGTCGGAACAGATACGCAGTATTTTGGCCCA	CSVEDQAVGTDTQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	4	3	1	8	25	39	44	40	52													Vb 4	CSVEDQAVGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGAGGGTGGGGTAGGCGAGCAGTACTTCGGGCCG	CSVGEGGVGEQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	9	0	6	0	9	25	-1	42	35	51													Vb 4	CSVGEGGVGEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAAATCGGAGCCGGGACAGGGGGCCGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	4.7638059633776745E-5		52	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	0	1	11	2	25	33	56	44	58													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGGCGGCCCTACAATGAGCAGTTCTTCGGGCCA	CSVRRPYNEQFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	7	5	2	2	1	25	34	40	36	41						01,02							Vb 4	CSVRRPYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCGCATATATCTCTGCAGCGGACTAGCGGGAGATGGGGAGACCCAGTACTTCGGGCCA	CSGLAGDGETQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	2	2	5	0	5	42	-1	61	49	66													Vb 4	CSGLAGDGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAGCATAGGGGGGACCAATCAGCCCCAGCATTTTGGTGAT	CSVSIGGTNQPQHF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	6	5	1	3	6	3	25	33	45	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVSIGGTNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGGACAGGTTATTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVGTGYSGANVLTF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	0	4	1	1	4	25	33	42	34	46													Vb 4	CSVGTGYSGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTCGCTAGCGGATCCTACGAGCAGTACTTCGGGCCG	CSVLASGSYEQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	5	1	4	1	25	34	45	38	46						01,02							Vb 4	CSVLASGSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCAACGTTGGGGGGACACAGATACGCAGTATTTTGGCCCA	CSVEDQRWGDTDTQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	9	1	2	8	1	25	39	53	47	54													Vb 4	CSVEDQRWGDTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCTCCCCCGGGACAGCTATGGCTACACCTTCGGTTCG	CSALPRDSYGYTF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	5	4	9	0	25	32	-1	41	48													Vb 4	CSALPRDSYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGAGGGGAGGCCTCTCCTCCGAGCAGTACTTCGGGCCG	CSVRGGLSSEQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	1	6	3	9	25	33	42	36	51													Vb 4	CSVRGGLSSEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGAGGGGGAAGCAGTACAGATACGCAGTATTTTGGCCCA	CSVRGGSSTDTQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	5	1	3	2	7	25	34	42	36	49													Vb 4	CSVRGGSSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCAAAAGATGGGACTAGCGGTACAGATACGCAGTATTTTGGCCCA	CSVAKDGTSGTDTQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	5	3	8	1	25	35	54	43	55						01,02							Vb 4	CSVAKDGTSGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCGATCGCTAGCGGGAGCTACGAGCAGTACTTCGGGCCG	CSVAIASGSYEQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	4	2	3	6	0	25	35	-1	41	51													Vb 4	CSVAIASGSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCTCCTGGACCGGTGACAATGAGCAGTTCTTCGGGCCA	CSSWTGDNEQFF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	8	1	7	5	4	5	25	31	39	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSSWTGDNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCAGGGGGCCCCCTACAATGAGCAGTTCTTCGGGCCA	CSAQGAPYNEQFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	0	2	2	2	25	32	42	34	44													Vb 4	CSAQGAPYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGTCGGCGGGGCGGGAGTACCTACAATGAGCAGTTCTTCGGGCCA	CSVEGRRGGSTYNEQFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	7	2	2	9	2	25	38	54	47	56													Vb 4	CSVEGRRGGSTYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAGTACAGGAGATGACTCCCCAAATACAATGAGCAGTTCTTCGGGCCA	CSVEEYRR*LPKYNEQFF	Stop	VDJ	1	27	6.124893381485581E-5		54	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	4	4	2	15	25	39	46	41	61													Vb 4	CSVEEYRR*LPKYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGTATACCGGGACTCTGGAAACACCATATATTTTGGAGAG	CSVGVYRDSGNTIYF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	8	3	0	8	0	25	35	-1	43	48													Vb 4	CSVGVYRDSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCGCAGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVSQNTGELFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	5	4	6	1	3	0	25	34	-1	37	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVSQNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCATTATCTCTGCAGCGGACTAGCGGGAGATGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	27	6.124893381485581E-5		38	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	21	1	2	5	12	5	43	36	61	48	66													Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCTTCGGACAGTTCACAGATACGCAGTATTTTGGCCCA	CSAFGQFTDTQYF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	1	5	2	5	2	25	32	43	37	45													Vb 4	CSAFGQFTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGAGTTCCGGGACAAGTCCTACGAGCAGTACTTCGGGCCG	CSAEFRDKSYEQYF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	6	1	9	2	25	32	47	41	49													Vb 4	CSAEFRDKSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGTGTTAATAGGGTTTCTCAGGGTTCCTACAATGAGCAGTTCTTCGGGCCA	CSVNRVSQGSYNEQFF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	1	12	1	25	34	51	46	52													Vb 4	CSVNRVSQGSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTATCCGGGGACAGGGCTATGGCTACACCTTCGGTTCG	CSVIRGQGYGYTF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	4	5	0	25	34	-1	39	48													Vb 4	CSVIRGQGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCAAGCCACGTTTGGTGGCCCTGAGACAGCAGCATATATCTCTGCAGCGGACTAGCGGGAGATGGGGAGACCCAGTACTTCGGGCCA	CSGLAGDGETQYF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	2	2	5	0	5	42	-1	61	49	66													Vb 4	CSGLAGDGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGAGGGGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	33	7.485980799593489E-5		35	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	10	0	5	0	1	25	-1	41	35	42													Vb 4	X+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCCAGTTCTAACGGGTTAGGAGAGAACTGGTTCGTTAGTATTTTGGCCCA	CSQF*RVRRELVR*YF	Stop	VDJ	1	35	7.939676605629458E-5		48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	8	4	13	9	21	25	31	44	40	65						01,02							Vb 4	CSQF*RVRRELVR*YF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTTTGGGACAGTCACCTACACCTTCGGTTCG		Out	VDJ	1	35	7.939676605629458E-5		37	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	5	10	3	4	25	38	48	41	52													Vb 4	X+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAAAAGGGGAGGCGGGAGCCTAAATGAGCAGTTCTTCGGGCCA	CSVKRGGGSLNEQFF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	7	2	7	11	4	25	33	51	44	55													Vb 4	CSVKRGGGSLNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGGGGGCTACGAGGAATGAACACTGAARCTTTCTTTGGACAA	CSVGGLRGMNTEXFF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	9	0	0	0	10	25	-1	40	33	50													Vb 4	CSVGGLRGMNTEXFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAAGGGCTAGTCACGGGGAGCTGTTTTTTGGAGAA	CSVERASHGELFF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	2	5	3	7	0	7	25	-1	41	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVERASHGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGCAGGGGGCGATACGGACACTGAAGCTTTCTTTGGACAA	CSVAGGDTDTEAFF	In	VDJ	1	38	8.620220314683411E-5	1.1064555859992605E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	0	3	2	7	25	33	43	35	50													Vb 4	CSVAGGDTDTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAAATCAACCTACAGTTTCCTATGGCTACACCTTCGGTTCG	CSVNQPTVSYGYTF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	5	4	10	4	25	33	47	43	51													Vb 4	CSVNQPTVSYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGCCGGACTAGCGGGACACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	39	8.847068217701396E-5		47	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	1	3	3	4	1	25	35	51	39	52													Vb 4	X+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCAAAAAGGGACTAGCGGGAGTACAGATACGCAGTATTTTGGCCCA	CSVEDQKGTSGSTDTQYF	In	VDJ	1	42	9.527611926755349E-5	1.222924595051814E-4	54	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	0	2	3	7	1	25	39	60	46	61													Vb 4	CSVEDQKGTSGSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGTGCCGGGGAGGTCCAAGAGACCCAGTACTTCGGGCCA	CSVGAGEVQETQYF	In	VDJ	1	42	9.527611926755349E-5	1.222924595051814E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	9	1	1	6	1	25	35	47	41	48													Vb 4	CSVGAGEVQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTGACTCTGTAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	42	9.527611926755349E-5		40	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	2	10	1	1	4	25	34	39	35	43						01,02							Vb 4	X+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD02-01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATACGGGGGGCAGCGAAAAACTGTTTTTTGGCAGT	CSVDTGGSEKLFF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	1	8	2	4	25	36	45	38	49													Vb 4	CSVDTGGSEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCACCCCTGGGACAGAGAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	46	1.0435003538827287E-4		40	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	0	5	0	5	4	25	29	41	34	45													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTATTAGGGTCGGAGATGAAGCTTTCTTTGGACAA	CSVIRVGDEAFF	In	VDJ	2	46	1.0435003538827287E-4	1.3393936041043678E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	5	5	3	7	3	7	25	34	41	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVIRVGDEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTAGGGGACAGGGGGACTGAAAAACTGTTTTTTGGCAGT	CSVEVGDRGTEKLFF	In	VDJ	2	46	1.0435003538827287E-4	1.3393936041043678E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	0	1	7	3	2	25	38	52	41	54													Vb 4	CSVEVGDRGTEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGTCAGGGCATTTCAATGAGCAGTTCTTCGGGCCA	CSVGSGHFNEQFF	In	VDJ	2	52	1.1796090956935194E-4	1.5140971176831985E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	3	6	3	5	25	35	43	38	48													Vb 4	CSVGSGHFNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTATGACGGAGCGGGAGGGCCATCGAGCAGTTCTTCGGGCCA	CSVEV*RSGRAIEQFF	Stop	VDJ	2	55	1.2476634665989147E-4		48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	6	0	10	8	5	25	38	56	46	61													Vb 4	CSVEV*RSGRAIEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTGGGAAGACGGCTCCTACGAGCAGTACTTCGGGCCG	CSVWEDGSYEQYF	In	VDJ	2	55	1.2476634665989147E-4	1.6014488744726138E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	5	0	8	0	1	6	25	34	39	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVWEDGSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGGACTAGCGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	57	1.2930330472025117E-4		43	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	0	3	0	0	0	25	-1	-1	32	45													Vb 4	X+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCAATATCTCTGCAGCGGACTAGCGGGAGATGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	60	1.361087418107907E-4		38	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	22	1	2	5	13	5	43	35	61	48	66													Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACACCGGGACTAGCGGATTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	61	1.3837722084097056E-4		49	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	5	3	4	3	25	37	52	41	55						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACGGACGTGGTGGGCAGGGCGCAAACTATGGCTACACCTTCGGTTCG	CSVDGRGGQGANYGYTF	In	VDJ	2	62	1.4064569987115038E-4	1.8052696403145828E-4	51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	2	13	4	25	36	54	49	58													Vb 4	CSVDGRGGQGANYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTACAGGGCGTGGAGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	66	1.4971961599186977E-4		41	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	3	4	0	7	25	-1	40	34	47													Vb 4	X+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGCCCAATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVAQSGANVLTF	In	VDJ	2	70	1.5879353211258916E-4	2.0382076584196903E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-06	01	6	4	6	1	4	1	25	33	39	37	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVAQSGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGACGGGGCTAGAGCCGACGAGCAGTACTTCGGGCCG	CSVEDGARADEQYF	In	VDJ	3	98	2.2231094495762482E-4	2.8534907217875663E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	0	7	0	5	1	8	25	39	45	40	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEDGARADEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTTTCCAGTTACAATCAGCCCCAGCATTTTGGTGAT	CSVVSSYNQPQHF	In	VDJ	3	103	2.3365334010852403E-4	2.999076983103259E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	5	3	4	3	25	35	42	39	45													Vb 4	CSVVSSYNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTTCCCGACCGAGAACACTGAAGCTTTCTTTGGACAA	CSVFPTENTEAFF	In	VDJ	4	105	2.3819029816888373E-4	3.057311487629535E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	5	2	7	1	5	3	25	34	42	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVFPTENTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCCTCCACCGGACTAGCGGGTAGCAACCCTAAGAGGAGCAGTTCTTCGGGCCA	CSLHRTSG*QP*EEQFF	Stop	VDJ	4	133	3.0170771101391936E-4		51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	1	4	10	7	15	25	31	49	38	64						01,02							Vb 4	CSLHRTSG*QP*EEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCGGCGGGTTCTAGCACAGATACGCAGTATTTTGGCCCA	CSVAAGSSTDTQYF	In	VDJ	5	136	3.0851314810445893E-4	3.959946307786827E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	7	4	0	2	4	25	35	42	37	46						01,02							Vb 4	CSVAAGSSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCTCCGGCGGCCAACACCGGGGAGCTGTTTTTTGGAGAA	CSVAPAANTGELFF	In	VDJ	5	143	3.2439250131571784E-4	4.163767073628796E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	7	5	2	5	2	25	35	44	40	46						01,02							Vb 4	CSVAPAANTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGTGACACGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVSDTNTGELFF	In	VDJ	5	151	3.425403335571566E-4	4.396705091733903E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	6	0	3	0	25	34	-1	37	41													Vb 4	CSVSDTNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGTGGGACAGGAGAACACTGAAGCTTTCTTTGGACAA	CSVVGQENTEAFF	In	VDJ	5	157	3.5615120773823566E-4	4.571408605312734E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	4	1	3	1	25	33	44	36	45													Vb 4	CSVVGQENTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTTAACCTACGAGGAGGGAGACGCCCGGGACACCATATATTTTGGAGAG		Out	VDJ	6	191	4.332794947643504E-4		50	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	7	10	0	8	12	11	25	32	50	44	61													Vb 4	X+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAGGAGACTCGTAAGGGGTTCTTCGGGCCA	CSVEEETRKGFF	In	VDJ	7	216	4.899914705188465E-4	6.289326488837901E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	0	5	3	15	11	0	25	39	-1	50	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEEETRKGFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGTTTAATGAACACTGAAGCTTTCTTTGGACAA	CSVGLMNTEAFF	In	VDJ	8	249	5.648512785147814E-4	7.25019581352147E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	5	9	0	3	1	25	35	40	38	41						01,02							Vb 4	CSVGLMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGGGGGACGGACGAGGACAGCCCCAGCATTTTGGTGAT	CSGGDGRGQPQHF	In	VDJ	12	342	7.758198283215069E-4	9.958100273993343E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	7	9	1	7	0	11	25	-1	38	32	49													Vb 4	CSGGDGRGQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCCCCGGGAGGAACAATGAGCAGTTCTTCGGGCCA	CSVVPGRNNEQFF	In	VDJ	17	512	0.0011614612634520806	0.0014908033158726878	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	1	5	4	1	25	35	46	39	47													Vb 4	CSVVPGRNNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGGGCCTGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	18	522	0.001184146053753879		44	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	7	0	0	0	3	25	-1	43	38	46													Vb 4	X+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGTTAGCGGGAGCGGGGTACAATGAGCAGTTCTTCGGGCCA	CSVELAGAGYNEQFF	In	VDJ	20	594	0.0013474765439268279	0.0017295647844304228	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	5	2	4	2	5	25	36	47	38	52													Vb 4	CSVELAGAGYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGCCCACCTAATAGAGATACGCAGTATTTTGGCCCA		Out	VDJ	25	753	0.0017081647097254233		41	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	4	9	5	5	4	25	38	46	43	50						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAACCGGAAGGGGGACCCAGTACTTCGGGCCA	CSVETGRGTQYF	In	VDJ	28	824	0.0018692267208681923	0.002399261586482607	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	5	2	7	6	0	25	37	-1	43	48													Vb 4	CSVETGRGTQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGACTAGCGGGAGATGGGGAGACCCAGTACTTCGGGCCA	CSGLAGDGETQYF	In	VDJ	311	9214	0.02090176578407709	0.026828636235255752	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	2	2	5	0	5	25	-1	44	32	49													Vb 4	CSGLAGDGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACCCGAGGGATGGCTACACCTTCGGTTCG	CASSYPRDGYTF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	36	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	11	0	6	2	0	23	38	-1	40	45		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSYPRDGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCCTCCCARACATCTGTGTACTTSTGTGCCAGCGGACTAGCGGATCGTATACGCAGTATTTTGGCCCA		Out	VDJ	1	10	2.2684790301798452E-5		38	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	1	5	7	0	5	23	-1	42	32	47		TCRBV06-02,TCRBV06-03,TCRBV06-08				01,02								X+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASGACTCSGCYGTGTATCTCTGTGCCAGCAGCTTTATAACAGGCAGAACTGAAGCTTTCTTTGGACAA	CASSFITGRTEAFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	4	5	4	4	19	33	42	37	46		TCRBV07-05,TCRBV07-08												CASSFITGRTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTTAAGCCGGGGGGGCAGGGACGACAATGAGCAGTTCTTCGGGCCA	CASSLSRGGRDDNEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	51	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	0	5	3	8	18	33	44	36	52		TCRBV07-06,TCRBV07-07												CASSLSRGGRDDNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCCCGGCAGAATTGAATGAAAAACTGTTTTTTGGCAGT	CASSPAELNEKLFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV07	unresolved					TCRBJ01	TCRBJ01-04	01	5	4	5	5	4	5	19	31	38	35	43		TCRBV07-05,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPAELNEKLFF+TCRBV07-X+TCRBJ01-04	unresolved		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTCCCTAGCGCCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFPSASSYNEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	48	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	6	0	2	4	19	33	41	35	45		TCRBV07-05,TCRBV07-07				01,02								CASSFPSASSYNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCCCTAGCGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSPSGATDTQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV05	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	3	2	1	1	19	31	41	32	42		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASSPSGATDTQYF+TCRBV05-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTCGCCGATGAACGATACGCAGTATTTTGGCCCA	CASSSPMNDTQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	TCRBV07	unresolved					TCRBJ02	TCRBJ02-03	01	3	2	8	6	3	5	22	36	41	39	46		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPMNDTQYF+TCRBV07-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGGCCCCCAGGGACTAGCGGAAACAATGAGCAGTTCTTCGGGCCA	CASRPPGTSGNNEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	5	5	7	2	28	39	57	46	59		TCRBV06-04,TCRBV06-08				01,02								CASRPPGTSGNNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACCCGGAAGACTCTGGAAACACCATATATTTTGGAGAG	CASSYPEDSGNTIYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	TCRBV06	unresolved					TCRBJ01	TCRBJ01-03	01	5	1	8	0	5	3	28	40	48	45	51		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPEDSGNTIYF+TCRBV06-X+TCRBJ01-03	unresolved		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTMSCTCCCAGACATCTGTRTACTTCTGTGCCAGCAGTGAATTGGTGCAGAACTCTGGAAACACCATATATTTTGGAGAG	CASSELVQNSGNTIYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	5	0	6	2	26	41	50	47	52		TCRBV06-01,TCRBV06-09												CASSELVQNSGNTIYF+TCRBV06-X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCTTTAGAATTCTCCGACAGGGAAGGACCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	12	2.722174836215814E-5		62	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	2	3	0	11	8	18	32	50	43	58		TCRBV07-05,TCRBV07-06												X+TCRBV07-X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTCRGCYRTGTATCKCTGTGCCAGCAGCCAAGTCGCGGGGATCGGTAGGAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	12	2.722174836215814E-5		50	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	5	7	3	5	6	9	22	34	46	40	55		TCRBV07-04,TCRBV07-06												X+TCRBV07-X+TCRBJ02-04	unresolved	TCRBD02-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTAGCCGCCGGGCCCACGATTGGCTACACCTTCGGTTCG	CASSLAAGPTIGYTF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV07	unresolved					TCRBJ01	TCRBJ01-02	01	0	8	0	7	4	7	22	39	47	43	54		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAAGPTIGYTF+TCRBV07-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGRGGACTYSGCYGTGTATCTCTGTGCCAGCAGCTTAGGTGGGACCGATGGCTACACCTTCGGTTCG	CASSLGGTDGYTF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	39	TCRBV07	unresolved					TCRBJ01	TCRBJ01-02	01	4	0	7	6	5	2	22	35	45	40	47		TCRBV07-01,TCRBV07-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGTDGYTF+TCRBV07-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGYWCCCTCYCAGACATCTGTRTACTTCTGTGCCAGCAGACTACTCTATGGCTACACCTTCGGTTCG	CASRLLYGYTF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	33	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	3	9	4	0	2	28	-1	43	39	45		TCRBV06-04,TCRBV06-09				01,02								CASRLLYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTCCGGGACAGGGAATGAAAAACTGTTTTTTGGCAGT	CASSSGTGNEKLFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	3	5	2	0	24	37	-1	39	48		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSSGTGNEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACCTATTTGACAGGGATGGCTACACCTTCGGTTCG	CASSYLFDRDGYTF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	3	6	6	0	26	41	-1	47	54		TCRBV06-07,TCRBV06-08												CASSYLFDRDGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTAGTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLVSNQPQHF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV07	unresolved		unresolved			TCRBJ01	TCRBJ01-05	01	4	5	8	0	0	1	22	-1	38	35	39		TCRBV07-01,TCRBV07-04		TCRBD02										CASSLVSNQPQHF+TCRBV07-X+TCRBJ01-05	unresolved	unresolved	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAACAGGGGTGGGGTGAGCAGTTCTTCGGGCCA	CASSEQGWGEQFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	2	9	0	5	23	-1	44	38	49		TCRBV06-01,TCRBV06-08												CASSEQGWGEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACTCGGCTGACAATACCTACGAGCAGTACTTCGGGCCG	CASSYSADNTYEQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	6	2	4	3	23	40	48	44	51		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSYSADNTYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCTAAGTATCCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSESKYPSSYNEQFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	51	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	11	2	0	9	0	26	43	-1	52	55		TCRBV10-01,TCRBV10-02												CASSESKYPSSYNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACAGGGACAGGGACATCTAAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	3.402718545269768E-5		52	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	1	1	8	26	41	51	42	59		TCRBV06-05,TCRBV06-06,TCRBV06-07												X+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGGAGGACAGGTGGACACTGAAGCTTTCTTTGGACAA	CASSGGQVDTEAFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	3	3	3	26	38	48	41	51		TCRBV06-07,TCRBV06-08												CASSGGQVDTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCCGCAGTATTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRSIGANVLTF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	4	5	3	2	3	19	31	36	33	39		TCRBV07-06,TCRBV07-07												CASSRSIGANVLTF+TCRBV07-X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTTAGCGGGAGGGGCAGATACGCAGTATTTTGGCCCA	CASSLAGGADTQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	9	0	4	0	1	19	-1	43	36	44		TCRBV07-06,TCRBV07-07												CASSLAGGADTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAGGGACTCAGCTGTGTAYTTYTGTGCCATACCCCGTCCGGACCACCCGAGCATAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CAIPRPDHPSIATNEKLFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	57	TCRBV12	unresolved					TCRBJ01	TCRBJ01-04	01	12	1	7	0	12	13	24	29	45	41	58		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIPRPDHPSIATNEKLFF+TCRBV12-X+TCRBJ01-04	unresolved		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTAGCGGGAAAGGTCGGTACGCAGTATTTTGGCCCA		Out	VDJ	1	17	3.8564143513057367E-5		44	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	6	3	8	0	8	23	-1	46	39	54		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTCACGGGGACAGGGACGTACCTACGAGCAGTACTTCGGGCCG	CASSSRGQGRTYEQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	48	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	2	4	5	19	32	45	36	50		TCRBV07-05,TCRBV07-07												CASSSRGQGRTYEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTTACAGTAGCGGGAGCGGCTACAATGAGCAGTTCTTCGGGCCA	CASSYSSGSGYNEQFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	5	2	3	3	3	26	40	52	43	55		TCRBV06-08,TCRBV06-09												CASSYSSGSGYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCRGCCCTGTATCTCTGCGCCAGCAGCCAAGTAGGTGGAAACACCATATATTTTGGAGAG	CASSQVGGNTIYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	39	TCRBV04	unresolved					TCRBJ01	TCRBJ01-03	01	1	5	4	3	1	0	21	37	-1	38	41		TCRBV04-01,TCRBV04-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVGGNTIYF+TCRBV04-X+TCRBJ01-03	unresolved		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCCAGAGGGGAAGCGGGAGGGCGGAGCAGTACTTCGGGCCG	CASSQRGSGRAEQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	45	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	6	0	7	9	2	22	34	53	43	55		TCRBV07-01,TCRBV07-04												CASSQRGSGRAEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCATGCATTGGGAGGGCCGGACCGGGGAGCTGTTTTTTGGAGAA	CASMHWEGRTGELFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	9	0	5	6	4	28	38	51	44	55		TCRBV06-04,TCRBV06-07												CASMHWEGRTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGGACCTTTGGAGCGGGAGATAAATATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	19	4.3101101573417056E-5		50	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	6	2	8	9	6	23	36	53	45	59		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTGGACTAGCGGGACCGGCGAGCAGTACTTCGGGCCG	CASSWTSGTGEQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	1	3	6	0	4	19	-1	44	32	48		TCRBV07-05,TCRBV07-07												CASSWTSGTGEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGGTCACAGGGGCCACTGAAGCTTTCTTTGGACAA	CASRVTGATEAFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	4	4	1	23	34	45	38	46		TCRBV06-07,TCRBV06-08												CASRVTGATEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTMSCTCCCAGACATCTGTRTACTTCTGTGCCAGCAGTTATAGCGCCACCAAACATTACAATGAGCAGTTCTTCGGGCCA	CASSYSATKHYNEQFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	6	6	4	0	11	26	-1	45	41	56		TCRBV06-05,TCRBV06-06,TCRBV06-09				01,02								CASSYSATKHYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCGACTAGCGGGAGGGCTGATAGGGGAGCTGTTTTTTGGAGAA	CASSRLAGGLIGELFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	2	0	8	1	6	26	38	53	39	59		TCRBV06-07,TCRBV06-08												CASSRLAGGLIGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTAGACAACAGCCGGTGGGAGACCCAGTACTTCGGGCCA	CASSLDNSRWETQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	45	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	6	5	2	11	22	35	41	37	52		TCRBV07-01,TCRBV07-04												CASSLDNSRWETQYF+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTAGTCCGGCAAGAGACCCAGTACTTCGGGCCA	CASSLVRQETQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	5	8	2	0	5	22	-1	38	35	43		TCRBV07-01,TCRBV07-04				01,02								CASSLVRQETQYF+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGGAGGACAGGGGGCCTGGTGACATTCAGTACTTCGGCGCC	CASREDRGPGDIQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	1	0	8	3	6	23	34	48	37	54		TCRBV06-07,TCRBV06-08												CASREDRGPGDIQYF+TCRBV06-X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGATTGGCCAGAGGGTGGAAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	4.7638059633776745E-5		50	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	0	1	9	5	23	35	49	44	54		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACCAAGCGGGGGTATGGGCAGATACGCAGTATTTTGGCCCA	CASSYQAGVWADTQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	2	4	2	6	23	38	48	40	54		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSYQAGVWADTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACCTTCCGGGACTAGCGGGAGGGCCTTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	21	4.7638059633776745E-5		58	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	0	0	3	5	4	23	38	59	43	63		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCTGGGTAGCCCACTACGAGCAGTACTTCGGGCCG	CASWVAHYEQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	36	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	5	7	3	4	3	23	32	40	36	43		TCRBV10-01,TCRBV10-02				01,02								CASWVAHYEQYF+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCTCCTCCGGGACAGGGAGGGGATACACCTTCGGTTCG	CASSSSGTGRGYTF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	11	5	6	19	32	46	37	52		TCRBV07-05,TCRBV07-06												CASSSSGTGRGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGCACCCAGGCGACAGGGGGCAGGTACAAGCAGTACTTCGGGCCG	CASSTQATGGRYKQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	0	8	9	7	26	37	56	46	63		TCRBV06-04,TCRBV06-07												CASSTQATGGRYKQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGATAGGGGGGACACAGTACTTCGGGCCG	CASSESIGGTQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	39	TCRBV10	unresolved					TCRBJ02	TCRBJ02-07	01	0	0	6	10	7	0	23	40	-1	47	53		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSESIGGTQYF+TCRBV10-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCCCCGCGGACAGGGTGGGGGACTACACCTTCGGTTCG	CASSPADRVGDYTF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	10	5	7	19	31	44	36	51		TCRBV07-06,TCRBV07-07												CASSPADRVGDYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAATTCTCGGGACAGGGTGAAAAATTGTTTTTTGGCAGT	CASSEFSGQGEKLFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	3	15	5	8	23	38	52	43	60		TCRBV06-01,TCRBV06-08												CASSEFSGQGEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACCAGACAGGGGGGGAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	23	5.2175017694136434E-5		46	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	1	5	2	3	23	38	49	40	52		TCRBV06-05,TCRBV06-06,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAGACATCTGTKTACTTSTGTGCCAGCAGTTATTCTCCCGCACGGGAGGCCCCTGGTGGTCGGATGATACGCAGTATTTTGGCCCA		Out	VDJ	1	23	5.2175017694136434E-5		62	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	8	1	6	10	16	9	23	40	33	56		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGTAGGTGGGTCTTCCTACGAGCAGTACTTCGGGCCG	CASSVGGSSYEQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	42	TCRBV06	unresolved					TCRBJ02	TCRBJ02-07	01	5	0	9	1	6	3	23	35	44	41	47		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGGSSYEQYF+TCRBV06-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTTCTCGGGCCCGGGAGGATACTGAAGCTTTCTTTGGACAA	CASSSRAREDTEAFF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	8	1	5	8	2	23	36	51	44	53		TCRBV06-08,TCRBV06-09												CASSSRAREDTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCACCGACACCTAGGGCAGCCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	24	5.444349672431628E-5		50	TCRBV06	unresolved					TCRBJ02	TCRBJ02-02	01	7	2	6	0	2	11	26	36	42	38	53		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCGGACGGGAGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASGRESNTGELFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	8	2	0	3	1	23	32	41	35	42		TCRBV06-07,TCRBV06-08												CASGRESNTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAAGTAGGGCCTCTACAATGAGCAGTTCTTCGGGCCA	CASK*GLYNEQFF	Stop	VDJ	1	26	5.898045478467597E-5		39	TCRBV06	unresolved					TCRBJ02	TCRBJ02-01	01	7	5	3	3	3	3	23	33	40	36	43		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASK*GLYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTAAAGCTCGGGACACCCGATTTGATACGCAGTATTTTGGCCCA	CASSKARDTRFDTQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	6	6	7	8	26	38	51	45	59		TCRBV06-07,TCRBV06-08												CASSKARDTRFDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGATACTTTGAGGGGTAGATAGAGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	26	5.898045478467597E-5		46	TCRBV10	unresolved					TCRBJ01	TCRBJ01-01	01	9	5	2	4	8	9	23	31	44	39	53		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGGACACAGAACCTATGGCTACACCTTCGGTTCG	CASSGHRTYGYTF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	39	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	6	4	0	6	26	-1	43	39	49		TCRBV10-01,TCRBV10-02												CASSGHRTYGYTF+TCRBV10-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCCCCGGAGTCAGCAAAAACATTCAGTACTTCGGCGCC	CASSPGVSKNIQYF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	10	2	3	4	4	23	34	42	38	46		TCRBV06-07,TCRBV06-08												CASSPGVSKNIQYF+TCRBV06-X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGTATGACTAGCCCCAGTTGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	28	6.351741284503566E-5		49	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	2	7	6	4	8	26	43	54	47	62		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCACCCGCAGGGTGGATTTAGCAAATCAGCCCCAGCATTTTGGTGAT	CATRRVDLANQPQHF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	4	3	4	4	11	26	33	42	37	53		TCRBV06-07,TCRBV06-08												CATRRVDLANQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGCTCTAGCGGGGGAATAAATGAGCAGTTCTTCGGGCCA	CASSSSGGINEQFF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	42	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	4	2	7	2	4	23	34	46	36	50		TCRBV10-01,TCRBV10-02												CASSSSGGINEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACTCGTCCGGCGACACTGAAGCTTTCTTTGGACAA	CASSYSSGDTEAFF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	42	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	0	9	0	3	4	1	26	43	50	47	51		TCRBV06-05,TCRBV06-06,TCRBV06-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSSGDTEAFF+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCCTGGACACGGAGCCTACGAGCAGTACTTCGGGCCG	CASSPGHGAYEQYF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	42	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	6	2	3	5	19	31	39	34	44		TCRBV11-01,TCRBV11-03												CASSPGHGAYEQYF+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCCAGGGGGCGCGGGTGGCTACACCTTCGGTTCG		Out	VDJ	1	33	7.485980799593489E-5		43	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	0	7	0	5	23	-1	48	40	53		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTAGGGACAGACTATGGCTACACCTTCGGTTCG	CASSLGTDYGYTF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	3	2	0	22	35	-1	37	44		TCRBV07-01,TCRBV07-02												CASSLGTDYGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCRGCCRTGTATCKCTGTGCCAGCAGCTTAGTGTGTGAGGGCTAGCGGGATAATGAGCAGTTCTTCGGGCCA	CASSLVCEG*RDNEQFF	Stop	VDJ	1	36	8.166524508647442E-5		51	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	4	3	7	10	1	18	34	53	44	54		TCRBV07-02,TCRBV07-07												CASSLVCEG*RDNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCCCGGCGCGAGCGGAGATAGATACGCAGTATTTTGGCCCA	CASSPARAEIDTQYF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	45	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	5	5	8	4	22	34	47	42	51		TCRBV07-01,TCRBV07-04				01,02								CASSPARAEIDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTGACAGGGGTTGCCACAGATACGCAGTATTTTGGCCCA	CASSLTGVATDTQYF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	45	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	2	2	0	4	18	-1	40	32	44		TCRBV11-01,TCRBV11-03												CASSLTGVATDTQYF+TCRBV11-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGYWCCCTCYCAGACATCTGTRTACTTCTGTGCCAGCAGTGATTTTAGCGGGATAACAGATACGCAGTATTTTGGCCCA	CASSDFSGITDTQYF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	5	3	3	1	2	26	42	51	43	53		TCRBV06-04,TCRBV06-09												CASSDFSGITDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCATAATTGACATCGGCCGGGGACAGGGGTGGAATACGCAGTATTTTGGCCCA	CAIIDIGRGQGWNTQYF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	51	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	0	2	7	16	4	23	30	56	46	60		TCRBV06-07,TCRBV06-08												CAIIDIGRGQGWNTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGTAATTTGACTAGCGGGAGTTGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	44	9.981307732791318E-5		43	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	9	2	2	8	6	3	26	34	52	40	55		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTAGCAGGGGACACTGAAGCTTTCTTTGGACAA	CASSLAGDTEAFF	In	VDJ	2	56	1.2703482569007132E-4	1.6305661267357522E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	2	3	0	0	22	-1	-1	39	44		TCRBV07-01,TCRBV07-02												CASSLAGDTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCCGAACTAGCGGGAGGACCAATGAGCAGTTCTTCGGGCCA	CASSRTSGRTNEQFF	In	VDJ	2	59	1.3384026278061086E-4	1.7179178835251675E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	3	1	6	4	2	26	37	53	41	55		TCRBV06-07,TCRBV06-08												CASSRTSGRTNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTAGCGGGAGGGCTCGTACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSD*REGSYSYNEQFF	Stop	VDJ	2	64	1.4518265793151007E-4		54	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	6	0	0	0	6	23	-1	49	39	55		TCRBV06-04,TCRBV06-08												CASSD*REGSYSYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCTGTGTACTTSTGTGCCAGCAGCCCGTACCCCCTCAGTAGACAGCATAAGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPYPLSRQHKANTGELFF	In	VDJ	3	76	1.7240440629366822E-4	2.212911171998521E-4	63	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	5	0	17	7	10	21	43	38	50		TCRBV06-01,TCRBV06-04,TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSPYPLSRQHKANTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGTCGGTAGCCCGGGAGCTGTTTTTTGGAGAA	CASRSVARELFF	In	VDJ	3	86	1.9508919659546667E-4	2.504083694629905E-4	36	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	5	7	9	5	2	26	37	46	42	48		TCRBV06-07,TCRBV06-08				01,02								CASRSVARELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCGCGGGAGGCCGACGAGACCCATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	4	110	2.4953269331978294E-4		50	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	7	1	0	0	13	23	-1	40	32	53		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGGGACTAGCGGGAGATGAGCAGTTCTTCGGGCCA	CASSYSGLAGDEQFF	In	VDJ	4	123	2.7902292071212094E-4	3.581422028366027E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	0	2	8	0	0	23	-1	-1	40	54		TCRBV06-07,TCRBV06-08												CASSYSGLAGDEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAAAGGGGAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	5	138	3.1305010616481863E-4		34	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	5	2	5	1	1	26	36	42	37	43		TCRBV06-04,TCRBV06-07												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYGGCYGTGTATCTCTGTGCTGGGATTACAGGGGGCACAGATACGCAGTATTTTGGCCCA	CAGITGGTDTQYF	In	VDJ	5	150	3.4027185452697675E-4	4.367587839470765E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	12	3	2	1	7	0	18	23	-1	30	37		TCRBV07-01,TCRBV07-02												CAGITGGTDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTAGCACCCCTTCGGGAGCTGTTTTTTGGAGAA	CASSLAPLRELFF	In	VDJ	5	158	3.5841968676841553E-4	4.600525857575872E-4	39	TCRBV07	unresolved					TCRBJ02	TCRBJ02-02	01	0	3	7	9	0	6	22	-1	41	39	47		TCRBV07-01,TCRBV07-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAPLRELFF+TCRBV07-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCAGCTTAGCCTCACTCTACGAGCAGTACTTCGGGCCG	CASSLASLYEQYF	In	VDJ	19	553	0.0012544689036894543	0.0016101840501515554	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	3	10	3	3	0	18	35	-1	38	41		TCRBV07-02,TCRBV07-04				01,02								CASSLASLYEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTATCGCGAAACGGGAGGGCCGTCAGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	36	1075	0.0024386149574433334		56	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	0	4	8	8	25	39	55	47	63		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGAGACCCTAGCGGGAGCAGGGAGCAGTTCTTCGGGCCA	CASRDPSGSREQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	10	5	4	23	34	49	39	53													Vb 22	CASRDPSGSREQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAACTAGAACGCGAGCCGGGGAGCTGTTTTTTGGAGAA	CASSETRTRAGELFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	3	8	6	0	8	23	-1	43	38	51						01,02							Vb 22	CASSETRTRAGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAGCCACGTTTGGTGCTGGAGGACTCAGCCATGTACTCTGTGCCAGCTTGAGAGGACAGGAGGTGGGCGAAGCTTTCTTTGGACAA		Out	VDJ	1	11	2.4953269331978296E-5		41	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	19	1	4	8	16	8	40	38	61	54	69													Vb 22	X+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGTACCCCGGGACAGGGGATTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	11	2.4953269331978296E-5		41	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	0	2	4	6	2	23	31	47	37	49													Vb 22	X+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAGCCACGTTTGGTGCTGGAGACTCAGCCATGTACTTCTGTGCCAGCTTGAGAGGACAGGAGGTGGGCGAAGCTTTCTTTGGACAA	CASLRGQEVGEAFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	1	4	8	6	8	39	48	61	54	69													Vb 22	CASLRGQEVGEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTATTTCCTCGGGGTCTCCCTCCTACGAGCAGTACTTCGGGCCG	CASSISSGSPSYEQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	3	0	7	5	23	35	47	42	52													Vb 22	CASSISSGSPSYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCCCCTAATAGGCAATGAGCAGTTCTTCGGGCCA	CASSPLIGNEQFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	39	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-01	01	5	5	4	6	8	0	23	35	-1	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSPLIGNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCACCGCTCTGGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	3.8564143513057367E-5		38	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-01	01	7	0	9	4	7	0	23	33	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	X+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCGAGGTCAGGAGCCGTCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRGQEPSSGANVLTF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	54	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-06	01	5	4	4	0	6	7	23	35	45	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSRGQEPSSGANVLTF+TCRBV02-01+TCRBJ02-06	TCRBV02-01*01		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAACTCGGGGAAAAGCGGGAGAAGGGCCGGGGAGCTGTTTTTTGGAGAA	CASNSGKSGRRAGELFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	51	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	6	2	6	11	5	23	33	52	44	57													Vb 22	CASNSGKSGRRAGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGATCGGGGGACCCCGAGGTCCGTTCTTCGGGCCA	CASRIGGPRGPFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	2	15	3	12	23	34	43	37	55													Vb 22	CASRIGGPRGPFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAAGGACAGGAAGGGGCCTTGAAGCTTTCTTTGGACAA	CASSERTGRGLEAFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	4	7	1	9	23	38	46	39	55													Vb 22	CASSERTGRGLEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGAGGTCGGGAGATGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	23	5.2175017694136434E-5		47	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	8	2	4	4	3	23	39	49	43	52													Vb 22	X+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTACGTCGGCCACAGTGGCTTTCTTTGGACAA	CASSTSATVAFF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	36	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	5	11	9	2	23	35	48	44	50													Vb 22	CASSTSATVAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGGGGACAGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSGDRGNTGELFF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	2	1	0	0	23	-1	-1	36	46													Vb 22	CASSGDRGNTGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTCTAGCGGGAGGGAGGATAGGGACGAGCAGTACTTCGGGCCG	CASSSSGREDRDEQYF	In	VDJ	2	49	1.1115547247881241E-4	1.4267453608937832E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	4	0	5	1	9	23	35	48	36	57													Vb 22	CASSSSGREDRDEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCATTCGGGGACAGGAGAACACTGAAGCTTTCTTTGGACAA	CASIRGQENTEAFF	In	VDJ	2	67	1.5198809502204962E-4	1.950855901630275E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	4	1	4	1	23	33	45	37	46													Vb 22	CASIRGQENTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAAGGAAGGGCATCCCACTACGAGCAGTACTTCGGGCCG	CASKGRASHYEQYF	In	VDJ	5	145	3.2892945937607754E-4	4.2220015781550726E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-07	01	7	5	3	3	5	7	23	33	42	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASKGRASHYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTTACGGGTCAGGCGGAAACACCATATATTTTGGAGAG	CASSYGSGGNTIYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV06	TCRBV06-04					TCRBJ01	TCRBJ01-03	01	5	4	4	4	7	1	28	40	51	47	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGSGGNTIYF+TCRBV06-04+TCRBJ01-03	TCRBV06-04		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTCAGGGAGGTCACTCTGGAAACACCATATATTTTGGAGAG	CASSQGGHSGNTIYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	9	1	0	2	3	28	40	48	42	51			01,02											CASSQGGHSGNTIYF+TCRBV06-04+TCRBJ01-03	TCRBV06-04	TCRBD02-01*02	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTTACTCAAGGGGAAACTATGGCTACACCTTCGGTTCG	CASSYSRGNYGYTF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	2	2	1	1	28	45	51	46	52			01,02											CASSYSRGNYGYTF+TCRBV06-04+TCRBJ01-02	TCRBV06-04	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGCGCGACTAGCGGGAGGGAGCAGTTCTTCGGGCCA	CASSATSGREQFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	39	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	2	1	10	3	0	28	39	-1	42	55			01,02											CASSATSGREQFF+TCRBV06-04+TCRBJ02-01	TCRBV06-04	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCATCAGTGAGGCGGGGATCGAAGAGACCCAGTACTTCGGGCCA	CAISEAGIEETQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	42	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	7	3	3	1	4	28	42	49	43	53			01,02											CAISEAGIEETQYF+TCRBV06-04+TCRBJ02-05	TCRBV06-04	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTTCCAGCTTCCCCACTAGGGGGGACGAGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	3.175870642251783E-5		55	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-03	01	5	5	1	5	15	6	26	38	59	53	65			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-04+TCRBJ02-03	TCRBV06-04		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCATCAGTGAAGAGGTTAGCAATCAGCCCCAGCATTTTGGTGAT	CAISEEVSNQPQHF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	11	1	0	1	1	28	42	47	43	48			01,02											CAISEEVSNQPQHF+TCRBV06-04+TCRBJ01-05	TCRBV06-04	TCRBD02-01*02	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGACCAAGGCCCCAAGCCTATGGCTACACCTTCGGTTCG	CASRPRPQAYGYTF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	42	TCRBV06	TCRBV06-04					TCRBJ01	TCRBJ01-02	01	6	5	4	4	4	8	28	39	46	43	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPRPQAYGYTF+TCRBV06-04+TCRBJ01-02	TCRBV06-04		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTTAAGTTCAGCCCCAGCATTTTGGTGAT	CASS*VQPQHF	Stop	VDJ	1	25	5.671197575449612E-5		33	TCRBV06	TCRBV06-04					TCRBJ01	TCRBJ01-05	01	5	5	5	6	2	1	28	40	44	42	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASS*VQPQHF+TCRBV06-04+TCRBJ01-05	TCRBV06-04		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTTACGTGGGAGAAGCTTTCTTTGGACAA	CASSYVGEAFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	33	TCRBV06	TCRBV06-04					TCRBJ01	TCRBJ01-01	01	5	0	8	8	5	0	28	40	-1	45	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYVGEAFF+TCRBV06-04+TCRBJ01-01	TCRBV06-04		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGCGAGAGGACTAGCGGGAGGACCTACGAGCAGTACTTCGGGCCG	CASSERTSGRTYEQYF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	48	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	1	1	2	5	1	28	39	58	44	59			01,02											CASSERTSGRTYEQYF+TCRBV06-04+TCRBJ02-07	TCRBV06-04	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCCGGCCCATTAGGTTTTATTACGAGCAGTACTTCGGGCCG	CASSRPIRFYYEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	45	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-07	01	6	5	4	4	10	6	26	37	50	47	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRPIRFYYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCATAATGAAAAACTGTTTTTTGGCAGT	CASSHNEKLFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	33	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	6	4	0	0	26	-1	-1	38	40														CASSHNEKLFF+TCRBV06-07+TCRBJ01-04	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACGGCCCCACCGCTCCAGAGACCCAGTACTTCGGGCCA	CASSYGPTAPETQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	9	0	4	0	11	26	-1	44	41	55														CASSYGPTAPETQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCTACGGACAGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSYGQSTGELFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	5	4	0	2	26	-1	47	41	49														CASSYGQSTGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASRSYNEQFF	In	VJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	33	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-01	01	6	0	0	1	0	1	26	-1	37	-1	38														CASRSYNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCGCTACAGGGTCTCACTCTGGAAACACCATATATTTTGGAGAG	CASATGSHSGNTIYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	3	3	0	3	5	26	35	44	38	49														CASATGSHSGNTIYF+TCRBV06-07+TCRBJ01-03	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGCAAGCCACGTTTGGTGCCCCAACCAGACAGCTTTTACTTCTGTGCCAGCAGTCAGGGACAGGGTGAAAAACTGTTTTTTGGCAGT	CASSQGQGEKLFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	3	7	2	0	42	54	-1	56	65														CASSQGQGEKLFF+TCRBV06-07+TCRBJ01-04	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCCAGCCGGTCAGCGACGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	12	2.722174836215814E-5		41	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	11	6	6	3	9	4	26	32	45	41	49						01,02								X+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAACCCGGGACTAGCGGTGACCCAGTACTTCGGGCCA	CASNPGLAVTQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	0	5	7	4	1	26	36	51	40	52						01,02								CASNPGLAVTQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGAGCGGGAGGTAGGAGGAACATTCAGTACTTCGGCGCC	CASRAGGRRNIQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	6	1	7	0	7	26	-1	46	37	53														CASRAGGRRNIQYF+TCRBV06-07+TCRBJ02-04	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCCGCTTAGGCCATCTTCTTGGCTACACCTTCGGTTCG	CASRLGHLLGYTF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-02	01	8	5	4	7	5	9	26	35	43	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLGHLLGYTF+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTCCAGGACAGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	3.402718545269768E-5		40	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	3	3	3	0	26	39	-1	42	50														X+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAACTCACCTGGCCAGCGCTACGAGCAGTACTTCGGGCCG	CASNSPGQRYEQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	6	6	3	12	0	26	36	-1	48	52						01,02								CASNSPGQRYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAACAGATCAGGACAGGGGGGGGCCTACGAGCAGTACTTCGGGCCG	CANRSGQGGAYEQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	1	2	4	3	26	37	51	41	54														CANRSGQGGAYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCACCAGTGATTCCCTAAAGCAGTTCTTCGGGCCA	CATSDSLKQFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	9	11	6	1	26	38	47	44	48						01,02								CATSDSLKQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGAACTACCGGGACAGGGGTAGCCAAAAACATTCAGTACTTCGGCGCC	CASRTTGTGVAKNIQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	51	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	0	2	0	7	1	26	37	54	44	55														CASRTTGTGVAKNIQYF+TCRBV06-07+TCRBJ02-04	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCGCCCCACTACAGGGCTCACAGATACGCAGTATTTTGGCCCA	CASSRPTTGLTDTQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	48	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	3	2	9	2	26	38	53	47	55														CASSRPTTGLTDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCTCAAGGGAATTCGGAGAGACTGAAGCTTTCTTTGGACAA	CASREFGETEAFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	39	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-01	01	11	0	8	5	4	10	26	32	40	36	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASREFGETEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAAAGAGCCAGGGTCTCCGATACGCAGTATTTTGGCCCA		Out	VDJ	1	21	4.7638059633776745E-5		41	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	4	3	6	6	5	26	36	47	42	52														X+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGAATCCGGGGTTCTCGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	4.7638059633776745E-5		40	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	3	6	4	7	26	37	46	41	53														X+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACCAGGGACAGGGCCCTTACAATGAGCAGTTCTTCGGGCCA	CASSYQGQGPYNEQFF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	48	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	3	4	2	4	26	41	52	43	56														CASSYQGQGPYNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGGGACAGGGACAGATACGCAGTATTTTGGCCCA	CASSEGTGTDTQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	3	3	0	26	38	-1	41	50														CASSEGTGTDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTCTGTTTACTTCTGTGCCAGCAGTTACTCGAGCACTCGGACTAGCGGGTCCCCAGTACCATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	30	6.805437090539536E-5		61	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	1	4	8	8	11	13	30	49	38	60						01,02								X+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCTCCTCTTCGACAGGAGTCTACAATGAGCAGTTCTTCGGGCCA	CASSSSSTGVYNEQFF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	48	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	4	3	9	3	26	37	52	46	55														CASSSSSTGVYNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGTCGAGGCGGCCAGCTCTGGAAACACCATATATTTTGGAGAG	CASSVEAASSGNTIYF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	48	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	7	5	0	6	4	26	38	48	44	52						01,02								CASSVEAASSGNTIYF+TCRBV06-07+TCRBJ01-03	TCRBV06-07*01	TCRBD02-01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACAGAAAGGGACAGCGGGAAACACGAGCAGTACTTCGGGCCG		Out	VDJ	1	41	9.300764023737364E-5		49	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-07	01	2	0	5	5	5	8	26	41	53	46	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCTACTTAGCGGGTCCCTCAGATACGCAGTATTTTGGCCCA	CASSYLAGPSDTQYF	In	VDJ	1	44	9.981307732791318E-5	1.281159099578091E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	5	4	4	0	5	26	-1	49	42	54						01,02								CASSYLAGPSDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCCCCCCTTTGGGGGCCTCCATCAGCCCCAGYATTTTGGTGAT	CASSPPFGGLHQPQXF	In	VDJ	2	59	1.3384026278061086E-4	1.7179178835251675E-4	48	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	6	0	5	9	4	26	38	53	47	57														CASSPPFGGLHQPQXF+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAAGTTCGGCTATGGCTACACCTTCGGTTCG	CASKFGYGYTF	In	VDJ	3	97	2.2004246592744497E-4	2.824373469524428E-4	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	7	8	5	4	4	0	26	36	-1	40	43						01,02								CASKFGYGYTF+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD02-01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGTCTCAGAAGGACAGGGTGAAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	32	950	0.0021550550786708527		44	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	13	1	3	1	8	3	26	30	46	38	49														X+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCACACCAACAGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSTPTGGSYNEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	48	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	1	0	6	0	19	31	-1	37	45														CASSTPTGGSYNEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCAAGGGACTAGCTTAGGGGAGAATGAGCAGTTCTTCGGGCCA	CASSQGTSLGENEQFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	48	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	7	7	3	9	19	31	43	34	52						01,02								CASSQGTSLGENEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCGTGGTGAGTAGTCGGTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	15	3.402718545269768E-5		47	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	8	3	8	5	19	31	42	39	47						01,02								X+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCGGAAGACGTGGCGGGTCCGTCGGGGAGCTGTTTTTTGGAGAA	CASSGRRGGSVGELFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	48	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	7	4	7	10	5	19	31	46	41	51						01,02								CASSGRRGGSVGELFF+TCRBV07-07+TCRBJ02-02	TCRBV07-07*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGTTTCTTAGCGGGGACCACAGATACGCAGTATTTTGGCCCA	CASSFLAGTTDTQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	5	3	2	5	2	19	30	43	35	45														CASSFLAGTTDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAAACCAGGAGGGGGGCTACGAGCAGTACTTCGGGCCG	CASSLNQEGGYEQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	45	TCRBV07	TCRBV07-07	01				TCRBJ02	TCRBJ02-07	01	2	5	1	3	7	1	19	34	47	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNQEGGYEQYF+TCRBV07-07+TCRBJ02-07	TCRBV07-07*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGTCGGACCGGGACAGTAGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSRTGTVVTGELFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	48	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	5	4	7	4	19	30	44	37	48														CASSRTGTVVTGELFF+TCRBV07-07+TCRBJ02-02	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAACGAACAGGCCTCTGGAAACACCATATATTTTGGAGAG	CASNEQASGNTIYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	3	4	0	4	1	19	29	38	33	39														CASNEQASGNTIYF+TCRBV07-07+TCRBJ01-03	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTATCCAGGGGGTCAGGAAACACCATATATTTTGGAGAG	CASSLSRGSGNTIYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	45	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	1	4	2	3	19	34	43	36	46														CASSLSRGSGNTIYF+TCRBV07-07+TCRBJ01-03	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTCAGGGACAGGAGGAGAAACCGGGGAGCTGTTTTTTGGAGAA	CASSSGTGGETGELFF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	48	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	4	5	2	7	19	32	42	34	49														CASSSGTGGETGELFF+TCRBV07-07+TCRBJ02-02	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ACGTTTGGTGACGAAGCTTGAGGATTCAGCAGTGTATTTTGTGCCAGCAGCCAATCCCTACCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	16	3.629566448287752E-5		41	TCRBV16	TCRBV16-01					TCRBJ02	TCRBJ02-03	01	17	4	5	2	4	15	40	40	47	44	62			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV16-01+TCRBJ02-03	TCRBV16-01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCGTGACTTACAATGAGCAGTTCTTCGGGCCA	CASSVTYNEQFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	36	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	10	4	2	0	29	41	-1	43	47			01,02			01,02								CASSVTYNEQFF+TCRBV16-01+TCRBJ02-01	TCRBV16-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATTGGGGGGCGCTGGCTACACCTTCGGTTCG	CASSQLGGAGYTF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	39	TCRBV16	TCRBV16-01					TCRBJ01	TCRBJ01-02	01	1	6	0	7	2	2	29	45	53	47	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQLGGAGYTF+TCRBV16-01+TCRBJ01-02	TCRBV16-01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAAGACAGCGTCTATGGCTACACCTTCGGTTCG	CASSQDSVYGYTF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	39	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	5	4	0	3	29	-1	49	44	52			01,02											CASSQDSVYGYTF+TCRBV16-01+TCRBJ01-02	TCRBV16-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAAGCGAGACAGGCGCTCGAGGGCTACACCTTCGGTTCG	CASSQARQALEGYTF	In	VDJ	1	42	9.527611926755349E-5	1.222924595051814E-4	45	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	4	8	4	8	29	44	54	48	62			01,02											CASSQARQALEGYTF+TCRBV16-01+TCRBJ01-02	TCRBV16-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCTCCCGGGGGGTCAGCCCCAGCATTTTGGTGAT	CASSLPGGQPQHF	In	VDJ	1	42	9.527611926755349E-5	1.222924595051814E-4	39	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	4	8	1	6	3	0	29	42	-1	45	52			01,02											CASSLPGGQPQHF+TCRBV16-01+TCRBJ01-05	TCRBV16-01	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATCGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSQSGAYEQYF	In	VDJ	4	114	2.5860660944050233E-4	3.3193667579977813E-4	39	TCRBV16	TCRBV16-01					TCRBJ02	TCRBJ02-07	01	0	6	1	2	0	0	29	-1	-1	46	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSGAYEQYF+TCRBV16-01+TCRBJ02-07	TCRBV16-01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATCCCTACCCACAGATACGCAGTATTTTGGCCCA	CASSQSLPTDTQYF	In	VDJ	29	866	0.0019645028401357456	0.0025215540459877883	42	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	9	2	1	2	29	46	50	47	52			01,02			01,02								CASSQSLPTDTQYF+TCRBV16-01+TCRBJ02-03	TCRBV16-01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTGGTGGTCAGGGACACAGCACGGTATTTCTGTGCCAGCAGTCCCTGGGGAGGTTATAGTTCTGTCGGGGAGCTGTTTTTTGGAGAA	CASSPWGGYSSVGELFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	51	TCRBV21	TCRBV21-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	9	1	7	6	12	30	41	53	47	65														CASSPWGGYSSVGELFF+TCRBV21-01+TCRBJ02-02	TCRBV21-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGGTCAGGGACACAGCACGGTATTTCTGTGCCAGCTTGAGAGGACAGGAGGTGGGCGAAGCTTTCTTTGGACAA	CASLRGQEVGEAFF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	42	TCRBV21	TCRBV21-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	1	4	8	6	8	39	48	61	54	69														CASLRGQEVGEAFF+TCRBV21-01+TCRBJ01-01	TCRBV21-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCACGTTTGGTGGTCAGGGACACAGCACGGTATTTCTGTGCCAGCAGCGTAACCCACGCCCAAAACACTGAAGCTTTCTTTGGACAA	CASSVTHAQNTEAFF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	45	TCRBV21	TCRBV21-01	01				TCRBJ01	TCRBJ01-01	01	5	3	7	2	3	10	36	48	53	51	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVTHAQNTEAFF+TCRBV21-01+TCRBJ01-01	TCRBV21-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGGTTTTGGCTACGAGCAGTACTTCGGGCCG	CASSLGFGYEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-07	01	4	5	4	3	1	6	22	35	39	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGFGYEQYF+TCRBV07-01+TCRBJ02-07	TCRBV07-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAACCTAGCGGGTGGATGAGCAGTTCTTCGGGCCA	CASSLT*RVDEQFF	Stop	VDJ	1	11	2.4953269331978296E-5		42	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	4	8	4	3	22	35	47	39	50						01,02								CASSLT*RVDEQFF+TCRBV07-01+TCRBJ02-01	TCRBV07-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAATAGGGAATGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLIGNGAGELFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-02	01	4	0	8	6	5	6	22	35	44	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLIGNGAGELFF+TCRBV07-01+TCRBJ02-02	TCRBV07-01*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGYAGCGCCCAGCTTGGGTGGCTACACCTTCGGTTCG		Out	VDJ	1	12	2.722174836215814E-5		37	TCRBV07	TCRBV07-01	01				TCRBJ01	TCRBJ01-02	01	5	0	9	7	9	0	22	34	-1	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-01+TCRBJ01-02	TCRBV07-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGTTACGGGACTAGGGAGCGGGGAGCTGTTTTTTGGAGAA	CASSLVTGLGSGELFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	48	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	8	7	7	4	22	35	50	42	54						01,02								CASSLVTGLGSGELFF+TCRBV07-01+TCRBJ02-02	TCRBV07-01*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTCGGCGCCCCCAATGAGCAGTTCTTCGGGCCA	CASSFGAPNEQFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	39	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-01	01	4	9	0	6	2	5	22	35	40	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGAPNEQFF+TCRBV07-01+TCRBJ02-01	TCRBV07-01*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTACGGGCGGGACAAGGGAACATTCAGTACTTCGGCGCC	CASSLRAGQGNIQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	45	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-04	01	4	0	6	7	7	4	22	35	48	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRAGQGNIQYF+TCRBV07-01+TCRBJ02-04	TCRBV07-01*01		TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTCACATGTCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	46	1.0435003538827287E-4		43	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	6	0	0	3	22	-1	39	37	42														X+TCRBV07-01+TCRBJ01-04	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAAGCCCTAGCGCATACACCGGGGAGCTGTTTTTTGGAGAA	CASSLSPSAYTGELFF	In	VDJ	4	106	2.4045877719906358E-4	3.086428739892674E-4	48	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	4	6	3	6	3	22	35	47	41	50						01,02								CASSLSPSAYTGELFF+TCRBV07-01+TCRBJ02-02	TCRBV07-01*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCTTGGGACTAGCGGACAATGAGCAGTTCTTCGGGCCA	CASSLGLADNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV07	TCRBV07-08		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	5	5	0	0	20	-1	-1	34	45			01,02			01,02								CASSLGLADNEQFF+TCRBV07-08+TCRBJ02-01	TCRBV07-08	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCCCGGGACATCTCTACGAGCAGTACTTCGGGCCG	CASSPGHLYEQYF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	39	TCRBV07	TCRBV07-08		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	6	3	2	3	20	32	40	34	43			01,02											CASSPGHLYEQYF+TCRBV07-08+TCRBJ02-07	TCRBV07-08	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAAGATAGGATGAACACTGAAGCTTTCTTTGGACAA	CASSEDRMNTEAFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	3	1	8	0	5	0	23	37	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEDRMNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCACCCAAGTGGAACAGCAGCTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	12	2.722174836215814E-5		41	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	3	5	7	10	4	23	30	44	40	48													Vb 12	X+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAACGAGGGATGGACTAGGTCCCCCGGAGAGCTGTTTTTTGGAGAA	CASNEGWTRSPGELFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	1	8	11	9	10	23	33	49	42	59						01,02							Vb 12	CASNEGWTRSPGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCGAGGGATAGACTAGATCCCCCGGGGAGCTGTTTTTTGGAGAA	CASSEG*TRSPGELFF	Stop	VDJ	1	12	2.722174836215814E-5		48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	2	8	6	5	5	23	38	49	43	54						01,02							Vb 12	CASSEG*TRSPGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCATCTAATCGGACAGTCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	14	3.175870642251783E-5		44	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	1	5	3	7	2	23	33	46	40	48													Vb 12	X+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAGCCACGTTTGGTGCGCTCCCAGACATCTGTGTATTCTGCGCCAGCAGTGGAGATGGGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	16	3.629566448287752E-5		41	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	19	0	8	0	19	0	40	38	-1	57	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGGCCGGCCCGGGGGGAGACCCAGTACTTCGGGCCA	CASSGPARGETQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	8	2	5	8	0	23	36	-1	44	50													Vb 12	CASSGPARGETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCCTCCAGAGTAGCAACCAAGAGACCTAGTACTTCGGGCCA	CASLQSSNQET*YF	Stop	VDJ	1	16	3.629566448287752E-5		42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	8	5	7	12	8	13	23	32	44	40	57						01,02							Vb 12	CASLQSSNQET*YF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTGGGGTGGTGAGCAGTTCTTCGGGCCA	CASSEWGGEQFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	36	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-01	01	1	6	2	9	0	3	23	-1	43	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEWGGEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGACAGGCACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	20	4.5369580603596903E-5		41	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	9	3	4	0	0	3	23	-1	36	31	39													Vb 12	X+TCRBV10-02+TCRBJ02-06	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTAAGTAGTAGGACTAGCGGGAGAACAATGAGCAGTTCTTCGGGCCA	CASSK**D*RENNEQFF	Stop	VDJ	1	22	4.990653866395659E-5		51	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	1	2	5	4	1	23	39	56	43	57													Vb 12	CASSK**D*RENNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACGAGTTCAGGCAGGCAAGAGACCCAGTACTTCGGGCCA	CASTSSGRQETQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	4	4	2	6	4	23	33	43	39	47													Vb 12	CASTSSGRQETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAATTGGGGAATAGCAAGCAGCAGTTCTTCGGGCCA	CASSELGNSKQQFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	42	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-01	01	3	0	8	11	4	9	23	37	45	41	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSELGNSKQQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGATGGAATGAACACTGAAGCTTTCTTTGGACAA	CASSEDGMNTEAFF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	2	1	8	0	3	1	23	38	44	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEDGMNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGGACGCGGTGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSGTRWGSYNEQFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	48	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-01	01	4	1	7	0	0	9	23	-1	40	36	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSGTRWGSYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCGGTCAGCAGCTGAGCAGTTCTTCGGGCCA	CASSRSAAEQFF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	36	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-01	01	5	4	5	9	4	4	23	35	42	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSRSAAEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTTCTGCGCCAGCAGTGAGTCCTGGGGGGGTTTCCTTACTTCTTGGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	34	7.712828702611473E-5		65	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	0	9	0	0	2	16	4	21	30	23	46													Vb 12	X+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD02-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTACCCCCCTAGGGCCACGAGCAGTACTTCGGGCCG		Out	VDJ	2	53	1.2022938859953179E-4		40	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-07	01	5	5	3	5	8	2	23	35	47	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGTACGCGGGTAAACACTGAAGCTTTCTTTGGACAA	CASTRVNTEAFF	In	VDJ	2	59	1.3384026278061086E-4	1.7179178835251675E-4	36	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	9	7	4	2	3	2	23	31	39	34	41						01,02							Vb 12	CASTRVNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAACCACACAGGGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	75	1.7013592726348837E-4		40	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	1	3	5	0	23	33	-1	38	46													Vb 12	X+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGATTGGCGAACCCTACAATGAGCAGTTCTTCGGGCCA	CASSESIGEPYNEQFF	In	VDJ	3	75	1.7013592726348837E-4	2.1837939197353825E-4	48	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-01	01	0	9	0	2	4	4	23	40	47	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESIGEPYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGGGACGGCATGAACACTGAAGCTTTCTTTGGACAA	CASSGDGMNTEAFF	In	VDJ	3	75	1.7013592726348837E-4	2.1837939197353825E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	4	0	7	0	0	4	23	-1	41	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSGDGMNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGAACTAGTTACCGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	4	112	2.5406965138014264E-4		44	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	6	3	8	1	1	6	23	34	40	35	46						01,02							Vb 12	X+TCRBV10-02+TCRBJ02-04	TCRBV10-02*01	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTATCCCGGGACTACCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	10	292	6.623958768125147E-4		41	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	9	6	5	1	23	35	47	40	48						01,02							Vb 12	X+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGGAAGGATCCCGGGGAGCTGTTTTTTGGAGAA	CASSGKDPGELFF	In	VDJ	30	883	0.002003066983648803	0.0025710533748351237	39	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-02	01	4	1	8	6	0	6	23	-1	39	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSGKDPGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCGAGGGATGGACTAGGTCCCCCGGGGAGCTGTTTTTTGGAGAA	CASSEGWTRSPGELFF	In	VDJ	32	955	0.002166397473821752	0.00278069759112972	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	1	8	6	4	5	23	38	49	42	54						01,02							Vb 12	CASSEGWTRSPGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGAGATGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSGDGMNTEAFF	In	VDJ	62	1823	0.0041354372720178575	0.005308075087570136	42	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	4	0	8	0	5	0	23	36	-1	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSGDGMNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCCTTCCTGGACACTTGAACACTGAAGCTTTCTTTGGACAA	CASLPGHLNTEAFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	1	6	0	8	2	24	31	44	39	46													Vb 12	CASLPGHLNTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTTGGGCAGCAACCTACAATGAGCAGTTTTTCGGGCCA		Out	VDJ	1	12	2.722174836215814E-5		46	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02			1	8	0	19	1	22	23	39	44	40	66								TCRBJ02-01,TCRBJ02-05					Vb 12	X+TCRBV10-03+TCRBJ02-X	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGGAACTCAGGCGGCAGCTTTCTTTGGACAA	CAISEGTQAAAFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-01	01	2	4	4	10	6	4	23	38	48	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISEGTQAAAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGACAGGGGGCAGGAGTACTTCGGGCCG	CAISESDRGQEYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	0	11	0	3	23	-1	51	40	54													Vb 12	CAISESDRGQEYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCACCAACAGGGCTGGGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	3.402718545269768E-5		40	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	3	3	0	3	5	24	31	40	34	45													Vb 12	X+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCTATCAGTGAGGGGAATTTGGAGGATGGCTACACCTTCGGTTCG	CAISEGNLEDGYTF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	10	1	6	8	0	23	38	-1	46	51													Vb 12	CAISEGNLEDGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGCGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAISERGSSYNEQFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	45	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	2	0	0	2	23	-1	44	38	46													Vb 12	CAISERGSSYNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGCTGGTTATGGAGGGCAACACCGGGGAGCTGTTTTTTGGAGAA	CAISESLVMEGNTGELFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	54	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	10	0	2	9	1	23	40	55	49	56													Vb 12	CAISESLVMEGNTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGGCCCGGCGACAGGGTCTCAGATACGCAGTATTTTGGCCCA	CAIRPGDRVSDTQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	4	7	3	24	35	49	42	52													Vb 12	CAIRPGDRVSDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAGTCCGACAGGGGAGGCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	20	4.5369580603596903E-5		52	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	2	2	2	1	3	24	41	50	42	53													Vb 12	X+TCRBV10-03+TCRBJ02-06	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCTCCCCGGGACCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPGPGANVLTF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	42	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-06	01	10	0	7	2	7	0	24	31	-1	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSPGPGANVLTF+TCRBV10-03+TCRBJ02-06	TCRBV10-03*01		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGAGTCGAGGAGACTAGTAAACCAGCAGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	21	4.7638059633776745E-5		52	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	2	8	9	5	11	24	41	52	46	63						01,02							Vb 12	X+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGACCGGACTGACATGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	5.2175017694136434E-5		35	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	10	1	10	6	4	6	24	31	40	35	46						01,02							Vb 12	X+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGGAAGTGGGGGAGCCAACGTCCTGACTTTCGGGGCC	CAISGSGGANVLTF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	42	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-06	01	4	6	1	7	5	1	24	37	47	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISGSGGANVLTF+TCRBV10-03+TCRBJ02-06	TCRBV10-03*01		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGGCAGCAACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	34	7.712828702611473E-5		46	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	8	0	2	0	5	23	-1	44	40	49													Vb 12	X+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGGGGGACAAATCGAAGCTTTCTTTGGACAA	CAISESGGQIEAFF	In	VDJ	2	65	1.4745113696168992E-4	1.8926213971039982E-4	42	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-01	01	0	0	6	8	3	4	23	40	49	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESGGQIEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAGTCGACAACCAACACCGGGGAGCTGTTTTTTGGAGAA	CAISESTTNTGELFF	In	VDJ	2	71	1.6106201114276898E-4	2.0673249106828288E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	6	2	0	3	23	-1	44	40	47													Vb 12	CAISESTTNTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGCTAGTTTTTTTACTAACTGGGACAAGAGACCCAGTACTTCGGGCCA	CASSMG*FFY*LGQETQYF	Stop	VDJ	1	9	2.0416311271618604E-5		57	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	3	0	8	2	21	0	24	38	-1	59	63			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMG*FFY*LGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAAACCGGGAGCGAGGGATCAGATACGCAGTATTTTGGCCCA	CASKTGSEGSDTQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	8	2	4	4	8	27	37	47	41	55			01,02										Vb 17	CASKTGSEGSDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACAGACTAGCGGAAGCTCCTACGAGCAGTACTTCGGGCCG	CASRQTSGSSYEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	5	0	3	3	27	38	50	41	53			01,02			01,02							Vb 17	CASRQTSGSSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAATTACAGGAACTAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	9	2.0416311271618604E-5		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	4	2	4	4	27	40	49	44	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAATTAGCGGGCAAGAGACCCAGTACTTCGGGCCA	CASSIISGQETQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	5	4	2	2	0	27	42	-1	44	51			01,02			01,02							Vb 17	CASSIISGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCCGGGATACGCAGTATTTTGGCCCA	CASSARDTQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	8	5	6	3	0	27	39	-1	42	45			01,02			01,02							Vb 17	CASSARDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCTCCGGGACAGGGGACTAACTATGGCTACACCTTCGGTTCG	CASSSPGQGTNYGYTF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	0	5	1	27	39	54	44	55			01,02										Vb 17	CASSSPGQGTNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTAAGGGGCAGGGGCTCGGGCCCCAGCATTTTGGTGAT	CATKGQGLGPQHF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	4	2	9	8	5	27	34	48	42	53			01,02										Vb 17	CATKGQGLGPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCTCCACTCTTGGGACAGGGCTTAATGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	2.2684790301798452E-5		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	0	3	7	11	5	27	35	55	46	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGGGACCTACACTGAAGCTTTCTTTGGACAA	CASTGTYTEAFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	7	0	7	3	2	2	27	37	44	39	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTGTYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTAGCGGGAGGGTACAATGAGCAGTTCTTCGGGCCA	CASSLAGGYNEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	0	4	1	0	27	38	-1	39	51			01,02										Vb 17	CASSLAGGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTCAGCGGGAGCCGGAAAGGTACGCAGTATTTTGGCCCA	CASSLSGSRKGTQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	2	8	4	9	27	38	50	42	59			01,02										Vb 17	CASSLSGSRKGTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGCGTGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIGGVYSNQPQHF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	7	0	0	0	5	27	-1	48	43	53			01,02										Vb 17	CASSIGGVYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCACGTTTGGTGCCAAAAGAACCCGACAGCTTTCTTCTCTGTGCCAGTAGTATATGGATCGGCCATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	10	2.2684790301798452E-5		41	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	22	1	8	6	20	6	40	35	58	55	64			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCACGTTTGGTGCCAAAAGAACCCGACAGCTTTTATCTCTGTGCCAGTAGTATAGGGATCACCGGGGGGTCCCAGCATTTTGGTGAT	CASSIGITGGSQHF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	1	8	1	11	7	1	39	55	69	62	70			01,02										Vb 17	CASSIGITGGSQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGTTTGGTGCCAAAAGAACCCGACAGCTTTTATCTCTGTGCCAGTCCTTAGAGGCCCACAAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	10	2.2684790301798452E-5		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	24	11	1	2	20	8	37	30	54	50	62			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGAGGGGCTACGAGCAGTACTTCGGGCCG	CASKRGYEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	7	5	2	3	2	0	27	37	-1	39	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASKRGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTCCAGACAGGGTCAATCAGCCCCAGCATTTTGGTGAT	CASSTPDRVNQPQHF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	3	3	5	1	27	40	52	45	53			01,02										Vb 17	CASSTPDRVNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCCTTCTCTCGGGACAGCTGATGGCTACACCTTCGGTTCG	CASSIDPSLGTADGYTF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	5	6	10	3	27	44	61	54	64			01,02										Vb 17	CASSIDPSLGTADGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCGACTCTACAATGAGCAGTTCTTCGGGCCA	CASSPRLYNEQFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	10	3	4	0	27	39	-1	43	47			01,02			01,02							Vb 17	CASSPRLYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCACGTTTGGTGCCAAAAGAACCCGACAGCTTTCTATTCTGTGCCAGTAGTATGGGCATACTAGGTAATAGGCAGTTCTTCGGGCCA		Out	VDJ	1	11	2.4953269331978296E-5		41	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	20	3	8	12	22	7	40	37	64	59	71			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAGTTACTCGGGACTAGCTTTGAATGAGCAGTTCTTCGGGCCA	CASSYSGLALNEQFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	7	7	5	4	27	39	53	44	57			01,02			01,02							Vb 17	CASSYSGLALNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGGCGCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSKAPNTGELFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	4	5	4	0	0	3	27	-1	43	40	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSKAPNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGAACCGGGACAGGGGGAGAGTTCTTCGGGCCA	CASSIGTGTGGEFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	1	14	7	2	27	41	59	48	61			01,02										Vb 17	CASSIGTGTGGEFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGGGAACTAGCGGGACAGTACGAGCAGTACTTCGGGCCG	CASSRELAGQYEQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	3	3	4	5	3	27	39	54	44	57			01,02										Vb 17	CASSRELAGQYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTATGGAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSYGTSTDTQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	5	1	8	0	3	3	27	39	45	42	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSYGTSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCGGGACAGGTGGAAACACCATATATTTTGGAGAG	CATGTGGNTIYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	0	4	3	2	0	27	34	-1	36	44			01,02										Vb 17	CATGTGGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAGGACAGATTACGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRTDYATNEKLFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	1	5	0	2	6	27	35	43	37	49			01,02										Vb 17	CASRTDYATNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGATACTAGCGGGGGGGGAAGATACGCAGTATTTTGGCCCA	CASKILAGGEDTQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	3	0	5	4	2	27	37	54	41	56			01,02										Vb 17	CASKILAGGEDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTCCCTTAATACGCAGTATTTTGGCCCA	CASRSLNTQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	10	7	4	2	27	38	44	42	46			01,02			01,02							Vb 17	CASRSLNTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCTCGCCTGGGGACAGCTGGGCTTATGGCTACACCTTCGGTTCG	CASSIVSPGDSWAYGYTF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	5	5	9	7	27	43	59	52	66			01,02										Vb 17	CASSIVSPGDSWAYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGACTAGCGGGATGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	13	2.9490227392337985E-5		53	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	2	3	0	2	4	27	41	54	43	58			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGGGGCACGGGCACAGATACGCAGTATTTTGGCCCA	CASSIRGTGTDTQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	5	2	1	1	5	27	41	47	42	52			01,02										Vb 17	CASSIRGTGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTTCAGGGTTCCACCGAGGGGGAGCTGTTTTTTGGAGAA	CASSFQGSTEGELFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	3	8	3	10	27	39	47	42	57			01,02										Vb 17	CASSFQGSTEGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTTAAACCCCCTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	13	2.9490227392337985E-5		35	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	8	3	7	5	4	5	27	36	42	40	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCACGTTTGGTGCCAAAAGAACCCGACAGTTTCTATCTCTGTGCCAGTAGCCTTGGACAGGGGAAAGCTGAAGCTTTCTTTGGACAA	CASSLGQGKAEAFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	2	6	4	4	39	50	63	54	67			01,02										Vb 17	CASSLGQGKAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGTTTGGTGCCAAAAGACCCGACAGCTTTCTATCTCTGTGCCAGTTCCCCAACTGGGCCCCCGAACACTGAAGCTTTCTTTGGACAA	CASSPTGPPNTEAFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	8	0	1	9	4	36	45	58	54	62			01,02										Vb 17	CASSPTGPPNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGGGACAGGAGCGCTATGGCTACACCTTCGGTTCG	CASSGGQERYGYTF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	4	4	2	4	27	39	49	41	53			01,02										Vb 17	CASSGGQERYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATGGGGCAGGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASMGQGSNQPQHF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	2	1	5	0	27	37	-1	42	48			01,02										Vb 17	CASMGQGSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTGCAACCGGGACCCCCTCCGAAACCCAGTACTTCGGGCCA	CASTATGTPSETQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	7	0	7	8	8	10	27	37	50	45	60			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTATGTPSETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAGGGTCCACTCGGCGGAAGCTTTCTTTGGACAA	CASSRVHSAEAFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	8	0	11	27	-1	43	38	54			01,02										Vb 17	CASSRVHSAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAGGTTTCAATCAGCCCCAGCATTTTGGTGAT	CASSTGFNQPQHF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	4	3	0	3	27	-1	44	40	47			01,02										Vb 17	CASSTGFNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCGATCCATGCCCAAGCTTTCTTTGGACAA	CASSIHAQAFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	33	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	8	2	8	9	2	9	27	36	40	38	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIHAQAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCATCCTATGGACAGATACGCAGTATTTTGGCCCA	CASSTILWTDTQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	9	3	5	3	27	40	48	45	51			01,02			01,02							Vb 17	CASSTILWTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGAGGGGGGGGAGACGGAGACCCAGTACTTCGGGCCA	CASSIEGGETETQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	9	0	5	3	6	27	41	51	44	57			01,02										Vb 17	CASSIEGGETETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAGAGTCCGGGAGATGGCTACACCTTCGGTTCG	CASSQSPGDGYTF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	8	2	6	7	0	27	39	-1	46	52			01,02										Vb 17	CASSQSPGDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCTTCCGTAAGCACAGATACGCAGTATTTTGGCCCA	CASSASVSTDTQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	5	10	0	0	0	7	27	-1	41	39	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSASVSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGGGCTAAGAGGACAGGGCGTTGGGACCCAGTACTTCGGGCCA	CAGLRGQGVGTQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	11	1	3	7	9	6	27	33	50	42	56			01,02										Vb 17	CAGLRGQGVGTQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCCGCGAGGTCAGCCCCAGCATTTTGGTGAT	CASRPRGQPQHF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	11	1	6	5	0	27	38	-1	43	47			01,02										Vb 17	CASRPRGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAGTCGGTACAGGGGGCGAGCAGTACTTCGGGCCG	CASSTVGTGGEQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	1	6	8	0	27	40	-1	48	56			01,02										Vb 17	CASSTVGTGGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTCTAGCGTGAGCAACCCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	17	3.8564143513057367E-5		49	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	4	6	4	2	9	27	40	48	42	57			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACGTTTGGTGCCAAAAGAACCCGACAGYTTCTATCTCTGTGCCAGTAGTCGACGGGAATTGTCGAACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	17	3.8564143513057367E-5		43	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	3	5	3	8	38	50	58	53	66			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTACCTCGGCGGGAGGTACAGATACGCAGTATTTTGGCCCA	CASTTSAGGTDTQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	7	1	3	8	1	27	37	53	45	54			01,02										Vb 17	CASTTSAGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAATGCGGTTCCGGGGGTCGGGCGGCTACACCTTCGGTTCG	CASSIMRFRGSGGYTF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	8	2	8	9	6	27	42	57	51	63			01,02										Vb 17	CASSIMRFRGSGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTTCATGCCAGGGGCGTCGGGAACACTGAAGCTTTCTTTGGACAA	CASSLHARGVGNTEAFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	1	8	6	27	39	53	47	59			01,02										Vb 17	CASSLHARGVGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGATGGGGTTCTGTATGGGTCGACCCAGTACTTCGGGCCA	CASSDGVLYGSTQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	5	6	2	7	3	13	27	39	46	42	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSDGVLYGSTQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCACGTTTGGTGCCAAAAGAACCCGACAGCTTTTATCTCTGTGCCAGTAGTATGGGCATACTAGGTAATAGGCAGTTCTTCGGGCCA		Out	VDJ	1	18	4.083262254323721E-5		41	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	24	3	8	12	26	7	40	33	64	59	71			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGGTCACAGGTTTACCTCCGGCCGGCGAAGAGAAGCTTTCTTTGGACAA		Out	VDJ	1	19	4.3101101573417056E-5		56	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	4	8	5	21	25	38	48	43	69			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACAGGCCTCCCAAGAGACCCAGTACTTCGGGCCA	CASSIQASQETQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	4	1	0	4	27	-1	46	42	50			01,02										Vb 17	CASSIQASQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCACGTTTGGTGCCAAAAGAACCCGACAGCTTTTATCTCTGTGCCAGTAGTATATGGATCGGCCATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	19	4.3101101573417056E-5		41	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	24	1	8	6	22	6	40	33	58	55	64			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAATGAAGGGGGCAGGGAATCAGCCCCAGCATTTTGGTGAT	CASSIMKGAGNQPQHF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	5	0	4	4	4	27	42	53	46	57			01,02										Vb 17	CASSIMKGAGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAGTCGTTCAGTGAAGGTGACTGAAGCTTTCTTTGGACAA	CASSISRSVKVTEAFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	4	5	5	0	16	27	-1	44	41	60			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSISRSVKVTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGAGGGGACTACGAGCAGTACTTCGGGCCG	CASSIGGDYEQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	0	3	1	2	27	41	48	42	50			01,02										Vb 17	CASSIGGDYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTATAGGTCCACCGGGGAGCTGTTTTTTGGAGAA	CASSYRSTGELFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	5	5	4	4	3	2	27	39	45	42	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSYRSTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCCCCTCCGGGACAGGGCGATCGGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	20	4.5369580603596903E-5		53	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	0	3	3	8	7	27	36	53	44	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGTTTGGTGCCAAAAGAACCCGACAGCTTTYATCTCTGTGCCAGTTCCCCAACTGGGCCCCCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	20	4.5369580603596903E-5		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	24	8	0	1	24	4	37	30	58	54	62			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGTCAGTAGTGCCAAATATCTCATAAATACGCAGTATTTTGGCCCA	CVSSAKYLINTQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	5	4	6	7	2	12	27	39	43	41	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CVSSAKYLINTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGCAGGGGGGGTGGAGGAGACCCAGTACTTCGGGCCA	CASRAGGVEETQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	6	4	1	5	2	7	27	38	47	40	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRAGGVEETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGCTTGGGACTCCTACAATGAGCAGTTCTTCGGGCCA	CASAWDSYNEQFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	8	0	8	0	4	0	27	36	-1	40	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASAWDSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCTCTTAGCGGGCAGTCTGGAGCCCCAGTACTTCGGGCCA		Out	VDJ	1	23	5.2175017694136434E-5		41	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	10	5	4	9	5	11	27	34	46	39	57			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGACACCTCCCGCTCCTACGAGCAGTACTTCGGGCCG	CASSDTSRSYEQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	6	0	1	7	27	38	43	39	50			01,02										Vb 17	CASSDTSRSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTTCTGGGCCCAACCCAACACAGATACGCAGTATTTTGGCCCA	CASSIFWAQPNTDTQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	8	0	2	5	9	27	41	50	46	59			01,02										Vb 17	CASSIFWAQPNTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCGGAGACCCAATCAGCCCCAGCATTTTGGTGAT	CASSPRRPNQPQHF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	10	2	3	4	3	27	39	47	43	50			01,02										Vb 17	CASSPRRPNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCACGTTTGGTGCCAAAAGAACCCGAAGCTTTCTATCTCTGTGCCAGTAGTATATGGATCGGCCATGAAAAACTGTTTTTTGGCAGT	CASSIWIGHEKLFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	2	1	8	6	1	6	39	54	58	55	64			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIWIGHEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACAGGGACAGGGACCGCGTCAGTCCTTGAAGCTTTCTTTGGACAA	CASTGTGTASVLEAFF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	3	7	2	14	27	37	48	39	62			01,02										Vb 17	CASTGTGTASVLEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAACAAACCTTGGGACAGTGAACACTGAAGCTTTCTTTGGACAA	CASRTNLGTVNTEAFF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	0	10	0	27	38	-1	48	55			01,02										Vb 17	CASRTNLGTVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGAGGGCCCACCTACGAGCAGTACTTCGGGCCG	CASSIGGPTYEQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	11	0	2	0	4	27	-1	48	43	52			01,02										Vb 17	CASSIGGPTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATGGATCGGCCATGAAAAACTGTTTTTGGCAGT		Out	VDJ	1	24	5.444349672431628E-5		41	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	2	1	8	18	1	17	27	42	46	43	63			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCCGTAATCAGCCCCAGCATTTTGGTGAT	CASSARNQPQHF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	10	0	4	0	4	27	-1	41	39	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSARNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCACGTTTGGTGCCAAAAGAACCCGACAGCTTCTATCTCTGTGCCAGTAGTATAGGGATCACCGGGGGGTCCCAGCATTTTGGTGAT	CASSIGITGGSQHF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	1	8	1	11	7	1	39	55	69	62	70			01,02										Vb 17	CASSIGITGGSQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGAGAACGCGTCGGACGAGAGACCCAGTACTTCGGGCCA	CASRERVGRETQYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	9	1	7	4	13	1	27	35	52	48	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRERVGRETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGAAGACAGGGACTCCTACGAGCAGTACTTCGGGCCG	CASREDRDSYEQYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	0	4	1	27	38	49	42	50			01,02										Vb 17	CASREDRDSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTAAATTGGGGGCCGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	25	5.671197575449612E-5		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	6	0	1	7	2	27	40	53	47	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTTTTACTGGAAACACCATATATTTTGGAGAG	CASSTFTGNTIYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	4	10	2	0	4	27	-1	42	40	46			01,02			01,02							Vb 17	CASSTFTGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCACGTTTGGTGCCAAAAGAACCCGACAGTTTCTATCTCTGTGCCAGTAGTATGGGCATACTAGGTAATAGGCAGTTCTTCGGGCCA	CASSMGILGNRQFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	3	8	12	6	7	39	53	64	59	71			01,02			01,02							Vb 17	CASSMGILGNRQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAGGACCCCCAGCCCCTTTAGTGAAGCTTTCTTTGGACAA	CASRTPSPFSEAFF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	9	1	7	7	2	15	27	35	41	37	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRTPSPFSEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGCCACGGGAACTAGCGGGAGGGCTGAGCAGTTCTTCGGGCCA	CASTATGTSGRAEQFF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	3	0	9	11	1	27	37	61	48	62			01,02										Vb 17	CASTATGTSGRAEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCCTAGCGGGAGTTGTTGAGCAGTTCTTCGGGCCA	CASSPLAGVVEQFF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	9	4	4	27	38	52	42	56			01,02										Vb 17	CASSPLAGVVEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGGCAGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSIRQGGTDTQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	1	1	3	0	27	42	-1	45	52			01,02										Vb 17	CASSIRQGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGAGGGATGGGACAATCAGCCCCAGCATTTTGGTGAT	CASSIEGWDNQPQHF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	11	0	3	1	6	27	41	47	42	53			01,02										Vb 17	CASSIEGWDNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCGGGGGAGGCCTGAGGAACACTGAAGCTTTCTTTGGACAA	CATGGGLRNTEAFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	10	8	2	1	1	9	27	34	41	35	50			01,02			01,02							Vb 17	CATGGGLRNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGGCGAATCAGCCCCAGCATTTTGGTGAT	CASSIEANQPQHF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	0	9	0	4	0	1	27	-1	47	44	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEANQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGTCCGGGACATGGAGAGGTGTTCAGCCCCAGCATTTTGGTGAT	CASSIESGTWRGVQPQHF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	6	6	4	11	27	44	54	48	65			01,02										Vb 17	CASSIESGTWRGVQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCCACGCGGGAAGGGAACAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	27	6.124893381485581E-5		49	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	7	3	6	6	7	27	41	53	47	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01*02	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGGGAAACACTGAAGCTTTCTTTGGACAA	CASSMGGNTEAFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	1	2	0	1	27	-1	47	41	48			01,02										Vb 17	CASSMGGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGTCAGTTCCCCAACTGGGTCCCCGAACACTGAAGCTTTCTTTGGACAA	CVSSPTGSPNTEAFF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	8	0	9	1	9	5	27	36	48	45	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CVSSPTGSPNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCGGAGACTAGCGGGGAAAAGCAATGAGCAGTTCTTCGGGCCA	CASSIDRRLAGKSNEQFF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	2	3	6	5	5	27	44	60	49	65			01,02										Vb 17	CASSIDRRLAGKSNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGTAGCGCTCACAATGAGCAGTTCTTCGGGCCA	CASSISSAHNEQFF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	6	5	3	3	27	41	49	44	52			01,02			01,02							Vb 17	CASSISSAHNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGTTTGGTGGGGCAGACCGCCTCACAGATACGCAGTATTTTGGCCCA	CASSPFGGADRLTDTQYF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	7	0	2	9	9	27	39	53	48	62			01,02										Vb 17	CASSPFGGADRLTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGAGGGACTAGCGGGCATCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSGGTSGHPSTDTQYF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	4	0	3	6	27	39	54	42	60			01,02			01,02							Vb 17	CASSGGTSGHPSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATCCCTGGATTTATGTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	29	6.578589187521551E-5		43	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	7	1	8	3	5	7	27	37	45	42	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGGTAAGGGTTGGCTCTAAAAGCATGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	29	6.578589187521551E-5		46	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	7	5	3	4	0	17	27	-1	41	37	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGTTTGGTGCCAAAAGAACCCGACAGCTTCTATCTCTGTGCCAGTTCCCCAACTGGGCCCCCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	29	6.578589187521551E-5		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	25	8	0	1	25	4	37	29	58	54	62			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGGGACTAGCGGGCTCCAAGAGACCCAGTACTTCGGGCCA	CASTGTSGLQETQYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	0	4	1	2	2	27	37	51	39	53			01,02			01,02							Vb 17	CASTGTSGLQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTCCCTATCCCGCCGAGAGACCCAGTACTTCGGGCCA	CASSISLSRRETQYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	4	9	4	4	8	27	41	48	45	56			01,02			01,02							Vb 17	CASSISLSRRETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGGGACTAGCGGGCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSPGTSGPSTDTQYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	4	0	3	3	27	39	54	42	57			01,02			01,02							Vb 17	CASSPGTSGPSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCTACAAGGGAGACAGGGTCGATATGGCTACACCTTCGGTTCG	CASLQGRQGRYGYTF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	2	3	5	11	4	27	35	53	46	57			01,02										Vb 17	CASLQGRQGRYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACCGGGGGGCTTTGGGACAGGGCGGGTCACTGAAGCTTTCTTTGGACAA	CASRPGGFGTGRVTEAFF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	4	13	5	27	38	60	51	65			01,02										Vb 17	CASRPGGFGTGRVTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACAGGGGGGATACGAGCAGTACTTCGGGCCG	CASSIQGGYEQYF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	1	4	0	2	27	-1	49	42	51			01,02										Vb 17	CASSIQGGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGTCCGGGGCAGCCCCAGCATTTTGGTGAT	CASSIGPGQPQHF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	1	8	3	7	3	0	27	43	-1	46	51			01,02										Vb 17	CASSIGPGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCGGTCTAGCGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSPRSSGGYNEQFF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	2	3	7	0	27	39	-1	46	56			01,02										Vb 17	CASSPRSSGGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGACGACTAGCGGGCATTACAACAATGAGCAGTTCTTCGGGCCA	CASSPTTSGHYNNEQFF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	4	5	5	7	27	39	54	44	61			01,02			01,02							Vb 17	CASSPTTSGHYNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCAACAACAGGGGAGGGGCCGGGGAGCTGTTTTTTGGAGAA	CATNNRGGAGELFF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	10	3	2	6	6	5	27	34	47	40	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CATNNRGGAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTCCGGGACCTACGAGCAGTACTTCGGGCCG	CASSMSGTYEQYF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	8	3	2	3	0	27	41	-1	44	49			01,02										Vb 17	CASSMSGTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCTTCCCTAGCGGGAGATCTCCTCCTACGAGCAGTACTTCGGGCCG	CASSILP*REISSYEQYF	Stop	VDJ	1	32	7.259132896575504E-5		54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	4	2	0	6	5	27	41	57	47	62			01,02										Vb 17	CASSILP*REISSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCAGGGACAGACAGGGCGGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASTPGTDRAGYSNQPQHF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	57	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	5	0	5	13	24	34	46	39	59			01,02										Vb 17	CASTPGTDRAGYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGGCGAGGGACCAGCCCCAGCATTTTGGTGAT	CASSTARDQPQHF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	4	0	7	7	6	0	27	40	-1	46	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTARDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCAGTTTACACAGATACGCAGTATTTTGGCCCA	CASSIAVYTDTQYF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	5	2	0	4	27	-1	46	43	50			01,02										Vb 17	CASSIAVYTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTTCGGGACAGGGGCGACTTCCTACGAGCAGTACTTCGGGCCG	CASSIFGTGATSYEQYF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	1	4	5	27	41	55	45	60			01,02										Vb 17	CASSIFGTGATSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCGCAGGGACGGCGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSFAGTASSYEQYF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	5	0	7	0	6	6	27	39	50	45	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSFAGTASSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCGGGGAGGGAGGGCCTAGCGGGATTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	34	7.712828702611473E-5		55	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	3	4	15	2	26	37	61	52	63			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCCTCGCAACGGGGCGGCCGTTTGAACGGGGAGCTGTTTTTTGGAGAA	CASSIASQRGGRLNGELFF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	57	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	1	7	0	7	9	11	24	40	54	49	65			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIASQRGGRLNGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGGACAGCTATGGCTACACCTTCGGTTCG	CASSSDSYGYTF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	5	4	2	0	27	39	-1	41	47			01,02										Vb 17	CASSSDSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACAAGGAAACAGGGTTACGATGGCTACACCTTCGGTTCG	CATRKQGYDGYTF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	3	3	6	7	5	27	34	47	41	52			01,02										Vb 17	CATRKQGYDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTCGGAGCGGGAGGATGGGGAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	35	7.939676605629458E-5		49	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	6	1	5	6	7	27	37	52	43	59			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAGTCCGGGGGCCGGCACTGAAGCTTTCTTTGGACAA	CASSSPGAGTEAFF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	6	6	0	4	6	3	27	38	50	44	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSSPGAGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGCAGAAGCACAGATACGCAGTATTTTGGCCCA	CASSGRSTDTQYF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	6	4	5	0	3	1	27	38	44	41	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSGRSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCTCGGGATCCGTCGGGGAGCTGTTTTTTGGAGAA	CASSPSGSVGELFF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	8	3	7	4	5	27	39	48	43	53			01,02										Vb 17	CASSPSGSVGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTAACCGGGACTAGTCCTGCCGAGCAGTACTTCGGGCCG	CASSLTGTSPAEQYF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	8	6	6	6	27	39	53	45	59			01,02			01,02							Vb 17	CASSLTGTSPAEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACAGCTTTCTATCTCTGTGCCGGATCCTCCACACAGGATGGGGACGGGACAACGGTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	35	7.939676605629458E-5		59	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	11	0	6	3	24	5	16	22	52	46	57			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAAAGTCAGGGGAGAGATGGCTACACCTTCGGTTCG	CASKSQGRDGYTF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	2	6	5	4	27	37	48	42	52			01,02										Vb 17	CASKSQGRDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGGGACTAGCGGGAGTTACGAGCAGTACTTCGGGCCG	CASSRGTSGSYEQYF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	0	2	4	2	1	27	40	56	42	57			01,02										Vb 17	CASSRGTSGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGCCAGGGCGCGCATCAGCCCCAGCATTTTGGTGAT	CASSISQGAHQPQHF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	3	5	3	5	27	42	50	45	55			01,02										Vb 17	CASSISQGAHQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTGGGGCCGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	36	8.166524508647442E-5		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	7	0	2	1	2	27	43	49	44	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSRSNQPQHF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	8	5	1	0	0	27	-1	-1	39	42			01,02			01,02							Vb 17	CASSRSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGACGGCATATAAGTAACGGTCGACGAAACACCATATATTTTGGAGAG		Out	VDJ	1	36	8.166524508647442E-5		53	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	5	2	7	5	0	21	27	-1	42	39	63			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTTTTGGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSVLGGNQPQHF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	6	1	2	5	0	27	39	-1	44	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSVLGGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGTTGGGATCCTTAGAGACTATGGCTACACCTTCGGTTCG	CASVGILRDYGYTF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	8	0	8	3	3	9	27	36	43	39	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASVGILRDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCGGGACAGGGGAGGAGGAAGCTACGAGCAGTACTTCGGGCCG	CATRDRGGGSYEQYF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	0	2	3	3	9	27	34	47	37	56			01,02										Vb 17	CATRDRGGGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGCCGGTTTGAACACTGAAGCTTTCTTTGGACAA	CASSAGLNTEAFF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	5	0	3	2	27	38	44	41	46			01,02			01,02							Vb 17	CASSAGLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTTGAGCGGGGGGGCCACGAGCAGTACTTCGGGCCG	CASSVERGGHEQYF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	6	0	5	4	2	27	39	53	43	55			01,02										Vb 17	CASSVERGGHEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCCGACGGGAGCACTGAAGCTTTCTTTGGACAA	CASSIADGSTEAFF	In	VDJ	1	38	8.620220314683411E-5	1.1064555859992605E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	8	2	4	4	0	27	43	-1	47	53			01,02										Vb 17	CASSIADGSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGGACTAGCGGCACAGATACGCAGTATTTTGGCCCA	CASSIRTSGTDTQYF	In	VDJ	1	38	8.620220314683411E-5	1.1064555859992605E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	1	6	1	2	0	27	41	-1	43	52			01,02			01,02							Vb 17	CASSIRTSGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCTCGGGACACCCAATTACCATGAGCAGTTCTTCGGGCCA	CASSTLGTPNYHEQFF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	6	8	5	10	27	40	51	45	61			01,02										Vb 17	CASSTLGTPNYHEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGCAGGGAGGGACACAATCAGCCCCAGCATTTTGGTGAT	CASSIGREGHNQPQHF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	9	0	3	5	3	27	41	53	46	56			01,02										Vb 17	CASSIGREGHNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGACTTAGGGGCGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSMDLGASNQPQHF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	3	5	2	1	6	2	27	41	52	47	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMDLGASNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGCTAGCGGGGACACAGATACGCAGTATTTTGGCCCA	CASSIASGDTDTQYF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	4	3	2	2	1	27	41	52	43	53			01,02										Vb 17	CASSIASGDTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATCCACGGGGGAGGGGGCACTGAAGCTTTCTTTGGACAA	CASIHGGGGTEAFF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	9	0	4	7	2	27	37	51	44	53			01,02										Vb 17	CASIHGGGGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCACGTTTGGTGCCAAAAGAACCCGACAGCTTCTATCTCTGTGCCAGTAGTATATGGATCGGCCATGAAAAACTGTTTTTTGGCAGT	CASSIWIGHEKLFF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	2	1	8	6	1	6	39	54	58	55	64			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIWIGHEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCGGCCGGGACTAGCGCGACCCTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CATRPGLARPSNTGELFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	0	6	0	7	7	27	34	51	41	58			01,02			01,02							Vb 17	CATRPGLARPSNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAATGGGACAGGGGCGTACCGACACCTTCGGTTCG	CASRMGQGRTDTF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	12	3	7	27	38	51	41	58			01,02										Vb 17	CASRMGQGRTDTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGAAGCGGGGGAGGATACAATGAGCAGTTCTTCGGGCCA	CASSRSGGGYNEQFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	6	2	4	2	4	27	40	50	42	54			01,02										Vb 17	CASSRSGGGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACGGTCCTCCTACGAGCAGTACTTCGGGCCG	CASSIRSSYEQYF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	8	5	0	0	2	27	-1	45	42	47			01,02			01,02							Vb 17	CASSIRSSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCCTAGCGGGAGGACGAGAGCAGTTCTTCGGGCCA	CASSIVLAGGREQFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	4	1	10	2	4	27	43	56	45	60			01,02										Vb 17	CASSIVLAGGREQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAGGAGTCGGTCAGCCCCAGCATTTTGGTGAT	CASSPGVGQPQHF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	4	4	6	1	6	27	39	44	40	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPGVGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGACTAGCGGGAGTTTCCGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	40	9.073916120719381E-5		49	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	0	2	6	0	6	27	-1	53	39	59			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAACCCCTAGGGGGAGGGGTCACAGATACGCAGTATTTTGGCCCA	CASKPLGGGVTDTQYF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	9	0	2	10	2	27	37	54	47	56			01,02										Vb 17	CASKPLGGGVTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGACAGACCTATGGCTACACCTTCGGTTCG	CASSIGQTYGYTF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	5	4	1	2	27	41	48	42	50			01,02										Vb 17	CASSIGQTYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCACTACAGGACCCCTCTGGAAACACCATATATTTTGGAGAG	CASSPLQDPSGNTIYF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	4	0	5	4	27	39	49	44	53			01,02										Vb 17	CASSPLQDPSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCAGAGGGGGGGAGCAGTTCTTCGGGCCA	CASSSRGGEQFF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	5	5	1	10	5	1	27	39	50	44	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSSRGGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTTCCCAACTGGGCCCTCGAACACTGAAGCTTTCTTTGGACAA	CASFPTGPSNTEAFF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	8	0	1	9	4	27	36	49	45	53			01,02										Vb 17	CASFPTGPSNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATCGGGGGGTCAACACCGGGGAGCTGTTTTTTGGAGAA	CASNRGVNTGELFF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	8	1	2	2	2	27	37	46	39	48			01,02										Vb 17	CASNRGVNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGTTTACTCCTGGAGAACTGAAGCTTTCTTTGGACAA	CASSTVYSWRTEAFF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	2	5	12	1	27	40	56	52	57			01,02										Vb 17	CASSTVYSWRTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAGGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSIRSTGELFF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	3	4	4	4	0	2	27	-1	45	41	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRSTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGGACAGGGGGTTTCGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	44	9.981307732791318E-5		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	1	6	2	5	27	40	52	42	57			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGGCAGGGGGAATAGCGGGAGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSIEAGGIAGGGNEQFF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	57	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	5	0	6	11	2	24	41	63	52	65			01,02										Vb 17	CASSIEAGGIAGGGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCCTTTCAAGAGACCCAGTACTTCGGGCCA	CASSTPFQETQYF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	4	10	2	4	2	27	40	46	44	48			01,02			01,02							Vb 17	CASSTPFQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCCCTGGACTAGCGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSSPGLAGYNEQFF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	4	3	6	0	27	39	-1	45	56			01,02			01,02							Vb 17	CASSSPGLAGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGCAGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSQVNTGELFF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	4	1	3	1	27	39	46	42	47			01,02										Vb 17	CASSSQVNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGGGGTCATATTACTCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	47	1.0661851441845271E-4		43	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	11	6	2	0	0	10	27	-1	37	33	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGGAACCCCAGGGGGAGATAACATTCAGTACTTCGGCGCC		Out	VDJ	2	48	1.0888699344863256E-4		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	9	4	1	7	9	4	27	35	51	44	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGACAGATCGGGAAACACCATATATTTTGGAGAG	CASSDRSGNTIYF	In	VDJ	2	48	1.0888699344863256E-4	1.3976281086306447E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	5	4	1	4	27	38	44	39	48			01,02										Vb 17	CASSDRSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGACATTGTGGCTAGCAAAAACATTCAGTACTTCGGCGCC	CASSDIVASKNIQYF	In	VDJ	2	48	1.0888699344863256E-4	1.3976281086306447E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-04	01	5	2	6	3	0	10	27	-1	43	39	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSDIVASKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01		TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCGAGGTCCACCGGGGAGCTGTTTTTTGGAGAA	CASSARSTGELFF	In	VDJ	2	48	1.0888699344863256E-4	1.3976281086306447E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	11	1	4	2	2	27	39	45	41	47			01,02										Vb 17	CASSARSTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCGGAGAGATCGTGGAAGCCAAAAACATTCAGTACTTCGGCGCC	CASSIVGEIVEAKNIQYF	In	VDJ	2	49	1.1115547247881241E-4	1.4267453608937832E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	1	10	2	0	2	10	27	43	49	45	59			01,02										Vb 17	CASSIVGEIVEAKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01*02	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCTCGCGGGGGCGGATGAATGAGCAGTTCTTCGGGCCA	CASSTSRGRMNEQFF	In	VDJ	2	50	1.1342395150899225E-4	1.4558626131569216E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	7	2	7	4	6	27	40	51	44	57			01,02										Vb 17	CASSTSRGRMNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCGGACAGTGGGGATTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSAGQWGLAKNIQYF	In	VDJ	2	50	1.1342395150899225E-4	1.4558626131569216E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	1	5	0	3	8	27	39	48	42	56			01,02										Vb 17	CASSAGQWGLAKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCTAAGGGGGAGACCCAGTACTTCGGGCCA	CASSKGETQYF	In	VDJ	2	50	1.1342395150899225E-4	1.4558626131569216E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	5	2	5	4	0	27	36	-1	40	45			01,02										Vb 17	CASSKGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGATCGGGGAGTCGTGGGGCCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRDRGVVGPTNEKLFF	In	VDJ	2	51	1.1569243053917209E-4	1.48497986542006E-4	54	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	6	7	0	0	15	0	27	38	-1	53	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRDRGVVGPTNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCAGAAGGGTACGAGCAGTACTTCGGGCCG	CASSTPEGYEQYF	In	VDJ	2	51	1.1569243053917209E-4	1.48497986542006E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	4	5	3	4	7	0	27	40	-1	47	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTPEGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGGCACGTCCAGGGGAGTAAATCAGCCCCAGCATTTTGGTGAT	CGTSRGVNQPQHF	In	VDJ	2	51	1.1569243053917209E-4	1.48497986542006E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	13	4	2	4	7	4	27	31	44	38	48			01,02										Vb 17	CGTSRGVNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACCCCCCCGTTTTCGAGCGGAAGTACAATGAGCAGTTCTTCGGGCCA	CASSIDPPVFERKYNEQFF	In	VDJ	2	52	1.1796090956935194E-4	1.5140971176831985E-4	57	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	6	5	4	14	3	24	41	60	55	63			01,02			01,02							Vb 17	CASSIDPPVFERKYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCGGAAAGTGGGGACAGTATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASTRKVGTVYSNQPQHF	In	VDJ	2	52	1.1796090956935194E-4	1.5140971176831985E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	5	0	11	4	27	37	55	48	59			01,02										Vb 17	CASTRKVGTVYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACAAACCGGGAGGGGGCAACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASTNREGATGANVLTF	In	VDJ	2	53	1.2022938859953179E-4	1.543214369946337E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	7	8	0	2	5	5	27	37	50	42	55			01,02										Vb 17	CASTNREGATGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD02-01*02	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTRCCAGTAGTATCAGATCCGGGTCCGAGCAGTACTTCGGGCCG	CXSSIRSGSEQYF	In	VDJ	2	54	1.2249786762971162E-4	1.5723316222094753E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	8	4	6	6	2	27	41	51	47	53			01,02			01,02							Vb 17	CXSSIRSGSEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGTCACACCTACTATGGCTACACCTTCGGTTCG	CASRHTYYGYTF	In	VDJ	2	54	1.2249786762971162E-4	1.5723316222094753E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	3	6	3	5	3	27	35	43	40	46			01,02										Vb 17	CASRHTYYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCATAGCGGGAGCCAATGAGCAGTTCTTCGGGCCA	CASSIIAGANEQFF	In	VDJ	2	54	1.2249786762971162E-4	1.5723316222094753E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	5	2	6	2	1	27	41	52	43	53			01,02										Vb 17	CASSIIAGANEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGATTAGGGACAGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSMRLGTGSNQPQHF	In	VDJ	2	54	1.2249786762971162E-4	1.5723316222094753E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	3	1	7	0	27	41	-1	48	57			01,02										Vb 17	CASSMRLGTGSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGTAGCGGGACCCACCCCAGGGGAGACCCAGTACTTCGGGCCA	CASSMVAGPTPGETQYF	In	VDJ	2	54	1.2249786762971162E-4	1.5723316222094753E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	5	3	5	2	12	27	41	51	43	63			01,02										Vb 17	CASSMVAGPTPGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTTCGGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSVRSTGELFF	In	VDJ	2	54	1.2249786762971162E-4	1.5723316222094753E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	10	2	4	4	0	27	39	-1	43	47			01,02										Vb 17	CASSVRSTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGTCAGGGAATACGCAGTATTTTGGCCCA	CASSIESGNTQYF	In	VDJ	2	55	1.2476634665989147E-4	1.6014488744726138E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	3	7	2	1	27	44	51	46	52			01,02										Vb 17	CASSIESGNTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCGTTGAAGGAGGAGCAGTTCTTCGGGCCA	CASSALKEEQFF	In	VDJ	2	55	1.2476634665989147E-4	1.6014488744726138E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	10	2	10	8	0	27	39	-1	47	51			01,02										Vb 17	CASSALKEEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCGGACCATGGAGAAAGATACGCAGTATTTTGGCCCA	CATRTMEKDTQYF	In	VDJ	2	56	1.2703482569007132E-4	1.6305661267357522E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	10	1	7	5	3	9	27	34	41	37	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CATRTMEKDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCTCGACGGCCTTACACCGGGGAGCTGTTTTTTGGAGAA	CASTPRRPYTGELFF	In	VDJ	2	56	1.2703482569007132E-4	1.6305661267357522E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	7	2	7	3	6	6	27	37	46	43	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTPRRPYTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATAGTGGGGGAGGCGACCAGCCCCAGCATTTTGGTGAT	CASSIDSGGGDQPQHF	In	VDJ	2	56	1.2703482569007132E-4	1.6305661267357522E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	9	1	7	6	4	27	44	56	50	60			01,02										Vb 17	CASSIDSGGGDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTTTGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSIFGTGELFF	In	VDJ	2	57	1.2930330472025117E-4	1.6596833789988907E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	3	0	10	4	4	0	27	41	-1	45	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIFGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTACCCGCAGGGGGCTTCTGGAAACACCATATATTTTGGAGAG	CASTYPQGASGNTIYF	In	VDJ	2	59	1.3384026278061086E-4	1.7179178835251675E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	4	0	1	8	1	27	37	53	45	54			01,02										Vb 17	CASTYPQGASGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGCTCCGCGGAGGGCTTTCAAACACTGAAGCTTTCTTTGGACAA	CASTLRGGLSNTEAFF	In	VDJ	2	59	1.3384026278061086E-4	1.7179178835251675E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	10	0	2	8	6	27	37	51	45	57			01,02										Vb 17	CASTLRGGLSNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGACATCGAGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	61	1.3837722084097056E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	6	2	0	5	27	-1	45	41	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCACCGGGACAGGGTCAAATCGGCAGCCCCAGCATTTTGGTGAT	CASTTGTGSNRQPQHF	In	VDJ	2	62	1.4064569987115038E-4	1.8052696403145828E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	3	7	5	9	27	37	51	42	60			01,02										Vb 17	CASTTGTGSNRQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCACAGCCCTGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	62	1.4064569987115038E-4		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	5	0	1	5	27	41	46	42	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGAGTCGGCCACCAGGGAGAGACCCAGTACTTCGGGCCA	CASSRVGHQGETQYF	In	VDJ	2	63	1.4291417890133023E-4	1.8343868925777213E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	3	4	11	0	27	40	-1	51	56			01,02										Vb 17	CASSRVGHQGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGAAGACAGGGGGAAACACCATATATTTTGGAGAG	CASKKTGGNTIYF	In	VDJ	2	64	1.4518265793151007E-4	1.8635041448408597E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	2	3	4	4	0	27	37	-1	41	48			01,02										Vb 17	CASKKTGGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACTCCGGGACAGCCTATGGCTACACCTTCGGTTCG	CASSIDSGTAYGYTF	In	VDJ	2	64	1.4518265793151007E-4	1.8635041448408597E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	5	4	4	1	27	44	55	48	56			01,02										Vb 17	CASSIDSGTAYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGCCCGGACCACCGGGGAGCTGTTTTTTGGAGAA	CASSPARTTGELFF	In	VDJ	2	64	1.4518265793151007E-4	1.8635041448408597E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	5	1	7	4	7	0	27	39	-1	46	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPARTTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTTGCGGACTGGCAATCCTACGAGCAGTACTTCGGGCCG	CASSIVADWQSYEQYF	In	VDJ	2	66	1.4971961599186977E-4	1.9217386493671366E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	1	10	1	4	5	27	43	52	47	57			01,02			01,02							Vb 17	CASSIVADWQSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTAGACGAGCAGGGAAAAACACCATATATTTTGGAGAG		Out	VDJ	2	66	1.4971961599186977E-4		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	4	3	6	9	2	27	41	55	50	57			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCCCCAACCAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	71	1.6106201114276898E-4		38	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	8	3	7	2	5	3	27	36	43	41	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCGTTGGTCAGCCCCAGCATTTTGGTGAT	CASSIGVGQPQHF	In	VDJ	2	72	1.6333049017294883E-4	2.0964421629459672E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	7	6	6	0	4	27	-1	46	43	50			01,02			01,02							Vb 17	CASSIGVGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACGGGGTTACAATGAGCAGTTCTTCGGGCCA	CASSIRGYNEQFF	In	VDJ	3	75	1.7013592726348837E-4	2.1837939197353825E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	3	4	0	1	27	-1	47	42	48			01,02										Vb 17	CASSIRGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGAAACGGGGCAGTCCCATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	3	76	1.7240440629366822E-4		40	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	9	7	0	6	4	6	27	35	44	39	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGGGACTAGCCCCAATGAGCAGTTCTTCGGGCCA	CASTGTSPNEQFF	In	VDJ	3	79	1.7920984338420777E-4	2.300262928787936E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	7	6	2	2	27	37	48	39	50			01,02			01,02							Vb 17	CASTGTSPNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGTGATGTAGGATCGCAGTATTTTGGCCCA	CASSSDVGSQYF	In	VDJ	3	79	1.7920984338420777E-4	2.300262928787936E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	4	1	8	10	8	1	27	40	51	48	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSSDVGSQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSIGGNTGELFF	In	VDJ	3	79	1.7920984338420777E-4	2.300262928787936E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	10	1	1	1	0	27	41	-1	42	47			01,02										Vb 17	CASSIGGNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTTTCGGGGGGAAAATCAGCCCCAGCATTTTGGTGAT	CASRFRGENQPQHF	In	VDJ	3	80	1.8147832241438761E-4	2.3293801810510745E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	8	1	4	4	2	27	38	49	42	51			01,02										Vb 17	CASRFRGENQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCCCGACTAGCTAACCGATGTCGGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	3	81	1.8374680144456743E-4		52	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	9	2	7	4	4	12	27	35	46	39	58			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD02-01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATCGCCGCCGTCGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	3	81	1.8374680144456743E-4		40	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	7	10	0	4	2	8	27	37	41	39	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCAGGGGGACAGCCGGACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	3	84	1.9055223853510698E-4		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	0	5	0	5	5	27	34	46	39	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGCGCGGCCACCGGATAACTATGGCTACACCTTCGGTTCG	CASSIGARPPDNYGYTF	In	VDJ	3	86	1.9508919659546667E-4	2.504083694629905E-4	51	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	1	8	0	1	0	12	27	-1	47	43	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGARPPDNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAAGCGGGAGGGCGTGATGAGCAGTTCTTCGGGCCA	CASSQAGGRDEQFF	In	VDJ	3	86	1.9508919659546667E-4	2.504083694629905E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	0	8	2	4	27	39	51	41	55			01,02										Vb 17	CASSQAGGRDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCACTGGGACGGACAGGGACTATGGCTACACCTTCGGTTCG		Out	VDJ	3	93	2.1096854980672558E-4		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	3	3	12	0	27	37	-1	49	57			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGACAGGGTTTTCGAGCTATGGCTACACCTTCGGTTCG	CASSMTGFSSYGYTF	In	VDJ	3	93	2.1096854980672558E-4	2.7079044604718744E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	3	4	0	8	27	-1	48	41	56			01,02										Vb 17	CASSMTGFSSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGGACTAGCGGGAGAGAGAGCACAGATACGCAGTATTTTGGCCCA	CASSRTSGRESTDTQYF	In	VDJ	3	94	2.1323702883690543E-4	2.7370217127350126E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	1	2	0	2	4	27	38	53	40	57			01,02										Vb 17	CASSRTSGRESTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGGGACAGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSIEGQGYNEQFF	In	VDJ	3	95	2.1550550786708528E-4	2.7661389649981513E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	3	0	0	27	-1	-1	44	53			01,02										Vb 17	CASSIEGQGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGTTCCTTACAGGGGGTAGGGCCCCAGCATTTTGGTGAT	CASSGSLQGVGPQHF	In	VDJ	3	97	2.2004246592744497E-4	2.824373469524428E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	1	9	8	4	27	39	55	47	59			01,02										Vb 17	CASSGSLQGVGPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAGGGGGCGCGGACACTGAAGCTTTCTTTGGACAA	CASSTGGADTEAFF	In	VDJ	3	98	2.2231094495762482E-4	2.8534907217875663E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	0	3	0	4	27	-1	48	40	52			01,02										Vb 17	CASSTGGADTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTATCTGGAGATACGCAGTATTTTGGCCCA	CASSIVSGDTQYF	In	VDJ	3	98	2.2231094495762482E-4	2.8534907217875663E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	1	0	10	5	5	0	27	43	-1	48	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIVSGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCACGGACATGGTGGAGCCCCAGCATTTTGGTGAT	CASTDMVEPQHF	In	VDJ	3	103	2.3365334010852403E-4	2.999076983103259E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	1	6	8	3	6	27	35	43	38	49			01,02										Vb 17	CASTDMVEPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGGGGGGGTACACTGAAGCTTTCTTTGGACAA	CASTGGYTEAFF	In	VDJ	4	107	2.4272725622924343E-4	3.115545992155812E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	0	3	0	1	27	-1	45	37	46			01,02										Vb 17	CASTGGYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGTGTCGGGGGATGAAGCTTTCTTTGGACAA	CASSIVSGDEAFF	In	VDJ	4	113	2.563381304103225E-4	3.2902495057346426E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	2	7	5	1	27	41	52	46	53			01,02										Vb 17	CASSIVSGDEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGAGAAGTTGGGCTGTTTTTTGGCAGT	CASSGEVGLFF	In	VDJ	4	117	2.6541204653104185E-4	3.4067185147871964E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	10	2	14	0	8	27	-1	43	39	51			01,02										Vb 17	CASSGEVGLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*02	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCCCCGTCTGGCGGGAGTAATCGGATACGCAGTATTTTGGCCCA	CAPVWRE*SDTQYF	Stop	VDJ	4	122	2.767544416819411E-4		42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	11	7	2	6	8	6	27	33	48	41	54			01,02										Vb 17	CAPVWRE*SDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCCCCGGGACTAGCGGGAGAGTAAACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	4	124	2.8129139974230076E-4		55	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	0	2	5	7	5	26	37	58	44	63			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGACAGGGGGATAGGGAACACTGAAGCTTTCTTTGGACAA	CASDRGIGNTEAFF	In	VDJ	4	124	2.8129139974230076E-4	3.6105392806291657E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	2	1	1	1	5	27	35	45	36	50			01,02										Vb 17	CASDRGIGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAACCAGATTAGGGCTATATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	4	128	2.9036531586302015E-4		46	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	10	5	3	0	8	5	27	34	46	42	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAGTTCGCGGAGGGGAAACGTACCACAGTACTTCGGGCCG	CASSSSRRGNVPQYF	In	VDJ	6	172	3.9017839319093335E-4	5.00816738925981E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	10	0	10	8	11	27	38	52	46	63			01,02										Vb 17	CASSSSRRGNVPQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCACTTTAGAGCGGGCCCTGAAAATCCGCAGTTCTTCGGGCCA	CASHFRAGPENPQFF	In	VDJ	6	179	4.0605774640219226E-4	5.211988155101779E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	6	4	12	8	12	27	36	50	44	62			01,02			01,02							Vb 17	CASHFRAGPENPQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATAGGACGAGGGACAGGGAATCAGCCCCAGCATTTTGGTGAT	CASIGRGTGNQPQHF	In	VDJ	6	180	4.083262254323721E-4	5.241105407364918E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	3	4	8	0	27	37	-1	45	54			01,02										Vb 17	CASIGRGTGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGGCAGGGAGGGACAGATACGCAGTATTTTGGCCCA	CASSIRQGGTDTQYF	In	VDJ	6	184	4.1740014155309147E-4	5.357574416417471E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	0	3	6	0	27	41	-1	47	54			01,02										Vb 17	CASSIRQGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTAACGGGGAATCAGCCCCAGCATTTTGGTGAT	CASSLTGNQPQHF	In	VDJ	6	187	4.2420557864363104E-4	5.444926173206886E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	3	4	4	0	27	39	-1	43	48			01,02										Vb 17	CASSLTGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGGGACAGGGAATGACTTACAGTTCTTCGGGCCA	CASSPGTGNDLQFF	In	VDJ	7	196	4.4462188991524964E-4	5.706981443575133E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	13	3	9	27	39	51	42	60			01,02										Vb 17	CASSPGTGNDLQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGTCCGGGACATGGGGAGGTGTTCAGCCCCAGCATTTTGGTGAT	CASSIESGTWGGVQPQHF	In	VDJ	7	201	4.5596428506614886E-4	5.852567704890825E-4	54	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	0	0	6	6	4	11	27	44	54	48	65			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIESGTWGGVQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGCTGTCCAATGAGCAGTTCTTCGGGCCA	CASSIGLSNEQFF	In	VDJ	8	232	5.262871350017241E-4	6.755202525048116E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	8	0	6	1	4	27	41	46	42	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGLSNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCTCGACTAGCGGGAGGGTAATAGAGCAGTTCTTCGGGCCA	CASSIVSTSGRVIEQFF	In	VDJ	8	235	5.330925720922636E-4	6.842554281837531E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	2	0	10	4	5	27	43	61	47	66			01,02										Vb 17	CASSIVSTSGRVIEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGTAGCAGGCTATTAAGGAGCGAGCAGTACTTCGGGCCG	CASSISSRLLRSEQYF	In	VDJ	8	236	5.353610511224434E-4	6.87167153410067E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	4	4	6	6	11	27	41	51	47	62			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSISSRLLRSEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTACAGCCCCGTTGGGCTACGAGCAGTACTTCGGGCCG	CASSITAPLGYEQYF	In	VDJ	8	238	5.398980091828031E-4	6.929906038626946E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	5	3	1	10	27	41	46	42	56			01,02										Vb 17	CASSITAPLGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGAGACAGGGAAGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSRDREGTGELFF	In	VDJ	8	240	5.444349672431628E-4	6.988140543153224E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	5	0	5	27	-1	49	44	54			01,02										Vb 17	CASSRDREGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAGGCCCCCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSTGPLAKNIQYF	In	VDJ	9	257	5.829991107562201E-4	7.483133831626578E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	4	4	0	0	6	27	-1	44	40	50			01,02										Vb 17	CASSTGPLAKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCAAGACGCGGGCCCTGAACACTGAAGCTTTCTTTGGACAA	CATKTRALNTEAFF	In	VDJ	10	300	6.805437090539535E-4	8.73517567894153E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	10	7	4	0	7	3	27	34	46	41	49			01,02			01,02							Vb 17	CATKTRALNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGGGGACAGGGGAGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	11	315	7.145708945066511E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	0	2	6	2	2	27	37	49	39	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCAAATATCTCACAAATACGCAGTATTTTGGCCCA	CASSAKYLTNTQYF	In	VDJ	12	348	7.894307025025861E-4	0.0010132803787572175	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	6	7	12	1	27	39	54	51	55			01,02										Vb 17	CASSAKYLTNTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSIRSSYEQYF	In	VDJ	14	419	9.504927136453551E-4	0.0012200128698255004	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	2	0	2	0	27	41	-1	43	47			01,02										Vb 17	CASSIRSSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGGGGTAGGGACAGGGGGCGAGAATCAGCCCCAGCATTTTGGTGAT	CASSPGVGTGGENQPQHF	In	VDJ	26	759	0.0017217755839065024	0.002209999446772207	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	0	4	9	3	27	39	60	48	63			01,02										Vb 17	CASSPGVGTGGENQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGACGGAATGGGACACTGAAGCTTTCTTTGGACAA	CASRTEWDTEAFF	In	VDJ	26	777	0.0017626082064497396	0.002262410500845856	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	6	0	9	3	8	0	27	38	-1	46	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRTEWDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGGGGACTAGCGGCTTTTACAATGAGCAGTTCTTCGGGCCA	CASSIGGTSGFYNEQFF	In	VDJ	31	923	0.002093806144855997	0.002687522383887677	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	5	4	4	4	27	41	56	45	60			01,02			01,02							Vb 17	CASSIGGTSGFYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCCTTAGAGGCCCACAAACACAGATACGCAGTATTTTGGCCCA	CASP*RPTNTDTQYF	Stop	VDJ	33	982	0.002227646407636608		45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	11	1	2	5	8	27	36	45	41	53			01,02										Vb 17	CASP*RPTNTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCTAGGACTAGCGGGAGGTTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASTLGLAGGSNTGELFF	In	VDJ	80	2360	0.005353610511224434	0.00687167153410067	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	1	1	0	5	2	27	37	56	42	58			01,02										Vb 17	CASTLGLAGGSNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTTGGACAGGGGAAAGCTGAAGCTTTCTTTGGACAA	CASSLGQGKAEAFF	In	VDJ	88	2593	0.005882166125256338	0.0075501035118317955	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	2	6	4	4	27	38	51	42	55			01,02										Vb 17	CASSLGQGKAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGACGGGAATTGTCGAACTGAAGCTTTCTTTGGACAA		Out	VDJ	93	2742	0.006220169500753135		43	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	3	5	3	8	27	39	47	42	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGATCACCGGGGGGTCCCAGCATTTTGGTGAT	CASSIGITGGSQHF	In	VDJ	103	3047	0.006912055604957988	0.00887202676457828	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	1	8	1	11	7	1	27	43	57	50	58			01,02										Vb 17	CASSIGITGGSQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCCCCAACTGGGCCCCCGAACACTGAAGCTTTCTTTGGACAA	CASSPTGPPNTEAFF	In	VDJ	128	3776	0.008565776817959095	0.010994674454561072	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	8	0	1	9	4	27	36	49	45	53			01,02										Vb 17	CASSPTGPPNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGCATACTAGGTAATAGGCAGTTCTTCGGGCCA	CASSMGILGNRQFF	In	VDJ	160	4732	0.010734442770811026	0.013778283770917107	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	3	8	12	6	7	27	41	52	47	59			01,02			01,02							Vb 17	CASSMGILGNRQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATGGATCGGCCATGAAAAACTGTTTTTTGGCAGT	CASSIWIGHEKLFF	In	VDJ	249	7376	0.01673230132660654	0.021476885269290907	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	2	1	8	6	1	6	27	42	46	43	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIWIGHEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATATTTGGGGGACTATGAGCAGTACTTCGGGCCG	CASSEYLGDYEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	9	7	5	1	23	40	52	45	53						01,02							Vb 11	CASSEYLGDYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGTCGACAGGGCGGAGATACGCAGTATTTTGGCCCA	CASRQGGDTQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	36	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	9	2	3	5	2	3	23	31	40	33	43													Vb 11	CASRQGGDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGGGTAGAAAAAGGCGAGCAGTATTTCGGGCCG	CASRVEKGEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	36	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-07	01	6	4	5	16	16	3	23	34	53	50	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASRVEKGEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCTCTTGGGGGGAGGCCACTGAAGCTTTCTTTGGACAA	CASSSWGEATEAFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	9	1	4	5	4	23	34	45	39	49						01,02							Vb 11	CASSSWGEATEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCTGACAGGGCCGGAGGGAGACCCAGTACTTCGGGCCA	CASS*QGRRETQYF	Stop	VDJ	1	13	2.9490227392337985E-5		42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	3	5	2	7	23	34	43	36	50													Vb 11	CASS*QGRRETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACGTTTAGGAGAGGCCTTTTGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	2.9490227392337985E-5		47	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	2	6	6	10	23	37	47	43	57													Vb 11	X+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATCTAGGCCCATCGATGAGCAGTTCTTCGGGCCA	CASSESRPIDEQFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	8	8	0	8	23	-1	43	39	51						01,02							Vb 11	CASSESRPIDEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTGGCAAGCCACGTTTGGTGGCCCTCACATACCTCTCAGTACTCTGTGCCAGCAGGGCAGAAAAAGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	3.402718545269768E-5		35	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	20	4	3	6	10	10	46	43	58	53	68													Vb 11	X+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATTCGACAGGAGCTACACCTTCGGTTCG	CASSEFDRSYTF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	36	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	4	9	2	1	23	39	47	41	48													Vb 11	CASSEFDRSYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGTAGTGAATATTCGGGGGACTACGAGCAGTACTTTGGGCCG	CASSEYSGDYEQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	9	19	5	13	23	40	52	45	65						01,02							Vb 11	CASSEYSGDYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACCTCGACTAGCGGGAACCTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	4.5369580603596903E-5		52	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	2	3	4	4	4	23	38	53	42	57													Vb 11	X+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACCGGGACGGAACTACGAGCAGTACTTCGGGCCG	CASSEPGRNYEQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	42	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-07	01	2	0	7	3	2	4	23	38	45	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSEPGRNYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATTGGGGGGAGGGCTCTACGAGCAGTACTTCGGGCCG	CASSELGGGLYEQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	9	0	3	4	2	23	39	50	43	52													Vb 11	CASSELGGGLYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGCTTCTATACAGGGAGGTAAGTGATACGCAGTATTTTGGCCCA		Out	VDJ	1	25	5.671197575449612E-5		50	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-03	01	4	3	3	6	8	8	23	36	50	44	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAACAGGGGTCCAATCGGGTACCAAGAGACCCAGTACTTCGGGCCA	CASNRGPIGYQETQYF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	48	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	3	2	0	0	11	23	-1	40	33	51													Vb 11	CASNRGPIGYQETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGACCCGGACAGAACACTGAAGCTTTCTTTGGACAA	CASRPGQNTEAFF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	6	1	4	0	23	34	-1	38	43													Vb 11	CASRPGQNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTRAATCCGAGACAGAGATAAACTATGGCTACACCTTCGGTTCG	CASSXSETEINYGYTF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	48	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	5	2	4	5	23	39	48	43	53													Vb 11	CASSXSETEINYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAAGACCCCCAGGCTAGCGGGCCTAGAAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	6.805437090539536E-5		56	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	4	4	0	11	8	23	33	52	44	60						01,02							Vb 11	X+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAATCTCCCCGACAGGTTTCCCTCCCACGAGCAGTACTTCGGGCCG	CASNLPDRFPSHEQYF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	48	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	4	5	8	10	23	33	47	41	57													Vb 11	CASNLPDRFPSHEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCCAGGTTCTTCCGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQVLPAGANVLTF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	48	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	4	4	2	1	9	23	34	39	35	48													Vb 11	CASSQVLPAGANVLTF+TCRBV25-01+TCRBJ02-06	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGTATTTGGCGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSVFGASTDTQYF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	45	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-03	01	4	9	0	0	5	3	23	36	44	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSVFGASTDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTTTAACAGGGTCTCAAGAGACCCAGTACTTCGGGCCA	CASSLTGSQETQYF	In	VDJ	1	42	9.527611926755349E-5	1.222924595051814E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	3	2	3	3	23	35	44	38	47													Vb 11	CASSLTGSQETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGTAGTGCAGGACTAGCGACGAGGAATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	48	1.0888699344863256E-4		50	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	6	4	2	8	23	36	47	38	55						01,02							Vb 11	X+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATATTCGGGGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	50	1.1342395150899225E-4		41	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	3	3	2	1	23	40	47	42	48													Vb 11	X+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCACCAAGGAGAGGGGTGAAGCTTTCTTTGGACAA	CASTKERGEAFF	In	VDJ	2	54	1.2249786762971162E-4	1.5723316222094753E-4	36	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	7	5	2	7	8	0	23	33	-1	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASTKERGEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGGCCCTCACATACCTCTCAGTACTCTGTGCCAGCAGTGAATATTCGGGGGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	97	2.2004246592744497E-4		41	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	20	8	2	3	21	1	40	37	64	58	65													Vb 11	X+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGAAGCGAGTCCGGGGATAACTATGGCTACACCTTCGGTTCG	CASRSESGDNYGYTF	In	VDJ	6	171	3.8790991416075347E-4	4.979050136996671E-4	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	3	1	9	1	23	34	48	43	49													Vb 11	CASRSESGDNYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD02-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATACGGGACGGGACCCGGGAGAGGCTACACCTTCGGTTCG	CASSEYGTGPGRGYTF	In	VDJ	7	198	4.4915884797560934E-4	5.76521594810141E-4	48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	8	2	8	12	1	23	40	58	52	59													Vb 11	CASSEYGTGPGRGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGAGGGGAACGGGAAAAACTGTTTTTTGGCAGT	CASRGEREKLFF	In	VDJ	8	250	5.671197575449613E-4	7.279313065784608E-4	36	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	5	2	8	0	5	23	-1	39	34	44													Vb 11	CASRGEREKLFF+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACAGGGCCTTTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSDRAFATNEKLFF	In	VDJ	9	278	6.306371703899969E-4	8.094596129152484E-4	48	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	3	0	0	6	23	-1	42	37	48													Vb 11	CASSDRAFATNEKLFF+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTTCCTGGGATCAGCCCCAGCATTTTGGTGAT	CASSSWDQPQHF	In	VDJ	15	447	0.0010140101264903907	0.001301541176162288	36	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-05	01	5	0	9	5	4	0	23	35	-1	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSSWDQPQHF+TCRBV25-01+TCRBJ01-05	TCRBV25-01*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCACCAAAGCCGGTCGCGGGGGTGGTACCTCCTACGAGCAGTACTTCGGGCCG	CATKAGRGGGTSYEQYF	In	VDJ	27	790	0.0017920984338420775	0.0023002629287879363	51	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	10	7	2	0	12	6	23	30	49	42	55													Vb 11	CATKAGRGGGTSYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGGGCAGAAAAAGGCGAGCAGTACTTCGGGCCG	CASRAEKGEQYF	In	VDJ	156	4617	0.010473567682340345	0.013443435369891014	36	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-07	01	6	4	5	6	2	7	23	34	39	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASRAEKGEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATATTCGGGGGACTACGAGCAGTACTTCGGGCCG	CASSEYSGDYEQYF	In	VDJ	1127	33352	0.07565831261455819	0.0971118597480193	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	2	3	2	1	23	40	48	42	49													Vb 11	CASSEYSGDYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCAGCAGTTTGTACAGGGACCCGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	13	2.9490227392337985E-5		43	TCRBV22	TCRBV22-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	13	3	3	4	13	5	25	28	47	41	52														X+TCRBV22-01+TCRBJ01-02	TCRBV22-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCGCCGGAGGCAGGGGGCAGTTGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	9	2.0416311271618604E-5		49	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	0	8	9	4	23	36	53	45	57													Vb 7.1	X+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAACTAGCGGGCACAATGAGCAGTTCTTCGGGCCA	YASSQTSGHNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	3	4	5	0	1	22	-1	46	37	47						01,02							Vb 7.1	YASSQTSGHNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAAGAGGGGGGGAGACCCAGTACTTCGGGCCA	YASSQRGGETQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	39	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-05	01	2	5	1	5	2	1	22	37	45	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	YASSQRGGETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGAAGGGGGGTTGTTCTATGGCTACACCTTCGGTTCG	XASSQEGGLFYGYTF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-02	01	0	5	1	4	0	6	22	-1	45	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	XASSQEGGLFYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGCCTTGGACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	11	2.4953269331978296E-5		43	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-04	01	1	0	10	2	4	0	23	39	-1	43	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	X+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGTTCTAGGACGGGGGGAGCTTTCTTTGGACAA	CASSSRTGGAFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	36	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	1	10	8	0	23	34	-1	42	49													Vb 7.1	CASSSRTGGAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCACACCTACTACGGTAATCAGCCCCAGCATTTTGGTGAT	CASSHTYYGNQPQHF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	3	9	4	5	4	23	37	46	42	50						01,02							Vb 7.1	CASSHTYYGNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGCGTCCAGGGGACTTTACGAGCAGTACTTCGGGCCG	CASSQASRGLYEQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-07	01	1	4	2	4	4	4	23	39	49	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQASRGLYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGTCCGGACAGGGATAATTACAATGAGCAGTTCTTCGGGCCA	CASSPDRDNYNEQFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	3	4	3	5	23	34	45	37	50													Vb 7.1	CASSPDRDNYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGAGCCCCTTGTTCTAGACACTGAAGCTTTCTTTGGACAA	YASSQEPLVLDTEAFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	4	8	3	10	0	22	39	-1	49	53						01,02							Vb 7.1	YASSQEPLVLDTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGGCCGGGGCTAGCAGGAGGGAAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQGPGLAGGKNTGELFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	60	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	10	0	1	14	2	21	37	57	51	59													Vb 7.1	CASSQGPGLAGGKNTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCACAATAGCGGGAAGCAATGAGCAGTTCTTCGGGCCA	CASSTIAGSNEQFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	3	6	4	2	23	35	47	39	49													Vb 7.1	CASSTIAGSNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAACCGACACCCTCTATGGCTACACCTTCGGTTCG	CASSQTDTLYGYTF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	6	4	3	4	23	38	45	41	49													Vb 7.1	CASSQTDTLYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGAACGTCTGAACACGCAGTATTTTGGCCCA	YASSQERLNTQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	39	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-03	01	0	2	8	9	6	2	22	39	47	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	YASSQERLNTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGAGCCTAACAGCAATCAGCCCCAGCATTTTGGTGAT	XASSQEPNSNQPQHF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	4	9	1	2	2	22	39	44	41	46						01,02							Vb 7.1	XASSQEPNSNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGTTAAGAACACCGGGGAGCTGTTTTTTGGAGAA	XASSQVKNTGELFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	5	9	1	1	1	22	38	41	39	42						01,02							Vb 7.1	XASSQVKNTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATTTTCACGGTATTGATGGCTACACCTTCGGTTCG	CASSQDFHGIDGYTF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	8	5	6	6	5	23	40	49	46	54						01,02							Vb 7.1	CASSQDFHGIDGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD02-01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCTACCGACAGGGGATTAACACTGAAGCTTTCTTTGGACAA	CASSYRQGINTEAFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	2	4	3	23	35	47	39	50													Vb 7.1	CASSYRQGINTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGATCGCCGAGCGGACCCGGGGGATGAGCAGTTCTTCGGGCCA	YASSQDRRADPGDEQFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	2	8	14	0	22	39	-1	53	59													Vb 7.1	YASSQDRRADPGDEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTGGCTTATTATGGCTACACCTTCGGTTCG	CASSQVAYYGYTF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	39	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	9	0	5	1	4	23	39	43	40	47													Vb 7.1	CASSQVAYYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGTGGCCGATACCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSGRYRSYNEQFF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	9	0	0	1	8	23	34	38	35	46													Vb 7.1	CASSGRYRSYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGACAGGATCCATTGTGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	43	9.754459829773334E-5		46	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	2	4	8	0	10	23	-1	45	39	55													Vb 7.1	X+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCCTCGCCTCGAGATACGCAGTATTTTGGCCCA	CASSPSPRDTQYF	In	VDJ	2	46	1.0435003538827287E-4	1.3393936041043678E-4	39	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-03	01	4	10	0	5	4	4	23	36	42	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSPSPRDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTTTCAGGCTACGAGCAGTACTTCGGGCCG	CASSQVSGYEQYF	In	VDJ	2	57	1.2930330472025117E-4	1.6596833789988907E-4	39	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	4	3	3	0	23	39	-1	42	46													Vb 7.1	CASSQVSGYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGTGCGGTCGAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	XASSQVRSNSGANVLTF	In	VDJ	2	73	1.6559896920312868E-4	2.1255594152091057E-4	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	1	7	5	0	1	5	22	38	43	39	48						01,02							Vb 7.1	XASSQVRSNSGANVLTF+TCRBV04-01+TCRBJ02-06	TCRBV04-01*01	TCRBD02-01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAGGGCGGGTCTACCTATGGCTACACCTTCGGTTCG	CASSQEGGSTYGYTF	In	VDJ	4	123	2.7902292071212094E-4	3.581422028366027E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	7	4	4	2	5	23	40	47	42	52						01,02							Vb 7.1	CASSQEGGSTYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD02-01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCATCTCTCGGGCGAGCAGTACTTCGGGCCG	CASSHLSGEQYF	In	VDJ	4	127	2.8809683683284033E-4	3.697891037418581E-4	36	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	8	4	6	5	0	23	37	-1	42	46						01,02							Vb 7.1	CASSHLSGEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGCTACAGGGACCTACAATGAGCAGTTCTTCGGGCCA	XASSQATGTYNEQFF	In	VDJ	17	510	0.001156924305391721	0.00148497986542006	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	3	3	2	2	1	23	39	47	41	48													Vb 7.1	XASSQATGTYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGTTGACCATCCGGGACTAGCCCCACAGATACGCAGTATTTTGGCCCA	CASS*PSGTSPTDTQYF	Stop	VDJ	1	9	2.0416311271618604E-5		51	TCRBV06	TCRBV06-09	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	7	2	8	2	26	39	56	47	58						01,02							Vb 13.1	CASS*PSGTSPTDTQYF+TCRBV06-09+TCRBJ02-03	TCRBV06-09*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCCTCGACAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	14	3.175870642251783E-5		38	TCRBV06	TCRBV06-09	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	2	6	1	3	0	26	35	-1	38	42													Vb 13.1	X+TCRBV06-09+TCRBJ02-02	TCRBV06-09*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGATGAACAGGGCGAATTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	9	2.0416311271618604E-5		46	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	3	4	6	26	37	47	41	53			01,02										Vb 12	X+TCRBV10-01+TCRBJ01-05	TCRBV10-01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGGAGAGCGGGACACAGATACGCAGTATTTTGGCCCA	CASSGERDTDTQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	6	3	2	3	0	26	39	-1	42	49			01,02										Vb 12	CASSGERDTDTQYF+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCCGACAGAATGTCTTACTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	13	2.9490227392337985E-5		46	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	2	5	0	1	9	26	35	41	36	50			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-01	TCRBV10-01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCCGCCACCATAGGGGCGACCCAGTACTTCGGGCCA	CASSESATIGATQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	45	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	2	7	9	1	26	43	57	52	58			01,02										Vb 12	CASSESATIGATQYF+TCRBV10-01+TCRBJ02-05	TCRBV10-01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGAAAAAATAGCGGGAGGGCTGAAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	15	3.402718545269768E-5		50	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	5	0	3	6	5	26	37	54	43	59			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-05	TCRBV10-01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGGGGTCCAGGGGGCAGGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	31	7.032284993557519E-5		44	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	4	0	3	5	3	26	34	47	39	50			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-02	TCRBV10-01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCAGCGGGCCGGGAAAAACTGTTTTTTGGCAGT	CASSESAGREKLFF	In	VDJ	1	38	8.620220314683411E-5	1.1064555859992605E-4	42	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	6	4	8	0	4	26	-1	49	43	53			01,02			01,02							Vb 12	CASSESAGREKLFF+TCRBV10-01+TCRBJ01-04	TCRBV10-01	TCRBD02-01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGGGGACTCAGCCCTGTATCTCTGTGCCAGCAGCCAAGGGGACAGGGCCCCGCAGTACTTCGGGCCG	CASSQGDRAPQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	39	TCRBV05	TCRBV05-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	9	6	4	22	32	47	38	51														CASSQGDRAPQYF+TCRBV05-02+TCRBJ02-07	TCRBV05-02*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAATCGGGGGGGAAGAGACCCAGTACTTCGGGCCA	CATSRIGGEETQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	0	3	2	0	18	33	-1	35	43														CATSRIGGEETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCTTCCAAGGACTAGCGGGACGATGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	10	2.2684790301798452E-5		56	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	1	3	1	6	4	18	30	48	36	52														X+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCGACAGGCAAAACACCATATATTTTGGAGAG	CATSSDRQNTIYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	39	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	2	4	6	1	2	18	32	39	33	41														CATSSDRQNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCCCTCGCCCGGGGGAGGGGGATATTCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	13	2.9490227392337985E-5		44	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	11	9	0	6	10	7	18	24	41	34	48														X+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGCCAGGGTAAACAATCAGCCCCAGCATTTTGGTGAT	CATSARVNNQPQHF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	3	2	4	18	30	37	32	41														CATSARVNNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCTTTAGGGGACTAGCGACTCCCTACGAGCAGTACTTCGGGCCG	CASSFRGLATPYEQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	6	2	5	4	18	30	45	35	49						01,02								CASSFRGLATPYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCCGTTTTATTAAGACCGGACAGGTTAATGAAGCTTTCTTTGGACAA	CASSRFIKTGQVNEAFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	7	15	4	18	30	52	45	56														CASSRFIKTGQVNEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAAAGAGTCGGGGACAGGGGGTGAAAAACTGTTTTTTGGCAGT	CATSKESGTGGEKLFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	1	7	4	0	18	35	-1	39	50														CATSKESGTGGEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGTAGAAGCGAGGTCTACGAGCAGTACTTCGGGCCG	CATSRGRSEVYEQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	6	6	3	5	4	18	34	43	39	47						01,02								CATSRGRSEVYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGGGCAGGTGACTATGGCTACACCTTCGGTTCG	CATSRDRAGDYGYTF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	45	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-02	01	0	4	4	3	5	2	18	35	44	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDRAGDYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGGGCGGGACTAGCGGGAGGGGGTGAGCAGTTCTTCGGGCCA	CATSRGAGLAGGGEQFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	0	0	9	4	2	18	34	54	38	56														CATSRGAGLAGGGEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCTTGGAGACAGGGATGGAGACCCAGTACTTCGGGCCA	CASSLETGMETQYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	3	5	5	3	18	30	42	35	45														CASSLETGMETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCAGGACTAGCGGGGGTTTCTACGAGCAGTACTTCGGGCCG	CATSSRTSGGFYEQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	1	2	3	2	3	18	32	47	34	50														CATSSRTSGGFYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCTGGGACTAGCGGCTTACAATGAGCAGTTCTTCGGGCCA	CATSRDLGLAAYNEQFF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	5	4	3	2	18	35	49	38	51						01,02								CATSRDLGLAAYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTTGGCAGGGGGGTAGCAGATACGCAGTATTTTGGCCCA	CATSRVGRGVADTQYF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	1	4	4	4	18	34	45	38	49														CATSRVGRGVADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGACCCACCGGGACAGGGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	39	8.847068217701396E-5		47	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	3	3	6	0	18	33	-1	39	48														X+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGGGTCGGCCATCGGACTGTTTTTTGGCAGT	CATSRDGSAIGLFF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	0	0	9	13	1	11	18	35	39	36	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDGSAIGLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCGGGGGGCCCAGATACGCAGTATTTTGGCCCA	CATSRAGGPDTQYF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	8	1	4	0	2	18	-1	41	34	43														CATSRAGGPDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAAGCAAGGCAGCCAAGAGACCCAGTACTTCGGGCCA	CATSKQGSQETQYF	In	VDJ	1	42	9.527611926755349E-5	1.222924595051814E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-05	01	4	4	5	1	7	0	18	31	-1	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSKQGSQETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGCCGACAGGGGGGTTACGAAAAACTGTTTTTTGGCAGT	CATSGRQGGYEKLFF	In	VDJ	1	42	9.527611926755349E-5	1.222924595051814E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	1	8	4	5	18	30	43	34	48														CATSGRQGGYEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGCGGGCGATAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSRAGDSSYNEQFF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	7	4	0	1	6	18	32	38	33	44						01,02								CATSRAGDSSYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATATATCCGGACAGGGGTACAATGAGCAGTTCTTCGGGCCA	CATSRDISGQGYNEQFF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	2	4	7	0	18	35	-1	42	51														CATSRDISGQGYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCAGATTTGAACACTGAAGCTTTCTTTGGACAA	CATSRADLNTEAFF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	5	0	0	3	18	-1	37	34	40														CATSRADLNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGCCAGAAATGACCAGGGAGCTGTTTTTTGGAGAA	CATSREPEMTRELFF	In	VDJ	2	48	1.0888699344863256E-4	1.3976281086306447E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-02	01	0	2	7	9	9	2	18	35	47	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSREPEMTRELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTATAGTACCCTAGCGGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CATSRDYSTLAGNTGELFF	In	VDJ	2	56	1.2703482569007132E-4	1.6305661267357522E-4	57	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	4	3	2	10	0	18	35	-1	45	54														CATSRDYSTLAGNTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGGGCGGCGGGAGGGCCGGTGGATACGCAGTATTTTGGCCCA	CATSRGAAGGPVDTQYF	In	VDJ	2	60	1.361087418107907E-4	1.747035135788306E-4	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	7	0	6	5	6	18	34	48	39	54														CATSRGAAGGPVDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCGGGGTGGGGTACAATGAGCAGTTCTTCGGGCCA	CATSSGVGYNEQFF	In	VDJ	2	60	1.361087418107907E-4	1.747035135788306E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	3	4	0	5	18	-1	37	32	42														CATSSGVGYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGACACAGGGGGCCGCAGCCCCAGCATTTTGGTGAT	CATSRHRGPQPQHF	In	VDJ	2	66	1.4971961599186977E-4	1.9217386493671366E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	0	7	1	2	18	33	43	34	45														CATSRHRGPQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAGGACTAGCGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSRDRTSGSSYNEQFF	In	VDJ	2	71	1.6106201114276898E-4	2.0673249106828288E-4	54	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	1	2	0	2	0	18	35	-1	37	50														CATSRDRTSGSSYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCTAAGGGCTAGGGGAAATGAGCAGTTCTTCGGGCCA	CATSRDLRARGNEQFF	In	VDJ	3	77	1.7467288532384807E-4	2.2420284242616594E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	5	2	7	10	1	18	35	50	45	51														CATSRDLRARGNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGGTTTGGGACAGGAGATAGGGTGAGCAGTTCTTCGGGCCA		Out	VDJ	3	77	1.7467288532384807E-4		50	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	0	4	9	5	8	18	34	47	39	55														X+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGTCAGGGGACTAGCAACACCGGGGAGCTGTTTTTTGGAGAA	CATSRGQGTSNTGELFF	In	VDJ	3	77	1.7467288532384807E-4	2.2420284242616594E-4	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	0	7	2	5	0	18	34	-1	39	48						01,02								CATSRGQGTSNTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCTCCCGGGGCAGTGGGTAATGAAAAACTGTTTTTTGGCAGT	CATSRAPGAVGNEKLFF	In	VDJ	3	78	1.7694136435402792E-4	2.2711456765247976E-4	51	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	1	7	0	4	5	6	18	34	44	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRAPGAVGNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCTCCCTAGGTAGCGGGAGGCGTGAGCAGTACTTCGGGCCG	CATSLGSGRREQYF	In	VDJ	3	88	1.9962615465582637E-4	2.562318199156182E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	5	1	7	8	3	18	27	45	35	48														CATSLGSGRREQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGTGGCGCCGGGACAGGGCGAAAAACTGTTTTTTGGCAGT	CATSRVAPGQGEKLFF	In	VDJ	3	91	2.0643159174636589E-4	2.6496699559455975E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	3	8	9	1	18	32	50	41	51														CATSRVAPGQGEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTAGCGGGTTCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSSSGFSYNEQFF	In	VDJ	3	94	2.1323702883690543E-4	2.7370217127350126E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	4	0	0	2	18	-1	39	32	41						01,02								CATSSSGFSYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATACGGCTAACAGGGACACTGAAGCTTTCTTTGGACAA	CATSRDTANRDTEAFF	In	VDJ	4	108	2.4499573525942325E-4	3.1446632444189507E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	3	3	8	0	18	35	-1	43	49														CATSRDTANRDTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTTGGACAGAAACGGGGAGCTGTTTTTTGGAGAA	CATSRDLDRNGELFF	In	VDJ	4	109	2.472642142896031E-4	3.173780496682089E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	1	5	7	3	3	18	35	44	38	47														CATSRDLDRNGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGACCGGCCGGGGCGTCCTACGAGCAGTACTTCGGGCCG	CATSRPAGASYEQYF	In	VDJ	4	112	2.5406965138014264E-4	3.2611322534715044E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-07	01	2	7	0	1	6	1	18	33	44	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRPAGASYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGGACTCGTTACAGGAGAGCAGTTCTTCGGGCCA	CATSRDGLVTGEQFF	In	VDJ	4	114	2.5860660944050233E-4	3.3193667579977813E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-01	01	0	3	4	10	10	1	18	35	50	45	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDGLVTGEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGATTTTCAAGGGGGGAGACCCAGTACTTCGGGCCA	CATSRFSRGETQYF	In	VDJ	4	116	2.6314356750086203E-4	3.377601262524058E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	5	1	5	6	0	18	33	-1	39	45														CATSRFSRGETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTTTGGGGATAATGAAGCTTTCTTTGGACAA	CATSRDFGDNEAFF	In	VDJ	4	124	2.8129139974230076E-4	3.6105392806291657E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-01	01	0	0	8	7	5	3	18	35	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDFGDNEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACATGGGAGGGATAAGAACAGGGGTTCCCTACGAGCAGTACTTCGGGCCG	CATSRDMGGIRTGVPYEQYF	In	VDJ	4	128	2.9036531586302015E-4	3.7270082896817194E-4	60	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-07	01	0	3	2	2	16	3	18	35	58	51	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDMGGIRTGVPYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCCAATGACAGGGGATACACACAGATACGCAGTATTTTGGCCCA	CATSSQ*QGIHTDTQYF	Stop	VDJ	6	170	3.8564143513057365E-4		51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	2	2	5	5	18	32	45	37	50														CATSSQ*QGIHTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACAGACAGGGGGACCTATGGCTACACCTTCGGTTCG	CATSTDRGTYGYTF	In	VDJ	7	199	4.5142732700578916E-4	5.794333200364548E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	1	4	0	2	18	-1	42	35	44														CATSTDRGTYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGGGGTGGAGGGTAGTCGGCATTTTGGTGAT	CATSRDGVEGSRHF	In	VDJ	8	235	5.330925720922636E-4	6.842554281837531E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	10	0	15	6	6	18	35	47	41	53														CATSRDGVEGSRHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCGACTAGCGGGGGCCGAGCAGTACTTCGGGCCG		Out	VDJ	13	380	8.620220314683411E-4		41	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	2	2	6	1	1	18	32	45	33	46														X+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCCGTGGGGACACTCAGGAAGGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	3.629566448287752E-5		47	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	6	6	5	11	22	34	45	39	56														X+TCRBV12-01+TCRBJ02-07	TCRBV12-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCCCGGATATCCCCCCTATGGCTACACCTTCGGTTCG	CASSPGYPPYGYTF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	42	TCRBV12	TCRBV12-01	01				TCRBJ01	TCRBJ01-02	01	5	1	8	4	3	8	22	34	40	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGYPPYGYTF+TCRBV12-01+TCRBJ01-02	TCRBV12-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTCGGGACAGGGTTTGTCCTTGAAAAACTGTTTTTTGGCAGT	CASSFGTGFVLEKLFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	3	7	1	8	18	32	42	33	50														CASSFGTGFVLEKLFF+TCRBV07-02+TCRBJ01-04	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCTTCTAGCGGGAGGACCCTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSSSGRTLSYNEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	54	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	4	1	0	3	5	18	31	45	34	50														CASSSSSGRTLSYNEQFF+TCRBV07-02+TCRBJ02-01	TCRBV07-02*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCGTGACAGGGGTTAATGAAAAACTGTTTTTTGGCAGT	CASSVTGVNEKLFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	42	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	2	4	2	1	18	30	40	32	41														CASSVTGVNEKLFF+TCRBV07-02+TCRBJ01-04	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGTCACAGCCCGCCGGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	4.083262254323721E-5		47	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	3	7	11	0	18	34	-1	45	50														X+TCRBV07-02+TCRBJ02-01	TCRBV07-02*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATCTCTGTGCCAGAAGCCCCCCGGGACAGCCGGACGAGCAGTACTTCGGGCCG	CARSPPGQPDEQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	42	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	5	5	4	18	30	42	35	46														CARSPPGQPDEQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGGAGGAGAGGGGAACGAGCAGTACTTCGGGCCG	CASSLGGEGNEQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	42	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-07	01	1	5	2	5	6	1	18	34	45	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGEGNEQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGTCCAGCGGGAGAAGAGACCCAGTACTTCGGGCCA	CASSPAGEETQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	6	2	3	3	0	18	29	-1	32	40														CASSPAGEETQYF+TCRBV07-02+TCRBJ02-05	TCRBV07-02*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTACCGGGGACAGATACGCAGTATTTTGGCCCA	CASSLPGTDTQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	8	3	3	1	0	18	33	-1	34	39														CASSLPGTDTQYF+TCRBV07-02+TCRBJ02-03	TCRBV07-02*01	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGGCGACAGGGTACCTACGAGCAGTACTTCGGGCCG	CASRRQGTYEQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	2	2	2	18	29	38	31	40														CASRRQGTYEQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATCTCTGTGCTAGCAGCCGCAGGGTAAAGACTGAAGCTTTCTTTGGACAA	CASSRRVKTEAFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	5	2	5	18	30	37	32	42														CASSRRVKTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCCTACAGGGACCTACGAGCAGTACTTCGGGCCG	CASSPTGTYEQYF	In	VDJ	2	63	1.4291417890133023E-4	1.8343868925777213E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	2	3	1	18	30	39	33	40														CASSPTGTYEQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGGCGTGAACACTGAAGCTTTCTTTGGACAA	CASSLGVNTEAFF	In	VDJ	3	102	2.3138486107834419E-4	2.96995973084012E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	7	6	0	0	0	18	-1	-1	34	37						01,02								CASSLGVNTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGAGCAGGGACAGGGAGGTTCGGCGTCAACACTGAAGCTTTCTTTGGACAA	CASSPRAGTGRFGVNTEAFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	60	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	2	9	12	18	30	48	39	60														CASSPRAGTGRFGVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTGGGGACTAGCCACTTACAATGAGCAGTTCTTCGGGCCA	CASSPWGLATYNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	7	4	5	4	18	30	44	35	48						01,02								CASSPWGLATYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAGGACTAGCGGTCGCAGAGACCCAGTACCTCGGGCCA	CASSRGLAVAETQYL	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02			5	1	5	20	3	18	18	30	43	33	61						01,02		TCRBJ02-01,TCRBJ02-05						CASSRGLAVAETQYL+TCRBV11-03+TCRBJ02-X	TCRBV11-03*01	TCRBD02-01	TCRBJ02	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAAGGGATTAGCGGGAGGGTGGGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	9	2.0416311271618604E-5		53	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	0	6	9	5	18	30	50	39	55														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCGAAGGGGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLEGENTGELFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	5	2	1	5	1	18	30	40	35	41														CASSLEGENTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGGACTTTGGGAGTCCAAATGAGCAGTTCTTCGGGCCA	CASSLDFGSPNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	10	7	2	11	18	30	37	32	48						01,02								CASSLDFGSPNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACCGGGACAGGGCCACAGATACGCAGTATTTTGGCCCA	CASSYRDRATDTQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	3	2	3	1	18	31	43	34	44														CASSYRDRATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGACAGGGGGGAGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	9	2.0416311271618604E-5		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	1	3	1	4	18	31	43	32	47														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTAGCGGGAGGACGGAGACCCAGTACTTCGGGCCA	CASSSSGRTETQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	4	1	5	0	3	18	-1	42	31	45														CASSSSGRTETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAAGGGACAGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSLKGQGYNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	2	4	2	0	18	33	-1	35	45														CASSLKGQGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGCGCGACGGACTACAATGAGCAGTTCTTCGGGCCA	CASSLSATDYNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	6	6	3	0	7	18	-1	37	33	44						01,02								CASSLSATDYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAGGGACTAGCAGCGACGAGCAGTACTTCGGGCCG	CASSLEGTSSDEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	7	5	1	4	18	35	45	36	49						01,02								CASSLEGTSSDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCATATTACTAGCGGACCCATAGATACGCAGTATTTTGGCCCA	CASSLHITSGPIDTQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	3	5	5	7	6	18	32	47	39	53						01,02								CASSLHITSGPIDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTGTAACAGGTTGAGGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	9	2.0416311271618604E-5		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	3	4	6	5	6	18	32	42	37	48														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCCCGGCATTTGCAGAACACTGAAGCTTTCTTTGGACAA	CASSPRHLQNTEAFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	6	9	0	1	5	7	18	29	37	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRHLQNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCATGGGATTAGCGGATTTTGAGCAGTTCTTCGGGCCA	CASSMGLADFEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	5	9	7	4	18	30	43	37	47						01,02								CASSMGLADFEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCCTAGCGGGAGGGACCCACCGTCGAAACATTCAGTACTTCGGCGCC	CASSALAGGTHRRNIQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	4	0	6	3	11	18	30	45	33	56														CASSALAGGTHRRNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTCGGGGGGTGCGGGAGCAACCTACGAGCAGTACTTCGGGCCG	CASSSSGGAGATYEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	8	1	2	3	11	18	31	41	34	52						01,02								CASSSSGGAGATYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGATCAGTAGGGGGCCTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	10	2.2684790301798452E-5		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	5	0	1	5	2	18	35	47	40	49														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAGCCGGGGGCAGGGCATCTGGAAACACCATATATTTTGGAGAG	CASSLGAGGRASGNTIYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	54	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	1	6	0	1	5	6	18	34	45	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGAGGRASGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGTGGAGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLVESNQPQHF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	10	2	1	1	0	18	34	-1	35	39														CASSLVESNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTCAAAGGAGGGACAGGGTAGGTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	10	2.2684790301798452E-5		55	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	3	1	7	5	18	32	48	39	53														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTTTTTAATAGGCAGGGAAAAGCAGATACGCAGTATTTTGGCCCA	CASSFFNRQGKADTQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	3	4	10	5	18	32	47	42	52														CASSFFNRQGKADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCATCCCCGGGACTGGCCCTAAGCGGGGAGCTGTTTTTTGGAGAA	CASSPSPGLALSGELFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	10	7	9	9	18	29	44	38	53						01,02								CASSPSPGLALSGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCTAGCAGCTGGGACAGGGGTTAGCGTCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	2.2684790301798452E-5		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	2	4	0	7	18	-1	41	31	48														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACCGGGGACAGGAAATAATGAAAAACTGTTTTTTGGCAGT	CASRPGTGNNEKLFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	4	4	4	3	18	29	41	33	44														CASRPGTGNNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACGAAGGACTAGCGGGAGGTACGAGCAGTACTTCGGGCCG	CASRRRTSGRYEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	1	1	4	5	0	18	29	-1	34	48														CASRRRTSGRYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACGGGCTGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	11	2.4953269331978296E-5		49	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	4	2	6	5	7	5	18	31	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTAGCGGGATAGCGCCCCAAGAGACCCAGTACTTCGGGCCA	CASSSSGIAPQETQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	4	3	1	0	7	18	-1	40	31	47														CASSSSGIAPQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAAGAGGGCGGGAGACAGCGCTAACTATGGCTACACCTTCGGTTCG	CASSLKRAGDSANYGYTF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	7	2	0	6	6	18	33	46	39	52														CASSLKRAGDSANYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAGGGTCCCCAGGGCTCTCCTACGAGCAGTACTTCGGGCCG	CASSLVGSPGLSYEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	3	0	9	2	18	34	48	43	50														CASSLVGSPGLSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCCAGCGAGAGAGGCAACAGATACGCAGTATTTTGGCCCA	CASSFPAREATDTQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	6	6	3	3	9	18	32	39	35	48						01,02								CASSFPAREATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCTTGGGACTAGCGGGTCTATAAGGGAGCTATTTTTTGGAGAA	CASSFLGTSGSIRELFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	0	4	17	4	15	18	32	48	36	63						01,02								CASSFLGTSGSIRELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACGATTCCGGGACAGGGGGCCACCTACGAGCAGTACTTCGGGCCG	CASSTIPGQGATYEQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	0	2	8	2	18	30	50	38	52														CASSTIPGQGATYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGACAGGACCTCAATGCCTACGAGCAGTACTTCGGGCCR	CASSRQDLNAYEQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	unresolved		5	2	4	2	1	9	18	30	37	31	46								TCRBJ02-05,TCRBJ02-07						CASSRQDLNAYEQYF+TCRBV11-03+TCRBJ02-X	TCRBV11-03*01	TCRBD01-01*01	unresolved	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCAGAGCGGGACCTGAGGAGAGACCCAGTACTTCGGGCCA	CASSQSGT*GETQYF	Stop	VDJ	1	12	2.722174836215814E-5		45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	6	3	4	3	7	18	30	40	33	47														CASSQSGT*GETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACGGTCCGGGAATGGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	12	2.722174836215814E-5		46	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	3	6	8	5	18	30	43	38	48														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAGCGACAGGGTGTCCGGGGAGCTGTTTTTTGGAGAA	CASSPSDRVSGELFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	3	6	6	3	18	30	43	36	46														CASSPSDRVSGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGAATCAGGCAGGGTCTAGCACTGAAGCTTTCTTTGGACAA	CASSPNQAGSSTEAFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	4	10	5	18	30	45	40	50														CASSPNQAGSSTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAACAGGGGGCACCTATGGCTACACCTTCGGTTCG	CASSRTGGTYGYTF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	0	4	3	2	18	30	42	33	44														CASSRTGGTYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCGCCAGAAGGCGGGGAGCCTACGAGCAGTACTTCGGGCCG	CASSARRRGAYEQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	3	2	8	2	18	30	44	38	46														CASSARRRGAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACGATTAGCGGGACATGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	12	2.722174836215814E-5		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	3	6	6	4	18	31	45	37	49														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGACAACGGGGCGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	12	2.722174836215814E-5		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	6	6	2	8	18	31	39	33	47														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTCATCCCGGGGCGGTCTCGAAAGGGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	12	2.722174836215814E-5		55	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	5	1	5	20	0	18	32	-1	52	58														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGGGGCGGACAGGGGGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	2.722174836215814E-5		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	1	0	5	0	18	32	-1	37	47														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGTGGGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSFVGASTDTQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	6	0	0	3	1	18	32	41	35	42														CASSFVGASTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTTAGCGGAGCCACAGATACGCAGTATTTTGGCCCA	CASSFSGATDTQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	5	2	3	3	18	29	38	32	41						01,02								CASSFSGATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGACGGCCGGAGGGGGTGGCTACACCTTCGGTTCG	CASSPGTAGGGGYTF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	5	1	7	14	0	18	30	-1	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGTAGGGGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCGGGACCAAAATCTACAATGAGCAGTTCTTCGGGCCA	CASSLGGTKIYNEQFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	7	3	3	0	7	18	-1	40	34	47														CASSLGGTKIYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCACCTGGTCCCCGCTGGAGCAGTACTTCGGGCCG	CASSFTWSPLEQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	0	10	7	5	9	18	32	39	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFTWSPLEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCGGGGGAGGGGTGAGACCCAGTACTTCGGGCCA	CASSFRGRGETQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	9	0	5	4	2	18	32	43	36	45														CASSFRGRGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACGTCAGCTCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPGRQLGANVLTF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	5	0	7	4	2	8	18	30	37	32	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGRQLGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAATTGACCAACCTACGAGCAGTACTTCGGGCCR		Out	VDJ	1	14	3.175870642251783E-5		43	TCRBV11	TCRBV11-03	01				TCRBJ02	unresolved		0	2	7	2	3	3	18	35	41	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01			TCRBJ02-05,TCRBJ02-07						X+TCRBV11-03+TCRBJ02-X	TCRBV11-03*01		unresolved	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACTAGAAGGTTGGGGTGAGACCCAGTACTTCGGGCCA	CASSLGLEGWGETQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	2	8	5	0	11	18	-1	40	34	51						01,02								CASSLGLEGWGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTCGGCCCCCAGCCGGTACGCAGTATTTTGGCCCA	CASSLGRPPAGTQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	1	4	5	8	9	4	18	34	46	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRPPAGTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTCCCCAGCGGGAGGGCCACCTACAATGAGCAGTTCTTCGGGCCA	CASSLFPSGRATYNEQFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	6	0	2	6	3	18	33	49	39	52														CASSLFPSGRATYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCTTCGGGGACAGGGGCCTGGAAACACCATATATTTTGGAGAG	CASLRGQGPGNTIYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	0	2	2	5	1	18	27	42	32	43														CASLRGQGPGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGCAGTGGCTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQAVANTGELFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	5	4	5	2	4	5	18	30	37	34	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAVANTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGCTGACAGGGTCGAACACTGAAGCTTTCTTTGGACAA	CASSLLTGSNTEAFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	1	5	2	18	30	42	35	44														CASSLLTGSNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAACGTGGGACGGCCTTATGGCTACACCTTCGGTTCG	CASSLNVGRPYGYTF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	3	0	7	5	6	5	18	32	43	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNVGRPYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCGTTGGGGCCCAAGAGACCCAGTACTTCGGGCCA	CASSLAVGAQETQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	7	0	1	7	0	18	32	-1	39	44														CASSLAVGAQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATGGTCGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLWSVNTGELFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	8	5	1	4	1	18	33	40	37	41						01,02								CASSLWSVNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCTCCCGCCAGGGGGTAGAGAAAAACTGTTTTTTGGCAGT	CASSFLPPGGREKLFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	1	8	8	4	18	32	47	40	51														CASSFLPPGGREKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGAGGCGGGAGCGGGGATACGCAGTATTTTGGCCCA	CASSFGGGSGDTQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	2	6	5	4	18	32	44	37	48														CASSFGGGSGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTTCAGTGGAGGGCAAGAGACCCAGTACTTCGGGCCA	CASSFFSGGQETQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	10	0	2	7	0	18	32	-1	39	45														CASSFFSGGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCGGGGGGACTAGCGGGAAACACAGATACGCAGTATTTTGGCCCA	CASSPGGLAGNTDTQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	0	3	2	6	2	18	29	48	35	50														CASSPGGLAGNTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATCTACGGACAGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSIYGQASTDTQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	4	0	6	2	18	30	43	36	45														CASSIYGQASTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGTGGGGGGGCACTAATGAAAAACTGTTTTTTGGCAGT	CASSQWGGTNEKLFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	9	0	2	4	1	18	30	41	34	42														CASSQWGGTNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGAGTGGGTACGGCAGATACGCAGTATTTTGGCCCA	CASSPRVGTADTQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	0	9	4	8	5	18	30	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRVGTADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAGCGCGGGAGGAAGGAAGCCTACGAGCAGTACTTCGGGCCG	CASSERGRKEAYEQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	1	2	4	7	18	30	42	34	49														CASSERGRKEAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGATTCGACATGAGACCCAGTACTTCGGGCCA	CASSFGIRHETQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	8	3	5	0	8	18	-1	37	32	45														CASSFGIRHETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACCCCGGGACAGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSHPGTGAKNIQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	0	3	1	6	0	18	30	-1	36	45														CASSHPGTGAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCAAAGGCTAGCGGGATTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	4.083262254323721E-5		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	4	3	4	7	1	18	30	46	37	47														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCTGGCGTCCCTCGTTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	18	4.083262254323721E-5		44	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	9	0	4	3	10	18	30	36	33	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACTGACTAGCAGGAGCACAGATACGCAGTATTTTGGCCCA	CASSSLTSRSTDTQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	2	7	0	4	3	18	31	42	35	45						01,02								CASSSLTSRSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCCGGCAGGGCAACCACAATGAGCAGTTCTTCGGGCCA	CASSLVRQGNHNEQFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	3	5	5	5	18	34	44	39	49														CASSLVRQGNHNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTCCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFSANTGELFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	4	10	0	0	3	18	-1	34	32	37						01,02								CASSFSANTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCAAGATATCCCCGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSFQDIPGYTGELFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	8	4	3	12	1	18	32	48	44	49						01,02								CASSFQDIPGYTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCATAGCGGGAGTGCCTACGAGCAGTACTTCGGGCCG	CASSHSGSAYEQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	5	2	2	2	2	18	30	41	32	43														CASSHSGSAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAATTACTACCGGGAGCTATGGCTACACCTTCGGTTCG	CASSPITTGSYGYTF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	8	2	4	11	0	18	30	-1	41	47														CASSPITTGSYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCAGACTAGCGGGAGCGGTAACGAGCAGTACTTCGGGCCG	CASSSQTSGSGNEQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	2	2	5	4	5	18	31	47	35	52														CASSSQTSGSGNEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTCCCCTACCCAGGCTTGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	19	4.3101101573417056E-5		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	4	4	2	9	4	18	27	40	36	44														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGAACCCGGGACAGGGGGCTTCCTGGAACTTCGGGCCA	CASSPNPGQGASWNF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	0	15	8	8	18	30	50	38	58														CASSPNPGQGASWNF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCCCGGGACAGGGGGAAGACCCAGGAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	20	4.5369580603596903E-5		61	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	1	0	6	12	18	30	47	36	59														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTCCCAGGGGGTGAGGGGGTACGAGCAGTACTTCGGGCCG	CASSSQGVRGYEQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	1	4	2	8	18	31	40	33	48														CASSSQGVRGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGGCAGGAGCACAGATACGCAGTATTTTGGCCCA	CASSWGRSTDTQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	7	0	0	0	3	18	-1	36	31	39														CASSWGRSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAATGAAGGCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	21	4.7638059633776745E-5		47	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-04	01	5	5	4	0	8	2	18	30	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01		TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTTACTAGCGACAATGAGCAGTTCTTCGGGCCA	CASSLFTSDNEQFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	3	6	5	3	0	18	33	-1	36	43						01,02								CASSLFTSDNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCCCGGAGGTAGCGGGAGGGATGAGCAGTTCTTCGGGCCA	CASSFPGGSGRDEQFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	5	0	8	9	0	18	32	-1	41	52														CASSFPGGSGRDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTACCCCGGGGGAACGGAAAGAGACCCAGTACTTCGGGCCA	CASSTPGERKETQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	2	3	5	6	18	29	40	34	46														CASSTPGERKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGGACATGGGAGCACCAATGAAAAACTGTTTTTTGGCAGT	CASGHGSTNEKLFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	8	1	6	5	0	10	18	-1	32	27	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGHGSTNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAGCGGGAGAGGTCGACGAGCAGTACTTCGGGCCG	CASSRAGEVDEQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	6	2	5	2	6	18	30	40	32	46														CASSRAGEVDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCAGCAGGTATCATGAACACTGAAGCTTTCTTTGGACAA	CASSSPAGIMNTEAFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	4	0	6	5	18	31	41	37	46														CASSSPAGIMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGACTATATAGCACAGATACGCAGTATTTTGGCCCA	CASSSGLYSTDTQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	9	0	2	3	18	31	39	33	42						01,02								CASSSGLYSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCAGGGGTGGCCTACGAGCAGTACTTCGGGCCG	CASSLPGVAYEQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	2	1	3	18	33	40	34	43														CASSLPGVAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCAAATCGACTAGCGGGAGGGCCGGGACCGGGGAACTGTTTTTTGGAGAA	CASSFKSTSGRAGTGELFF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	2	0	14	6	14	18	32	52	38	66														CASSFKSTSGRAGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTGACAGGGGGCGCGGAGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLTGGAEAGELFF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	0	6	3	7	18	29	42	32	49														CASSLTGGAEAGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCAAGGTTTAGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASQGLGAKNIQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-04	01	8	5	3	1	8	0	18	27	-1	35	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASQGLGAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01		TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTAAAGATCCCCAGGGGGCTGTACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	25	5.671197575449612E-5		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	0	3	9	3	18	31	48	40	51														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGCACCGGGGCCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSSGTGAYSNQPQHF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	4	7	0	0	8	3	18	31	44	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGTGAYSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCTCTTCCCTGGACAGGGGTGCAGATACGCAGTATTTTGGCCCA	CASTSSLDRGADTQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	1	2	4	10	2	18	28	47	38	49														CASTSSLDRGADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAARCAACGGGGCGCTACGAGCAGTACTTCGGGCCG	CASSQXTGRYEQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	7	0	3	8	1	18	30	43	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQXTGRYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCGGACAGGGCGGATGAAAAACTGTTTTTTGGCAGT	CASSADRADEKLFF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	3	6	2	3	18	30	40	32	43														CASSADRADEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCTGGCGGCGGGCAGCCCCAGCATTTTGGTGAT	CASSLPGGGQPQHF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	7	4	7	7	0	18	33	-1	40	45						01,02								CASSLPGGGQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAGGGACAGGGGAGGACTACTAATGAAAAACTGTTTTTTGGCAGT	CASSEGQGRTTNEKLFF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	2	2	2	6	18	30	42	32	48														CASSEGQGRTTNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAGGGGGCAGCCTTGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	28	6.351741284503566E-5		52	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	5	0	1	0	7	18	-1	42	35	49														X+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCGGACAGGGATCAGCCCCCAGCATTTTGGTGAT		Out	VDJ	1	29	6.578589187521551E-5		41	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	3	10	3	6	18	30	41	33	47														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTGCGAGTTGGCGGAACCGCCTACGAGCAGTACTTCGGGCCG	CASSVRVGGTAYEQYF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	7	5	2	10	5	18	30	44	40	49						01,02								CASSVRVGGTAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCCTCCACGAGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLHEGTGELFF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	11	0	4	6	0	18	30	-1	36	41														CASSLHEGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGACCAAGGGATTACTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSPTKGLLAKNIQYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-04	01	5	0	8	0	8	5	18	30	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTKGLLAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01		TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTATCGACGGTGGCTACGAGCAGTACTTCGGGCCG	CASSSIDGGYEQYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	4	2	7	3	5	5	18	31	39	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSIDGGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCCGGGGACAATCAGCCCCAGCATTTTGGTGAT	CASSLPGDNQPQHF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	2	8	3	3	2	1	18	33	40	35	41														CASSLPGDNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCCAGAATACCTACGAGCAGTACTTCGGGCCG	CASSLGQNTYEQYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	5	2	2	4	18	34	39	36	43														CASSLGQNTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAACGACTCTCTAATGAAAAACTGTTTTTTGGCAGT	CASSKRLSNEKLFF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	2	10	3	4	2	18	30	38	34	40						01,02								CASSKRLSNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAAAACAGGTCAATGGAAACACCATATATTTTGGAGAG	CASSPKQVNGNTIYF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	4	3	5	4	18	30	40	35	44														CASSPKQVNGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACCGGGGACAGGGAACTATGGCTACACCTTCGGTTCG	CASSPPGTGNYGYTF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	2	6	0	18	30	-1	36	45														CASSPPGTGNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTACCAAGGGGGGGACAGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	32	7.259132896575504E-5		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	3	12	0	18	30	-1	42	51														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTTTAAATCAACATTCTAATGAGCAGTTCTTCGGGCCA	CASSPLNQHSNEQFF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	6	7	11	4	18	30	44	41	48														CASSPLNQHSNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCGAAACGGACGGAACGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	33	7.485980799593489E-5		49	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	1	7	0	7	7	18	30	41	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGTTGCCAGCCCCAGGCACTGAAGCTTTCTTTGGACAA	CASSLLPAPGTEAFF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	4	4	11	0	18	32	-1	43	47														CASSLLPAPGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCACCGGATTCGGACAGTGTTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	35	7.939676605629458E-5		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	5	3	8	4	18	28	42	36	46														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCAAGGGGGACTAGCGGGAGGGGAGCAGTACTTCGGGCCG	CASSQGGLAGGEQYF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	0	0	7	5	0	18	30	-1	35	51														CASSQGGLAGGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTTCGTACTCGACACCAATGAGCAGTTCTTCGGGCCA	CASSFFVLDTNEQFF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	6	6	10	1	18	32	46	42	47														CASSFFVLDTNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGCGGAGGGAGAACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	38	8.620220314683411E-5		43	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	0	3	3	4	18	32	41	35	45														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGGACTAGTCTCTTACGAGCAGTACTTCGGGCCG	CASSPGLVSYEQYF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	8	4	3	5	18	30	40	33	45						01,02								CASSPGLVSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGAAGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGEENTGELFF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	3	6	1	1	0	4	18	-1	37	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGEENTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTGAGGACTAGCGGGAGAATTAGGGAGACCCAGTACTTCGGGCCA	CASSLRTSGRIRETQYF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	1	2	5	5	7	18	29	47	34	54														CASSLRTSGRIRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTGGGGGGATAGGCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLVGGIGANTGELFF	In	VDJ	1	42	9.527611926755349E-5	1.222924595051814E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	9	1	0	2	7	18	34	42	36	49														CASSLVGGIGANTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGACAGGGGGGATAATTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSDRGDNSGANVLTF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	4	1	1	0	6	18	-1	42	35	48														CASSSDRGDNSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCATTAGCGGGATAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSISGINTGELFF	In	VDJ	1	44	9.981307732791318E-5	1.281159099578091E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	5	3	2	4	2	18	31	43	35	45														CASSSISGINTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGCCTGAGGGGGGCCCTTGGGCTTCCTATGGCTACACCTTCGGTTCG	CASSSPEGGPWASYGYTF	In	VDJ	1	44	9.981307732791318E-5	1.281159099578091E-4	54	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	4	5	1	4	6	13	18	31	43	37	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPEGGPWASYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACAGGGGATAGACGAGCAGTACTTCGGGCCG	CASSLGQGIDEQYF	In	VDJ	2	46	1.0435003538827287E-4	1.3393936041043678E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	5	0	4	18	-1	42	32	46														CASSLGQGIDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTGGACTAGCGGGAGGCCTGTACAATGAGCAGTTCTTCGGGCCA	CASSSGLAGGLYNEQFF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	1	1	4	2	4	18	31	47	33	51														CASSSGLAGGLYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCTTGGGCGGAGGGGGATCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	48	1.0888699344863256E-4		50	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	5	5	1	4	11	2	18	30	47	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGAGGACTAGCGGGAGAGGCGAGCAGTTCTTCGGGCCA	CASSLVRTSGRGEQFF	In	VDJ	2	51	1.1569243053917209E-4	1.48497986542006E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	1	2	10	3	4	18	34	50	37	54														CASSLVRTSGRGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACGAGGGGGGCCGGGCCCCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	51	1.1569243053917209E-4		52	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	5	1	3	5	11	18	32	43	37	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACGGGCCCACAGATACGCAGTATTTTGGCCCA	CASSLDGPTDTQYF	In	VDJ	2	53	1.2022938859953179E-4	1.543214369946337E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	3	1	7	2	0	5	18	-1	36	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGPTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCAACAGGGGATGGGAGAGCAGTACTTCGGGCCG	CASSFQQGMGEQYF	In	VDJ	2	53	1.2022938859953179E-4	1.543214369946337E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	2	7	3	6	18	32	42	35	48														CASSFQQGMGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAACAGCCGCCGGTGGTGAAAAACTGTTTTTTGGCAGT	CASSLTAAGGEKLFF	In	VDJ	2	56	1.2703482569007132E-4	1.6305661267357522E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	5	7	3	10	18	30	37	33	47														CASSLTAAGGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACTTCAGGGGGCTGGAACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	56	1.2703482569007132E-4		52	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	0	3	3	5	18	35	46	38	51														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTCCCCGAACCGTGCCGACGAGCAGTACTTCGGGCCG	CASSLSPNRADEQYF	In	VDJ	2	58	1.3157178375043101E-4	1.688800631262029E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	2	8	5	6	9	18	32	40	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSPNRADEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCCGGCCGGGACTAGCGCGCTCGACTACGAGCAGTACTTCGGGCCG	CASTPAGTSALDYEQYF	In	VDJ	2	59	1.3384026278061086E-4	1.7179178835251675E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	6	3	8	7	18	28	46	36	53						01,02								CASTPAGTSALDYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTGACGGGTGCACTCACAGATACGCAGTATTTTGGCCCA	CASSLTGALTDTQYF	In	VDJ	2	60	1.361087418107907E-4	1.747035135788306E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	8	4	2	2	6	18	32	38	34	44						01,02								CASSLTGALTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGAGGACAGGGCGACGAGCAGTACTTCGGGCCG	CASSLGGQGDEQYF	In	VDJ	2	62	1.4064569987115038E-4	1.8052696403145828E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	3	5	4	2	18	32	44	36	46														CASSLGGQGDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACTTGGACGGGACTACGAGCAGTACTTCGGGCCG	CASSSLGRDYEQYF	In	VDJ	2	63	1.4291417890133023E-4	1.8343868925777213E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	3	3	8	0	18	31	-1	39	44														CASSSLGRDYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGGACCTCCGGTGAAAAACTGTTTTTTGGCAGT	CASSSRTSGEKLFF	In	VDJ	2	63	1.4291417890133023E-4	1.8343868925777213E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	4	1	7	7	3	6	18	31	38	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRTSGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAAAAGCGTAAGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	64	1.4518265793151007E-4		44	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	5	3	3	10	0	18	32	-1	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTCCCGGACAGGCCCGGGGACCACTGAAGCTTTCTTTGGACAA	CASSFSRTGPGTTEAFF	In	VDJ	2	64	1.4518265793151007E-4	1.8635041448408597E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	4	4	5	9	18	32	44	37	53														CASSFSRTGPGTTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCAGGACAGGATTACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	66	1.4971961599186977E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	4	3	4	4	18	30	41	34	45														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACAGGCAGGATGGAGCGCAGATACGCAGTATTTTGGCCCA	CASSLQAGWSADTQYF	In	VDJ	2	67	1.5198809502204962E-4	1.950855901630275E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	2	4	4	4	0	12	18	-1	37	33	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQAGWSADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGGACACCGGAACAATGAGCAGTTCTTCGGGCCA	CASSWGHRNNEQFF	In	VDJ	2	69	1.5652505308240931E-4	2.009090406156552E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	6	5	1	5	18	31	38	32	43														CASSWGHRNNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCCCAGGACAGGTTTATGGCTACACCTTCGGTTCG	CASSRPGQVYGYTF	In	VDJ	2	70	1.5879353211258916E-4	2.0382076584196903E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	4	5	6	2	18	30	43	36	45														CASSRPGQVYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCGACTAGCGGGAGGGCCGGGTACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	71	1.6106201114276898E-4		53	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	2	0	5	3	6	18	30	47	33	53														X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACAGGGGAATACAATGAGCAGTTCTTCGGGCCA	CASSLGTGEYNEQFF	In	VDJ	2	71	1.6106201114276898E-4	2.0673249106828288E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	2	4	0	2	18	-1	43	34	45														CASSLGTGEYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAGGATTCCTCGCACAGATACGCAGTATTTTGGCCCA	CASSPRIPRTDTQYF	In	VDJ	2	74	1.6786744823330853E-4	2.154676667472244E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	4	1	2	7	18	30	36	32	43														CASSPRIPRTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTCCGGGACAGTGCCCAAGAGACCCAGTACTTCGGGCCA	CASSLVRDSAQETQYF	In	VDJ	2	74	1.6786744823330853E-4	2.154676667472244E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	5	1	5	3	18	32	44	37	47														CASSLVRDSAQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTCCCTCACGGCAGGGGGCGACAATCAGCCCCAGCATTTTGGTGAT	CASSLTAGGDNQPQHF	In	VDJ	2	74	1.6786744823330853E-4	2.154676667472244E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	4	0	3	10	2	18	27	45	37	47														CASSLTAGGDNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCTTACGGGACAGGGGAGCCAATGAGCAGTTCTTCGGGCCA	CASSLRDRGANEQFF	In	VDJ	2	74	1.6786744823330853E-4	2.154676667472244E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	2	6	1	3	18	33	44	34	47														CASSLRDRGANEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTCGGCGGGGCTGGCGAGCACTGAAGCTTTCTTTGGACAA	CASSFSAGLASTEAFF	In	VDJ	3	77	1.7467288532384807E-4	2.2420284242616594E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	7	3	4	4	8	18	32	42	36	50														CASSFSAGLASTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCAGGGGTGGGCAATGAAGCTTTCTTTGGACAA	CASSSPGVGNEAFF	In	VDJ	3	81	1.8374680144456743E-4	2.358497433314213E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	2	7	3	7	18	31	40	34	47														CASSSPGVGNEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGAGTTTAGGTGTGGAGGGACAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	81	1.8374680144456743E-4		56	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	4	0	6	2	16	0	18	31	-1	47	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGCGACAGGGGTGTGAACTATGGCTACACCTTCGGTTCG	CASSPRDRGVNYGYTF	In	VDJ	3	82	1.8601528047474728E-4	2.3876146855773513E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	2	2	6	4	18	30	44	36	48														CASSPRDRGVNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGACGGGACCCAGCACAGATACGCAGTATTTTGGCCCA	CASSLTGPSTDTQYF	In	VDJ	3	83	1.8828375950492713E-4	2.4167319378404898E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	3	0	7	0	3	2	18	32	40	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTGPSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACAGGGAGGTTACGAGCAGTACTTCGGGCCG	CASSLGQGGYEQYF	In	VDJ	3	84	1.9055223853510698E-4	2.445849190103628E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	3	4	0	4	18	-1	41	34	45														CASSLGQGGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCACCCCTCTGGGACAGGGCCCTGGACTAGCTAAGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	87	1.9735767562564652E-4		58	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	3	6	7	16	18	28	44	35	60														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGGTGTCGGGGGGCGCGATCAGCCCCAGCATTTTGGTGAT	CASSPGVGGRDQPQHF	In	VDJ	3	88	1.9962615465582637E-4	2.562318199156182E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	1	5	8	4	18	30	45	38	49														CASSPGVGGRDQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAAGGCCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLVRPTGELFF	In	VDJ	3	90	2.0416311271618604E-4	2.620552703682459E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	1	5	4	4	2	2	18	34	39	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVRPTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCGAACCTACCTATGGACAGTAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	93	2.1096854980672558E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	1	5	5	14	2	18	28	48	42	50														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCCGGGAGTTGCCTACGAGCAGTACTTCGGGCCG	CASSLPGVAYEQYF	In	VDJ	3	95	2.1550550786708528E-4	2.7661389649981513E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	8	2	2	2	3	18	32	40	34	43														CASSLPGVAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGGCGGGAAGGGTTAAAATTCAGGAACACCATATATTTTGGAGAG		Out	VDJ	3	97	2.2004246592744497E-4		55	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	7	3	7	6	16	18	30	42	36	58														X+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGAAGCGGGAGTAGGAATGAGCAGTTCTTCGGGCCA	CASSLGSGSRNEQFF	In	VDJ	3	102	2.3138486107834419E-4	2.96995973084012E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	6	2	7	4	4	18	32	44	36	48														CASSLGSGSRNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACAGGGAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLTGNSNQPQHF	In	VDJ	4	106	2.4045877719906358E-4	3.086428739892674E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	0	0	2	18	-1	39	33	41														CASSLTGNSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGATAGCGGGAGTGTGAAGACCCAGTACTTCGGGCCA	CASSLDSGSVKTQYF	In	VDJ	4	109	2.472642142896031E-4	3.173780496682089E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	5	2	6	3	5	18	32	44	35	49														CASSLDSGSVKTQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGACTAGCCTCCAAGAGACCCAGTACTTCGGGCCA	CASSLETSLQETQYF	In	VDJ	4	110	2.4953269331978294E-4	3.2028977489452276E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	2	7	1	0	2	18	-1	42	35	44						01,02								CASSLETSLQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGACAGGGAGCCCTACGAGCAGTACTTCGGGCCG	CASSPDREPYEQYF	In	VDJ	4	111	2.518011723499628E-4	3.232015001208366E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	2	3	3	18	30	40	33	43														CASSPDREPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACAAGGACTAGCGGCAAGGTACGAGCAGTACTTCGGGCCG	CASSLQGLAARYEQYF	In	VDJ	4	113	2.563381304103225E-4	3.2902495057346426E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	1	5	4	3	5	18	33	46	36	51						01,02								CASSLQGLAARYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTCCGCGGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSFSAGSTDTQYF	In	VDJ	4	126	2.8582835780266045E-4	3.6687737851554426E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	3	0	4	0	18	32	-1	36	42														CASSFSAGSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTAGCGGGACCTGGGGGGAGACCCAGTACTTCGGGCCA	CASSPSGTWGETQYF	In	VDJ	5	137	3.1078162713463875E-4	3.989063560049965E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	4	3	5	1	8	18	30	40	31	48														CASSPSGTWGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACTAACCTCCTACGAGCAGTACTTCGGGCCG	CASSLGLTSYEQYF	In	VDJ	5	138	3.1305010616481863E-4	4.018180812313104E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	9	0	0	2	18	-1	39	32	41						01,02								CASSLGLTSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCAGCGGGAGTACTAATGAGCAGTTCTTCGGGCCA	CASSFSGSTNEQFF	In	VDJ	5	140	3.175870642251783E-4	4.0764153168393807E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	6	2	7	1	4	18	32	41	33	45														CASSFSGSTNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAGGACAGCATCAACACTGAAGCTTTCTTTGGACAA	CASSKDSINTEAFF	In	VDJ	5	142	3.2212402228553797E-4	4.1346498213656576E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	2	2	4	18	30	38	32	42														CASSKDSINTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAATGACAGGAGCTAACTATGGCTACACCTTCGGTTCG	CASSSMTGANYGYTF	In	VDJ	5	144	3.2666098034589766E-4	4.1928843258919344E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	0	4	2	18	31	41	35	43														CASSSMTGANYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCGGGCCCTCCAGTCCGCCCCCCGACTCTACGAGCAGTACTTCGGGCCG	CASSFRALQSAPRLYEQYF	In	VDJ	5	156	3.5388272870805584E-4	4.542291353049595E-4	57	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	8	0	3	2	21	18	32	38	34	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRALQSAPRLYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACGACCACGGGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASNDHGTGNTEAFF	In	VDJ	6	163	3.6976208191931474E-4	4.7461121188915645E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	4	1	8	0	18	28	-1	36	44														CASNDHGTGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTGAAGGGACAGGGGGGTACGAGCAGTACTTCGGGCCG	CASSLGEGTGGYEQYF	In	VDJ	6	166	3.7656751900985426E-4	4.8334638756809795E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	1	4	5	1	18	34	50	39	51														CASSLGEGTGGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGATTCGAGAGATGGGAAACACCATATATTTTGGAGAG	CASSLIREMGNTIYF	In	VDJ	6	169	3.8337295610039383E-4	4.920815632470395E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	3	11	2	4	5	5	18	32	40	37	45														CASSLIREMGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCAGAAGTATGGAAAAACTGTTTTTTGGCAGT	CASSLGRSMEKLFF	In	VDJ	6	190	4.3101101573417056E-4	5.532277929996303E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	4	5	8	1	7	18	34	38	35	45														CASSLGRSMEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCGGGACAGGGGCTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSSPGQGLSNQPQHF	In	VDJ	7	198	4.4915884797560934E-4	5.76521594810141E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	2	0	4	2	18	31	45	35	47														CASSSPGQGLSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGCAGTATGACAGGGGGAAGCTTTCTTTGGACAA	CASSFAV*QGEAFF	Stop	VDJ	7	200	4.53695806035969E-4		42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	2	8	8	0	18	32	-1	40	48														CASSFAV*QGEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCCGGGGGACAGAGGTGAGCAGTTCTTCGGGCCA	CASSPPGDRGEQFF	In	VDJ	7	210	4.7638059633776746E-4	6.11462297525907E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	5	9	7	3	18	30	44	37	47														CASSPPGDRGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTTAGCGACAGAATACAATGAGCAGTTCTTCGGGCCA	CASSSLATEYNEQFF	In	VDJ	7	210	4.7638059633776746E-4	6.11462297525907E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	4	2	5	4	7	2	18	31	43	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSLATEYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGCAAGGGCAGGGAAAGAGACCCAGTACTTCGGGCCA	CASSPARAGKETQYF	In	VDJ	8	246	5.580458414242419E-4	7.162844056732054E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	3	3	10	1	18	30	45	40	46														CASSPARAGKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCTTGACAGCATAAACACTGAAGCTTTCTTTGGACAA	CASSLDSINTEAFF	In	VDJ	9	271	6.14757817178738E-4	7.890775363310515E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	2	4	4	18	29	38	33	42														CASSLDSINTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTATAGCGGGACTGGCTTCGGGGAGCAGTACTTCGGGCCG	CASSYSGTGFGEQYF	In	VDJ	9	273	6.192947752390977E-4	7.949009867836792E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	5	3	7	1	11	18	31	40	32	51														CASSYSGTGFGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACGGACCCACAGATACGCAGTATTTTGGCCCA	CASSLDGPTDTQYF	In	VDJ	12	358	8.121154928043845E-4	0.0010423976310203558	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	0	1	7	2	1	1	18	35	40	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGPTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCTGACAAGAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFLTRANTGELFF	In	VDJ	13	398	9.028546540115783E-4	0.0011588666400729095	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	2	6	0	3	4	18	32	39	35	43														CASSFLTRANTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGTGGGCTAGCGGGATCTACGAGCAGTACTTCGGGCCG	CASSLEWASGIYEQYF	In	VDJ	14	404	9.164655281926574E-4	0.0011763369914307928	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	4	3	3	5	1	18	35	49	40	50														CASSLEWASGIYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATAGCGATTGGAGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLIAIGAGANVLTF	In	VDJ	14	423	9.595666297660745E-4	0.0012316597707307557	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	2	5	6	2	1	7	18	33	39	34	46						01,02								CASSLIAIGAGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAGCGGTCCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	14	424	9.618351087962543E-4		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	6	5	0	0	2	18	-1	40	35	42						01,02								X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGGACTAGCGGGAGTTGAAGAGCAGTACTTCGGGCCG	CASSQGLAGVEEQYF	In	VDJ	16	461	0.0010457688329129087	0.0013423053293306817	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	0	2	7	2	5	18	30	46	32	51														CASSQGLAGVEEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGCGGGGACTAGTCTATACAATGAGCAGTTCTTCGGGCCA	CASSFAGTSLYNEQFF	In	VDJ	16	468	0.0010616481861241674	0.0013626874059148785	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	8	4	4	4	18	32	44	36	48						01,02								CASSFAGTSLYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGACGGACTAGCGGGAGAGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSRRTSGRGSTDTQYF	In	VDJ	16	481	0.0010911384135165055	0.0014005398338569586	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	1	2	0	4	4	18	30	47	34	51														CASSRRTSGRGSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCGGGAGTGATAGGGGCAATGAGCAGTTCTTCGGGCCA	CASSLGGSDRGNEQFF	In	VDJ	17	498	0.0011297025570295629	0.001450039162704294	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	7	2	6	0	9	18	-1	41	34	50														CASSLGGSDRGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGACTAGCGGCACAGATACGCAGTATTTTGGCCCA	CASSPGTSGTDTQYF	In	VDJ	21	612	0.001388309166470065	0.001781975838504072	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	6	1	3	0	18	30	-1	33	43						01,02								CASSPGTSGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTTTCGGGAAGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	21	622	0.0014109939567718637		43	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	8	3	5	4	2	18	33	42	37	44														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCGACGGGGCGGACCCCGGGGAGCTGTTTTTTGGAGAA	CASSRDGADPGELFF	In	VDJ	25	729	0.001653721213001107	0.002122647689982792	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	5	7	0	6	6	5	18	30	41	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDGADPGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACGGAGCTAACTATGGCTACACCTTCGGTTCG	CASSLDGANYGYTF	In	VDJ	25	738	0.0016741375242727257	0.0021488532170196163	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	3	1	7	0	0	4	18	-1	36	32	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGANYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTCCTCCGCGGGGTTCGGAGATACGCAGTATTTTGGCCCA	CASSPSSAGFGDTQYF	In	VDJ	26	777	0.0017626082064497396	0.002262410500845856	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	3	5	9	5	18	30	45	39	50														CASSPSSAGFGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTTACGTGGGAGGGGCCTACGAGCAGTACTTCGGGCCG	CASSSYVGGAYEQYF	In	VDJ	36	1075	0.0024386149574433334	0.0031301046182873817	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	9	0	2	7	1	18	31	45	38	46														CASSSYVGGAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTCCGGGACAGGGGGCCGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	37	1101	0.0024975954122280096		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	0	3	4	2	18	32	48	36	50														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTATTTGCAGAGGGACGAGCAGTACTTCGGGCCG	CASSSYLQRDEQYF	In	VDJ	38	1118	0.0025361595557410665	0.003255308803018877	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	11	0	5	10	0	18	31	-1	41	46														CASSSYLQRDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGCAGTGGTTGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	59	1748	0.003965301344754369		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	5	1	3	6	18	30	36	33	42														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGTCAACCAGCGGGACGGTCGCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	9	2.0416311271618604E-5		49	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	6	3	0	6	7	26	36	49	42	56														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAATGAGGATAGCACAGATACGCAGTATTTTGGCCCA	CASNEDSTDTQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	12	11	1	0	7	2	26	31	42	38	44														CASNEDSTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ACGTTTGGTGGAACCCAGGGACTCAGCTGTGTATTTTGTGCCAGCAGCGTAACCCACGCCCAAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	2.2684790301798452E-5		44	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	17	6	6	2	8	14	37	37	49	45	63						01,02								X+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCCACGTTTGGTGGAACCCGGGACTCAGCTGTGTATTTTTGTGCCAGCTTGAGAGGACAGGAGGTGGGCGAAGCTTTCTTTGGACAA	CASLRGQEVGEAFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	1	4	8	10	8	39	44	61	54	69														CASLRGQEVGEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCACAGTTGGGCCCGCTAACACAGATACGCAGTATTTTGGCCCA	CATVGPANTDTQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	12	3	5	2	1	13	26	31	36	32	49														CATVGPANTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTAAGGACAGGGTGGCAGCCCCAGCATTTTGGTGAT	CASGLVRTGWQPQHF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	3	7	2	3	26	43	53	45	56														CASGLVRTGWQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCGCCCATTGGGGACTAGCGGGCAATGAGCAGTTCTTCGGGCCA	CASAHWGLAGNEQFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	12	0	4	6	12	0	26	31	-1	43	55						01,02								CASAHWGLAGNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAAAGCTAGCGGGAGCCCTCCCTACAATGAGCAGTTCTTCGGGCCA	CASKASGSPPYNEQFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	48	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	12	4	2	2	8	5	26	31	49	39	54														CASKASGSPPYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCATGTGGACAGACCAGGCCGAGCAGTTCTTCGGGCCA	CASMWTDQAEQFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	12	1	5	10	8	8	26	31	45	39	53														CASMWTDQAEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAACGGGGGGCTAACTGCCAACGAGCAGTACTTCGGGCCG	CASNGGLTANEQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	12	8	1	5	6	10	26	31	44	37	54														CASNGGLTANEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTCCAAGGGAAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	23	5.2175017694136434E-5		41	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-05	01	3	0	8	4	4	1	26	40	48	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTCGGACGCCGGGACCAGGAGAATCAGCCCCAGCATTTTGGTGAT	CASGFGRRDQENQPQHF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	51	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-05	01	3	0	7	4	8	6	26	40	53	48	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGFGRRDQENQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTGGGACAGGGGGTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	6.124893381485581E-5		44	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	1	4	0	1	26	-1	54	43	55														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCCCAGCAGGGTGAAGCTTTCTTTGGACAA		Out	VDJ	1	28	6.351741284503566E-5		34	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	3	7	6	0	26	36	-1	42	47														X+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCCTGTTAGAGCGGGAGTGGGTCGAGCAGTACTTCGGGCCG		Out	VDJ	1	29	6.578589187521551E-5		47	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	6	2	6	8	5	26	39	55	47	60														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTACAGAGGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	30	6.805437090539536E-5		41	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	3	5	4	0	2	26	-1	47	43	49														X+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCACGGTATTGAGCAGCGAGCAGTTCTTCGGGCCA	CASGTVLSSEQFF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	6	4	5	10	12	1	26	37	52	49	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGTVLSSEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTGGGGCGGTGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	37	8.393372411665426E-5		43	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	7	0	5	0	6	26	-1	48	43	54														X+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTACTGGGGAGCCCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	38	8.620220314683411E-5		37	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	10	2	2	0	3	26	-1	41	37	44														X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCTCCCCGGGGGTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	38	8.620220314683411E-5		44	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	2	0	6	1	26	38	50	44	51														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTACCCAGACAGGAGTCGGCTACACCTTCGGTTCG	CASGTQTGVGYTF	In	VDJ	1	44	9.981307732791318E-5	1.281159099578091E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	4	8	5	4	26	38	49	43	53														CASGTQTGVGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCGGGGGTATGACGGCTGAAGCTTTCTTTGGACAA	CASTGGMTAEAFF	In	VDJ	2	52	1.1796090956935194E-4	1.5140971176831985E-4	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	12	8	2	6	6	8	26	31	43	37	51														CASTGGMTAEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCATTAGACACGAGATTAACACTGAAGCTTTCTTTGGACAA	CASIRHEINTEAFF	In	VDJ	2	62	1.4064569987115038E-4	1.8052696403145828E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	2	6	2	8	7	26	31	43	39	50														CASIRHEINTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCATACAGGGCAGAGTGTAAATGAGCAGTTCTTCGGGCCA	CASGHTGQSVNEQFF	In	VDJ	2	65	1.4745113696168992E-4	1.8926213971039982E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	3	7	4	9	26	37	47	41	56														CASGHTGQSVNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGCGATAGGACGGACAGGGGGCAGGAGCAAGTACTTCGGGCCG	CASGLAIGRTGGRSKYF	In	VDJ	2	66	1.4971961599186977E-4	1.9217386493671366E-4	51	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	0	11	9	7	26	42	62	51	69														CASGLAIGRTGGRSKYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAAGCAGCTAATCACCGGGGAGCTGTTTTTTGGAGAA	CASKQLITGELFF	In	VDJ	3	88	1.9962615465582637E-4	2.562318199156182E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-02	01	12	4	5	4	0	12	26	-1	34	31	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKQLITGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGAAACGGGTTTTGAAGCTTTCTTTGGACAA	CASGLETGFEAFF	In	VDJ	4	118	2.676805255612217E-4	3.435835767050335E-4	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	8	4	7	3	3	26	42	49	45	52						01,02								CASGLETGFEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCCTGACTAGCCCTTGTTGCCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	6	191	4.332794947643504E-4		47	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	12	2	7	6	9	9	26	31	47	40	56						01,02								X+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCCACACAGGCCTCAGCACCGGGGAGCTGTTTTTTGGAGAA	CASHTGLSTGELFF	In	VDJ	35	1032	0.0023410703591456	0.003004900433555886	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	12	3	4	4	7	6	26	31	43	38	49														CASHTGLSTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAGCCACGTTTGGTGCTGGAGGACTCAGCCTGTACTTCTGTGCCAGCTTGAGAGGACAGGAGGTGGGCGAAGCTTTCTTTGGACAA	CASLRGQEVGEAFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV13	TCRBV13-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	1	4	8	6	8	39	48	61	54	69													Vb 23	CASLRGQEVGEAFF+TCRBV13-01+TCRBJ01-01	TCRBV13-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGGGGAGGGGAGATACGAGCAGTACTTCGGGCCG	CASSQGEGRYEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	9	0	4	1	4	20	35	43	36	47														CASSQGEGRYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGGTCGGCTTGGGGGAGCTGTTTTTTGGAGAA	CASSLVGLGELFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	39	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-02	01	6	9	0	8	7	3	20	31	41	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGLGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCATACTATGAAGGGAAACATTCAGTACTTCGGCGCC	CASSHTMKGNIQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-04	01	6	5	3	6	11	0	20	31	-1	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHTMKGNIQYF+TCRBV23-01+TCRBJ02-04	TCRBV23-01*01		TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGTTAGGGGAAGAGACCCAGTACTTCGGGCCA	CASSLLGEETQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	5	2	3	6	0	20	31	-1	37	42														CASSLLGEETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTTTTAGGGGGGGGCTATACGAGCAGTACTTCGGGCCG	CASSFRGGLYEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	9	0	4	4	4	20	32	43	36	47														CASSFRGGLYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACACGGCACTGTATCTCTGCGCCAGCAGCCAAGACAGGGTAGCGGGAGGGCCTGCTAAGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQDRVAGGPAKSYNEQFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	63	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	5	0	1	7	9	18	33	51	40	60														CASSQDRVAGGPAKSYNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAACGAAAAGGGCCACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	3.175870642251783E-5		44	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-07	01	2	5	3	2	5	3	20	35	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGGCCGAGGGGGGGACCCAGTACTTCGGGCCA	CASSLAEGGTQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	39	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-05	01	6	5	1	7	8	1	20	31	45	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAEGGTQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATTCCGCAGACAACACTGAAGCTTTCTTTGGACAA	CASSQDSADNTEAFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	2	2	7	2	9	0	20	35	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDSADNTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCTGGACACCGAGGGGACCCAGTACTTCGGGCCA	CASSLDTEGTQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	39	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-05	01	6	1	6	7	3	7	20	31	39	34	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDTEGTQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACTTATCCCCGGGGGTACCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQLIPGGTGANVLTF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	54	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	2	8	2	4	8	4	20	35	49	43	53														CASSQLIPGGTGANVLTF+TCRBV23-01+TCRBJ02-06	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGAACCGGACCTCCGGGACCTGAAGCTTTCTTTGGACAA	CARTGPPGPEAFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	39	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	9	0	7	6	12	0	20	28	-1	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CARTGPPGPEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGGGGCGGGGACAGGGGGATTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	4.7638059633776745E-5		47	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	1	1	5	2	20	31	47	36	49														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCACACTGAGGGGGTAGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	22	4.990653866395659E-5		41	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	5	1	6	5	3	20	30	41	35	44														X+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGGACTAGCGGGAGGGCCTTGCATAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	25	5.671197575449612E-5		49	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	2	0	4	0	8	20	-1	45	31	53														X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCAGCCAGCGGTTATAACAATGAGCAGTTCTTCGGGCCA	CASSQSASGYNNEQFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	6	5	5	4	5	20	37	46	41	51						01,02								CASSQSASGYNNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCATCGATGACAGGGGGGCTGAAAAACTGTTTTTTGGCAGT	CASIDDRGAEKLFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	2	1	7	5	2	20	30	44	35	46														CASIDDRGAEKLFF+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACACGGCACTGTATCTCTGCGCCAGCCCTCCGTGGGGACATCAATCCTTACGGACCTCGGGGTTCTACGAGCAGTACTTCGGGCCG	CASPPWGHQSLRTSGFYEQYF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	63	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	6	3	8	24	18	27	41	35	65														CASPPWGHQSLRTSGFYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCTAGGCACTGGAAACACCATATATTTTGGAGAG	CASSLGTGNTIYF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	4	8	2	1	3	20	31	36	32	39						01,02								CASSLGTGNTIYF+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01	TCRBD02-01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCCCGGACGGCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	31	7.032284993557519E-5		46	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	0	1	7	0	2	3	20	37	43	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGTGGCGGGCCTCGGGGGGTGATACGCAGTATTTTGGCCCA	CASSQSWRASGGDTQYF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	51	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	1	6	11	1	20	37	55	48	56														CASSQSWRASGGDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCCCGTGGAGGGGCCGGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSPRGGAGENTEAFF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	51	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	0	1	7	8	20	31	44	38	52														CASSPRGGAGENTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCTCTACCCGGGACGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	35	7.939676605629458E-5		46	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-02	01	4	0	7	0	7	1	20	33	45	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCACCACTTTCAACCTCCTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	36	8.166524508647442E-5		44	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	3	10	1	2	11	20	30	35	32	46						01,02								X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGACTAGGGACGGTTTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	37	8.393372411665426E-5		43	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-04	01	6	0	7	4	4	4	20	31	40	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGAGACCCTACATGGCGATACGCAGTATTTTGGCCCA	CASSQETLHGDTQYF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	45	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-03	01	2	2	7	6	2	10	20	35	40	37	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQETLHGDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCTCCGGTGAGAGGCCAGGGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLR*EARENTGELFF	Stop	VDJ	2	45	1.0208155635809302E-4		54	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	3	1	15	1	20	31	51	46	52														CASSLR*EARENTGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCGGAGGGTAGCCCGAGATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	46	1.0435003538827287E-4		40	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	11	10	0	4	0	10	20	-1	32	26	42														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCGCGCCCCGAAGCTAGCGGGAGGGCAGATACGCAGTATTTTGGCCCA	CASSPRPEASGRADTQYF	In	VDJ	2	50	1.1342395150899225E-4	1.4558626131569216E-4	54	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	4	0	4	14	0	20	31	-1	45	57														CASSPRPEASGRADTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCAGGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	55	1.2476634665989147E-4		43	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	2	0	0	2	20	-1	39	33	41														X+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACCTTTAGAGCCCAAGAGCACAGATACGCAGTATTTTGGCCCA	CASSQPLEPKSTDTQYF	In	VDJ	3	83	1.8828375950492713E-4	2.4167319378404898E-4	51	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	5	8	0	4	8	20	35	42	39	50						01,02								CASSQPLEPKSTDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCGGTTTGGGGGGGTAGCCCCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASGLGG*PLSGANVLTF	Stop	VDJ	3	95	2.1550550786708528E-4		54	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	8	9	0	0	5	8	20	29	41	34	49														CASGLGG*PLSGANVLTF+TCRBV23-01+TCRBJ02-06	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGGAAGGAGGTATAGGTGGGGCCAAACACAGATACGCAGTATTTTGGCCCA	CASRKEV*VGPNTDTQYF	Stop	VDJ	5	136	3.0851314810445893E-4		54	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-03	01	6	7	0	2	15	4	20	31	51	46	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRKEV*VGPNTDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTTCTTTACCCTGACAGGGGTTGGACAACACCATATATTTTGGAGAG	CASSSLP*QGLDNTIYF	Stop	VDJ	5	161	3.6522512385895505E-4		51	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	2	7	10	6	20	32	50	42	56														CASSSLP*QGLDNTIYF+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCACAGGGGGGAAGGGGGACTAGCGGAGAGGGATTTCCTACGAGCAGTACTTCGGGCCG	CASTGGKGD*RRGISYEQYF	Stop	VDJ	6	192	4.3554797379453025E-4		60	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	5	1	12	9	20	30	53	42	62						01,02								CASTGGKGD*RRGISYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCAGGACAGACCCCCCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	9	264	5.988784639674791E-4		50	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	5	2	2	6	20	33	41	35	47														X+TCRBV23-01+TCRBJ02-06	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCGAGGGGCCCCGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	13	380	8.620220314683411E-4		41	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-05	01	4	5	2	4	1	6	20	33	39	34	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACACGGCACTGTATCTCTGCGCCAGCGGACCAAGAAGCCTCGGGAAAGACCCAGTACTTCGGGCCA		Out	VDJ	29	856	0.0019418180498339474		43	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	8	3	6	14	1	20	29	48	43	49														X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTATCTTTATTCCGGAAACACCATATATTTTGGAGAG	CASSYLYSGNTIYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	4	9	4	0	10	23	-1	37	34	47						01,02								CASSYLYSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACACCGACCCTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSTPTLSSYNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	2	7	0	5	6	23	35	43	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTPTLSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCAGGGAGGGGAGGGCACAGATACGCAGTATTTTGGCCCA	CASSPQGGEGTDTQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	9	0	1	5	4	23	35	47	40	51														CASSPQGGEGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCGACCTACGGGCGGGGGCACTGGTGTACTTCGGGCCG		Out	VDJ	1	9	2.0416311271618604E-5		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	2	12	13	7	23	35	55	48	62														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCAAGAGACAGCTGAAGCTTTCTTTGGACAA	CASSDQETAEAFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	6	8	0	23	35	-1	43	48														CASSDQETAEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCAATCAGGGGGTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	9	2.0416311271618604E-5		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	1	2	5	1	23	38	50	43	51														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGACAGGGCATATGGTTACACCTTCGGTTCG	CASSYSDRAYGYTF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	11	0	8	23	-1	48	40	56														CASSYSDRAYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGGAAACCCCCGCCTAACAGGGAGGAAGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSGNPRLTGRKDTGELFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	60	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	6	3	3	3	16	7	21	32	54	48	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGNPRLTGRKDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAATCGTCCGAGACAGGATACAATCAGCCCCAGCATTTTGGTGAT	CASKSSETGYNQPQHF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	4	3	10	3	23	33	49	43	52														CASKSSETGYNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACCAAAGACAGGGGGCAGGGAACACTGAAGCTTTCTTTGGACAA	CASNQRQGAGNTEAFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	0	1	6	3	23	33	49	39	52														CASNQRQGAGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCACCGGGGGGGCGGCTCTCCTATGGCTACACCTTCGGTTCG	CASRPPGGRLSYGYTF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	0	4	5	8	23	34	47	39	55														CASRPPGGRLSYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGGACAGGGAGGCCCCGAGCAGTACTTCGGGCCG	CASSPGQGGPEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	3	6	4	6	23	34	46	38	52														CASSPGQGGPEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGACTAGCGTTTACGAGCAGTACTTCGGGCCG	CASSPTSVYEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	6	4	2	2	23	35	45	37	47						01,02								CASSPTSVYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTCGGGCAGGTTGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVGQVGSGANVLTF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	5	4	4	0	6	4	23	35	45	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGQVGSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGAATCTCTGGAAACACCATATATTTTGGAGAG	CASSYGISGNTIYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	2	1	8	0	0	2	23	-1	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGISGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTGGTAGCCAAACAAGAGACCCAGTACTTCGGGCCA	CASSYVVAKQETQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	5	7	2	4	4	23	38	46	42	50						01,02								CASSYVVAKQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAAGTTCCCGTCAGCCCCAGCATTTTGGTGAT	CASSYSSSRQPQHF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	0	5	5	6	1	6	23	40	43	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSSSRQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAGCAGGGGCCTCAGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYSAGASGSNQPQHF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	2	1	2	8	23	40	48	42	56														CASSYSAGASGSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGAAGGGAACACTGAAGCTTTCTTTGGACAA	CASSYSEGNTEAFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	1	8	1	0	3	23	-1	43	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSEGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTAGGGTGCCCGAGACCCAGTACTTCGGGCCA	CASSFRVPETQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	4	5	3	5	2	5	23	36	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRVPETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTTCGCGGGAGGCGTCAGAGACCCAGTACTTCGGGCCA	CAISSREASETQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	7	1	4	1	4	23	36	45	37	49														CAISSREASETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTGGCAAGCCACGTTTGGTGCCCTCCCAGACATTGTGTACTTGTGTGCCAGAAAACTAGCGTACCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	10	2.2684790301798452E-5		38	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	3	6	6	3	3	43	51	61	54	64						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTTCTAGTGGGGCCTATGGCTACACCTTCGGTTCG	CASTSSGAYGYTF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	7	0	4	8	0	23	33	-1	41	46														CASTSSGAYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAGGTGGCCAGCGCCCTTGGCCAGCCCCAGCATTTTGGTGAT	CASSEVASALGQPQHF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	6	6	7	10	8	23	34	48	44	56						01,02								CASSEVASALGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTGGAGTCCGAGCAGTACTTCGGGCCG	CASSYVESEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	10	2	6	2	2	23	38	44	40	46														CASSYVESEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGCGGCACCACAGATACGCAGTATTTTGGCCCA	CASSYSGGTTDTQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	7	5	2	2	3	23	40	46	42	49						01,02								CASSYSGGTTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGGCATAGTCAAGAGACCCAGTACTTCGGGCCA	CASSYSRHSQETQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	11	1	2	0	6	23	-1	44	40	50														CASSYSRHSQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTTAACAGGGGGCGAATATGGCTACACCTTCGGTTCG	CASSYSLTGGEYGYTF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	0	5	4	3	23	40	53	44	56														CASSYSLTGGEYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGGGACAGGGACCCTACGAGCAGTACTTCGGGCCG	CASSSGQGPYEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	2	1	2	23	36	46	37	48														CASSSGQGPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAAGCAGCCAGAATCAGCCCCAGCATTTTGGTGAT	CASSLSSQNQPQHF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	4	4	5	4	4	4	23	36	43	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSSQNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTACAGGGGAACTATGGCTACACCTTCGGTTCG	CASSLQGNYGYTF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	2	2	1	0	23	36	-1	37	44														CASSLQGNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGTTCTACGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASVLRSYNEQFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	4	9	0	3	2	23	32	38	35	40						01,02								CASVLRSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCGACCCGGGACGGGGGTCCTCCGAGCAGTACTTCGGGCCG	CAISDPGRGSSEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	2	6	10	5	23	34	50	44	55														CAISDPGRGSSEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGGGGTAGCACAAATACGCAGTATTTTGGCCCA	CAISGGSTNTQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	5	6	1	7	0	8	23	-1	40	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISGGSTNTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCTAGAAAACTAGCGTACCTGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	11	2.4953269331978296E-5		38	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	12	3	6	8	6	5	23	28	41	34	46						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAACTGGCTACCCTTTCCTACAATGAGCAGTTCTTCGGGCCA	CASKLATLSYNEQFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	7	9	0	1	4	7	23	33	40	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKLATLSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCAGGGGGAAGTAGGAACATTCAGTACTTCGGCGCC	CASTPGGSRNIQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	4	1	7	3	7	23	33	43	36	50														CASTPGGSRNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACAGGTAAGGTGGGGTCGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	2.722174836215814E-5		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	4	2	0	13	23	-1	41	35	54														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCGGTTCAGGGGGCCGATCAGCCCCAGCATTTTGGTGAT	CASSAVQGADQPQHF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	0	5	6	2	23	35	49	41	51														CASSAVQGADQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGCTATCYCTAGCGGGACATCTACGAGCAGTACTTCGGGCCG	CASSYRYX*RDIYEQYF	Stop	VDJ	1	12	2.722174836215814E-5		51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	4	3	3	8	3	23	38	55	46	58														CASSYRYX*RDIYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTGGAGGGCCCTGTCTATGGCTACACCTTCGGTTCG	CASSYLEGPVYGYTF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	10	0	4	1	6	23	39	46	40	52														CASSYLEGPVYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCTTAGCGGGAGTCACAGATACGCAGTATTTTGGCCCA	CASSSLAGVTDTQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	5	2	2	3	1	23	36	48	39	49														CASSSLAGVTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGCAAGCCACGTTTGGTGCCCTCCCAGRACATCTGTGTACTTGTGTGCCAGAAAACTAGCGTACCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	12	2.722174836215814E-5		38	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	3	6	6	3	3	43	51	61	54	64						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTCTAGCCGCTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTLAASSYNEQFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	4	7	0	2	6	23	33	40	35	46						01,02								CASTLAASSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGTCGACAGGGGGCATCAGCCCCAGCATTTTGGTGAT	CASRVDRGHQPQHF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	0	5	4	0	23	34	-1	38	48														CASRVDRGHQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCTCGGAGGGGTAGTCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	2.9490227392337985E-5		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	0	0	2	6	23	40	48	42	54														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTACCCCAACGGGAGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	2.9490227392337985E-5		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	8	2	4	7	0	23	39	-1	46	52														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCAGACATCTGTGTACTTGTGTGCCAGCAGTGATTTAGGGTGAGGCGGCCAGGGATCCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	14	3.175870642251783E-5		62	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	4	3	0	18	5	19	31	54	49	59														X+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAGACTAGCGGGGATACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	3.175870642251783E-5		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	2	2	3	23	34	47	36	50														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAGGGGAGCCCAAGAGACCCAGTACTTCGGGCCA	CASSRGAQETQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	2	1	0	3	23	-1	40	34	43														CASSRGAQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGTTGGCTACTGTGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	3.175870642251783E-5		41	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	9	0	4	3	7	23	35	41	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTGGCAAGCCACGTTTGGTGCCCTCCCGACATCTGTGTACTTGTGTGCCAGAAAACTAGCGTACCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	14	3.175870642251783E-5		38	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	3	6	6	3	3	43	51	61	54	64						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGCCAGACAGGGGACGCACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	3.402718545269768E-5		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	2	2	5	5	23	34	47	39	52														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGATCCCCAGCCGACGAGCACAGATATGCAGTATTTTGGCCCA		Out	VDJ	1	15	3.402718545269768E-5		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	5	11	19	4	23	35	58	54	62														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCAGGGGGCAGCGGCACAGATACGCAGTATTTTGGCCCA	CASSPGGSGTDTQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	0	1	1	4	23	35	44	36	48														CASSPGGSGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGAGCGGGGACAGGGGCCTACGAGCAGTACTTCGGGCCG	CASSPGAGTGAYEQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	2	9	0	23	35	-1	44	54														CASSPGAGTGAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCGCGTCTCTAGCGGGAGGGGAGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	15	3.402718545269768E-5		53	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	4	0	8	8	4	23	38	58	46	62														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCCGGATTAGCTGAAAAACTGTTTTTTGGCAGT	CASSYAGLAEKLFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	5	7	7	7	0	23	38	-1	45	49						01,02								CASSYAGLAEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGTGCGGGATCTCTCCTACGAGCAGTACTTCGGGCCG	CASSYSVRDLSYEQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	3	0	3	3	23	40	49	43	52														CASSYSVRDLSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCTCTGTGGGCCACAATGAGCAGTTCTTCGGGCCA	CASSSSVGHNEQFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	8	0	5	3	1	23	40	47	43	48														CASSSSVGHNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAGGGGGGACAGGTCCAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLGGTGPSSYEQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	4	0	5	6	23	36	49	41	55														CASSLGGTGPSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTACCAGCAGCCGGGACCGCCGGAGGTACGAGCAGTACTTCGGGCCG	CTSSRDRRRYEQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	0	7	4	2	9	23	34	41	36	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSSRDRRRYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTCAGGGGTTAGGGCCAGATACGCAGTATTTTGGCCCA	CASSPQGLGPDTQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	4	3	7	23	35	44	38	51														CASSPQGLGPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGACAGACGATCAAGAGACCCAGTACTTCGGGCCA	CASSYGTDDQETQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	5	2	0	5	23	-1	45	38	50														CASSYGTDDQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATACCCCCATAGGGTACGAGCAGTACTTCGGGCCG	CASSYTPIGYEQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	3	5	3	4	9	0	23	37	-1	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYTPIGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGGGACGGTCTACGAGCAGTACTTCGGGCCG	CASSSGTVYEQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	4	0	7	3	2	3	23	36	43	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGTVYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTGGCTACCCAGCTGAAGCTTTCTTTGGACAA	CASIGYPAEAFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	7	4	5	6	9	0	23	33	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIGYPAEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCTTAGGATCGCTCAGCAGGGGTCTCACGAGCAGTACTTCGGGCCG	CASLRIAQQGSHEQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	4	2	5	15	4	23	32	53	47	57														CASLRIAQQGSHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGGGAGGGACACCCGGGGAGCTGTTTTTTGGAGAA	CASKGGTPGELFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	9	0	6	1	4	23	33	41	34	45														CASKGGTPGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCACGGCGCTAGCCGCTCCTACGAGCAGTACTTCGGGCCG	CASSHGASRSYEQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	7	0	8	2	23	34	47	42	49						01,02								CASSHGASRSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGATAATGAACACTGAAGCTTTCTTTGGACAA	CASRIMNTEAFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	2	8	0	0	3	23	-1	36	34	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRIMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGGCAGATTCCTATGGCTACACCTTCGGTTCG	CASSVADSYGYTF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	5	4	4	4	23	35	42	39	46														CASSVADSYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGGGGCCTTGGGGTGTCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	17	3.8564143513057367E-5		49	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	2	7	0	2	1	10	23	38	44	39	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTTATGGGGGCACTCGAGCAGTACTTCGGGCCG	CASSYLMGALEQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	6	0	6	5	3	23	38	49	43	52														CASSYLMGALEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAGTAGGGGGCCATGAGCAGTTCTTCGGGCCA	CASSYSVGGHEQFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	5	0	8	3	1	23	40	50	43	51														CASSYSVGGHEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTGCGGGATTGAACGAGCAGTACTTCGGGCCG	CASSYSAGLNEQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	3	5	1	4	23	40	47	41	51														CASSYSAGLNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTGTAGCGGACCTCGATAGCACAGATACGCAGTATTTTGGCCCA	CASSYSVADLDSTDTQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	5	5	0	2	8	23	40	48	42	56						01,02								CASSYSVADLDSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCCCAGAGGGGCTGGAGATACGCAGTATTTTGGCCCA	CASSSPRGAGDTQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	4	5	2	5	7	4	23	36	48	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPRGAGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGCCAGGGGGTGGCTACACCTTCGGTTCG	CASSWPGGGYTF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	1	7	3	0	23	36	-1	39	46														CASSWPGGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTCGGGCAGGGCCTCACTATGGCTACACCTTCGGTTCG	CASRAGPHYGYTF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	4	3	3	5	4	23	31	41	36	45														CASRAGPHYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACGGACAGCGGGACTAACTATGGCTACACCTTCGGTTCG	CAITDSGTNYGYTF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	10	6	3	0	8	0	23	30	-1	38	45														CAITDSGTNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCAGAATTCAAATGAAAAACTGTTTTTTGGCAGT	CAISQNSNEKLFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	5	5	1	6	23	34	38	35	44														CAISQNSNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGGGACAGGGGGTCTCCAATGAGCAGTTCTTCGGGCCA	CASTGQGVSNEQFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	1	6	1	4	23	33	45	34	49														CASTGQGVSNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTACAGGGTTGGAATCAGCCCCAGCATTTTGGTGAT	CASSLQGWNQPQHF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	4	3	4	23	34	43	37	47														CASSLQGWNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGATCCGGCACCCCGACCAGCCCCAGCATTTTGGTGAT	CASSDSIRHPDQPQHF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	0	2	7	7	13	0	23	40	-1	53	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSIRHPDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACAGGTTGAGGGTCCATGAGCAGTTCTTCGGGCCA	CASSYDRLRVHEQFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	4	8	0	10	23	-1	44	38	54														CASSYDRLRVHEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGGGTTAAAGAACACTGAAGCTTTCTTTGGACAA	CASSYGLKNTEAFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	3	0	9	1	1	5	23	37	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGLKNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCAGGGAAGGGCACAGATACGCAGTATTTTGGCCCA	CASSSGKGTDTQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	3	1	0	4	23	-1	41	36	45														CASSSGKGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTGATCCTAGCGGGTATAACAATGAGCAGTTCTTCGGGCCA	CASSFDPSGYNNEQFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	4	5	6	4	23	36	50	42	54						01,02								CASSFDPSGYNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCCAACCTAGCGGGAGCCCCTAGGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	4.083262254323721E-5		55	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	4	2	0	6	8	23	32	48	38	56														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTGGCAAGCCACGTTTGGTGCCCTCCCAGAATCTGTGTACTTGTGTGCCAGAAAACTAGCGTACCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	18	4.083262254323721E-5		38	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	3	6	6	3	3	43	51	61	54	64						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCACCGGGACAGGGGACCAAGCTTTCTTTGGACAA	CASSPTGTGDQAFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	9	7	3	23	34	51	41	54														CASSPTGTGDQAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTACCGGGACCCTCAGGAATGAGCAGTTCTTCGGGCCA	CASSYSTGTLRNEQFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	0	0	7	7	4	7	23	40	49	44	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSTGTLRNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAGAGGGTGGGGAACACTGAAGCTTTCTTTGGACAA	CASS*RVGNTEAFF	Stop	VDJ	1	19	4.3101101573417056E-5		42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	11	0	1	0	4	23	-1	42	37	46														CASS*RVGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAGTACAGGGGGCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	19	4.3101101573417056E-5		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	0	1	2	0	23	37	-1	39	48														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGAGGGCGGTGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSYEGGGAKNIQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	11	0	1	1	7	23	37	43	38	50														CASSYEGGGAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGAGACAGGCCGATCAGCCCCAGCATTTTGGTGAT	CASSWRQADQPQHF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	4	5	3	3	23	36	45	39	48														CASSWRQADQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGATCCTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASGILSYNEQFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	8	0	8	0	0	4	23	-1	36	32	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGILSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTAGTTACTCGGAGGAGTGGGAGACCCAGTACTTCGGGCCA	CASSYSEEWETQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	10	1	5	0	5	23	-1	45	40	50														CASSYSEEWETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACAGGACAGAAGTTTTACACAGATACGCAGTATTTTGGCCCA	CASSTGQKFYTDTQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	5	2	3	8	23	35	44	38	52														CASSTGQKFYTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGACAGGACACAGATACGCAGTATTTTGGCCCA	CASSDGQDTDTQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	4	2	3	1	23	35	45	38	46														CASSDGQDTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACGGGGTACACTGAAGCTTTCTTTGGACAA	CASSYTGYTEAFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	3	3	1	1	23	38	44	39	45														CASSYTGYTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCCGGGACTAGCCCTCGTAGATACGCAGTATTTTGGCCCA	CASSYSPGLALVDTQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	7	5	3	6	23	40	52	43	58						01,02								CASSYSPGLALVDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCAGGGTGGAAACTATGGCTACACCTTCGGTTCG	CASSYQGGNYGYTF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	2	1	4	23	37	43	38	47														CASSYQGGNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACCCAGGGTGCGGGTTAYGACAATGAGCAGTTCTTCGGGCCA	CAITQGAGYDNEQFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	10	4	3	5	5	11	23	30	40	35	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAITQGAGYDNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCAAAAATTGAGACAGGAAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	4.7638059633776745E-5		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	1	11	2	23	34	51	45	53														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCTACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSDLQGNTEAFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	3	1	5	0	23	35	-1	40	46														CASSDLQGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGGCGGGCACTGAAGCTTTCTTTGGACAA	CASSLAGTEAFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	7	4	4	2	0	23	36	-1	38	43						01,02								CASSLAGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCCCGTCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSRLAKNIQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	8	4	10	0	6	0	23	32	-1	38	40						01,02								CASSRLAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCTCGGGACAGACTTATGAAGCTTTCTTTGGACAA	CAISGQTYEAFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	0	5	7	4	5	23	30	41	34	46														CAISGQTYEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAAGCCGAGGGCCCAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRKPRAQNTGELFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	11	0	1	6	4	23	34	45	40	49														CASRKPRAQNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCAGGTGCGTCTCGTTGGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	22	4.990653866395659E-5		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	4	6	1	13	23	35	40	36	53														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACATGTCCCAGGGGGGGAGAAACTATGGCTACACCTTCGGTTCG	CASSYMSQGGRNYGYTF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	51	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	4	1	2	6	5	23	38	51	44	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYMSQGGRNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGATGGCCTGGACAGAAGCTTTCTTTGGACAA	CASSYSMAWTEAFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	6	8	8	0	23	40	-1	48	53														CASSYSMAWTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCCGGCAGGGGGCGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYSPAGGAGANVLTF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	4	0	2	5	1	23	40	53	45	54														CASSYSPAGGAGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGAGACACCAGCCGAAAAGCAGTACTTCGGGCCA	CASSYSETPAEKQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	0	2	6	11	3	12	23	40	47	43	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSETPAEKQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGAGGGGGCGGAAAAACTGTTTTTTGGCAGT	CASSYSEGAEKLFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	5	0	8	2	1	23	40	49	42	50														CASSYSEGAEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTATCGAGCAAACGGGCCTACGAGCAGTACTTCGGGCCG	CASSLSSKRAYEQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	8	4	2	11	0	23	36	-1	47	51						01,02								CASSLSSKRAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTCATGGGGGACGGCAAGAGACCCAGTACTTCGGGCCA	CASSVHGGRQETQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	0	7	2	8	2	23	35	48	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVHGGRQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGGACTAGCGGGTACACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	23	5.2175017694136434E-5		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	1	4	0	1	3	23	38	50	39	53						01,02								X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCATCCCGCTACGAGCAGTACTTCGGGCCG	CASSYSSRYEQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	8	6	3	4	0	23	40	-1	44	46						01,02								CASSYSSRYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTRCCCTGACTAGCGGGAGTGTAGGGAGACCCAGTACTTCGGGCCA	CASSXPD*RECRETQYF	Stop	VDJ	1	23	5.2175017694136434E-5		51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	2	2	5	5	6	23	36	53	41	59														CASSXPD*RECRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCAGACAGGACAACGTCCTGACTTTCGGGGCC	CASSFRQDNVLTF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	2	4	9	3	1	23	36	45	39	46														CASSFRQDNVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAACGACCTGGCTAGCGGGAGAGAGACCCAGTACTTCGGGCCA	CASSNDLASGRETQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	4	2	4	11	0	23	34	-1	45	55														CASSNDLASGRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAGGACAGGGGGCGCGAGCAGTACTTCGGGCCG	CASSQDRGREQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	0	6	2	1	23	35	48	37	49														CASSQDRGREQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGGCAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSYRATSTDTQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	2	5	3	0	0	5	23	-1	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRATSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCCCCCAGGGGCTTGGGGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	24	5.444349672431628E-5		52	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	2	2	6	7	23	38	50	44	57														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTCCGGTGACACTGAAGCTTTCTTTGGACAA	CASSYSSGDTEAFF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	5	3	3	2	23	40	46	43	48						01,02								CASSYSSGDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGGGGCAGGGGAGTTACGAGCAGTACTTCGGGCCG	CASSWGQGSYEQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	4	5	3	23	36	47	41	50														CASSWGQGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATACGCTCCGGGGACAGTGGTGAAAAACTGTTTTTTGGCAGT	CASIRSGDSGEKLFF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	5	7	9	3	23	33	49	42	52														CASIRSGDSGEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCTCATCGGTGGATAGCGGGAGAGGAGAGTTCTTCGGGCCA	CASSVDSGRGEFF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	11	5	2	14	11	5	23	29	49	40	54														CASSVDSGRGEFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCGACAGGGTCTAACTATGGCTACACCTTCGGTTCG	CASTPTGSNYGYTF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	3	0	4	1	23	33	44	37	45														CASTPTGSNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTATCAAGGCATCTCCTACGAGCAGTACTTCGGGCCG	CASRYQGISYEQYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	5	4	0	6	3	23	34	43	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRYQGISYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTGACAGGGAATTATGGCTACACCTTCGGTTCG	CASSLTGNYGYTF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	5	2	3	23	35	44	37	47														CASSLTGNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGAAGGGTTCAGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVKGSGANVLTF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	5	5	3	4	4	4	23	35	43	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVKGSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGAGCTACCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	5.671197575449612E-5		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	10	2	2	0	5	23	-1	42	38	47														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTGGTTAATGAACACTGAAGCTTTCTTTGGACAA	CASSYSWLMNTEAFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	0	10	0	2	4	23	40	44	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSWLMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCCCATGGACTAGTCACAGATACGCAGTATTTTGGCCCA	CASTPHGLVTDTQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	1	8	2	8	1	23	33	48	41	49						01,02								CASTPHGLVTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCTCCTGGGCGGGACGCACTAGCACAGATACGCAGTATTTTGGCCCA	CASTSWAGRTSTDTQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	7	3	0	8	6	23	33	47	41	53														CASTSWAGRTSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTCCGTGGAGGGGTCACTGCTAACTATGGCTACACCTTCGGTTCG	CASSLRGGVTANYGYTF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	10	0	0	6	7	23	35	47	41	54														CASSLRGGVTANYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGCAGGGGATCTCCAAGAGACCCAGTACTTCGGGCCA	CASSYGAGDLQETQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	2	1	4	4	23	38	48	42	52														CASSYGAGDLQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGGTCAGGGACGAACACTGGGGAGCTGTTTTTTGGAGAA	CASSYWSGTNTGELFF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	1	0	7	8	5	7	23	39	49	44	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYWSGTNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCGTCGGGACAGAACTAACAATGAGGGCAGTTCTTCGGGCCA		Out	VDJ	1	26	5.898045478467597E-5		50	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	5	12	6	14	23	36	49	42	63														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCACCCGGACTCCGGGTTAATCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	27	6.124893381485581E-5		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	1	10	7	6	10	23	33	44	39	54						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGACAGGGGGAGGGTGAGACCCAGTACTTCGGGCCA	CASSYRQGEGETQYF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	2	1	5	1	5	23	38	48	39	53														CASSYRQGEGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTGGGGGCCATATCCCCACTGAAGCTTTCTTTGGACAA	CASGGHIPTEAFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	6	0	4	1	8	23	31	38	32	46														CASGGHIPTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAGGGCTAGCGGCCTACAATGAGCAGTTCTTCGGGCCA	CASKGLAAYNEQFF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	4	5	2	5	0	23	33	-1	38	45						01,02								CASKGLAAYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACCCACCCGGCGAGGGTTCCTATGGCTACACCTTCGGTTCG	CASNPPGEGSYGYTF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	11	0	4	11	3	23	33	49	44	52														CASNPPGEGSYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGCGGGAGAGGGGAATACGCAGTATTTTGGCCCA	CASTAGEGNTQYF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	7	2	7	2	6	23	33	42	35	48														CASTAGEGNTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCATAGCGGGTTACAATGAGCAGTTCTTCGGGCCA	CASSIAGYNEQFF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	5	4	4	2	1	23	34	43	36	44						01,02								CASSIAGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTCAGGGGCGACTGAAGCTTTCTTTGGACAA	CASRSGATEAFF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	5	2	2	23	34	42	36	44														CASRSGATEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCAAAGACTAGCGGGGGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	28	6.351741284503566E-5		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	2	2	3	4	1	23	40	56	44	57														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTACGGCAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYSYGNSGANVLTF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	0	9	0	0	4	2	23	40	47	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSYGNSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGGGGTCGAGAGCCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	29	6.578589187521551E-5		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	8	3	0	1	8	23	30	36	31	44														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACCGAGCGGGAGCCAAAAACATTCAGTACTTCGGCGCC	CASNRAGAKNIQYF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	7	6	4	0	4	0	23	33	-1	37	43						01,02								CASNRAGAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAAAACAACTACGTGGGTGCCTCAGCATTTTGGTGAT	CASRKTTTWVPQHF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	3	9	13	7	11	23	34	45	41	56						01,02								CASRKTTTWVPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTTTACAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYSLQGNTGELFF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	3	3	1	3	0	23	40	-1	43	49														CASSYSLQGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTATAGTGGGCCAGGGAGGGAAGGTGAGCACAGATACGCAGTATTTTGGCCCA	CASIVGQGGKVSTDTQYF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	9	9	0	0	12	6	23	31	50	43	56														CASIVGQGGKVSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACATCCACTGGACTGGGGTCATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	30	6.805437090539536E-5		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	10	8	10	6	23	34	49	44	55						01,02								X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGAGGCGGAACTAACCCCTACGAGCAGTACTTCGGGCCG	CASSGGGTNPYEQYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	1	2	0	11	23	-1	40	35	51														CASSGGGTNPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACAGGGGGTGTGGGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYTGGVGNTGELFF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	3	1	2	0	7	23	-1	46	38	53														CASSYTGGVGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGGAGGGGGCAAAAACATTCAGTACTTCGGCGCC	CASSYGGGGKNIQYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	2	9	0	3	2	2	23	38	47	40	49														CASSYGGGGKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGAGCTAGCTCTGGAAACACCATATATTTTGGAGAG	CASSYSGASSGNTIYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	9	2	0	0	4	23	-1	45	40	49														CASSYSGASSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCCACCCCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRPTPTNEKLFF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	6	3	7	0	0	6	23	-1	36	34	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPTPTNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTACTCAGGGGATACGCAGTATTTTGGCCCA	CASRYSGDTQYF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	5	3	6	0	0	23	-1	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRYSGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAAAGGCGGGAGGTTCTGAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	31	7.032284993557519E-5		52	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	7	1	0	3	5	23	37	48	40	53														X+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTAAGAACGAATGAGCAGTTCTTCGGGCCA	CASSYLRTNEQFF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	1	2	8	7	3	3	23	39	44	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLRTNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACAAAAGGCCTACTAGCGGGGGCCCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	32	7.259132896575504E-5		55	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	3	2	2	11	3	23	33	55	44	58														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTCTCGGGGCAGGGGCTTACAATGAGCAGTTCTTCGGGCCA	CASTLGAGAYNEQFF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	2	4	9	2	23	33	48	42	50														CASTLGAGAYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCGTACAATGAAAAACTGTTTTTTGGCAGT	CASRPYNEKLFF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	6	3	7	5	0	5	23	-1	36	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPYNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCTAACGGGAACATTTAGCACAGATACGCAGTATTTTGGCCCA	CASLTGTFSTDTQYF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	8	3	0	4	6	23	32	41	36	47														CASLTGTFSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGACGGGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASGRGGNTEAFF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	8	8	0	1	3	0	23	32	-1	35	43														CASGRGGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAAGTCGGGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSEVGSSGNTIYF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	8	2	0	6	0	23	34	-1	40	46														CASSEVGSSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCGGACAGGGCGGAATCAGCCCCAGCATTTTGGTGAT	CASRRTGRNQPQHF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	3	4	2	3	23	34	44	36	47														CASRRTGRNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGGACAGTTCTGGTTACGAGCAGTACTTCGGGCCG	CASSRDSSGYEQYF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	4	1	7	23	35	43	36	50														CASSRDSSGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTCCGGAGGACACCTCTTGGAGCAGTACTTCGGGCCG		Out	VDJ	1	33	7.485980799593489E-5		43	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	1	6	7	7	7	23	35	47	42	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGGGCCGGGACACCTACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	34	7.712828702611473E-5		38	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	0	6	3	4	4	23	31	41	35	45														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGGGACTAGCGACAATTTACAATGAGCAGTTCTTCGGGCCA	CASKGLATIYNEQFF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	6	4	1	6	23	33	44	34	50						01,02								CASKGLATIYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGAGGCAGCGGCTCTGGAAACACCATATATTTTGGAGAG	CASSYSRGSGSGNTIYF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	0	6	5	0	7	0	23	40	-1	47	52						01,02								CASSYSRGSGSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCCCGATTCGATAGAGACTAGCGGGAGGGCCCCGGAGATCCAGTACTTCGGGCCA	CASPDSIETSGRAPEIQYF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	2	0	10	14	10	23	32	60	46	70														CASPDSIETSGRAPEIQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGGAGGGAATCAGCCCCAGCATTTTGGTGAT	CASSDSGGNQPQHF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	9	0	4	0	0	23	-1	-1	40	47														CASSDSGGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTGCGGGGGGTGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVAGGGSGANVLTF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	5	7	1	0	3	3	23	35	46	38	49														CASSVAGGGSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCTCCAAATCCCTAGCTGGGGGAAACATTCAGTACTTCGGCGCC	CASKSLAGGNIQYF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-04	01	11	6	1	6	15	0	23	29	-1	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKSLAGGNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01		TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATAAGACAAGGCGAGATCTATGGCTACACCTTCGGTTCG	CASSIRQGEIYGYTF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	6	4	4	9	23	35	43	39	52														CASSIRQGEIYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCGGGGCATAGATACGCAGTATTTTGGCCCA	CASSYSRGIDTQYF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	3	5	0	3	23	-1	46	40	49														CASSYSRGIDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGAGGCAGGCCGCCTACAATGAGCAGTTCTTCGGGCCA	CASSWRQAAYNEQFF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	10	1	2	0	7	23	-1	41	36	48														CASSWRQAAYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTCACAGGGAGGCAGCCCCAGCATTTTGGTGAT	CASSLTGRQPQHF	In	VDJ	1	38	8.620220314683411E-5	1.1064555859992605E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	5	3	3	7	3	3	23	35	44	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTGRQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGATGGAGGACACTGAAGCTTTCTTTGGACAA	CASSYGMEDTEAFF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	10	1	3	5	0	23	38	-1	43	48														CASSYGMEDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGGGACAGGGTGGGGGATGAAGCTTTCTTTGGACAA	CASSYRDRVGDEAFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	7	1	7	23	38	48	39	55														CASSYRDRVGDEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCTAGCAGTTCGCCGGGACTAGCGGCCATCGAGCAGTTCTTCGGGCCA	CASSSPGLAAIEQFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	5	10	4	5	23	36	51	40	56						01,02								CASSSPGLAAIEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGCACCCCTCAGCGGGCTACACCTTCGGTTCG	CASSSHPSAGYTF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	6	6	8	10	0	23	36	-1	46	50						01,02								CASSSHPSAGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCAGGGTTCAGTGAAAAACTGTTTTTTGGCAGT	CASSGFSEKLFF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	4	3	7	1	5	23	32	38	33	43														CASSGFSEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGCCGGGACATGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSRDMANTGELFF	In	VDJ	1	42	9.527611926755349E-5	1.222924595051814E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	6	0	4	3	23	35	45	39	48														CASSSRDMANTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCACATTGGGGGTCCCTCAGGGACTTCGGGCCG		Out	VDJ	1	43	9.754459829773334E-5		38	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	7	4	3	14	18	0	23	33	-1	51	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGGATGGACAGAACACTGAAGCTTTCTTTGGACAA	CASKDGQNTEAFF	In	VDJ	1	44	9.981307732791318E-5	1.281159099578091E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	1	6	1	5	0	23	33	-1	38	43														CASKDGQNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGGTGGGGGATTACAATCAGCCCCAGCATTTTGGTGAT	CASTVGDYNQPQHF	In	VDJ	1	44	9.981307732791318E-5	1.281159099578091E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	7	6	1	3	4	4	23	33	42	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTVGDYNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGGCGCGGGACAGCTCGGGGTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRRGTARGYSNQPQHF	In	VDJ	1	44	9.981307732791318E-5	1.281159099578091E-4	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	0	5	0	6	10	23	32	45	38	55														CASRRGTARGYSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACCTGACAGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASST*QYSNQPQHF	Stop	VDJ	2	45	1.0208155635809302E-4		45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	5	0	5	2	23	34	44	39	46														CASST*QYSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGCAGGGATCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYGAGISGANVLTF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	4	3	0	4	2	23	38	47	42	49														CASSYGAGISGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTGGGGGTGGCGGGAGCAGTTCTTCGGGCCA	CASRWGWREQFF	In	VDJ	2	46	1.0435003538827287E-4	1.3393936041043678E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	6	1	10	2	6	23	34	41	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRWGWREQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGAAAACTAGCGTACCCGGGGAGCTGTTTTTGGAGAA		Out	VDJ	2	47	1.0661851441845271E-4		37	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	3	6	18	3	14	23	31	41	34	55						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCGAAGATCCGGATGTCAATGAGCAGTTCTTCGGGCCA	CAISEDPDVNEQFF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	1	8	6	9	3	23	34	46	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISEDPDVNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGACGGGGAGTGGTGGTAGGGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	48	1.0888699344863256E-4		50	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	5	2	5	17	0	23	34	-1	51	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGCGGGGGCTATGGCTACACCTTCGGTTCG	CASSGGGYGYTF	In	VDJ	2	50	1.1342395150899225E-4	1.4558626131569216E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	7	2	4	1	0	23	35	-1	36	43														CASSGGGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCATCTAGCGGGGAATGAGCAGTTCTTCGGGCCA	CASSHLAGNEQFF	In	VDJ	2	51	1.1569243053917209E-4	1.48497986542006E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	7	4	0	23	34	-1	38	47														CASSHLAGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGCCCTGACTGGCCTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSCPDWPSNQPQHF	In	VDJ	2	52	1.1796090956935194E-4	1.5140971176831985E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	2	10	0	5	4	23	36	45	41	49						01,02								CASSCPDWPSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGTGGACAGGGGGCGGTCGGCGTCTACGAGCAGTACTTCGGGCCG	CASSSGQGAVGVYEQYF	In	VDJ	2	53	1.2022938859953179E-4	1.543214369946337E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	0	3	3	9	23	35	49	38	58														CASSSGQGAVGVYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGAAACTAGCGGGAGAGTGATGTCGGGGAGCTGTTTTTTGGAGAA	CAISGN*RESDVGELFF	Stop	VDJ	2	54	1.2249786762971162E-4		51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	3	2	7	4	8	23	35	50	39	58														CAISGN*RESDVGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGACGGGACCAGCCTACGAGCAGTACTTCGGGCCG	CASSETGPAYEQYF	In	VDJ	2	55	1.2476634665989147E-4	1.6014488744726138E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	0	7	2	5	3	23	35	45	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSETGPAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAGGACTATAGCGGGAGAGGACCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	55	1.2476634665989147E-4		53	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	5	2	2	6	4	23	37	52	43	56														X+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCAACTTACCCAGTACAGGGCACCGAGCAGTACTTCGGGCCG	CASTPTYPVQGTEQYF	In	VDJ	2	58	1.3157178375043101E-4	1.688800631262029E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	3	3	6	16	3	23	33	55	49	58														CASTPTYPVQGTEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGACCGGACTAGCGGGAGTAGAGAGCTGTTTTTTGGAGAA	CASRDRTSGSRELFF	In	VDJ	2	58	1.3157178375043101E-4	1.688800631262029E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	1	2	11	5	4	23	34	52	39	56														CASRDRTSGSRELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAGGGCCTCTAGCAAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	58	1.3157178375043101E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	7	5	6	2	23	37	48	43	50						01,02								X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCTCAGGGGGAGAAGAGACCCAGTACTTCGGGCCA	CATSGGEETQYF	In	VDJ	2	59	1.3384026278061086E-4	1.7179178835251675E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	4	1	3	3	2	23	30	40	33	42														CATSGGEETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGACGACAGAAACTAGGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	63	1.4291417890133023E-4		46	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	5	2	5	7	5	8	23	35	45	40	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTATAGGGATCTCTACCTACGAGCAGTACTTCGGGCCG	CAISIGISTYEQYF	In	VDJ	2	63	1.4291417890133023E-4	1.8343868925777213E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	0	8	2	3	6	23	35	42	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISIGISTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGAGGACTAGCGGGAGGAGACAATGAGCAGTTCTTCGGGCCA	CASSRGLAGGDNEQFF	In	VDJ	2	64	1.4518265793151007E-4	1.8635041448408597E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	1	1	5	3	2	23	35	52	38	54														CASSRGLAGGDNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCGACAGGGGAGGTCGAGCAGTACTTCGGGCCG	CASRPTGEVEQYF	In	VDJ	2	66	1.4971961599186977E-4	1.9217386493671366E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	2	6	3	4	23	34	45	37	49														CASRPTGEVEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCCCGATCAGCCCCAGCATTTTGGTGAT	CASSPPDQPQHF	In	VDJ	2	68	1.5425657405222947E-4	1.9799731538934135E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	8	6	5	5	0	23	35	-1	40	42						01,02								CASSPPDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGGTCTACAATGAGCAGTTCTTCGGGCCA	CASSSVYNEQFF	In	VDJ	2	68	1.5425657405222947E-4	1.9799731538934135E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	8	5	3	0	1	23	-1	39	36	40						01,02								CASSSVYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCTTTCCCTACAGGACACCATATATTTTGGAGAG	CASLSLQDTIYF	In	VDJ	2	68	1.5425657405222947E-4	1.9799731538934135E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	3	4	8	8	0	23	32	-1	40	45														CASLSLQDTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCACAGTGGACCAAGAAGACCCAGTACTTCGGGCCA	CASSYSQWTKKTQYF	In	VDJ	2	69	1.5652505308240931E-4	2.009090406156552E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	0	1	7	6	5	5	23	40	49	45	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSQWTKKTQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACGTTACCTAGCGGTGGGACGGGGAATGAGCAGTTCTTCGGGCCA	CATLPSGGTGNEQFF	In	VDJ	2	70	1.5879353211258916E-4	2.0382076584196903E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	10	4	5	7	6	10	23	30	43	36	53						01,02								CATLPSGGTGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATCGACTATCCGGGACGGACGGCTACACCTTCGGTTCG	CASNRLSGTDGYTF	In	VDJ	2	70	1.5879353211258916E-4	2.0382076584196903E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	7	0	7	8	11	4	23	33	49	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNRLSGTDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGACTAGAACCCAAGACCCAGTACTTCGGGCCA	CASSRLEPKTQYF	In	VDJ	2	70	1.5879353211258916E-4	2.0382076584196903E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	2	8	6	2	6	23	34	42	36	48						01,02								CASSRLEPKTQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAATCGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSYNRATNEKLFF	In	VDJ	2	71	1.6106201114276898E-4	2.0673249106828288E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	8	4	0	3	0	23	38	-1	41	45						01,02								CASSYNRATNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCATAACCCCTATCAGGGCTACACCTTCGGTTCG	CASSHNPYQGYTF	In	VDJ	3	78	1.7694136435402792E-4	2.2711456765247976E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	6	4	5	8	13	0	23	34	-1	47	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHNPYQGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTCCGCGTATGTACAATGAGCAGTTCTTCGGGCCA	CASSSPRMYNEQFF	In	VDJ	3	78	1.7694136435402792E-4	2.2711456765247976E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	7	6	4	4	4	23	36	43	40	47						01,02								CASSSPRMYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCCGGGCAATGAAGCTTTCTTTGGACAA	CASSYPGNEAFF	In	VDJ	3	80	1.8147832241438761E-4	2.3293801810510745E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	3	8	0	7	3	2	23	37	44	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPGNEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTTCCAGGGAACTAATCAGCCCCAGCATTTTGGTGAT	CASSFQGTNQPQHF	In	VDJ	3	81	1.8374680144456743E-4	2.358497433314213E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	4	4	4	23	34	43	38	47														CASSFQGTNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCACAGACAGGACTCCTACGAGCAGTACTTCGGGCCG	CASSYHRQDSYEQYF	In	VDJ	3	86	1.9508919659546667E-4	2.504083694629905E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	4	0	4	1	23	38	48	42	49														CASSYHRQDSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGACTAGCGGGAGTCTTGATACGCAGTATTTTGGCCCA	CASSYGTSGSLDTQYF	In	VDJ	3	90	2.0416311271618604E-4	2.620552703682459E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	0	2	6	0	4	23	-1	52	38	56														CASSYGTSGSLDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTCAGGGGCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSYSQGLAKNIQYF	In	VDJ	3	92	2.0870007077654573E-4	2.6787872082087357E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	2	0	1	2	23	40	47	41	49														CASSYSQGLAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTCGGGGGGTACAGAATGAACTGGGTGAAGCTTTCTTTGGACAA	CASSSRGVQNELGEAFF	In	VDJ	3	93	2.1096854980672558E-4	2.7079044604718744E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	1	7	2	16	23	36	45	38	61														CASSSRGVQNELGEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGGGTAGCGGGAGGGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	94	2.1323702883690543E-4		38	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	9	5	0	2	2	0	23	31	-1	33	44														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCACCTGGACGGAAGCTAACTATGGCTACACCTTCGGTTCG	CASSPTWTEANYGYTF	In	VDJ	4	105	2.3819029816888373E-4	3.057311487629535E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	6	1	7	0	8	5	23	34	46	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTWTEANYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGACTAGCGGGCTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	107	2.4272725622924343E-4		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	4	3	1	2	23	34	45	35	47						01,02								X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCAACAGGGGGCATCGGGGAGCTGTTTTTTGGAGAA	CASSATGGIGELFF	In	VDJ	4	107	2.4272725622924343E-4	3.115545992155812E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	0	7	3	2	23	35	47	38	49														CASSATGGIGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCACTCGTGTCTCAGGGTCGGATGGCTACACCTTCGGTTCG	CASSSTRVSGSDGYTF	In	VDJ	4	109	2.472642142896031E-4	3.173780496682089E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	3	6	12	4	23	36	53	48	57														CASSSTRVSGSDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTCGACGGGGGCGGGAATCAGCCCCAGCATTTTGGTGAT	CASSLDGGGNQPQHF	In	VDJ	4	130	2.9490227392337985E-4	3.7852427942079963E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	6	0	4	7	3	23	34	47	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGGGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTGCCCAAGTTGGCACAATGAGCAGTTCTTCGGGCCA	CASCPSWHNEQFF	In	VDJ	4	131	2.971707529535597E-4	3.8143600464711345E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	9	0	5	10	0	23	32	-1	42	45														CASCPSWHNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGGAGCACGCGGAGGCGAGCAGTACTTCGGGCCG	CASRGARGGEQYF	In	VDJ	5	142	3.2212402228553797E-4	4.1346498213656576E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	10	1	6	10	0	23	34	-1	44	49														CASRGARGGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGACAGGAGACTACGAGCAGTACTTCGGGCCG	CASSYGTGDYEQYF	In	VDJ	5	152	3.4480881258733644E-4	4.425822343997042E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	4	3	0	3	23	-1	46	38	49														CASSYGTGDYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTCATTGGGAGGTTGGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	5	154	3.4934577064769614E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	1	9	1	8	5	5	23	39	50	44	55														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSTSSYEQYF	In	VDJ	5	159	3.6068816579859535E-4	4.629643109839011E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	11	2	0	2	0	23	35	-1	37	40														CASSTSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGAGTAAACTATGAGGACTAGCGGGATTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	5	162	3.6749360288913487E-4		53	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	9	1	3	2	12	2	23	31	55	43	57														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCCAATAGTCTCGCCTACGAGCAGTACTTCGGGCCG	CASTPNSLAYEQYF	In	VDJ	6	167	3.7883599804003414E-4	4.862581127944118E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	5	8	2	7	5	23	33	43	40	48						01,02								CASTPNSLAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGGACTAGCGGGAGGGGTGGTGAGCAGTTCTTCGGGCCA	CASSYWTSGRGGEQFF	In	VDJ	6	168	3.8110447707021396E-4	4.891698380207256E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	1	0	9	0	4	23	-1	54	39	58														CASSYWTSGRGGEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTGAAGAGGGGGCAGATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	6	173	3.9244687222111317E-4		40	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	5	0	3	5	4	23	31	43	36	47														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGACAGGAACTTTACAATGAGCAGTTCTTCGGGCCA	CASRQELYNEQFF	In	VDJ	6	180	4.083262254323721E-4	5.241105407364918E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	2	4	4	1	5	23	32	39	33	44														CASRQELYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGGGAGTAGCGGATGGATCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSYGSSGWISYNEQFF	In	VDJ	6	182	4.1286318349273177E-4	5.299339911891195E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	5	0	6	6	23	37	49	43	55						01,02								CASSYGSSGWISYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATGGAGTGAGTCGGACTACAATGAGCAGTTCTTCGGGCCA	CASRWSESDYNEQFF	In	VDJ	6	185	4.1966862058327134E-4	5.38669166868061E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	10	2	3	2	9	23	34	40	36	49														CASRWSESDYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGACTAGAATATCCAGAGACCCAGTACTTCGGGCCA		Out	VDJ	6	188	4.2647405767381086E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	0	8	4	1	7	23	38	47	39	54						01,02								X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGGACAGGGGTGGACTGAGCAGTTCTTCGGGCCA	CASSSGQGWTEQFF	In	VDJ	6	192	4.3554797379453025E-4	5.590512434522579E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	2	9	2	5	23	36	47	38	52														CASSSGQGWTEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCGGGGCGCACAGATACGCAGTATTTTGGCCCA	CASSYAGRTDTQYF	In	VDJ	7	194	4.4008493185488995E-4	5.648746939048856E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	7	3	1	0	1	23	-1	44	38	45														CASSYAGRTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACAAGGTGTGGAGGCTAACACTGAAGCTTTCTTTGGACAA	CASRQGVEANTEAFF	In	VDJ	7	199	4.5142732700578916E-4	5.794333200364548E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	1	2	9	2	23	34	48	43	50														CASRQGVEANTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATGGTCCCGGGACTCGAGAGACCCAGTACTTCGGGCCA	CASNGPGTRETQYF	In	VDJ	7	200	4.53695806035969E-4	5.823450452627686E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	0	10	4	8	2	23	33	47	41	49						01,02								CASNGPGTRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACAGAAGGTTACGAGCAGTACTTCGGGCCG	CASSYSTEGYEQYF	In	VDJ	7	203	4.6050124312650855E-4	5.910802209417101E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	5	4	0	5	23	-1	45	40	50														CASSYSTEGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACAGAAACTTGGGCGGGAGTGGGCTACGAGCAGTACTTCGGGCCG	CASTETWAGVGYEQYF	In	VDJ	7	214	4.8545451245848685E-4	6.231091984311624E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	7	2	3	11	4	23	33	51	44	55														CASTETWAGVGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCACTAGCGGAGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSPLAEAYNEQFF	In	VDJ	7	215	4.8772299148866667E-4	6.260209236574763E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	5	2	2	3	23	35	45	37	48						01,02								CASSPLAEAYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCGGACAGGAAAGCACAGATACGCAGTATTTTGGCCCA	CASSAGQESTDTQYF	In	VDJ	7	218	4.945284285792062E-4	6.347560993364178E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	4	0	3	2	23	35	45	38	47														CASSAGQESTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGGACACCAGCCGAAAAGCAGTACTTCGGGCCG	CASSYSGTPAEKQYF	In	VDJ	7	222	5.036023446999256E-4	6.464030002416731E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	6	8	1	10	23	40	47	41	57														CASSYSGTPAEKQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCGGGCAGTACCAAGAGACCCAGTACTTCGGGCCA	CASIGQYQETQYF	In	VDJ	8	225	5.104077817904651E-4	6.551381759206148E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	7	8	0	0	2	3	23	33	39	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIGQYQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCCAGGGGACGGGAGAGGATACGCAGTATTTTGGCCCA	CAIQGTGEDTQYF	In	VDJ	8	227	5.149447398508248E-4	6.609616263732424E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	10	4	2	6	2	9	23	30	38	32	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIQGTGEDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTACGGGGTAGCCCTGGAAACACCATATATTTTGGAGAG	CASSLRGSPGNTIYF	In	VDJ	9	257	5.829991107562201E-4	7.483133831626578E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	4	8	3	2	2	5	23	36	43	38	48														CASSLRGSPGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTTAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	9	261	5.920730268769395E-4		38	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	5	10	0	1	0	2	23	-1	37	35	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCATACGTCGGTGGGCTAAGGTACTTCGGCGCC	CASSSYVGGLRYF	In	VDJ	9	263	5.966099849372993E-4	7.657837345205408E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	8	0	15	13	4	23	34	51	47	55														CASSSYVGGLRYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGGAGAATCCACAGATACGCAGTATTTTGGCCCA	CASSSGESTDTQYF	In	VDJ	10	283	6.419795655408961E-4	8.240182390468176E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	10	2	2	2	4	23	36	42	38	46														CASSSGESTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACTCGGGACAGCAAGGGGCCAACGTCCTGACTTTCGGGGCC	CASNSGQQGANVLTF	In	VDJ	10	293	6.646643558426946E-4	8.53135491309956E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	0	5	4	4	3	23	33	44	37	47														CASNSGQQGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATAGAACAGGGCTTATACAATGAGCAGTTCTTCGGGCCA	CAIEQGLYNEQFF	In	VDJ	11	311	7.054969783859319E-4	9.055465453836053E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	3	3	4	4	4	23	30	40	34	44														CAIEQGLYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCCGGGGGGGGAGGTTGAACGAGCAGTACTTCGGGCCG	CARGGRLNEQYF	In	VDJ	11	329	7.463296009291691E-4	9.579575994572544E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	11	8	0	5	0	8	23	-1	37	29	45														CARGGRLNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGAGGGACCGATGGAGTGGGAGCAGTACTTCGGGCCG	CASSYGEGPMEWEQYF	In	VDJ	12	343	7.780883073516869E-4	9.987217526256482E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	9	0	7	1	13	23	38	46	39	59														CASSYGEGPMEWEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCTCCGGGACAGGGTAACGAGAAGCAGTACTTCGGGCCG	CASSPGQGNEKQYF	In	VDJ	12	345	7.826252654120465E-4	0.001004545203078276	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	3	8	5	8	23	32	46	37	54														CASSPGQGNEKQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATGTACAGGAACACTGAAGCTTTCTTTGGACAA	CASSMYRNTEAFF	In	VDJ	14	401	9.096600911021179E-4	0.0011676018157518512	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	5	1	4	0	23	35	-1	39	43														CASSMYRNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGGGGAGGAGAGAGACCCAGTACTTCGGGCCA	CASSRGRRETQYF	In	VDJ	15	430	9.754459829773333E-4	0.0012520418473149525	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	8	2	4	1	5	23	34	41	35	46						01,02								CASSRGRRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTAGACTAGCGGGAGTCGCGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYSRLAGVAGANVLTF	In	VDJ	19	551	0.0012499319456290947	0.0016043605996989277	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	0	2	2	4	2	5	23	40	54	42	59														CASSYSRLAGVAGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCTACGAGACTAGCGGGAGAGGGTACGAGCAGTACTTCGGGCCG	CASSYPYETSGRGYEQYF	In	VDJ	20	593	0.001345208064896648	0.001726653059204109	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	2	2	4	8	4	23	38	58	46	62														CASSYPYETSGRGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGACGGGACGACCAAGAGACCCAGTACTTCGGGCCA	CAISGRDDQETQYF	In	VDJ	24	710	0.0016106201114276899	0.002067324910682829	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	0	7	0	4	1	23	35	44	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISGRDDQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCTCCCCAGGGGAGGATCGCGAGCAGTACTTCGGGCCG	CASSPSPGEDREQYF	In	VDJ	33	973	0.002207230096364989	0.0028331086452033694	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	4	2	6	8	7	23	34	48	42	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSPGEDREQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGGGACTAGCGGAACTACGAGCAGTACTTCGGGCCG	CASSRD*RNYEQYF	Stop	VDJ	44	1301	0.0029512912182639785		42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	5	3	1	2	23	35	47	36	49						01,02								CASSRD*RNYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTACGGACTGGACTAGCGGCAAAAACATTCAGTACTTCGGCGCC	CASITDWTSGKNIQYF	In	VDJ	48	1418	0.00321670326479502	0.00412882637091303	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	7	1	5	3	9	0	23	33	-1	42	52						01,02								CASITDWTSGKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACCCGGGCGACAGGGGGCAGGTACGAGCAGTACTTCGGGCCG	CASSTRATGGRYEQYF	In	VDJ	49	1455	0.0033006369889116744	0.004236560204286642	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	0	4	9	3	23	34	53	43	56														CASSTRATGGRYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCTACAGGGTATTTTAACGAAAAACTGTTTTTTGGCAGT	CASSPTGYFNEKLFF	In	VDJ	53	1557	0.0035320218499900187	0.004533556177370654	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	3	8	4	9	23	34	44	38	53														CASSPTGYFNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAGGGACTAGCAATCTCCTACGAGCAGTACTTCGGGCCG	CASSQGLAISYEQYF	In	VDJ	83	2447	0.00555096818685008	0.007124991628789975	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	7	0	2	3	23	35	46	37	49						01,02								CASSQGLAISYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCCACTAGCGGTTACCCCTACGAGCAGTACTTCGGGCCG	CASRPTSGYPYEQYF	In	VDJ	101	2977	0.0067532620728453984	0.00866820599873631	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	3	5	2	4	5	23	34	46	38	51						01,02								CASRPTSGYPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCCATAGGTAGGTCCTGGAGGGTCCAGATACGCAGTATTTTGGCCCA	CAHR*VLEGPDTQYF	Stop	VDJ	140	4142	0.009396040143004918		45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	11	10	0	4	14	2	23	29	49	43	51														CAHR*VLEGPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGAAAACTAGCGTACCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	514	15203	0.034487686695824187		38	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	3	6	6	3	3	23	31	41	34	44						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACATTATTACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSHYYSYNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	5	9	0	2	3	24	37	41	39	44						01,02							Vb 18	CASSHYYSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTGGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSPLGMNTEAFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	1	0	8	0	2	0	24	40	-1	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPLGMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGGGACTAGCGGCTACGGGCGGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	9	2.0416311271618604E-5		50	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	5	9	2	10	24	38	51	40	61						01,02							Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCGGACCGAGGCGAGCAGTACTTCGGGCCG	CASSSDRGEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	5	1	7	6	2	5	24	36	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSSDRGEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCGCTCCAGAACACTGAAGCTTTCTTTGGACAA	CASSPLQNTEAFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	6	4	6	1	7	0	24	35	-1	42	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPLQNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGGTTGGCGGTGCCGGTATCCTTCTTCGCCGAGCTTTCTTTGGACAA		Out	VDJ	1	11	2.4953269331978296E-5		56	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	7	5	10	7	21	24	38	49	45	70						01,02							Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGTGAGATTGAAGCTTTCTTTGGACAA	CASSPGEIEAFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	0	9	7	0	6	24	-1	41	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGEIEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCAAAGCGGTAGGGATCAGCCCCAGCATTTTGGTGAT	CASSQSGRDQPQHF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	6	5	5	4	5	24	35	44	39	49						01,02							Vb 18	CASSQSGRDQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGCAGGGGCGGCTACGAGCAGTACTTCGGGCCG	CASSPSRGGYEQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	3	2	3	24	39	47	41	50													Vb 18	CASSPSRGGYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACATTGGGCAGTACAGTTCTTCGGGCCA	CASSPHWAVQFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	8	0	13	3	4	24	40	47	43	51													Vb 18	CASSPHWAVQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCAGGGTATTCGGTCAATGAGCAGTTCTTCGGGCCA	CASSPAGYSVNEQFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	3	6	1	8	24	39	45	40	53													Vb 18	CASSPAGYSVNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTAAGGGGAATTAGCGGGAGTTACGAGCAGTACTTCGGGCCG	CASSLRGISGSYEQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	5	2	4	10	1	24	37	56	47	57													Vb 18	CASSLRGISGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTACAGGAGGGGGTAGCGGTCAGCCCCAGCATTTTGGTGAT	CASSTGGGSGQPQHF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	6	5	1	6	6	6	24	35	47	41	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSTGGGSGQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGGATTAGCGGGAGGCAATGAGCAGTTCTTCGGGCCA	CASSPGLAGGNEQFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	5	1	6	5	0	24	38	-1	43	53													Vb 18	CASSPGLAGGNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAATGTTGGGGATACGCAGTATTTTGGCCCA	CASSPNVGDTQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	2	0	9	6	6	0	24	39	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPNVGDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACAGGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSPTGVNTEAFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	2	0	0	0	24	-1	-1	39	46													Vb 18	CASSPTGVNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGGGAAGAAGGAGCTTTCTTTGGACAA	CASSPREEGAFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	2	0	8	10	1	6	24	39	44	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPREEGAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGTCTAGCGGGTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	3.629566448287752E-5		46	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	4	1	2	1	24	41	51	43	52						01,02							Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGACCCGGGGCACGAGCAGTACTTCGGGCCG	CASSPDPGHEQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	3	7	0	5	6	0	24	38	-1	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPDPGHEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCATCGCATTCGACAGGGATGGTATGAACACTGAAGCTTTCTTTGGACAA	CASSLIAFDRDGMNTEAFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	57	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	0	11	6	24	37	55	48	61													Vb 18	CASSLIAFDRDGMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGGGATTCCGAAGCTTTCTTTGGACAA	CASSPRDSEAFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	8	3	8	1	4	24	38	44	39	48													Vb 18	CASSPRDSEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACATGGGACTCGGGCCCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSTWDSGPGANVLTF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	0	10	2	4	6	24	36	46	40	52						01,02							Vb 18	CASSTWDSGPGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD02-01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGAACTAGCGGGAGTGGTCTACGAGCAGTACTTCGGGCCG	CASSPPELAGVVYEQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	3	2	3	3	4	24	41	55	44	59													Vb 18	CASSPPELAGVVYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGACTCCACGGGTACGCAGTATTTTGGCCCA	CASSPDSTGTQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	2	10	8	0	7	24	-1	43	39	50						01,02							Vb 18	CASSPDSTGTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGTTCACGGGACAGCAAGAGACCCAGTACTTCGGGCCA	CASSPRFTGQQETQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	5	2	7	0	24	40	-1	47	54													Vb 18	CASSPRFTGQQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTACGACAGGGTGGGGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	21	4.7638059633776745E-5		47	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	2	3	5	3	5	24	38	48	41	53													Vb 18	X+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGGGACATGAGGGCCCAGGGGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	22	4.990653866395659E-5		53	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	1	5	15	1	24	39	61	54	62													Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAATAAGGGACAGGACCTACGAGCAGTACTTCGGGCCG	CASSPIRDRTYEQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	4	2	4	1	24	39	51	43	52													Vb 18	CASSPIRDRTYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACGACAGGGACAGATACGCAGTATTTTGGCCCA	CASSPTTGTDTQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	3	3	3	0	24	38	-1	41	48													Vb 18	CASSPTTGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCAGGACTAGCGGTTACCTACGAGCAGTACTTCGGGCCG	CASSPGLAVTYEQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	1	5	2	0	3	24	-1	49	39	52						01,02							Vb 18	CASSPGLAVTYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGGCTAGCGGTTACACAGATACGCAGTATTTTGGCCCA	CASSRASGYTDTQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	5	2	3	3	24	37	47	40	50						01,02							Vb 18	CASSRASGYTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCGTGGACCTGCGAGGGGACTATGGCTACACCTTCGGTTCG	CASSVDLRGDYGYTF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	6	5	2	3	12	0	24	35	-1	47	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSVDLRGDYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCTAAACTCCAGGGGGCAGGGGGACGAGCAGTACTTCGGGCCG	CASSLNSRGQGDEQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	0	5	9	6	24	35	52	44	58													Vb 18	CASSLNSRGQGDEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCCTATACAGAACACTGAAGCTTTCTTTGGACAA	CASSPIQNTEAFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	6	3	6	1	6	0	24	35	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPIQNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACGGAAAATCAGCCCCAGCATTTTGGTGAT	CASSPTENQPQHF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	3	1	8	4	3	1	24	38	44	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPTENQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGAGGGAGCGGGACTCTCTAGGGAGCAGTACTTCGGGCCG	CASSPEGAGLSREQYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	6	3	7	6	9	24	38	51	44	60													Vb 18	CASSPEGAGLSREQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTAGGGAGAGGGAACAGGGGGTCCACGAGCAGTACTTCGGGCCG	CASSPREREQGVHEQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	1	5	12	3	24	38	58	50	61													Vb 18	CASSPREREQGVHEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCCTAGCGGAGGCGGTTCCTACGAGCAGTACTTCGGGCCG	CASSPSGGGSYEQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	5	1	2	7	24	35	44	37	51						01,02							Vb 18	CASSPSGGGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGTCTAGAAGAGACCCAGTACTTCGGGCCA	CASSPRLEETQYF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	4	8	3	2	0	24	40	-1	42	46						01,02							Vb 18	CASSPRLEETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGAACCGGAATGTCTAAGGGGATCCGGAACGAGCAGTACTTCGGGCCG	CASSRTGMSKGIRNEQYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	5	2	5	15	7	24	37	57	52	64													Vb 18	CASSRTGMSKGIRNEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCGGGTCGGATCAGCAGTACTTCGGGCCG	CASSLGSDQQYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	8	4	8	1	7	24	37	42	38	49						01,02							Vb 18	CASSLGSDQQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAACCCCAGCGGGCGGTCGTACGAGCAGTACTTCGGGCCG	CASSPNPSGRSYEQYF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	6	4	4	6	6	24	39	51	45	57						01,02							Vb 18	CASSPNPSGRSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGGGTCAGGGACCTACTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPRVRDLLNTGELFF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	54	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	2	0	7	1	7	5	24	39	51	46	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRVRDLLNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGATTCGGCAGATACGCAGTATTTTGGCCCA	CASSPDSADTQYF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	8	5	4	4	0	24	39	-1	43	46						01,02							Vb 18	CASSPDSADTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCAGAATGCGGGGATCTACGCGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	34	7.712828702611473E-5		56	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	3	7	3	1	6	9	24	38	50	44	59													Vb 18	X+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGGGGGCAGGCTATGGCTACACCTTCGGTTCG	CASSLGAGYGYTF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	6	0	4	1	3	24	37	44	38	47													Vb 18	CASSLGAGYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGTATCCCTCCAAGAGACCCAGTACTTCGGGCCA	CASSVSLQETQYF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	4	10	1	6	0	24	36	-1	42	44						01,02							Vb 18	CASSVSLQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGTCGGGACTAGCGGGGAGCTACGAGCAGTACTTCGGGCCG	CASSSGLAGSYEQYF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	3	3	2	24	35	51	38	53													Vb 18	CASSSGLAGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGTCTGGTCACGGAAGCTTTCTTTGGACAA	CASSPRLVTEAFF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	1	0	10	8	4	5	24	40	46	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRLVTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTAGCGGGAACTACAATGAGCAGTTCTTCGGGCCA	CASSLSGNYNEQFF	In	VDJ	1	38	8.620220314683411E-5	1.1064555859992605E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	3	3	1	1	24	37	46	38	47													Vb 18	CASSLSGNYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTAGACAGGGCCCCTACGAGCAGTACTTCGGGCCG	CASSPRQGPYEQYF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	3	2	2	2	24	38	47	40	49													Vb 18	CASSPRQGPYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCACACACGGGCTACAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	39	8.847068217701396E-5		50	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	6	3	5	0	13	0	24	35	-1	48	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGGCGGGGGCGAGACCCAGTACTTCGGGCCA	CASSGGGETQYF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	7	2	5	1	1	24	36	44	37	45													Vb 18	CASSGGGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCGTCCAGGGGGCGGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	40	9.073916120719381E-5		41	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	0	6	6	3	24	35	49	41	52													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGTGGACGGCATTTACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	41	9.300764023737364E-5		55	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-06	01	4	1	7	5	3	15	24	37	44	40	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTTCCGGGACAACCTCTCCCCTGAAGCTTTCTTTGGACAA	CASSPFRDNLSPEAFF	In	VDJ	1	42	9.527611926755349E-5	1.222924595051814E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	6	5	9	24	38	49	43	58													Vb 18	CASSPFRDNLSPEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGCATGATCGAAGGCGAGCAGTACTTCGGGCCG	CASSPRMIEGEQYF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	1	5	4	6	10	0	24	40	-1	50	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRMIEGEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTTGACAGCTAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFDS*SSYNEQFF	Stop	VDJ	2	45	1.0208155635809302E-4		48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	5	0	3	6	24	36	44	39	50													Vb 18	CASSFDS*SSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGGGTATCTTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	47	1.0661851441845271E-4		43	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	4	0	9	1	1	5	24	37	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTACCGGGCGGGGGTCGAACACTGAAGCTTTCTTTGGACAA	CASSPTGRGSNTEAFF	In	VDJ	2	48	1.0888699344863256E-4	1.3976281086306447E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	7	2	1	6	2	24	38	51	44	53													Vb 18	CASSPTGRGSNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGGGGACTAGCGGATCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	49	1.1115547247881241E-4		44	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	5	7	2	2	24	37	50	39	52						01,02							Vb 18	X+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGCCTGACGGGAGCTGGAATGAGCAGTTCTTCGGGCCA	CASSPGPDGSWNEQFF	In	VDJ	2	52	1.1796090956935194E-4	1.5140971176831985E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	8	2	7	8	4	24	39	53	47	57													Vb 18	CASSPGPDGSWNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCATCCACAGATACGCAGTATTTTGGCCCA	CASSPPSTDTQYF	In	VJ	2	53	1.2022938859953179E-4	1.543214369946337E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	0	0	0	2	0	3	24	-1	41	-1	44													Vb 18	CASSPPSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGACAGGGACCGGTATAATGAAAAACTGTTTTTTGGCAGT	CASSDRDRYNEKLFF	In	VDJ	2	53	1.2022938859953179E-4	1.543214369946337E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	3	4	0	7	24	-1	43	36	50													Vb 18	CASSDRDRYNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCTCGGACAGTTTGTGGTACGAGCAGTACTTCGGGCCG	CASSSDSLWYEQYF	In	VDJ	2	54	1.2249786762971162E-4	1.5723316222094753E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	5	4	3	7	24	35	44	38	51													Vb 18	CASSSDSLWYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCACCACCCCGACCTCTGGAAACACCATATATTTTGGAGAG	CASSPTTPTSGNTIYF	In	VDJ	2	56	1.2703482569007132E-4	1.6305661267357522E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	3	2	7	0	9	0	24	38	-1	47	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPTTPTSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAACGAGAGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	58	1.3157178375043101E-4		40	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	1	1	5	0	24	36	-1	41	45													Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGGACAGGGTGGGCTACGAGCAGTACTTCGGGCCG	CASSQDRVGYEQYF	In	VDJ	2	58	1.3157178375043101E-4	1.688800631262029E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	3	3	1	4	24	37	46	38	50													Vb 18	CASSQDRVGYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGTCAGCTCACCAGGACAGGGTGGACGGCTACACCTTCGGTTCG		Out	VDJ	2	70	1.5879353211258916E-4		40	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	3	8	0	5	24	-1	47	39	52													Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACGACCAGAGGGACACGTCCTTACAATGAGCAGTTCTTCGGGCCA	CASSTTRGTRPYNEQFF	In	VDJ	2	72	1.6333049017294883E-4	2.0964421629459672E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	6	4	9	6	24	36	51	45	57													Vb 18	CASSTTRGTRPYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCAGGGTCCGTCTTTAGAGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSGSVFRAGANVLTF	In	VDJ	3	77	1.7467288532384807E-4	2.2420284242616594E-4	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	4	3	2	1	13	24	36	42	37	55													Vb 18	CASSSGSVFRAGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCGAGTGGGAGGAAACCCCCTACGAGCAGTACTTCGGGCCG	CASSEWEETPYEQYF	In	VDJ	3	81	1.8374680144456743E-4	2.358497433314213E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	1	2	5	6	24	35	46	40	52													Vb 18	CASSEWEETPYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTTGGCAATGAGCAGTTCTTCGGGCCA	CASSPVGNEQFF	In	VDJ	3	82	1.8601528047474728E-4	2.3876146855773513E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	2	0	10	6	3	0	24	39	-1	42	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPVGNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCGTCAGGGGGCTATGGCTACACCTTCGGTTCG	CASSPASGGYGYTF	In	VDJ	3	91	2.0643159174636589E-4	2.6496699559455975E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	1	4	4	0	24	39	-1	43	50													Vb 18	CASSPASGGYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTCCAGTGGCGGGAGCTACGAGCAGTACTTCGGGCCG	CASSPSSGGSYEQYF	In	VDJ	3	93	2.1096854980672558E-4	2.7079044604718744E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	2	3	8	0	24	38	-1	46	53													Vb 18	CASSPSSGGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCAAAGCGGGAATGCCTACGAGCAGTACTTCGGGCCG	CASSPQSGNAYEQYF	In	VDJ	3	103	2.3365334010852403E-4	2.999076983103259E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	6	3	2	4	3	24	38	49	42	52													Vb 18	CASSPQSGNAYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCGGACAGGGGCGAGCAGTACTTCGGGCCG	CASSSDRGEQYF	In	VDJ	4	105	2.3819029816888373E-4	3.057311487629535E-4	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	6	2	0	24	36	-1	38	47													Vb 18	CASSSDRGEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCAAGACAGGGACACTGAAGCTTTCTTTGGACAA	CASSQDRDTEAFF	In	VDJ	4	117	2.6541204653104185E-4	3.4067185147871964E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	3	4	0	24	35	-1	39	46													Vb 18	CASSQDRDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAAGGGGGAGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSKGESNQPQHF	In	VDJ	4	122	2.767544416819411E-4	3.552304776102889E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	5	1	1	1	2	24	36	43	37	45													Vb 18	CASSKGESNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCGAGCGACGGGACTAGCGGGAGATGAGCAGTTCTTCGGGCCA	CASSRATGLAGDEQFF	In	VDJ	4	128	2.9036531586302015E-4	3.7270082896817194E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	2	8	9	0	24	35	-1	44	58													Vb 18	CASSRATGLAGDEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGTAAGGTGATGGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	5	139	3.1531858519499845E-4		46	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	1	5	4	2	3	6	24	40	46	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGGCCAGGGAAGATACGCAGTATTTTGGCCCA	CASSAREDTQYF	In	VDJ	6	163	3.6976208191931474E-4	4.7461121188915645E-4	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	3	5	3	1	24	35	43	38	44													Vb 18	CASSAREDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGACGGACAGGCCTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	6	167	3.7883599804003414E-4		46	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	4	0	3	3	24	35	45	38	48													Vb 18	X+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCGGGCGGGGAGACCCAGTACTTCGGGCCA	CASSSGGETQYF	In	VDJ	14	427	9.686405458867938E-4	0.0012433066716360111	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	7	4	5	4	0	24	36	-1	40	45						01,02							Vb 18	CASSSGGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGACAGTTGGGGGGAAAAACTGTTTTTTGGCAGT	CASSPDSWGEKLFF	In	VDJ	20	588	0.001333865669745749	0.0017120944330725398	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	2	2	5	8	0	7	24	-1	44	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPDSWGEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGCCAGACCTATCTGTACCACTGTGCCAGCAGTTATGACGGTCTCCCTGGTGCCACAGATACGCAGTATTTTGGCCCA	CASSYDGLPGATDTQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	51	TCRBV08	TCRBV08-02	01				TCRBJ02	TCRBJ02-03	01	4	2	7	2	5	14	22	32	40	37	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYDGLPGATDTQYF+TCRBV08-02+TCRBJ02-03	TCRBV08-02*01		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCAGGGAGAACGAGCAGTACTTCGGGCCG	CASSRENEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	33	TCRBV12						TCRBJ02	TCRBJ02-07	01	6	4	3	5	0	3	26	-1	42	37	45		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRENEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTGATCGTCCATTTCCATTCCGACAATGAGCAGTTCTTCGGGCCA	CASSLIVHFHSDNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	51	TCRBV12						TCRBJ02	TCRBJ02-01	01	6	2	8	5	3	18	26	37	42	40	60		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLIVHFHSDNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGTATTAGTGAACTAGCGGGGGTAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	9	2.0416311271618604E-5		53	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	3	2	7	9	2	26	42	62	51	64		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCCATAGGTAGGTCCTGGAGGGTCCAGATACGCAGTATTTTGGCCCA	CAHR*VLEGPDTQYF	Stop	VDJ	1	9	2.0416311271618604E-5		45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	11	10	0	4	14	2	36	42	62	56	64	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CAHR*VLEGPDTQYF+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGTCCGGCGGGAGGCGGACACCAAACTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	9	2.0416311271618604E-5		64				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	7	1	0	7	13	17	31	46	38	59	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03												X+X+TCRBJ02-04		TCRBD02-01*02	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCCATCAGGGCGGAAACTATGGCTACACCTTCGGTTCG	CASSHQGGNYGYTF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	3	2	4	4	24	35	44	39	48	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSHQGGNYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCCCACAGAGCCCACTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSPQSPLAKNIQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	3	5	0	3	8	24	35	42	38	50	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSPQSPLAKNIQYF+X+TCRBJ02-04		TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTTCTCCCTACATAGCGGGCCCCTCCTACGAGCAGTACTTCGGGCCG	CASSSPYIAGPSYEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	51	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	5	4	0	9	3	24	37	53	46	56		TCRBV06-05,TCRBV06-06				01,02								CASSSPYIAGPSYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCACTAGCAGGTAGTTCTTCGGGCCA		Out	VDJ	1	9	2.0416311271618604E-5		34	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	7	14	3	4	26	39	48	42	52		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCCAGCAGCTGAATGAGCAGTTCTTCGGGCCA	CASQQLNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	33	TCRBV03						TCRBJ02	TCRBJ02-01	01	8	4	5	7	0	6	26	-1	38	35	44		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASQQLNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCTCCGGGGGTTGGTCAGCCCCAGCATTTTGGTGAT	CSAAPGVGQPQHF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	8	2	6	5	4	26	34	45	39	49		TCRBV20-01,TCRBV20-or09_02												CSAAPGVGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGACTAGGGTACGAGCAGTACTTCGGGCCG	CSARLGYEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	33	TCRBV20						TCRBJ02	TCRBJ02-07	01	2	5	3	4	2	0	26	38	-1	40	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARLGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGGGAGGCGAGGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	9	2.0416311271618604E-5		41	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	8	1	8	0	6	26	-1	47	40	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTCGGCAGGGGAAATGGGAAACACCATATATTTTGGAGAG	CSASSAGEMGNTIYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	4	2	4	5	5	26	37	48	42	53		TCRBV20-01,TCRBV20-or09_02												CSASSAGEMGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAAAGATGAAAAACTGTTTTTTGGCAGT	CSASKDEKLFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	33	TCRBV20						TCRBJ01	TCRBJ01-04	01	3	5	5	6	3	0	26	37	-1	40	42		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASKDEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGGAGGTGGGAGGCCTAGCGGGAGACGAGCAGTACTTCGGGCCG	CSAPEVGGLAGDEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	4	2	5	15	0	26	35	-1	50	60		TCRBV20-01,TCRBV20-or09_02												CSAPEVGGLAGDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACCGGCGGCAGGGCTGTGGGGACTAATGAAAAACTGTTTTTTGGCAGT	CASTGGRAVGTNEKLFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	4	3	2	7	8	22	32	44	39	52		TCRBV12-03,TCRBV12-04												CASTGGRAVGTNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGGCGCAACAGGGGGCATTAGAACAGATACGCAGTATTTTGGCCCA	CASSGATGGIRTDTQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	0	3	6	6	22	34	49	40	55		TCRBV12-03,TCRBV12-04												CASSGATGGIRTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCATTCTTGATACCTACAATGAGCAGTTCTTCGGGCCA	CASILDTYNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	39	TCRBV12						TCRBJ02	TCRBJ02-01	01	7	2	8	2	5	2	22	32	39	37	41		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASILDTYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGTCAGACGAGTATGAACACTGAAGCTTTCTTTGGACAA	CASQTSMNTEAFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	9	2	7	0	3	5	22	30	36	33	41		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASQTSMNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACTAGTGGACGCACAGGGGGCCGAGACTATGGCTACACCTTCGGTTCG	CATSGRTGGRDYGYTF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	0	3	5	4	24	37	51	42	55		TCRBV24-01,TCRBV24-or09_02												CATSGRTGGRDYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACTCAGGGCGCTATCTCCTACAATGAGCAGTTCTTCGGGCCA	CATQGAISYNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	4	3	0	1	6	24	32	38	33	44		TCRBV24-01,TCRBV24-or09_02												CATQGAISYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCCGGGAGGGGGAGCAGTACTTCGGGCCG	CASSPREGEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	36	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	8	0	7	3	1	24	36	47	39	48		TCRBV24-01,TCRBV24-or09_02												CASSPREGEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATATGAGGGGGAGACCCAGTACTTCGGGCCA	CASSLYEGETQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	39	TCRBV24						TCRBJ02	TCRBJ02-05	01	6	5	2	5	7	0	24	36	-1	43	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLYEGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCCGGGACTAGCGGGAGCTACAATGAGCAGTTCTTCGGGCCA	CASSLSGTSGSYNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	51				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	2	3	6	0	24	36	-1	42	56	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSGTSGSYNEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGGGGGCGGCGAGCAGTACTTCGGGCCG	CASSLGGGEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	36	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	6	0	6	3	2	24	36	45	39	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGGEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCATCCAGGGGGGCAGGGAAGATACGCAGTATTTTGGCCCA	CASIQGGREDTQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	11	4	1	5	5	7	24	31	43	36	50		TCRBV24-01,TCRBV24-or09_02												CASIQGGREDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCTCGACGGAAGATGGACAGGTGTCAGATGAGCAGTTCTTCGGGCCA	CASSTEDGQVSDEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	11	1	4	8	14	6	24	31	52	45	58		TCRBV24-01,TCRBV24-or09_02												CASSTEDGQVSDEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATCGCAACCGGGACAGGGCAACAATGAGCAGTTCTTCGGGCCA	CASSESQPGQGNNEQFF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	51	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	3	5	8	2	23	38	55	46	57		TCRBV06-01,TCRBV06-08												CASSESQPGQGNNEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGATAATCCGGGACAGGGGTAATGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	9	2.0416311271618604E-5		52				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	3	8	5	23	35	53	43	58	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												X+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTGGCAAGCCACGTTTGGTGCCCTCCCAGACATCTGGTACTTGTGTGCCAGAAAACTAGCGTACCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	9	2.0416311271618604E-5		37	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	25	3	6	6	18	3	44	36	61	54	64		TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV06-08,TCRBV06-09				01,02								X+TCRBV06-X+TCRBJ02-02	TCRBV06	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATAGGACAGTCTACGAGCAGTACTTCGGGCCG	CASSQDRTVYEQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	5	3	2	1	18	35	43	37	44	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDRTVYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTACGCGGAGACACAGATACGCAGTATTTTGGCCCA	CASSLRGDTDTQYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	42	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	7	5	2	2	3	19	33	39	35	42		TCRBV05-06,TCRBV05-07				01,02								CASSLRGDTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTGTATCTCTGTGCCAGCAGCTTAGGAGGGTTCTCTGGAAACACCATATATTTTGGAGAG	CASSLGGFSGNTIYF	In	VDJ	1	9	2.0416311271618604E-5	2.620552703682459E-5	45				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	2	10	0	0	1	2	19	33	40	34	42	TCRBV05,TCRBV11	TCRBV05-05,TCRBV11-01,TCRBV11-03												CASSLGGFSGNTIYF+X+TCRBJ01-03		TCRBD02-01*02	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGCAAGCCACGTTTGGTGCAGCTCCAGACATCTGTGTACTTCTGTGCCAGAAAACTAGCGTACCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	9	2.0416311271618604E-5		38	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	3	6	6	3	3	43	51	61	54	64		TCRBV06-01,TCRBV06-05,TCRBV06-06				01,02								X+TCRBV06-X+TCRBJ02-02	TCRBV06	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTRCCAGCAGCCCCAGGGGGACAGGGGGAATGTACGAGCAGTACTTCGGGCCG	CXSSPRGTGGMYEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	14	0	1	4	15	4	26	29	55	44	59	TCRBV12,TCRBV21													CXSSPRGTGGMYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCACAGACAGGGTTACGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	10	2.2684790301798452E-5		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	3	4	4	6	26	37	48	41	54	TCRBV09,TCRBV12													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCTTAGATGCCGGGGAGCTGTTTTTTGGAGAA	CASSLDAGELFF	In	VJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	36	unresolved			unresolved			TCRBJ02	TCRBJ02-02	01	1	0	0	6	0	3	26	-1	42	-1	45	TCRBV12,TCRBV21			TCRBD02										CASSLDAGELFF+X+TCRBJ02-02	unresolved	unresolved	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCMRGGGACTCAGCYSTGTATYTYTGTGCCAGCAGTGAAAGAAAGACAGACTACGAGCAGTACTTCGGGCCG	CASSERKTDYEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	5	3	8	1	26	38	51	46	52	TCRBV05,TCRBV12													CASSERKTDYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTATGTCCCTGGCAGCTACGAGCAGTACTTCGGGCCG	CASSYVPGSYEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	5	3	10	0	26	39	-1	49	52		TCRBV12-03,TCRBV12-04												CASSYVPGSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACTTAGGACAGGGGGCCCCCCTGAAGCTTTCTTTGGACAA	CASSLLRTGGPPEAFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	0	6	4	4	26	41	56	45	60		TCRBV12-03,TCRBV12-04												CASSLLRTGGPPEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGAGGTCAGGGGTACGAGCAGTACTTCGGGCCG	CASSLGGQGYEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	2	4	5	0	26	42	-1	47	53		TCRBV12-03,TCRBV12-04												CASSLGGQGYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGACCCACTAGCGGTTACCCCTACGAGCAGTACTTCGGGCCG	CASRPTSGYPYEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	3	5	2	4	5	36	47	59	51	64	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01				01,02								CASRPTSGYPYEQYF+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGCTGTACCCTCTCAACATCTGTGTACTTCTGTGCCAGAAAACTAGCGTACCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	10	2.2684790301798452E-5		38	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	3	6	6	3	3	43	51	61	54	64		TCRBV06-02,TCRBV06-03				01,02								X+TCRBV06-X+TCRBJ02-02	TCRBV06	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGGGACTCGGCCTGTATCGCTGTGCCAGCAGCTTAGCGTCTAGCGGAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLASSGAKNIQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	48	TCRBV07			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	4	5	0	2	0	33	50	-1	52	59		TCRBV07-06,TCRBV07-07				01,02								CASSLASSGAKNIQYF+TCRBV07-X+TCRBJ02-04	TCRBV07	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAACCGGGAGAACTACGAGCAGTACTTCGGGCCG	CASSNRENYEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	2	3	3	2	26	38	47	41	49		TCRBV03-01,TCRBV03-02												CASSNRENYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTAGTCGTATTAACTATGGCTACACCTTCGGTTCG	CASSQGSRINYGYTF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	5	8	1	1	6	26	42	46	43	52		TCRBV03-01,TCRBV03-02				01,02								CASSQGSRINYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCTTATTGCTCAAAGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLLLKGDTGELFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	5	2	3	11	0	26	38	-1	49	54	TCRBV03,TCRBV12													CASSLLLKGDTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCARGGACTCRGCYSTGTATYTYTGTGCCAGCACTCACCACACCAACCAAGAGACCCAGTACTTCGGGCCA	CASTHHTNQETQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	6	3	6	0	6	3	20	30	39	36	42	TCRBV05,TCRBV12			TCRBD01,TCRBD02										CASTHHTNQETQYF+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACCTCCGCCACCCAAGAGACCCAGTACTTCGGGCCA	CSTSATQETQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	36	TCRBV20						TCRBJ02	TCRBJ02-05	01	8	3	7	1	0	9	26	-1	34	32	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSTSATQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCATACGAAGGGCAATGAGCAGTTCTTCGGGCCA	CSHTKGNEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	33	TCRBV20						TCRBJ02	TCRBJ02-01	01	8	5	3	6	7	0	26	32	-1	39	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSHTKGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACGAAAATGACAGACAATGAGCAGTTCTTCGGGCCA	CSATKMTDNEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	5	5	9	0	26	34	-1	43	48		TCRBV20-01,TCRBV20-or09_02												CSATKMTDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCAGGGGGCGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	2.2684790301798452E-5		40	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	0	0	2	2	26	34	44	36	46		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACACGGGAGGGTCCAATGAGCAGTTCTTCGGGCCA	CSANTGGSNEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	0	6	3	2	26	36	47	39	49		TCRBV20-01,TCRBV20-or09_02												CSANTGGSNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAACGGGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	10	2.2684790301798452E-5		41	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	3	0	3	0	26	40	-1	43	48		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACCTCTCCTACGAGCAGTACTTCGGGCCG	CSARDLSYEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	1	7	0	0	2	26	-1	41	37	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGGGGCTAGCGGGAGGCCGAGACGAGCAGTACTTCGGGCCG	CSAMGLAGGRDEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	4	1	5	5	5	26	36	52	41	57		TCRBV20-01,TCRBV20-or09_02												CSAMGLAGGRDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAAATACGGGCCTACCGGGATGAGCAGTTCTTCGGGCCA	CSAEIRAYRDEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	5	8	0	8	7	8	26	35	46	42	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAEIRAYRDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCGGATTCGCGAAACGAGCAGTACTTCGGGCCG		Out	VDJ	1	10	2.2684790301798452E-5		44	unresolved						TCRBJ02	TCRBJ02-07	01	0	1	8	5	2	8	23	40	45	42	53	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGAAGACTCRGCCSTGTATCTCTGYGCCAGCAGCCCGACGGTGGCAGGCACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	10	2.2684790301798452E-5		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	4	0	9	2	23	36	49	45	51	TCRBV04,TCRBV11													X+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCACCGCACGGCGGGAGAGGACCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	10	2.2684790301798452E-5		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	7	2	4	7	5	22	32	46	39	51	TCRBV09,TCRBV12													X+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAAAGGGGGAACTATGGCTACACCTTCGGTTCG	CASSERGNYGYTF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	5	1	2	3	0	22	34	-1	37	43	TCRBV09,TCRBV12													CASSERGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCGAGGGCGGGTATGATGAGACCCAGTACTTCGGGCCA	CASEGGYDETQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	8	7	4	5	4	6	22	31	40	35	46	TCRBV09,TCRBV12					01,02								CASEGGYDETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCGAGCGGGATGGAACTACGAGCAGTACTTCGGGCCG	CASSRAGWNYEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	6	3	3	3	5	24	35	45	38	50		TCRBV24-01,TCRBV24-or09_02												CASSRAGWNYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTAGAAATCACAGGAACACTGAAGCTTTCTTTGGACAA	CASSRNHRNTEAFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	5	1	7	0	24	36	-1	43	47		TCRBV24-01,TCRBV24-or09_02												CASSRNHRNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCAGGGGGCGGTGTCCCCCTACGAGCAGTACTTCGGGCCG	CASSQGAVSPYEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	0	2	0	8	24	-1	44	36	52		TCRBV24-01,TCRBV24-or09_02												CASSQGAVSPYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCAGTCCAATCCTAAGCTCCTACAATGAGCAGTTTTTCGGGCCA	CASSPILSSYNEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	unresolved						TCRBJ02			6	3	6	19	16	11	24	36	55	52	66	TCRBV24,TCRBV28			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01			TCRBJ02-01,TCRBJ02-05						CASSPILSSYNEQFF+X+TCRBJ02-X	unresolved		TCRBJ02	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGCCTAGGACGGTCTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGRSSNQPQHF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	unresolved						TCRBJ01	TCRBJ01-05	01	6	1	7	0	4	4	23	34	42	38	46	TCRBV06,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRSSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCCCCTAGGGCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPLGPNTGELFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	unresolved						TCRBJ02	TCRBJ02-02	01	5	5	3	0	5	1	23	35	44	40	45	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLGPNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTGGCAAGCCACGTTTGGTGCCCTCCCAGACATCTGTGTATTGTGTGCCAGAAAACTAGCGTACCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	10	2.2684790301798452E-5		37				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	21	3	6	6	14	3	44	40	61	54	64	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV06-08,TCRBV10-02				01,02								X+X+TCRBJ02-02		TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCRGCYGTGTAYYTCTGTGCCAGCAACACAACCGACAGGCAACCGGGGGACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	10	2.2684790301798452E-5		53	unresolved						TCRBJ02	TCRBJ02-05	01	7	2	4	2	8	11	18	28	42	36	53	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCAAATCGGCCGGGACTAGCGGGAGGGCGGTCGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	10	2.2684790301798452E-5		55	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	0	0	3	3	7	18	29	48	32	55	TCRBV11,TCRBV12													X+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAACTGGATGATTCCCCTGGACTAGCGGGATAATGGCGGGGAGCTGTTTTTTGGAGAA	CASNWMIPLD*RDNGGELFF	Stop	VDJ	1	10	2.2684790301798452E-5		60	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	1	3	7	16	6	18	28	56	44	62	TCRBV07,TCRBV11													CASNWMIPLD*RDNGGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCCCAACAGACTGGAGCCCGTACAATGAGCAGTTCTTCGGGCCA	CASSPTDWSPYNEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	48	unresolved						TCRBJ02	TCRBJ02-01	01	5	3	5	4	3	11	18	30	37	33	48	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTDWSPYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCGGCGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGGNTGELFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	7	5	1	2	0	18	35	-1	37	41	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAGGNTGELFF+X+TCRBJ02-02		TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCTTAGTGCCAGGACAACCCTACGAGCAGTACTTCGGGCCG	CASSLVPGQPYEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	6	2	5	2	18	34	44	39	46	TCRBV03,TCRBV11													CASSLVPGQPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTCACTAGAGCCGGGGAGCTGTTTTTTGGAGAA	CASSFTRAGELFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	3	8	6	4	2	20	31	40	35	42	TCRBV07,TCRBV23					01,02								CASSFTRAGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGGACTCRGCCMTGTATCKCTGTGCCAGCAGCCCGAACTCTCTCTCGGAGACCCAGTACTTCGGGCCA	CASSPNSLSETQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	3	10	5	4	8	19	31	38	35	46	TCRBV05,TCRBV07					01,02								CASSPNSLSETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCCCGGAAAACCTGGCCACTGAAGCTTTCTTTGGACAA	CASSPENLATEAFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	unresolved						TCRBJ01	TCRBJ01-01	01	5	1	8	4	2	9	19	31	36	33	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPENLATEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCRGCYSTSTATYTYTGTGCCAGCACCACCAACGGGGGTCAAGAGACCCAGTACTTCGGGCCA	CASTTNGGQETQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	2	2	7	1	19	29	42	36	43	TCRBV05,TCRBV12													CASTTNGGQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGKGACTCKGCYSTSTATYTCTGTGCCAGCAGTTCCGGACCGGGAACTTACGAGCAGTACTTCGGGCCG	CASSSGPGTYEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	3	4	8	3	19	30	43	38	46	TCRBV03,TCRBV05													CASSSGPGTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCCGCCCACGCTGGGGGCCCTACGAGCAGTACTTCGGGCCG	CASRPRWGPYEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	6	0	2	10	0	19	28	-1	38	44	TCRBV05,TCRBV07													CASRPRWGPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGCAAGCCACGTTTGSYSMMMSMSASASCTCTKTACYTCTGTGCCAGCAAACCACTTAGGGGGGCAGATACGCAGTATTTTGGCCCA	CASKPLRGADTQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	unresolved						TCRBJ02	TCRBJ02-03	01	7	5	1	4	8	1	39	49	63	57	64	TCRBV24,TCRBV25,TCRBV27,TCRBV28			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKPLRGADTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGCAAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCTTGAGAGGACAGGAGGTGGGCGAAGCTTTCTTTGGACAA	CASLRGQEVGEAFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	1	4	8	6	8	39	48	61	54	69	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASLRGQEVGEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGACTCRGCCMTGTAYYKCTGTGCCAGCAGTTTAACTAGCGGGGTGGAGACCCAGTACTTCGGGCCA	CASSLTSGVETQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	3	3	5	0	2	20	-1	45	35	47	TCRBV07,TCRBV13													CASSLTSGVETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCATGCGGCTACCCGAGGTGTGAACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	10	2.2684790301798452E-5		50	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	7	5	3	2	16	22	34	40	36	56	TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGGGGACTYRGCTKTGTATYTCTGTGCCAGCAGCGTCGTAGCGGGAGGGCCAGGTGAGCAGTTCTTCGGGCCA	CASSVVAGGPGEQFF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	0	9	4	5	22	34	49	38	54	TCRBV07,TCRBV09													CASSVVAGGPGEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ACCAGACAKCTSTKTACTTCTGTGCCATCAGAGACAGGGTGGCAAGGAGCAAGGTTTAATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	10	2.2684790301798452E-5		61	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	3	0	1	20	12	23	31	24	51	TCRBV06,TCRBV10,TCRBV24													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCACCAAGGGGGGGTGGTTCTCCGAGCAGTACTTCGGGCCG	CATKGGWFSEQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	10	9	0	6	4	8	23	30	41	34	49	TCRBV02,TCRBV21													CATKGGWFSEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGCAAGCCACGTTTGGTGCATCCTGAAGACAGCAGCTTCTAATCTGCAGTGGGGCTGTGGGAAGAAAGACGCAGTATTTTGGCCCA		Out	VDJ	1	10	2.2684790301798452E-5		35	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	18	7	0	9	9	13	46	42	56	51	69		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGACTCTCGCACAGATACGCAGTATTTTGGCCCA	CASSDSRTDTQYF	In	VDJ	1	10	2.2684790301798452E-5	2.911725226313843E-5	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	10	1	1	3	23	34	39	35	42	TCRBV02,TCRBV09					01,02								CASSDSRTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCCCGGGGTTAGAGACCCAGTACTTCGGGCCA	CASSPPGLETQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	3	4	5	2	26	37	47	42	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPPGLETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGACTCCCCGAGGCAGTACTTCGGGCCG	CASSDSPRQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	33	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	10	9	0	7	26	-1	42	38	49		TCRBV12-03,TCRBV12-04				01,02								CASSDSPRQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGGACTCCACAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSGLHSSYNEQFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	10	0	0	6	26	-1	43	38	49		TCRBV12-03,TCRBV12-04				01,02								CASSGLHSSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGTTACAGGAGGGCGAGCAGTACTTCGGGCCG	CASSLLQEGEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	0	6	6	0	26	40	-1	46	52		TCRBV12-03,TCRBV12-04												CASSLLQEGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTACTGTTGATGGGACAGTAGAGACCCAGTACTTCGGGCCA	CASSTVDGTVETQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	5	4	9	1	36	48	64	57	65	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASSTVDGTVETQYF+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCCACGTTTGGTGGCACCAACCAGACACTATGTACCTCTGTGCCAGCAGTGAATATTCGGGGGACTACGAGCAGTACTTCGGGCCG	CASSEYSGDYEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV25			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	2	3	2	1	39	56	64	58	65		TCRBV25-01,TCRBV25-or09_02												CASSEYSGDYEQYF+TCRBV25-X+TCRBJ02-07	TCRBV25	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTACCCCCGGGACAGCCTATGGCTACACCTTCGGTTCG	CASSTPGTAYGYTF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	4	6	1	24	36	49	42	50	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSTPGTAYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGATCTGGGTCTTAGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	11	2.4953269331978296E-5		53	TCRBV03						TCRBJ01	TCRBJ01-05	01	0	0	9	1	6	6	26	43	52	49	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGGGGCGGGAGGGTACATGACAATGAGCAGTTCTTCGGGCCA	CASSQDGGGRVHDNEQFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	54	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	0	5	5	6	26	43	57	48	63		TCRBV03-01,TCRBV03-02												CASSQDGGGRVHDNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCGAGAGTCTTAGAAAAACTGTTTTTTGGCAGT	CASSSRVLEKLFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	11	2	8	2	7	26	38	43	40	50		TCRBV03-01,TCRBV03-02												CASSSRVLEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*02	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTATGCCGTCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	11	2.4953269331978296E-5		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	5	20	0	26	38	-1	58	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGGGGGTCAATCAGCCCCAGCATTTTGGTGAT	CSARGVNQPQHF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	1	3	0	2	26	-1	41	34	43		TCRBV20-01,TCRBV20-or09_02												CSARGVNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGTCTGGGGAGGGGGATCACGAGCAGTACTTCGGGCCG	CSASGEGDHEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	0	5	5	5	26	34	46	39	51		TCRBV20-01,TCRBV20-or09_02												CSASGEGDHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGAGGGACAGGGGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	11	2.4953269331978296E-5		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	2	3	4	1	26	38	52	42	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCCGGCAACCTCGGGACGCTCCCTGGGGGCTACACCTTCGGTTCG	CSARDSGNLGTLPGGYTF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	54	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	0	7	8	13	10	26	40	58	53	68		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDSGNLGTLPGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTCAGCGGGAGTACCGGGGAGCTGTTTTTTGGAGAA	CSARFSGSTGELFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	6	2	5	3	1	26	38	49	41	50		TCRBV20-01,TCRBV20-or09_02												CSARFSGSTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGCAGCCAAGAGACCCAGTACTTCGGGCCA	CSASGSQETQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	36	TCRBV20						TCRBJ02	TCRBJ02-05	01	3	4	5	1	3	0	26	37	-1	40	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGSQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAGCGGGAGTACGCCGGGGAGCTGTTTTTTGGAGAA	CSAREREYAGELFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	6	2	6	2	4	26	37	47	39	51		TCRBV20-01,TCRBV20-or09_02												CSAREREYAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCCGGGACTACCTACGAGCAGTACTTCGGGCCG	CSARSGTTYEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	9	2	4	0	26	37	-1	41	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSGTTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTTTGGGCGGGGGGAGGAGCACTGAAGCTTTCTTTGGACAA	CSAPLGGGRSTEAFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	1	4	7	5	26	35	50	42	55		TCRBV20-01,TCRBV20-or09_02												CSAPLGGGRSTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGACCCCCCTAGCGGGAGTTGAGGATACGCAGTATTTTGGCCCA	CSARTPLAGVEDTQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	4	2	6	9	5	26	35	54	44	59		TCRBV20-01,TCRBV20-or09_02												CSARTPLAGVEDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCGGGGGTCGTTCCCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CGGRSLSGANVLTF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV20						TCRBJ02	TCRBJ02-06	01	11	6	1	0	0	9	26	-1	34	29	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CGGRSLSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCARCCARACMKCTYTGTACTTCTGTGCCAGCAGCCGACGGGACAGCACAGATACGCAGTATTTTGGCCCA	CASSRRDSTDTQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	unresolved						TCRBJ02	TCRBJ02-03	01	13	0	7	0	13	0	25	28	-1	41	46	TCRBV22,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRRDSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCARCCARACAKCTWTGTACYTCTGTGCCAGCAGTTCGGGAGGGGAGGGGAAAGAGACCCAGTACTTCGGGCCA	CASSSGGEGKETQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	13	8	0	3	10	7	25	28	46	38	53	TCRBV22,TCRBV28													CASSSGGEGKETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTAACCCAGGGCCTTCCTACGAGCAGTACTTCGGGCCG	CASSNPGPSYEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	1	4	3	22	34	43	38	46		TCRBV12-03,TCRBV12-04												CASSNPGPSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTCCCCGACCGCCCGGGACACCATATATTTTGGAGAG	CASSSPTARDTIYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	8	4	8	11	0	22	35	-1	46	50		TCRBV12-03,TCRBV12-04				01,02								CASSSPTARDTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGCCTCCGGGACAGGGAGGGCGGGACCCCCTGGGGAGCAGTTCTTCGGGCCA		Out	VDJ	1	11	2.4953269331978296E-5		56	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	3	10	6	18	24	35	50	41	68		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCTAGGACTGAACGAGGTGGGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	11	2.4953269331978296E-5		47	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	1	10	8	3	11	24	37	45	40	56		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGATAACAGAACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	11	2.4953269331978296E-5		35	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	5	5	4	1	24	35	43	39	44		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCAGGGACAGGGTGAAAAACTGTTTTTGGCAGT		Out	VDJ	1	11	2.4953269331978296E-5		38	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	3	18	2	10	24	36	47	38	57		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGAAAGAAATTCTGGAGCGGGTGGCCTATAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	11	2.4953269331978296E-5		55	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	6	4	7	12	8	24	38	56	50	64		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATGGGGACAGGGAGGAACATCAAATGGCTACACCTTCGGTTCG	CASSLWGQGGTSNGYTF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	6	5	11	24	36	50	41	61		TCRBV24-01,TCRBV24-or09_02												CASSLWGQGGTSNGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTACTAGCGGGAGGACGGCCTCCCTCCTCCAATGAGCAGTTCTTCGGGCCA	CASSLLAGGRPPSSNEQFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	57	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	3	1	6	3	15	24	35	50	38	65		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLLAGGRPPSSNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAGTGAAGGATTTTGAGACCCAGTACTTCGGGCCA	CASSQEVKDFETQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45							TCRBJ02	TCRBJ02-05	01	0	1	8	5	6	4	18	35	44	41	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEVKDFETQYF+X+TCRBJ02-05			TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAATGGGGCGGGCAGGGTAGATTTCGGTACACCTTCGGTTCG	CASSQEWGGQGRFRYTF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	51							TCRBJ01	TCRBJ01-02	01	0	4	3	11	10	10	18	35	50	45	60	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEWGGQGRFRYTF+X+TCRBJ01-02			TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCTACGGACAGGGCTACGAGCAGTACTTCGGGCCG	CASSLAYGQGYEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	3	3	4	0	18	35	-1	39	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAYGQGYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCACCGCGGGAGTGGCACCGGGGAGCTGTTTTTTGGAGAA	XASSHRGSGTGELFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	7	2	4	2	3	22	36	45	38	48	TCRBV04,TCRBV07,TCRBV17													XASSHRGSGTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCGAGCGGGAGCCACAGATACGCAGTATTTTGGCCCA	CASSRAGATDTQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	6	2	2	2	1	19	31	41	33	42		TCRBV05-06,TCRBV05-07												CASSRAGATDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGAGGTCTAGCGGGAGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLEV*REASTDTQYF	Stop	VDJ	1	11	2.4953269331978296E-5		54	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	4	1	0	6	2	19	33	50	39	52		TCRBV05-06,TCRBV05-07												CASSLEV*REASTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTATAGAGAGGGAGGTGCGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	11	2.4953269331978296E-5		53	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	2	9	1	0	7	4	19	33	46	40	50		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ01-03	TCRBV05	TCRBD02-01*02	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTCGAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFEGNTGELFF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	42	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	11	0	1	1	0	19	33	-1	34	39		TCRBV05-06,TCRBV05-07												CASSFEGNTGELFF+TCRBV05-X+TCRBJ02-02	TCRBV05	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTTGTCCGGGGGCGCTCTGGAAACACCATATATTTTGGAGAG	CASSFVRGRSGNTIYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	48	TCRBV05						TCRBJ01	TCRBJ01-03	01	2	6	0	0	5	1	19	33	44	38	45		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFVRGRSGNTIYF+TCRBV05-X+TCRBJ01-03	TCRBV05		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCTTAACTAGCGGGGGGTCCGGCGAGCAGTACTTCGGGCCG	CASSLTSGGSGEQYF	In	VDJ	1	11	2.4953269331978296E-5	3.2028977489452274E-5	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	3	1	6	1	5	19	33	46	34	51	TCRBV05,TCRBV11													CASSLTSGGSGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGCAAGCCACGTTTGGTGCTCCCTCCAAACATCTGTGTACTTCTGTGCCAGAAAACTAGCGTACCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	11	2.4953269331978296E-5		38	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	3	6	6	3	3	43	51	61	54	64		TCRBV06-02,TCRBV06-03				01,02								X+TCRBV06-X+TCRBJ02-02	TCRBV06	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GTTTGGTGCATCCTGAAGACAGCAGCTTCTMATCTGCAGTGCTTGAACTACTACCCACCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	11	2.4953269331978296E-5		46	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	18	3	9	0	15	10	35	31	50	46	60		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGTGCATCCTGAAGCAGCAGCTTCTACATCTGCAGTGCTAGGGGAGACAGAATCTTCAGTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	11	2.4953269331978296E-5		50	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	2	5	0	4	10	31	42	51	46	61		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCSRGGGACTYRGCTGTGTATYTYTGTGCCAGAAGAGAAATAGCGGGAGGGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	12	2.722174836215814E-5		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	12	5	0	1	11	0	26	31	-1	42	53	TCRBV07,TCRBV12													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCCAGGGACTTTCGACCGGGGAGCTGTTTTTTGGAGAA	CASSPQGLSTGELFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	10	5	6	4	26	37	49	43	53		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSPQGLSTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGCCCGGGACAGGCCCTACGAGCAGTACTTCGGGCCG	CASSARDRPYEQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	2	5	1	26	37	50	42	51	TCRBV12,TCRBV21													CASSARDRPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTAGTGGGGGACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	12	2.722174836215814E-5		43	TCRBV12						TCRBJ01	TCRBJ01-04	01	1	6	1	2	1	0	26	42	-1	43	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGAGGACAGGTGACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	12	2.722174836215814E-5		43	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	4	2	3	3	26	38	48	41	51		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGCGCAAGGAGGGGGCTAATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	2.722174836215814E-5		46	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	0	6	6	2	26	43	56	49	58		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCCACGTTTGGTGGGGACTCGGCCTSTATCTCTGTGCCAGCAGCTTAGCGTCTAGCGGAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLASSGAKNIQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	4	5	0	2	0	33	50	-1	52	59	TCRBV05,TCRBV07,TCRBV11					01,02								CASSLASSGAKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCAGCAACCCTCCGGGACCCAAAATAACCTACGAGCAGTACTTCGGGCCG	CASNPPGPKITYEQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	48	unresolved						TCRBJ02	TCRBJ02-07	01	7	0	7	2	7	9	24	34	46	41	55	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNPPGPKITYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGKGACTCKGCYRTGTATYTCTGTGCCAGCACCCCAGGGGACCGAGGTGTAAGCTATGGCTACACCTTCGGTTCG	CASTPGDRGVSYGYTF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	2	4	3	13	26	36	45	39	58	TCRBV03,TCRBV11													CASTPGDRGVSYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGTGCGGAATGAGCAGTTCTTCGGGCCA	CASSQEVRNEQFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	7	5	7	3	0	26	43	-1	46	50		TCRBV03-01,TCRBV03-02				01,02								CASSQEVRNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACACATTCTCTAACTATGGCTACACCTTCGGTTCG	CASSQDTFSNYGYTF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	6	0	1	4	26	43	47	44	51		TCRBV03-01,TCRBV03-02												CASSQDTFSNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTKGRKGACTCWGCYRTGTAYTTCTGTGCCAGCAGCCATGGACAGGGAGAAGGCGAGCAGTACTTCGGGCCG	CASSHGQGEGEQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	3	6	1	6	26	40	49	41	55	TCRBV02,TCRBV03													CASSHGQGEGEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGACGGCGACAGGCAGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSDGDRQATNEKLFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	4	0	6	4	26	38	50	44	54		TCRBV03-01,TCRBV03-02												CASSDGDRQATNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCGTAGCCCCAAAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	12	2.722174836215814E-5		41	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	5	7	2	1	6	26	38	43	39	49	TCRBV03,TCRBV12					01,02								X+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGTCAAATTCACCCCCCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQIHPPGANVLTF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	48	unresolved						TCRBJ02	TCRBJ02-06	01	2	3	7	2	4	4	26	41	47	45	51	TCRBV03,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQIHPPGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGGACTCSGCCGTGTATSTCTGTGCCAGCAGCTTAGGGGACCTTGGATATCTGAACACTGAAGCTTTCTTTGGACAA	CASSLGDLGYLNTEAFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	51	unresolved						TCRBJ01	TCRBJ01-01	01	1	0	7	0	0	10	20	-1	41	36	51	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGDLGYLNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGGACTCGGCCSTGTATSTCTGTGCCAGCAGCTTAGCGGGGAGAGGGGATAGCGGGATTCAGCAGTACTTCGGGCCG	CASSLAGRGDSGIQQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	5	3	8	15	3	20	34	57	49	60	TCRBV05,TCRBV07,TCRBV11													CASSLAGRGDSGIQQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAGGACAGGGCGAGAAGTGGAAACACCATATATTTTGGAGAG	CSAKDRARSGNTIYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	3	3	3	7	26	34	45	37	52		TCRBV20-01,TCRBV20-or09_02												CSAKDRARSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGACGGGGGGAGGACAGCCCCAGCATTTTGGTGAT	CSAPTGGGQPQHF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	8	1	7	5	4	26	34	46	39	50		TCRBV20-01,TCRBV20-or09_02												CSAPTGGGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCACAACAGGGGTAGCTATGGCTACACCTTCGGTTCG	CSARDHNRGSYGYTF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	2	4	5	3	26	40	52	45	55		TCRBV20-01,TCRBV20-or09_02												CSARDHNRGSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCGGGGAGGGGATACGCAGTATTTTGGCCCA	CSARRGGDTQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	0	6	3	0	26	37	-1	40	47		TCRBV20-01,TCRBV20-or09_02												CSARRGGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGACAGGGAACTACGAGCAGTACTTCGGGCCG	CSARTGNYEQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	3	1	2	26	35	44	36	46		TCRBV20-01,TCRBV20-or09_02												CSARTGNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CYMCCWSYCARACWKCTKTKTACTTCTGTGCCCCCACCAGGATCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	12	2.722174836215814E-5		34	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	13	4	4	6	8	2	25	28	40	36	42	TCRBV06,TCRBV22													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACCCCTACGAGCAGTACTTCGGGCCG	CASSQDPYEQYF	In	VJ	1	12	2.722174836215814E-5	3.494070271576612E-5	36	unresolved						TCRBJ02	TCRBJ02-07	01	0	0	0	2	0	2	23	-1	40	-1	42	TCRBV01,TCRBV04													CASSQDPYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCWSSSASWCAKCTGTGTACTTCTGTGCCAGCAGCATCAGGGRAGGTCGGACACCCCTCCACTTTGGGAAC	CASSIRXGRTPLHF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	unresolved			unresolved			TCRBJ01	TCRBJ01-06	01	6	4	3	11	3	9	22	33	41	36	50	TCRBV06,TCRBV10,TCRBV12			TCRBD01,TCRBD02										CASSIRXGRTPLHF+X+TCRBJ01-06	unresolved	unresolved	TCRBJ01-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCCCCCAGAAGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSPQKGSGNTIYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV12						TCRBJ01	TCRBJ01-03	01	6	5	3	0	8	0	22	33	-1	41	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQKGSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGTCAGCCTGAGGGGACGGCTCTATGGCTACACCTTCGGTTCG	CVSLRGRLYGYTF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	39	unresolved						TCRBJ01	TCRBJ01-02	01	8	0	7	4	5	4	22	31	41	36	45	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CVSLRGRLYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CARGGACTYGGSCCTRTATYTCTGTGCCAGCAGCTTCCAGACCCGCTACGAGCAGTACTTCGGGCCG	CASSFQTRYEQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	39	unresolved						TCRBJ02	TCRBJ02-07	01	3	2	7	3	3	3	22	36	42	39	45	TCRBV05,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFQTRYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCCTTGGGGACCATTTACCAAGAGACCCAGTACTTCGGGCCA	CATSDSLGTIYQETQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	51	TCRBV24						TCRBJ02	TCRBJ02-05	01	2	0	7	0	5	5	24	40	50	45	55		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDSLGTIYQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGAATAGCGGGATTGAGACCCAGTACTTCGGGCCA	CATSDLNSGIETQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	5	3	5	2	2	24	42	52	44	54		TCRBV24-01,TCRBV24-or09_02												CATSDLNSGIETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGCGGGTCGGGACATCCTACCCGCAGTTCTTCGGGCCA		Out	VDJ	1	12	2.722174836215814E-5		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	0	6	12	7	8	24	33	46	40	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTAACAGGGTTTCGGCAGCCCCAGCATTTTGGTGAT	CASSLTGFRQPQHF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	7	3	6	24	36	45	39	51	TCRBV06,TCRBV24													CASSLTGFRQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGCCCGTAATAGTTCGGTTCCGAGCAGTACTTCGGGCCG	CASSLSP**FGSEQYF	Stop	VDJ	1	12	2.722174836215814E-5		48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	5	8	6	12	8	24	36	51	48	59		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLSP**FGSEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGTCAGCTCGGTGGTGCGGCGTAATCAGCCCCAGCATTTTGGTGAT	CVSSVVRRNQPQHF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	14	7	5	4	13	3	24	28	45	41	48		TCRBV24-01,TCRBV24-or09_02				01,02								CVSSVVRRNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASGACTCGGCYSTGTATCTCTGTGCCAGCAGCTTAACGACTAGCGGGACAAAAAACATTCAGTACTTCGGCGCC	CASSLTTSGTKNIQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	1	2	3	4	2	2	19	34	47	36	49	TCRBV05,TCRBV07													CASSLTTSGTKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTAGGGGTCCGACTCGGCCCCAGCATTTTGGTGAT		Out	VDJ	1	12	2.722174836215814E-5		41	unresolved			unresolved			TCRBJ01	TCRBJ01-05	01	1	2	10	9	6	2	18	34	44	40	46	TCRBV05,TCRBV07			TCRBD01,TCRBD02										X+X+TCRBJ01-05	unresolved	unresolved	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGATCTGGGGAAGGTTTTGCAGCCCCAGCATTTTGGTGAT	CASSLDLGKVLQPQHF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	48	unresolved						TCRBJ01	TCRBJ01-05	01	1	0	8	7	5	8	18	34	43	39	51	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDLGKVLQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTCGACGTTACCTCCTACGAGCAGTACTTCGGGCCG	CASSFDVTSYEQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	unresolved						TCRBJ02	TCRBJ02-07	01	3	2	7	0	1	5	18	32	36	33	41	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFDVTSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTTGGACACCGAATACCAAGTTCCTACGAGCAGTACTTCGGGCCG	CASSFGHRIPSSYEQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	6	1	1	13	18	32	38	33	51	TCRBV07,TCRBV11													CASSFGHRIPSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCGCACCCACCCCCCCCTTAGAGTACAATGAGCAGTTCTTCGGGCCA	CASSAPTPPLEYNEQFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	8	4	16	2	18	30	49	46	51	TCRBV07,TCRBV11					01,02								CASSAPTPPLEYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTACATTGTGGGAGGGCTGTGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	12	2.722174836215814E-5		49	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	9	0	7	6	6	18	33	46	39	52	TCRBV05,TCRBV11													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTACCAAGTGGGCGGGGGCGCCCCGGGGAGCTGTTTTTTGGAGAA	CASSLPSGRGRPGELFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	7	2	6	8	4	18	33	48	41	52	TCRBV05,TCRBV11													CASSLPSGRGRPGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTACCGGGACGATTGAACACTGAAGCTTTCTTTGGACAA	CASSLPGRLNTEAFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	unresolved						TCRBJ01	TCRBJ01-01	01	2	0	7	0	2	3	18	33	40	35	43	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLPGRLNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTACGTCGGATGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLRRMNTGELFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	unresolved						TCRBJ02	TCRBJ02-02	01	2	1	8	1	4	1	18	33	40	37	41	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRRMNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTAGCGTTTAGTGGAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLAFSGAKNIQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	5	8	0	3	3	18	35	41	38	44	TCRBV07,TCRBV11					01,02								CASSLAFSGAKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTTGCGGGAGGGCCCACAGATACGCAGTATTTTGGCCCA	CASSFAGGPTDTQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	0	2	1	2	18	32	42	33	44	TCRBV07,TCRBV11													CASSFAGGPTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
RMGACWCGGCMCTGTATCTCTGYGCCAGCAGCCAAGAGGCAGGGGGCAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQEAGGNSNQPQHF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	0	0	4	2	20	35	47	39	49	TCRBV04,TCRBV05,TCRBV23													CASSQEAGGNSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCCACGTTTGGTGGCCCTCACATACCTCTCAAGTACCTCTGTGCCAGCAGTGAATATTCGGGGGACTACGAGCAGTACTTCGGGCCG	CASSEYSGDYEQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	TCRBV25			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	2	3	2	1	39	56	64	58	65		TCRBV25-01,TCRBV25-or09_02												CASSEYSGDYEQYF+TCRBV25-X+TCRBJ02-07	TCRBV25	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTGGCAAGCCACGTTTGGTGGCCCTCAATACCTCTCAGTACCTCTGTGCCAGCAGGGCAGAAAAAGGCGAGCAGTACTTCGGGCCG	CASRAEKGEQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	36	TCRBV25						TCRBJ02	TCRBJ02-07	01	6	4	5	6	2	7	45	56	61	58	68		TCRBV25-01,TCRBV25-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRAEKGEQYF+TCRBV25-X+TCRBJ02-07	TCRBV25		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCGGAACAGGGACAGGGGTGAATGAGCAGTTCTTCGGGCCA	CASGTGTGVNEQFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	2	7	6	2	19	28	44	34	46	TCRBV07,TCRBV11													CASGTGTGVNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGGACTCSGCCRTGTATCTCTGTGCCAGCAGCTCCGGGCAGGTTCTGGAGACCCAGTACTTCGGGCCA	CASSSGQVLETQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	unresolved						TCRBJ02	TCRBJ02-05	01	4	4	4	5	5	5	19	32	41	37	46	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGQVLETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCCAAGATTCCCGGCCGGCGGTTGGTGGCTACACCTTCGGTTCG	CASSQDSRPAVGGYTF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	7	5	7	15	4	19	31	50	46	54	TCRBV05,TCRBV07					01,02								CASSQDSRPAVGGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTGCAGGGGGGCGCCTATGGCTACACCTTCGGTTCG	CASSLQGGAYGYTF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	1	4	0	4	19	-1	41	34	45	TCRBV05,TCRBV07													CASSLQGGAYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGGACTCSGCCSTSTATCTCTGTGCCAGCAGTTCCGACAGGTTTAACTATGGCTACACCTTCGGTTCG	CASSSDRFNYGYTF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	4	1	4	2	19	30	40	34	42	TCRBV05,TCRBV07													CASSSDRFNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCTTGGGGACCTCTAACTATGGCTACACCTTCGGTTCG	CASSLGTSNYGYTF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	unresolved						TCRBJ01	TCRBJ01-02	01	0	1	7	0	0	2	19	-1	39	35	41	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTSNYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GRGACWCGGCMCTKTATCTYTGCGCCAGCAGCTTGTTAGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSLLGAKNIQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	unresolved						TCRBJ02	TCRBJ02-04	01	1	5	3	1	2	0	19	34	-1	36	40	TCRBV05,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLGAKNIQYF+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTCRGCYGTGTATSTCTGTGCYAGCAGCGGGGAACAGGGGTCTTAGGTATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	2.722174836215814E-5		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	2	5	5	7	22	34	46	39	53	TCRBV07,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAAAAGGACGAAGTCCTGGCACAGATACGCAGTATTTTGGCCCA	CASSLKGRSPGTDTQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	51	unresolved						TCRBJ02	TCRBJ02-03	01	4	1	7	1	5	9	22	35	44	40	53	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKGRSPGTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GTTTGGTGCATCCTGAAGACAGCAGCTTCTACWCTGCAGTGCTTGAACTACTACCCACCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	12	2.722174836215814E-5		46	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	17	3	9	0	14	10	35	32	50	46	60		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCTTCTTCCGGGACAGCTAACTATGGCTACACCTTCGGTTCG	CASSASSGTANYGYTF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	0	9	0	24	36	-1	45	52	TCRBV09,TCRBV21													CASSASSGTANYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGGACAGGTACAATGAGCAGTTCTTCGGGCCA	CASSVGDRYNEQFF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	4	4	4	0	24	36	-1	40	48	TCRBV09,TCRBV21													CASSVGDRYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGCAAGCCACGTTTGGTGCATCCTGAAGACAGCAGCTTTACATCTGCAGTGGGGCTGTGGGAAGAAAGACGCAGTATTTTGGCCCA		Out	VDJ	1	12	2.722174836215814E-5		35	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	21	7	0	9	12	13	46	39	56	51	69		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGCAAGCCACGTTTGGTGCATCCTGAAGACAGCAGYTCTACATCTGCAGTGGGGCTGTGGGAAGAAAGACGCAGTATTTTGGCCCA		Out	VDJ	1	12	2.722174836215814E-5		35	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	24	7	0	9	15	13	46	36	56	51	69		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAAGCGCGGGAGGGCCGCTCGAGCAGTACTTCGGGCCG	CASSESAGGPLEQYF	In	VDJ	1	12	2.722174836215814E-5	3.494070271576612E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	0	6	7	5	23	34	50	41	55	TCRBV02,TCRBV09													CASSESAGGPLEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGCCGGTGGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	12	2.722174836215814E-5		37	unresolved						TCRBJ01	TCRBJ01-01	01	5	0	9	4	7	0	23	34	-1	41	44	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTGGTGCATCCTGAAGACAGCAGCTTYCATCTGCAGTGCTAGGGGAGACAGAATCTTCAGTTGAACACTGAAGCTTTCTTTGGACAA	QC*GRQNLQLNTEAFF	Stop	VDJ	1	12	2.722174836215814E-5		48	TCRBV20						TCRBJ01	TCRBJ01-01	01	21	2	5	0	20	10	33	26	51	46	61		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									QC*GRQNLQLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGAACAGGAGCGGGAGGGCGCACAGATACGCAGTATTTTGGCCCA	CASRTGAGGRTDTQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	0	1	6	1	26	37	53	43	54	TCRBV09,TCRBV12													CASRTGAGGRTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCAACCAGGGGAGGAACGGCTACACCTTCGGTTCG	CASSNQGRNGYTF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	39	TCRBV12						TCRBJ01	TCRBJ01-02	01	6	4	2	8	4	6	26	37	47	41	53		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNQGRNGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATTACTAGCGGGATCGAGAAGTTACGAGCAGTACTTCGGGCCG	CASSLLLAGSRSYEQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	51	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	3	3	4	2	9	26	41	53	43	62		TCRBV12-03,TCRBV12-04												CASSLLLAGSRSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTATGGGGGAACACGAGCAGTACTTCGGGCCG	CASSFMGEHEQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	39	TCRBV12						TCRBJ02	TCRBJ02-07	01	3	6	1	5	3	3	26	40	48	43	51		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFMGEHEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACAGGTCTAGCGGGAGGGCCAACTACGAGCAGTACTTCGGGCCG	CASSHRSSGRANYEQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	4	0	3	5	4	26	40	57	45	61		TCRBV03-01,TCRBV03-02												CASSHRSSGRANYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTAACACCGGAACAGGGCAATGAGCAGTTCTTCGGGCCA	CSALTPEQGNEQFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	3	6	12	0	26	34	-1	46	52		TCRBV20-01,TCRBV20-or09_02												CSALTPEQGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCTCCTCTTGCGGGAGGGCTAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	2.9490227392337985E-5		47	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	7	0	5	10	2	26	36	55	46	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACTTATGGACTAGCGGGAGGGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	2.9490227392337985E-5		55	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	1	0	0	5	2	26	40	60	45	62		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGAACGGTATCCCTACGAGCAGTACTTCGGGCCG	CSARDERYPYEQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	8	5	2	4	4	26	40	47	44	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDERYPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGAGGGCCTCCATAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	2.9490227392337985E-5		40	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	11	0	5	1	7	26	37	43	38	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAAAATTGGACCGACCTTGGGGGAGCAGTACTTCGGGCCG	CSARKIGPTLGEQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	45	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	1	7	7	7	11	26	37	48	44	59		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARKIGPTLGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCCCAGGGGGCAGTGAACAATGAGCAGTTCTTCGGGCCA	CSASPQGAVNNEQFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	0	5	4	5	26	37	49	41	54		TCRBV20-01,TCRBV20-or09_02												CSASPQGAVNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGCCGGGACTAGCGAGGGAGCAGTACTTCGGGCCG	CSAMPGLAREQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	6	7	4	3	26	36	50	40	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSAMPGLAREQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTAGCGGGAGGCACAGATACGCAGTATTTTGGCCCA	CSALAGGTDTQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	2	1	1	0	26	35	-1	36	45		TCRBV20-01,TCRBV20-or09_02												CSALAGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTTCCGGAGGAGTGGCGTAGGTGAAGCTTTCTTTGGACAA	CSFRRSGVGEAFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	10	1	7	4	11	26	32	41	36	52		TCRBV20-01,TCRBV20-or09_02												CSFRRSGVGEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAAGCCACGTTTGGTGGCCCTCACATACCTCAGTACCTCTGTGCCAGCAGTGAATATTCGGGGGACTACGAGCAGTACTTCGGGCCG	CASSEYSGDYEQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	42	TCRBV25			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	2	3	2	1	39	56	64	58	65		TCRBV25-01,TCRBV25-or09_02												CASSEYSGDYEQYF+TCRBV25-X+TCRBJ02-07	TCRBV25	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAATAAGGGACAGGTAAATGAGCAGTTCTTCGGGCCA	CASNKGQVNEQFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	4	7	4	2	22	32	44	36	46		TCRBV12-03,TCRBV12-04												CASNKGQVNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCACCGGGACTAGCGGGAATCAAGTGCTCTTCGGGCCA	CASTGTSGNQVLF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	0	3	17	2	9	22	32	47	34	56	TCRBV02,TCRBV12													CASTGTSGNQVLF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTAGCCCGACTAGCGGGATCCTTTACGAGCAGTACTTCGGGCCG	CASSSPTSGILYEQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	2	3	4	5	5	22	34	50	39	55		TCRBV12-03,TCRBV12-04												CASSSPTSGILYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTATCCACGCCTCAGCAGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	13	2.9490227392337985E-5		56	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	15	5	22	34	53	49	58		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTTGGCGGGAGAAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	2.9490227392337985E-5		43	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	7	2	2	2	3	24	36	45	38	48		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCCCATTATCCCGGTCTGTGAGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	13	2.9490227392337985E-5		47	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	9	8	5	3	10	8	24	33	46	43	54		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTAGCGGGAAGGTAGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	2.9490227392337985E-5		44	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	3	3	0	7	24	-1	43	36	50		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAACTACGGCAACATTCAGTACTTCGGCGCC	CASSLNYGNIQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	6	3	9	7	4	4	24	36	44	40	48		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLNYGNIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCCTCGAGACAGCTTAATGAAAAACTGTTTTTTGGCAGT	CASSLSSRQLNEKLFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	5	4	10	2	24	36	51	46	53	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSSRQLNEKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGGGGGCGTGAGGACCGAACAACTGAAGCTTTCTTTGGACAA	CAIRGREDRTTEAFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	7	0	5	0	14	23	-1	39	34	53	TCRBV06,TCRBV10													CAIRGREDRTTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTGACTCGATTGTAGTTAACACTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	2.9490227392337985E-5		52	unresolved						TCRBJ02	TCRBJ02-03	01	0	3	6	2	11	2	26	43	57	54	59	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCKGCYGTGTATYTCTGTGCCAGCAGCTTAGATCTTGCGGGCGAGCAGTACTTCGGGCCG	CASSLDLAGEQYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	7	4	6	5	0	18	34	-1	39	44	TCRBV03,TCRBV07,TCRBV11					01,02								CASSLDLAGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGTCGGCGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLVGGYSNQPQHF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	48	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	7	4	0	5	2	19	33	43	38	45		TCRBV05-06,TCRBV05-07				01,02								CASSLVGGYSNQPQHF+TCRBV05-X+TCRBJ01-05	TCRBV05	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGGCAGGCCGGGGTACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGRGTGELFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	45	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	8	3	5	5	1	19	35	45	40	46		TCRBV05-06,TCRBV05-07												CASSLAGRGTGELFF+TCRBV05-X+TCRBJ02-02	TCRBV05	TCRBD02-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGGTTAACGGGGTGGGGGAGCTGTTTTTTGGAGAA	CASSLVNGVGELFF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	42	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	8	3	8	4	2	19	35	44	39	46		TCRBV05-06,TCRBV05-07												CASSLVNGVGELFF+TCRBV05-X+TCRBJ02-02	TCRBV05	TCRBD02-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCGTAGTAGACAGGGTCAGCGGCTCTGGAAACACCATATATTTTGGAGAG	CASSVVDRVSGSGNTIYF	In	VDJ	1	13	2.9490227392337985E-5	3.785242794207996E-5	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	3	0	6	7	24	36	49	42	56	TCRBV12,TCRBV21													CASSVVDRVSGSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGTGCATCCTGAAGACAGCAGCTTCTACWCTGCAGTGCTAGGGGAGACAGAATCTTCAGTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	13	2.9490227392337985E-5		49	TCRBV20						TCRBJ01	TCRBJ01-01	01	17	2	5	0	17	10	32	29	51	46	61		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCAAGGATGGGATGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	3.175870642251783E-5		40	TCRBV12						TCRBJ01	TCRBJ01-02	01	6	0	8	4	7	2	26	37	48	44	50		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCAGGGACGTCTACAATGAGCAGTTCTTCGGGCCA	CASSRDVYNEQFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV12						TCRBJ02	TCRBJ02-01	01	6	0	7	3	2	2	26	37	44	39	46		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDVYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGAGTCACGGATTTATGGCTACACCTTCGGTTCG	CASSESRIYGYTF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV12						TCRBJ01	TCRBJ01-02	01	5	1	8	5	7	2	26	38	48	45	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSESRIYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCCAGGGGACCTCTAACTATGGCTACACCTTCGGTTCG	CASSQGTSNYGYTF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	2	0	1	4	24	35	42	36	46	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSQGTSNYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAAGATGACAGGGGGCGGCACTGAAGCTTTCTTTGGACAA	CASKMTGGGTEAFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	0	4	4	2	26	36	50	40	52	TCRBV03,TCRBV12													CASKMTGGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCATTGGCGGTTTCGGTGGCTACACCTTCGGTTCG	CASSIGGFGGYTF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	7	5	7	4	6	26	38	46	42	52		TCRBV03-01,TCRBV03-02				01,02								CASSIGGFGGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACGGACTCATCAATGAGCAGTTCTTCGGGCCA	CASSHGLINEQFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	10	6	1	3	26	40	46	41	49		TCRBV03-01,TCRBV03-02				01,02								CASSHGLINEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGTGGAAACAGCTACGAGCAGTACTTCGGGCCG	CASSGNSYEQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	5	3	5	0	26	37	-1	42	46	TCRBV03,TCRBV09													CASSGNSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGGGGACTCRGCCSTGTATCTCTGTGCCAGCACGAGCCAGCGGGAGGGCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASTSQREGANTGELFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	6	0	0	6	2	22	32	48	38	50	TCRBV05,TCRBV07													CASTSQREGANTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGGGGACTCRGCCSTGTATCTCTGTGCCAGCAGCTTCGACCGGGGCCACGAGCAGTACTTCGGGCCG	CASSFDRGHEQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	unresolved						TCRBJ02	TCRBJ02-07	01	2	7	0	5	5	1	22	36	46	41	47	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFDRGHEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACATCAGCGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CSATSAGSYNEQFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	3	1	6	0	26	34	-1	40	47		TCRBV20-01,TCRBV20-or09_02												CSATSAGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACTGGGGATAAACACTGAAGCTTTCTTTGGACAA	CSALGINTEAFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	0	8	2	4	2	26	34	42	38	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALGINTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGAATACAGTAGCAATCAGCCCCAGCATTTTGGTGAT	CSAEYSSNQPQHF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	5	0	5	0	26	34	-1	39	43		TCRBV20-01,TCRBV20-or09_02												CSAEYSSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACGGGGGGCGGATGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	14	3.175870642251783E-5		44	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	8	1	5	2	6	26	40	49	42	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGGGTGTTAGGGGCCCTGGCTACACCTTCGGTTCG	CSARDRGVRGPGYTF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	2	7	1	12	26	40	46	41	58		TCRBV20-01,TCRBV20-or09_02												CSARDRGVRGPGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAGCCGGGGGACGTCCTGACTTTCGGGGCC	CSARDQPGDVLTF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	0	8	2	11	5	0	26	40	-1	45	51		TCRBV20-01,TCRBV20-or09_02												CSARDQPGDVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTTAAGCGGGCCCCTCTATAGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	14	3.175870642251783E-5		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	6	4	9	4	11	26	39	49	43	60		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATGATTTGGCTCTGGAAACACCATATATTTTGGAGAG	CSAR*FGSGNTIYF	Stop	VDJ	1	14	3.175870642251783E-5		42	TCRBV20						TCRBJ01	TCRBJ01-03	01	2	0	10	0	6	0	26	38	-1	44	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAR*FGSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGAAACAGGAGATACGCAGTATTTTGGCCCA	CSASETGDTQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	4	5	4	0	26	37	-1	41	46		TCRBV20-01,TCRBV20-or09_02												CSASETGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTACGTGGGTCCGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	3.175870642251783E-5		43	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	0	9	0	5	5	26	37	45	42	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGACAGGGCCGGTAAAGAGACCCAGTACTTCGGGCCA	CSADRAGKETQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	3	3	0	6	26	-1	42	35	48		TCRBV20-01,TCRBV20-or09_02												CSADRAGKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGTCAGGTAGGCGGGGAGACCCAGTACTTCGGGCCA	CSAGQVGGETQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	7	4	5	10	0	26	35	-1	45	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGQVGGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTCACAGGGGGCCGAACTGGAGGCTACACCTTCGGTTCG	CSAVTGGRTGGYTF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	0	8	3	9	26	35	47	38	56		TCRBV20-01,TCRBV20-or09_02												CSAVTGGRTGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCGGACTAGCGGGAGAGGGGAGACCCAGTACTTCGGGCCA	CASSRTSGRGETQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	1	2	5	1	4	22	34	48	35	52		TCRBV12-03,TCRBV12-04												CASSRTSGRGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCWSKSASWCWKCTGTKTACTTCTGTGCCAGCAGTTACCCTGGGTCGGGAGTCCTCCGGACTTACAATGAGCAGTTCTTCGGGCCA	CASSYPGSGVLRTYNEQFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	2	4	9	11	22	35	50	44	61	TCRBV06,TCRBV12													CASSYPGSGVLRTYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTGTGGGGGTCAGATACGCAGTATTTTGGCCCA	CASSLWGSDTQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV12						TCRBJ02	TCRBJ02-03	01	3	6	1	4	2	1	22	36	43	38	44		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLWGSDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGTCGTTCGGGGCTCAATCAGCCCCAGCATTTTGGTGAT	CASRSGLNQPQHF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	TCRBV12						TCRBJ01	TCRBJ01-05	01	9	7	0	3	6	1	22	30	41	36	42		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRSGLNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAAAAGACAGGGGCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	3.175870642251783E-5		41	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	11	2	2	0	3	2	24	31	42	34	44		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGTCAGCAGCGAGGGGGCCTCCCAGATACGCAGTATTTTGGCCCA	CATGQQRGGLPDTQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	9	5	0	4	11	4	24	33	51	44	55		TCRBV24-01,TCRBV24-or09_02												CATGQQRGGLPDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTAGGTTTGGGTTAACTATGGCTACACCTTCGGTTCG	CASS*VWVNYGYTF	Stop	VDJ	1	14	3.175870642251783E-5		42	unresolved						TCRBJ01	TCRBJ01-02	01	6	0	9	1	7	1	24	36	46	43	47	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASS*VWVNYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTTCGGCTAGCGGGAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSFRLAGDTGELFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	4	2	3	6	0	24	36	-1	42	52	TCRBV06,TCRBV24													CASSFRLAGDTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCACCCGCTTACAAAAGGGACGGACCTACAATGAGCAGTTCTTCGGGCCA	CASTRLQKGRTYNEQFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	51	unresolved						TCRBJ02	TCRBJ02-01	01	7	0	7	2	13	3	23	33	51	46	54	TCRBV06,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTRLQKGRTYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATCAGGGAATGAGCAGTTCTTCGGGCCA	CASSESGNEQFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	36	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	3	7	1	0	23	38	-1	39	44		TCRBV06-01,TCRBV06-08												CASSESGNEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGTTTGGTGCCCCAACCAGACAGCTCTTACTTCTGTGCCAGCAGTCTGACAGGTCCCTCCAGCACAGATACGCAGTATTTTGGCCCA	CASSLTGPSSTDTQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	4	0	2	7	33	45	53	47	60	TCRBV06,TCRBV24	TCRBV06-07,TCRBV24-01,TCRBV24-or09_02												CASSLTGPSSTDTQYF+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAAGACTCGGCCSTGTATCTCTGTGCCAGCAGCGTTGGTTGGAACACTGAAGCTTTCTTTGGACAA	CASSVGWNTEAFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	unresolved						TCRBJ01	TCRBJ01-01	01	5	0	10	1	3	3	18	30	35	33	38	TCRBV04,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGWNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCAAGAAAAGGGGGGAGGTGTCACAGATACGCAGTATTTTGGCCCA	CASSQEKGGGVTDTQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	51							TCRBJ02	TCRBJ02-03	01	0	5	1	2	2	7	18	35	43	37	50	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEKGGGVTDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCGGGAGGTAGGGTCCTCCCCTTACAATGAGCAGTTCTTCGGGCCA	CASSREVGSSPYNEQFF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	1	4	0	14	18	-1	37	30	51	TCRBV07,TCRBV11													CASSREVGSSPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTTCTTGGACAGGGGCCTGGCGAGCAGTACTTCGGGCCG	CASSFLGQGPGEQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	2	6	4	5	18	32	45	36	50	TCRBV07,TCRBV11													CASSFLGQGPGEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CRRRRGACTCAGCCSTGTATCTCTRCACCAGCAGCCACACCGGAGCCAGAGATACGCAGTATTTTGGCCCA	XTSSHTGARDTQYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	10	10	2	5	14	4	22	26	44	40	48	TCRBV04,TCRBV17													XTSSHTGARDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTGGCAAGCCACGTTTGGTGGCCCTCACATACCTCTCGTACCTCTGTGCCAGCAGGGCAGAAAAAGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	3.175870642251783E-5		35				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	25	4	3	6	15	10	46	38	58	53	68	TCRBV25,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV28-01												X+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCTTGGGGGAGAGAGACAGCCCCAGCATTTTGGTGAT	CASSLGGERQPQHF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	42	unresolved						TCRBJ01	TCRBJ01-05	01	4	6	1	7	3	7	19	31	39	34	46	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGERQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTATGACAGGTTATATACATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	3.175870642251783E-5		43	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	4	6	2	8	19	32	40	34	48		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ01-02	TCRBV05	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGRGACWCRGCMCKSTATYTCTGTGCCAGCAGCCGGGACCGGCTCTCTGGAAACACCATATATTTTGGAGAG	CASSRDRLSGNTIYF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	45	unresolved						TCRBJ01	TCRBJ01-03	01	5	0	7	0	1	5	24	36	42	37	47	TCRBV05,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDRLSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTAGGGACAGGGAACGGCTACACCTTCGGTTCG	CASSLGTGNGYTF	In	VDJ	1	14	3.175870642251783E-5	4.0764153168393806E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	8	4	3	24	35	48	39	51	TCRBV12,TCRBV21													CASSLGTGNGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCCGGTGTGGGACAGGGAGATAATAAGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	14	3.175870642251783E-5		59	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	3	4	9	11	22	34	52	43	63		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCACCTGACAGGGGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	3.175870642251783E-5		38	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	2	2	0	3	0	23	30	-1	33	41	TCRBV09,TCRBV21													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCTGGGAAGGTTATAATTCTGTCGGGGAGCTGTTTTTTGGAGAA	CASSPWEGYNSVGELFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	51	TCRBV12						TCRBJ02	TCRBJ02-02	01	5	0	8	7	4	15	26	38	46	42	61		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPWEGYNSVGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLTSGANVLTF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	42	TCRBV12						TCRBJ02	TCRBJ02-06	01	2	3	7	0	0	0	26	-1	-1	41	43		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTSGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGGGCGCCGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGGADTGELFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	7	0	3	0	4	26	-1	47	42	51		TCRBV12-03,TCRBV12-04												CASSLGGADTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCCAATCGGGACTAGTCTTCAAGATACGCAGTATTTTGGCCCA	CASSPIGTSLQDTQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	8	5	5	6	23	36	49	41	55	TCRBV01,TCRBV23					01,02								CASSPIGTSLQDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCAGGGACTAGCAATCTCCTACGAGCAGTACTTCGGGCCG	CASSQGLAISYEQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	7	0	2	3	36	48	59	50	62	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01				01,02								CASSQGLAISYEQYF+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGACAGACTAGCGGGGAGCAGTACTTCGGGCCG	CASRQTSGEQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	4	7	3	0	26	37	-1	40	50		TCRBV03-01,TCRBV03-02				01,02								CASRQTSGEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGTAGCGGGACCTTATTTACGAGCAGTACTTCGGGCCG	CASSQG*RDLIYEQYF	Stop	VDJ	1	15	3.402718545269768E-5		48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	5	3	4	2	7	26	42	52	44	59		TCRBV03-01,TCRBV03-02												CASSQG*RDLIYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCATAGCGGACTCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSP*RTPSTDTQYF	Stop	VDJ	1	15	3.402718545269768E-5		48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	5	5	0	2	6	26	39	47	41	53		TCRBV03-01,TCRBV03-02				01,02								CASSP*RTPSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAAACCGCGCCGGGACAGCGAACACTGAAGCTTTCTTTGGACAA	CASSLNRAGTANTEAFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	1	12	1	26	38	57	50	58		TCRBV03-01,TCRBV03-02												CASSLNRAGTANTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACTAGCACGAGAGACCCAGTACTTCGGGCCA	CSALARETQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	3	7	4	0	3	26	-1	40	34	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSALARETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCAGGGACAGGGGAAGAGTTCTATGGCTACACCTTCGGTTCG	CSAPGTGEEFYGYTF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	4	4	7	26	34	48	38	55		TCRBV20-01,TCRBV20-or09_02												CSAPGTGEEFYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGGGGAGTGTGACTGAAGCTTTCTTTGGACAA	CSARGGSVTEAFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	0	5	0	6	26	-1	44	37	50		TCRBV20-01,TCRBV20-or09_02												CSARGGSVTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGACTAGCGGGAGGAGACTCCTACGAGCAGTACTTCGGGCCG	CSASGLAGGDSYEQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	1	1	0	1	3	26	37	52	38	55		TCRBV20-01,TCRBV20-or09_02												CSASGLAGGDSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCGGGGAACACTGAAGCTTTCTTTGGACAA	CSASSGNTEAFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	8	4	1	2	0	26	37	-1	39	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSASSGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATACGGACTAGCGGGAGAACACCCGTTTTCGGGCCA	CSAIRTSGRTPVF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02			4	1	2	19	3	10	26	36	52	39	62		TCRBV20-01,TCRBV20-or09_02						TCRBJ02-01,TCRBJ02-05						CSAIRTSGRTPVF+TCRBV20-X+TCRBJ02-X	TCRBV20	TCRBD02-01*02	TCRBJ02	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGGACACGACCTACGAGCAGTACTTCGGGCCG	CSAPDTTYEQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	6	2	2	3	26	35	42	37	45		TCRBV20-01,TCRBV20-or09_02												CSAPDTTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGTGGGGGTCAGATACGCAGTATTTTGGCCCA	CSARWGSDTQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	36	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	6	1	4	4	1	26	35	44	39	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARWGSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCGCTCCGGAACTCCTACAATGAGCAGTTCTTCGGGCCA	CSAALRNSYNEQFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	5	1	8	0	7	1	26	35	45	42	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAALRNSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTTCGGCCGGACTAGCGGGAGCCCCTTATGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	3.402718545269768E-5		55	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	1	2	3	8	11	26	33	54	41	65		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACGTTTGGTGCCCCAACCAGACAGCTCTTACTTCTGTGCCTCCTTGACGATTAGCGGGGACTTACAATGAGCAGTTCTTCGGGCCA	VPP*RLAGTYNEQFF	Stop	VDJ	1	15	3.402718545269768E-5		45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	24	5	3	4	22	3	36	30	60	52	63		TCRBV24-01,TCRBV24-or09_02												VPP*RLAGTYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAATACAGGGGGCGGGGACGAGCAGTACTTCGGGCCG	CASNTGGGDEQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	3	0	5	2	4	22	32	43	34	47	TCRBV02,TCRBV12													CASNTGGGDEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
SRGGGACTYRGCTGTGTAYYTCTGTGCCAGCAGCCTCCCTTAGCGGGAGGTCTGTAATGAGCAGTTCTTCGGGCCA	CASSLP*REVCNEQFF	Stop	VDJ	1	15	3.402718545269768E-5		48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	1	7	7	5	22	33	50	40	55	TCRBV07,TCRBV12													CASSLP*REVCNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCGTAGGGGGGGGTGAGACCCAGTACTTCGGGCCA	CASSVGGGETQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	9	0	5	4	2	22	33	44	37	46		TCRBV12-03,TCRBV12-04												CASSVGGGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAGTCTCCGGGAGCTACATTCAGTACTTCGGCGCC	CASSEVSGSYIQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	8	2	8	8	2	22	34	48	42	50		TCRBV12-03,TCRBV12-04												CASSEVSGSYIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD02-01*02	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCGAAAGAGGGACAAACACAGATACGCAGTATTTTGGCCCA	CASERGTNTDTQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	0	6	2	6	2	22	31	43	37	45	TCRBV09,TCRBV12													CASERGTNTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCGACAGGGGACACTGAAGCTTTCTTTGGACAA	CASSSTGDTEAFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	3	2	0	24	36	-1	38	46		TCRBV24-01,TCRBV24-or09_02												CASSSTGDTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTACCGACAGGGGCCTATGGCTACACCTTCGGTTCG	CASSLLPTGAYGYTF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	2	4	8	1	24	36	52	44	53		TCRBV24-01,TCRBV24-or09_02												CASSLLPTGAYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCTCCCGGGCAGAACTCTCCTACGAGCAGTACTTCGGGCCG	CASSRAELSYEQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	42	TCRBV24						TCRBJ02	TCRBJ02-07	01	11	8	0	0	6	6	24	31	41	37	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRAELSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGTGAATAGCGGGATTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	15	3.402718545269768E-5		44	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	3	4	5	1	23	35	48	40	49	TCRBV06,TCRBV10													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CACCWSCCARACAKCTKTGTACTTSTGTGCCAGCAGTTCCCCCTCTAGCGGTCCAGATACGCAGTATTTTGGCCCA	CASSSPSSGPDTQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	5	4	6	2	23	36	49	42	51	TCRBV06,TCRBV22					01,02								CASSSPSSGPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTACACGGGGATACGCAGTATTTTGGCCCA	CASSLHGDTQYF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	8	4	6	4	0	23	36	-1	40	44	TCRBV06,TCRBV24					01,02								CASSLHGDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCTTTTACGGACTTTAAGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	3.402718545269768E-5		41	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	1	10	6	7	5	20	31	43	38	48	TCRBV04,TCRBV23					01,02								X+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTATTCGCGGGAGGGATCAATGAGCAGTTCTTCGGGCCA	CASSLFAGGINEQFF	In	VDJ	1	15	3.402718545269768E-5	4.367587839470765E-5	45	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	7	0	6	4	2	19	33	46	37	48		TCRBV05-06,TCRBV05-07												CASSLFAGGINEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCCTCCCAAACATCTGTGTACTTCTGTGCCAGCAGTTAAGGGCGGGGGGCTAACTATGGCTACACCTTCGGTTCG	CASS*GRGANYGYTF	Stop	VDJ	1	15	3.402718545269768E-5		45	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	7	1	0	3	0	25	39	-1	42	50		TCRBV06-02,TCRBV06-03												CASS*GRGANYGYTF+TCRBV06-X+TCRBJ01-02	TCRBV06	TCRBD02-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGTGACTCTGCTGTGTATTTCTGTGCCTCCCGGGGGGTAGCGGTTTTTACAGGTCCTATGGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	15	3.402718545269768E-5		59	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	11	8	1	1	3	24	22	28	38	31	62		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGTGCATCCTGAAGACRCAGCTTCTACATCTGCAGTGCTAGGGGAGACAGAATCTTCAGTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	3.402718545269768E-5		50	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	2	5	0	4	10	31	42	51	46	61		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGTGGGGAATGAGCAGTTCTTCGGGCCA	CASSVVGNEQFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	36	TCRBV12						TCRBJ02	TCRBJ02-01	01	6	6	2	7	6	0	26	37	-1	43	47		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVVGNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCCAGCCGGGTATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSSRVSGANVLTF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	8	4	1	7	2	26	37	48	44	50		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSSSRVSGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD02-01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCTTGACCGGGACAGCCAACACTGAAGCTTTCTTTGGACAA	CASSLTGTANTEAFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	2	7	2	26	37	51	44	53	TCRBV09,TCRBV12													CASSLTGTANTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGARGACTCRGCYSYKTATCTYTGCGCCAGCAGCCAAGATTGGGCGGGAGAAAAACTGTTTTTTGGCAGT	CASSQDWAGEKLFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	7	3	8	4	0	23	40	-1	44	50	TCRBV01,TCRBV05													CASSQDWAGEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGCATCCTGAAGACAGCAGCTTCTMATCTGCGACTTCTAGCGGGACTAGCACAGATACGCAGTATTTTGGCCCA	ATSSGTSTDTQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	19	4	3	0	12	2	42	37	58	49	60		TCRBV20-01,TCRBV20-or09_02												ATSSGTSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATGAACCGTTGAGCAGTTCTTCGGGCCA	CASSQ*TVEQFF	Stop	VDJ	1	16	3.629566448287752E-5		36	TCRBV03						TCRBJ02	TCRBJ02-01	01	2	2	8	9	1	5	26	41	44	42	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQ*TVEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGGGACAAAAATCAGCCCCAGCATTTTGGTGAT	CASSPRDKNQPQHF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	6	4	3	2	26	39	48	42	50		TCRBV03-01,TCRBV03-02												CASSPRDKNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGKGACTCKGCYRTGTATYTCTGTGCCAGCAGCTCCCGACTAGCGTCAAACTCCTACGAGCAGTACTTCGGGCCG	CASSSRLASNSYEQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	6	0	4	5	26	38	50	42	55	TCRBV03,TCRBV11					01,02								CASSSRLASNSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGKGACTCWGCYRTGTATYKCTGTGCCAGCAGCTTAGCGTCTAGCGGAGCTAAAAACATTTAGTACTTCGGCGCC	CASSLASSGAKNI*YF	Stop	VDJ	1	16	3.629566448287752E-5		48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	4	5	14	7	14	26	38	52	45	66	TCRBV03,TCRBV07					01,02								CASSLASSGAKNI*YF+X+TCRBJ02-04	unresolved	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCATCGCATCACAGGGGTTCAATGAGCAGTTCTTCGGGCCA	CASIASQGFNEQFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	3	2	6	7	2	26	36	50	43	52		TCRBV03-01,TCRBV03-02												CASIASQGFNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGGGGACTCRGCCSTGTATSTCTGTGCCAGCAGCTTGGGGGGGTCAAGGAGCTACGAGCAGTACTTCGGGCCG	CASSLGGSRSYEQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	9	1	3	0	8	22	-1	43	37	51	TCRBV05,TCRBV11													CASSLGGSRSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGGGGATAAAGGCCCCCACGAGACCCAGTACTTCGGGCCA	CSGDKGPHETQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	9	8	3	5	0	14	26	-1	36	31	50		TCRBV20-01,TCRBV20-or09_02												CSGDKGPHETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGGTGGACTAGTTCGTTTTACAATGAGCAGTTCTTCGGGCCA	CSAGWTSSFYNEQFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	8	4	5	7	26	34	46	39	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGWTSSFYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGATCACCGGGGGGGATTCTAGCAATCAGCCCCAGCATTTTGGTGAT	CSAITGGDSSNQPQHF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	8	0	0	6	4	26	34	48	40	52		TCRBV20-01,TCRBV20-or09_02												CSAITGGDSSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGCGGAGTTGAGCTACGAGCAGTACTTCGGGCCG	CSARRAELSYEQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	2	5	3	3	0	10	26	-1	42	38	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRAELSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAACGGAGGACTAGCCAGGGGAGAGATACGCAGTATTTTGGCCCA	CSARERRTSQGRDTQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	1	7	5	5	8	26	40	53	45	61		TCRBV20-01,TCRBV20-or09_02				01,02								CSARERRTSQGRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTACTAGTGGGAGGAGGCACCGGGGAGCTGTTTTTTGGAGAA	CSARVLVGGGTGELFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	9	1	4	7	3	26	39	52	46	55		TCRBV20-01,TCRBV20-or09_02												CSARVLVGGGTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCTGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	16	3.629566448287752E-5		35	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	4	10	4	2	1	26	37	41	39	42		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGTTAGGTGGGAGCGGCACTGAAGCTTTCTTTGGACAA	CSGLGGSGTEAFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	6	5	4	11	0	26	33	-1	44	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSGLGGSGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCCTCTCGACTAGAACTAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	16	3.629566448287752E-5		50	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	2	8	5	7	5	24	39	52	46	57		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCAGGGGTGGTAGCTTTCTTTGGACAA	CATSDSGVVAFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	10	0	4	24	-1	46	40	50		TCRBV24-01,TCRBV24-or09_02												CATSDSGVVAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCCCCCCTCGGGAGGTTCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	16	3.629566448287752E-5		52				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	8	1	2	11	3	24	36	54	47	57	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												X+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTTCTGTACCAGGAGCGGGAGAGACCCAGTACTTCGGGCCA	CASSFSVPGAGETQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	6	4	4	14	0	24	36	-1	50	56		TCRBV24-01,TCRBV24-or09_02				01,02								CASSFSVPGAGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTTGGYSYCMSMSASAYCTSTGTACYTSTGTGCCAGCAGTACCAACTTTAGCGGGAGGGACTTTTGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	16	3.629566448287752E-5		53	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	0	7	8	7	23	35	54	43	61	TCRBV06,TCRBV25,TCRBV27,TCRBV28													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTCCTGAGAATCGGAGCAGCCCCAGCATTTTGGTGAT	CASSDS*ESEQPQHF	Stop	VDJ	1	16	3.629566448287752E-5		45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	10	2	7	9	0	23	40	-1	49	53	TCRBV06,TCRBV10													CASSDS*ESEQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCTCCTGACAGGCTCGAACACTGAAGCTTTCTTTGGACAA	CASSLLTGSNTEAFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	4	1	5	3	18	30	41	35	44	TCRBV07,TCRBV11													CASSLLTGSNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCTCCGGGACAGTCCCTATTTGGCTACACCTTCGGTTCG	CASSSPGQSLFGYTF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	7	4	8	18	31	42	35	50	TCRBV07,TCRBV11													CASSSPGQSLFGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCAAGCCACGTTTGGTGCCAGGGACTCAGCTGTTACTTCTGTGCCAGCTTGAGAGGACAGGAGGTGGGCGAAGCTTTCTTTGGACAA	CASLRGQEVGEAFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	1	4	8	6	8	39	48	61	54	69	TCRBV06,TCRBV12	TCRBV06-07,TCRBV12-03,TCRBV12-04,TCRBV12-05												CASLRGQEVGEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTCRGCYSTSTATCTCTGTGCCAGCAGCAGATATGGATCGGCCCCCGCCGGTGGAAACACCATATATTTTGGAGAG	CASSRYGSAPAGGNTIYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	54	unresolved						TCRBJ01	TCRBJ01-03	01	4	1	8	3	6	14	19	31	40	37	54	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRYGSAPAGGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTCGGGTAGCGAAGGCACTACGAGCAGTACTTCGGGCCG	CASSFG*RRHYEQYF	Stop	VDJ	1	16	3.629566448287752E-5		45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	5	6	3	4	6	22	36	45	40	51	TCRBV07,TCRBV11					01,02								CASSFG*RRHYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGRGACWCRGCWSTGTATCTCTGYGCTAGCAGCTTAGAACAGACCTACGAGCAGTACTTCGGGCCG	CASSLEQTYEQYF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	5	2	1	1	22	38	43	39	44	TCRBV07,TCRBV23													CASSLEQTYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTCRGCYGTGTATCTCTGTGCTAGCAGCTTAGACCCGGGGAATGAGCAGTTCTTCGGGCCA	CASSLDPGNEQFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	3	7	3	0	22	38	-1	41	46	TCRBV07,TCRBV11													CASSLDPGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGTGCTTTTTAGCCCTGAGCAGTTCTTCGGGCCA	CASSVLFSPEQFF	In	VDJ	1	16	3.629566448287752E-5	4.658760362102149E-5	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	7	9	9	2	23	34	47	43	49	TCRBV02,TCRBV09					01,02								CASSVLFSPEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGCCAGCTCTGAGCAGTTCTTCGGGCCA	CASSASSEQFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	33	TCRBV12						TCRBJ02	TCRBJ02-01	01	6	4	5	9	3	3	26	37	43	40	46		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSASSEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGGGACAGGGCGAGTTGAGACCCAGTACTTCGGGCCA	CASSGTGRVETQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	5	0	6	26	-1	47	38	53		TCRBV12-03,TCRBV12-04												CASSGTGRVETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCCTGAACACTGAAGCTTTCTTTGGACAA	CASSSLNTEAFF	In	VJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	36	TCRBV12						TCRBJ01	TCRBJ01-01	01	4	0	0	0	0	3	26	-1	39	-1	42		TCRBV12-03,TCRBV12-04												CASSSLNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGAGCTACTCCGGAGGGGGGGAACTATGGCTACACCTTCGGTTCG	CAIRATPEGGNYGYTF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	9	0	2	12	0	24	35	-1	47	54	TCRBV06,TCRBV10													CAIRATPEGGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGCTGACATCCCATTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	3.8564143513057367E-5		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	6	5	4	12	26	38	46	42	58		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCTTTTATAACGGGAGAGTACTACAATGAGCAGTTCTTCGGGCCA	CASSSFITGEYYNEQFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	2	3	10	4	26	38	54	48	58		TCRBV03-01,TCRBV03-02												CASSSFITGEYYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCTCGACTAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSTSTGELFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	2	8	4	2	0	26	35	-1	37	43		TCRBV03-01,TCRBV03-02				01,02								CASSTSTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACTTTAGGTAACGAGCAGTACTTCGGGCCG	CSATLGNEQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	33	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	5	4	5	6	2	26	34	43	40	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATLGNEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGGGGCTAACAGGGAAGAACTATGGCTACACCTTCGGTTCG	CSAPGLTGKNYGYTF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	2	10	3	26	34	50	44	53		TCRBV20-01,TCRBV20-or09_02												CSAPGLTGKNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAAGATAACTTATACGCAGTATTTTGGCCCA	CSAKITYTQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	3	10	7	7	1	26	34	44	41	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSAKITYTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAATAGCGGGAGGACAGATACGCAGTATTTTGGCCCA	CSANSGRTDTQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	5	1	3	3	0	26	34	-1	37	47		TCRBV20-01,TCRBV20-or09_02												CSANSGRTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGACGGGACAGCCTATTAGCCTTCGGGCTACACCTTCGGTTCG		Out	VDJ	1	17	3.8564143513057367E-5		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	8	3	14	26	34	44	37	58		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGAGGTCAGGGAGGGGACGAGCAGTACTTCGGGCCG	CSARDGGQGGDEQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	9	0	5	9	1	26	40	56	49	57		TCRBV20-01,TCRBV20-or09_02												CSARDGGQGGDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCCCAGCTCAACCCTACGTCCGAGCAGTACTTCGGGCCG	CSARDSQLNPTSEQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	48	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	4	5	6	4	14	26	40	47	44	61		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDSQLNPTSEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAGGGGGGCCGAGCAGTACTTCGGGCCG	CSASRGAEQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	1	6	0	2	26	-1	44	37	46		TCRBV20-01,TCRBV20-or09_02												CSASRGAEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCACAGGGGTCATGGAAACACCATATATTTTGGAGAG	CSASHRGHGNTIYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	3	2	3	2	3	26	37	46	39	49		TCRBV20-01,TCRBV20-or09_02												CSASHRGHGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATACAGCAAGACAGATCCTATGGCTACACCTTCGGTTCG	CSAIQQDRSYGYTF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	5	4	8	3	26	36	49	44	52		TCRBV20-01,TCRBV20-or09_02												CSAIQQDRSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGGCCGGGACAGGGGATTTATTTTTGGAGGAAAAACTGTTTTTTGGCAGT	CSAMAGTGDLFLEEKLFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	2	8	5	14	26	36	51	41	65		TCRBV20-01,TCRBV20-or09_02												CSAMAGTGDLFLEEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCAACACAGAAGGACTCCACCTACGAGCAGTACTTCGGGCCG	CATQKDSTYEQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	12	1	10	2	9	3	22	27	41	36	44	TCRBV12,TCRBV21					01,02								CATQKDSTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTAGGACAGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSRTGMNTEAFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	0	1	1	24	36	45	37	46		TCRBV24-01,TCRBV24-or09_02												CASSRTGMNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCGTTACGCATATAATGAGCAGTTCTTCGGGCCA	CASSRYAYNEQFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	39	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	3	7	7	4	6	24	36	42	40	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRYAYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCTACAGCTCTCGGATGAACACTGAAGCTTTCTTTGGACAA	CASSSYSSRMNTEAFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	5	0	4	8	24	36	44	40	52		TCRBV24-01,TCRBV24-or09_02												CASSSYSSRMNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTGGGGTTGGAAACACCATATATTTTGGAGAG	CASSFGVGNTIYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	39	TCRBV24						TCRBJ01	TCRBJ01-03	01	6	6	2	3	3	1	24	36	43	39	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGVGNTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCATGTCATCTTCGGTGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	17	3.8564143513057367E-5		41	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	11	8	5	2	9	2	24	31	43	40	45		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCAGGGGCTTCTCGCAATCAGCCCCAGCATTTTGGTGAT	CASSLAGASRNQPQHF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	2	2	0	6	18	-1	40	35	46	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAGASRNQPQHF+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GRAGACWCGGCMCTGTATCTCTGCGCCAGCAGCCACTGGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSHWGSYNEQFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	42	unresolved						TCRBJ02	TCRBJ02-01	01	6	6	1	1	5	0	20	31	-1	36	41	TCRBV04,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHWGSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCATTACAGGGGGCACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSITGGTNTGELFF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	0	0	3	1	19	31	43	34	44	TCRBV05,TCRBV11													CASSITGGTNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCTACTAGCGGAGAGCACAGATACGCAGTATTTTGGCCCA	CASSLLAESTDTQYF	In	VDJ	1	17	3.8564143513057367E-5	4.949932884733534E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	3	5	0	2	2	19	31	41	33	43	TCRBV05,TCRBV11					01,02								CASSLLAESTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTCAAAGGAGGGACAGGGTGGGTACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	17	3.8564143513057367E-5		55	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	3	2	7	6	19	33	49	40	55		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GTTTGGTGCATCCTGAAGACAGCAGYTCTACATCTGCAGTGCTTGAACTACTACCCACCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	17	3.8564143513057367E-5		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	9	0	3	10	34	43	50	46	60		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCTACTTGGTCTAGCGGGAGGGAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	3.8564143513057367E-5		56	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	0	0	10	4	25	33	55	43	59		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCACCCGTTGGCTAGCGGGATTCTCCACCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	3.8564143513057367E-5		49	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	10	4	3	2	8	8	23	30	47	38	55	TCRBV02,TCRBV12													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTCGGGACAGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSSGQGTGELFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	3	4	1	0	26	39	-1	40	49	TCRBV12,TCRBV21													CASSSGQGTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCTCCATACGGCGAGCAGTACTTCGGGCCG	CASSSPYGEQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	36	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	8	5	6	7	0	26	39	-1	46	49		TCRBV12-03,TCRBV12-04				01,02								CASSSPYGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ARRRRGACTCAGCYGYGTATCTCTRCACCAGCAGCCACGAACGATGGGGGTAGCCGGTATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	4.083262254323721E-5		49	unresolved						TCRBJ02	TCRBJ02-01	01	3	6	1	8	8	8	23	37	50	45	58	TCRBV01,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCATCAAGGACAGTTGGAACTATGGCTACACCTTCGGTTCG	CASIKDSWNYGYTF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	5	2	4	4	24	34	44	38	48	TCRBV06,TCRBV10													CASIKDSWNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGGTAAGCCCCCGACAGGTGATACGGGGAGCTGTTTTTTGGAGAA	CAR*APDR*YGELFF	Stop	VDJ	1	18	4.083262254323721E-5		45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	2	4	7	11	5	24	31	48	42	53	TCRBV06,TCRBV10													CAR*APDR*YGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGTTCCTCGGACAGGGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	4.083262254323721E-5		53	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	2	0	7	0	26	43	-1	50	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTCGGCGGTCACCATATATTTTGGAGAG	CASSQDSAVTIYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	0	7	5	9	4	1	26	43	51	47	52		TCRBV03-01,TCRBV03-02				01,02								CASSQDSAVTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD02-01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGATTCCACAGGGGGAGAAAGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	18	4.083262254323721E-5		53	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	3	1	4	6	5	26	39	53	45	58		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGGCATAGCACAGATACGCAGTATTTTGGCCCA	CARHSTDTQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	33	TCRBV03						TCRBJ02	TCRBJ02-03	01	9	4	6	0	1	1	26	34	37	35	38		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CARHSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGAAGGGGACAGGGGAATCAGCCCCAGCATTTTGGTGAT	CSAGRGQGNQPQHF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	2	4	6	0	26	34	-1	40	50		TCRBV20-01,TCRBV20-or09_02												CSAGRGQGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCAGCGGGAGTTACTCCTACGAGCAGTACTTCGGGCCG	CSARASGSYSYEQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	6	2	0	2	3	26	39	49	41	52		TCRBV20-01,TCRBV20-or09_02												CSARASGSYSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGGGACTAGAAGGAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CSASGGLEGTNTGELFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	0	8	0	3	6	26	37	48	40	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSASGGLEGTNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCAGGGTTACTCCTACGAGCAGTACTTCGGGCCG	CSARQGYSYEQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	0	1	3	26	37	43	38	46		TCRBV20-01,TCRBV20-or09_02												CSARQGYSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGACTAGCGCAAATACGCAGTATTTTGGCCCA	CSARTSANTQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	6	7	1	3	26	35	45	36	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSARTSANTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGACTAGCGGTCCTTAACGAGCAGTACTTCGGGCCG	CSAGLAVLNEQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	5	5	0	6	26	-1	45	35	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGLAVLNEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCCCGGGACAGTTTGGTCAACGTCCCTACGAGCAGTACTTCGGGCCG	CSASPGQFGQRPYEQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	2	5	13	26	35	47	40	60		TCRBV20-01,TCRBV20-or09_02												CSASPGQFGQRPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTGCGCCTGCCCTACGAGCAGTACTTCGGGCCG	CSALRLPYEQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	7	6	2	2	5	26	35	40	37	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSALRLPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCWSCCAGACMTMTSTGTACYWSTGTGCCAGCAGTCCTCTTTACTGGGGCGGTGTACAAGAGACCCAGTACTTCGGGCCA	CASSPLYWGGVQETQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	7	0	2	12	6	22	32	49	44	55	TCRBV06,TCRBV08													CASSPLYWGGVQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGCTCGGACTAGCGGAACCCTAGCTGAGCAGTTCTTCGGGCCA	CASSARTSGTLAEQFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	5	9	4	9	22	34	48	38	57		TCRBV12-03,TCRBV12-04				01,02								CASSARTSGTLAEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAAACCGGGACAGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSETGTVNTGELFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	5	1	4	1	24	38	49	42	50		TCRBV24-01,TCRBV24-or09_02												CATSETGTVNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTGTCCCGGGACAGAGGGTCCATGGCTACACCTTCGGTTCG		Out	VDJ	1	18	4.083262254323721E-5		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	6	7	7	24	36	50	43	57	TCRBV24,TCRBV27													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGSGACTCRGCTGTGTATYTYTGTGCCAGCAGCTCGCCGGGTATTCGGTGGCTACACCTTCGGTTCG		Out	VDJ	1	18	4.083262254323721E-5		40	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	8	4	7	3	7	19	32	39	35	46	TCRBV07,TCRBV12					01,02								X+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTTCCTACCGGGACAGGGCTTGAACACTGAAGCTTTCTTTGGACAA	CASSFLPGQGLNTEAFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	0	6	2	18	32	47	38	49	TCRBV07,TCRBV11													CASSFLPGQGLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGACTYGGCYGTGTATSTCTGTGCCAGCACCTTAGGTGGGACAGGGAACCCCACTTACTCTGGAAACACCATATATTTTGGAGAG	CASTLGGTGNPTYSGNTIYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	60	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	0	3	0	2	11	18	34	45	36	56	TCRBV07,TCRBV11													CASTLGGTGNPTYSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
RRGACWCGGCMCTGTATCTCTGYGCCAGAAGACGAAGACTAGAGGCTCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	18	4.083262254323721E-5		53	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	9	2	8	0	8	6	20	28	42	36	48	TCRBV05,TCRBV23					01,02								X+X+TCRBJ02-06	unresolved	TCRBD02-01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCCCGAGCGTCCCCGACACTGAAGCTTTCTTTGGACAA	CASSPSVPDTEAFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	6	6	3	3	6	19	31	38	34	44	TCRBV07,TCRBV11					01,02								CASSPSVPDTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTGGAAGGGGGAAACTATGGCTACACCTTCGGTTCG	CASSLEGGNYGYTF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	1	2	1	1	19	35	42	36	43	TCRBV05,TCRBV11													CASSLEGGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGRGACWCRGCMCKGTATYTCTGTGCCACCATTTCCGGGACAGGGCTTTACGAGCAGTACTTCGGGCCG	CATISGTGLYEQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	0	3	4	8	3	19	26	43	34	46	TCRBV05,TCRBV21													CATISGTGLYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCCAGGACAGCATAAACACTGAAGCTTTCTTTGGACAA	CASSQDSINTEAFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	5	2	2	4	19	31	39	33	43	TCRBV05,TCRBV11													CASSQDSINTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCRGCCSTGTATCTCYGTGCCAGCTGCGGTACTATCTCGCGAAAGACCTATGGCTACACCTTCGGTTCG	XASCGTISRKTYGYTF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	7	3	9	4	6	13	19	28	38	34	51	TCRBV05,TCRBV07					01,02								XASCGTISRKTYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCKGCCSTGTATCTCTGTGCCAGCATATAGTCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	18	4.083262254323721E-5		40	unresolved						TCRBJ01	TCRBJ01-02	01	7	2	7	4	11	0	19	29	-1	40	43	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTCGTAGCGGGAGCGTACAATGAGCAGTTCTTCGGGCCA	CASSVVAGAYNEQFF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	2	4	4	2	24	36	49	40	51	TCRBV09,TCRBV21													CASSVVAGAYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCCCWMCCARACAKCTSTKTACTTCTGTGCCAGCAGTTTATCTGGCGGCCGGGAGACCCAGTACTTCGGGCCA	CASSLSGGRETQYF	In	VDJ	1	18	4.083262254323721E-5	5.241105407364918E-5	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	7	5	5	6	4	25	38	48	44	52	TCRBV06,TCRBV24,TCRBV27					01,02								CASSLSGGRETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGTGCATCCTGAAGACAGCRCTTCTACATCTGCAGTGCTAGGGGAGACAGAATCTTCAGTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	4.083262254323721E-5		50	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	2	5	0	4	10	31	42	51	46	61		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGATGGACGGTGGGAGGGACAGATACGCAGTATTTTGGCCCA	CASRWTVGGTDTQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	9	0	3	9	0	26	37	-1	46	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRWTVGGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCACGGACAAGCAGTCTTTTCTTCGGGCCA	CASSPRTSSLFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	6	16	5	9	26	37	47	42	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPRTSSLFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGAAGCGGAACGGAACTATGAAAAACTGTTTTTTGGCAGT	CASSEAERNYEKLFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	6	6	5	6	3	9	26	37	45	40	54		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSEAERNYEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGGGACAGGGGAACCGGAACACTGAAGCTTTCTTTGGACAA	CASRGQGNRNTEAFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	1	0	5	26	-1	47	37	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRGQGNRNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGAACCCGGGACAGGGTGAAATGAGCAGTTCTTCGGGCCA	CASSFEPGTG*NEQFF	Stop	VDJ	1	19	4.3101101573417056E-5		48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	7	7	3	26	40	56	47	59		TCRBV12-03,TCRBV12-04												CASSFEPGTG*NEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCTCAATTAGGGGGGATACGCAGTATTTTGGCCCA	CASSIRGDTQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	12	5	1	6	10	0	26	31	-1	41	47	TCRBV12,TCRBV21													CASSIRGDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCAGCATAGGGACCGGGTTTTTCTACAATGAGCAGTTCTTCGGGCCA	CASIGTGFFYNEQFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	45	unresolved						TCRBJ02	TCRBJ02-01	01	7	0	7	3	2	9	24	34	41	36	50	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIGTGFFYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACGCGGGAGGACAAGAGACCCAGTACTTCGGGCCA	CASSQDAGGQETQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	7	1	2	1	1	26	43	52	44	53		TCRBV03-01,TCRBV03-02												CASSQDAGGQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCCGGGGTACGCAGTATTTTGGCCCA	CASSQARGTQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	36	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	8	3	8	2	0	26	42	-1	44	49		TCRBV03-01,TCRBV03-02												CASSQARGTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAAGGACAGGGGAGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	19	4.3101101573417056E-5		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	2	2	2	2	26	36	47	38	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCACAGGGGGATCCCTACGAGCAGTACTTCGGGCCG	CSAPQGDPYEQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	1	2	2	3	26	35	45	37	48		TCRBV20-01,TCRBV20-or09_02												CSAPQGDPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGGCGGGACCTTCGGGTTACGAGCAGTACTTCGGGCCG	CSAEAGPSGYEQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	3	4	3	9	26	35	44	38	53		TCRBV20-01,TCRBV20-or09_02												CSAEAGPSGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGCGGGAGGGCCCCTACGAGCAGTACTTCGGGCCG	CSAGREGPYEQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	0	2	2	2	26	35	46	37	48		TCRBV20-01,TCRBV20-or09_02												CSAGREGPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGGGGCCGCGAACACTGAAGCTTTCTTTGGACAA	CSAGGAANTEAFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	1	0	4	26	-1	42	35	46		TCRBV20-01,TCRBV20-or09_02												CSAGGAANTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGTAGAGGACGTGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSVEDVDTGELFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	45	TCRBV12						TCRBJ02	TCRBJ02-02	01	6	1	7	3	6	4	22	33	43	39	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVEDVDTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTCCCTGGGGAGGTTATAGTTCTGTCGGGGAGCTGTTTTTGGAGAA		Out	VDJ	1	19	4.3101101573417056E-5		50	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	9	1	18	5	22	22	34	45	39	67		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAGGAGGAAACACAGATACGCAGTATTTTGGCCCA	CASSEGGNTDTQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	1	2	3	3	22	34	42	37	45		TCRBV12-03,TCRBV12-04												CASSEGGNTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCCTGGGCTAGCTGGCATGGAGCAGTTCTTCGGGCCA		Out	VDJ	1	19	4.3101101573417056E-5		46	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	7	10	7	7	24	39	51	46	58		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACTTCGACGTCAGCCCAGCGGGGGATGAGTAGTTCTTTGGGCCA		Out	VDJ	1	19	4.3101101573417056E-5		44	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02			10	6	2	22	14	14	24	32	54	46	68		TCRBV24-01,TCRBV24-or09_02						TCRBJ02-01,TCRBJ02-05						X+TCRBV24-X+TCRBJ02-X	TCRBV24	TCRBD02-01*01	TCRBJ02	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCTTCATCGGGACTAGCATCAATGAGCAGTTCTTCGGGCCA	CASSFIGTSINEQFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	7	6	7	2	24	35	51	42	53	TCRBV24,TCRBV27					01,02								CASSFIGTSINEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGGGACCGGGGCTAGCGGGACGATCACCAGGGAGCAGTTCTTCGGGCCA	CASGTGASGTITREQFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	11	4	3	10	12	11	24	31	52	43	63		TCRBV24-01,TCRBV24-or09_02												CASGTGASGTITREQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTMSCTCCCAGACATCTGTRTACTTCTGTGCCTGCTCGGGAGGAGGAAACACCATATATTTTGGAGAG	CACSGGGNTIYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	36	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	11	8	1	4	4	1	26	32	43	36	44	TCRBV06,TCRBV10													CACSGGGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCCTTTGGGAACTGGTAACGAGCAGTACTTCGGGCCG	CASSLAPLGTGNEQYF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	48							TCRBJ02	TCRBJ02-07	01	0	0	8	5	6	7	18	35	45	41	52	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAPLGTGNEQYF+X+TCRBJ02-07			TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACWCRGCMSKGTATYTCTGTGCCAGCAGCCACCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSHPNTGELFF	In	VDJ	1	19	4.3101101573417056E-5	5.5322779299963024E-5	39	unresolved						TCRBJ02	TCRBJ02-02	01	5	3	7	0	1	1	24	36	39	37	40	TCRBV07,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHPNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAAGSMCTYKSMSMTGTMYCTSTGTGCCACCGCTTGGCTGGACACCGGGGAGCTGTTTTTTGGAGAA	CATAWLDTGELFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	16	9	0	3	10	3	22	25	38	35	41	TCRBV05,TCRBVA													CATAWLDTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGAACAGGGAACTATCAGCCCCAGCATTTTGGTGAT	CASSRTGNYQPQHF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	5	4	4	26	37	47	41	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRTGNYQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCGCCGGGGAGCTGTTTTTTGGAGAA	CASSSAGELFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	33	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	8	6	6	1	0	26	39	-1	40	42		TCRBV12-03,TCRBV12-04				01,02								CASSSAGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGTTCTCGGCGGGAGAGAGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	4.5369580603596903E-5		46	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	7	2	6	10	5	26	34	51	44	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCAGGACTAGCGGGTGGTGAGCAGTTCTTCGGGCCA	CSAPGLAGGEQFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	4	9	4	3	26	34	49	38	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPGLAGGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAACAGGGGGCGGCTCAGCCCCAGCATTTTGGTGAT	CSAKQGAAQPQHF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	0	6	1	3	26	36	46	37	49		TCRBV20-01,TCRBV20-or09_02												CSAKQGAAQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGGGGAGTGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	4.5369580603596903E-5		41	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	9	0	4	0	5	26	-1	44	37	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTCGGTTTATGGGCTATGAGCAGTTCTTCGGGCCA	CSAPRFMGYEQFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	8	0	8	11	1	26	35	50	46	51		TCRBV20-01,TCRBV20-or09_02												CSAPRFMGYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAAGAAGCGGTCCTTCACTACGAGCAGTACTTCGGGCCG	CSAEEAVLHYEQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	6	5	3	5	7	26	35	45	40	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAEEAVLHYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTGCTGAGGGCTACTAGCGGGAGGGGGGGCTACGAGCAGTACTTCGGGCCG	CSVLRATSGRGGYEQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	3	0	3	11	4	26	33	57	44	61		TCRBV20-01,TCRBV20-or09_02												CSVLRATSGRGGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGARGACTCRGCCCTKTATCTYTGCGCCAGCAGCCACGGGACGGCCGGCGGTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	4.5369580603596903E-5		44	unresolved						TCRBJ01	TCRBJ01-02	01	3	0	7	5	1	9	23	37	43	38	52	TCRBV04,TCRBV05			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCATTAAAGGGGGCGGGAGCTATGGCTACACCTTCGGTTCG	CAIKGGGSYGYTF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	39	unresolved						TCRBJ01	TCRBJ01-02	01	10	5	0	4	4	5	22	29	40	33	45	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIKGGGSYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCCGGGCCTGGGGAGCAGTACTTCGGGCCG	CATSDSGPGEQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	39	TCRBV24						TCRBJ02	TCRBJ02-07	01	2	8	0	7	2	5	24	40	46	42	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDSGPGEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTCGGGTTTAACTATGGCTACACCTTCGGTTCG	CATSVGFNYGYTF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	8	4	1	1	2	24	37	42	38	44		TCRBV24-01,TCRBV24-or09_02				01,02								CATSVGFNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGAGAGGGTGGACACCGGGGAGCTGTTTTTTGGAGAA	CATERVDTGELFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	9	11	0	3	2	3	24	33	40	35	43		TCRBV24-01,TCRBV24-or09_02												CATERVDTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCAGGGCTTCGGATACGCAGTATTTTGGCCCA	CASSRASDTQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	4	3	6	0	5	24	-1	40	35	45		TCRBV24-01,TCRBV24-or09_02												CASSRASDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAAGGGACAGCGGCCGGGGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	20	4.5369580603596903E-5		52	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	5	3	5	10	24	36	48	41	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCTCCCGATCTGGAGAGGACGGCTACACCTTCGGTTCG	CASSFSRSGEDGYTF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	45	TCRBV24						TCRBJ01	TCRBJ01-02	01	6	1	7	8	17	0	24	36	-1	53	57		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSRSGEDGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCCTCCTCCTCGGGGGGAGGACTGAAGCTTTCTTTGGACAA	CASSLLLGGRTEAFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	1	5	8	3	18	30	45	38	48	TCRBV11,TCRBV23													CASSLLLGGRTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCGGGACGCAAGTCGTGAACACTGAAGCTTTCTTTGGACAA	CASSGTQVVNTEAFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	45	unresolved						TCRBJ01	TCRBJ01-01	01	5	0	7	0	0	8	18	-1	35	30	43	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGTQVVNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCTTACAGCAATGGGACAATGAGCAGTTCTTCGGGCCA	CASSLQQWDNEQFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	42	unresolved			unresolved			TCRBJ02	TCRBJ02-01	01	2	0	9	5	7	0	18	33	-1	40	43	TCRBV03,TCRBV11			TCRBD01,TCRBD02										CASSLQQWDNEQFF+X+TCRBJ02-01	unresolved	unresolved	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTGCAGTCAACTATGGCTACACCTTCGGTTCG	CASSLAAVNYGYTF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	5	2	2	2	18	35	40	37	42	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAAVNYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTCGGACTAGCGCGAGGAGATGAGCAGTTCTTCGGGCCA	CASSFGLARGDEQFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	6	8	1	7	18	32	42	33	49	TCRBV07,TCRBV11					01,02								CASSFGLARGDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGGGACTCRGCCSTKTATCTYTRCGCCAGCAGCCTCAGGGACAGGGACATAGATACGCAGTATTTTGGCCCA	XASSLRDRDIDTQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	5	4	4	22	34	47	38	51	TCRBV05,TCRBV07,TCRBV17													XASSLRDRDIDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGGATCAGGGTGAGGCCTACGAGCAGTACTTCGGGCCG	CASSLDQGEAYEQYF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	2	2	5	19	35	42	37	47		TCRBV05-06,TCRBV05-07												CASSLDQGEAYEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTCCCCGGCCAGGGGGCTTGACTGAAGCTTTCTTTGGACAA	CASSFPRPGGLTEAFF	In	VDJ	1	20	4.5369580603596903E-5	5.823450452627686E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	0	5	8	3	19	33	49	41	52	TCRBV05,TCRBV11													CASSFPRPGGLTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGAGCTTTACAATGAGCAGTTCTTCGGGCCA	CASSLELYNEQFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	6	7	4	0	2	26	-1	45	42	47		TCRBV12-03,TCRBV12-04				01,02								CASSLELYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCACCAGCAGCCCCTCCGGGACTAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	21	4.7638059633776745E-5		46	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	9	0	5	0	23	36	-1	41	48	TCRBV01,TCRBV04					01,02								X+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACCGAGAAGACAGGCCTCTATGGCTACACCTTCGGTTCG	CASSQTEKTGLYGYTF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	4	4	8	3	26	41	55	49	58		TCRBV03-01,TCRBV03-02												CASSQTEKTGLYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGAGACTAGCGGGAGGGTTTATTCGGAGACCCAGTACTTCGGGCCA	CASSETSGRVYSETQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	2	0	5	2	8	26	38	54	40	62		TCRBV03-01,TCRBV03-02												CASSETSGRVYSETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGTGAACGGGCGGGAGAGTTGTGAATCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	4.7638059633776745E-5		50	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	7	2	1	8	9	26	34	49	42	58		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCCGACAGGGACTATGAAAAACTGTTTTTTGGCAGT	CSARSDRDYEKLFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	2	3	6	4	3	26	37	48	41	51		TCRBV20-01,TCRBV20-or09_02												CSARSDRDYEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAACCGTTCCGGGACTATCGAAATGAGCAGTTCTTCGGGCCA	CSAQPFRDYRNEQFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	9	7	10	4	26	35	52	45	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSAQPFRDYRNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCATCGTCCCACCGGGGGAACACTGAAGCTTTCTTTGGACAA	CSAPSSHRGNTEAFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	3	1	12	0	26	35	-1	47	52		TCRBV20-01,TCRBV20-or09_02												CSAPSSHRGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTACCCGGGACAGGGAATCGTGGACTATGGCTACACCTTCGGTTCG	CSYPGQGIVDYGYTF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	0	3	3	5	8	26	32	46	37	54		TCRBV20-01,TCRBV20-or09_02												CSYPGQGIVDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCAGTTGGAATAGCGGACGCTTTGACGAGCAGTTCTTCGGGCCA	CASSWNSGRFDEQFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	5	5	10	4	10	23	36	46	40	56	TCRBV06,TCRBV27					01,02								CASSWNSGRFDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCGGAGACAGGCGCTTGGACGGGGAACTGTTTTTTGGAGAA	CASGDRRLDGELFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	2	4	14	3	15	23	32	41	35	56	TCRBV24,TCRBV27													CASGDRRLDGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAAGGGAGGAAACACTGAAGCTTTCTTTGGACAA	CATKGGNTEAFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	36	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	9	1	2	1	1	24	34	41	35	42		TCRBV24-01,TCRBV24-or09_02												CATKGGNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGGAGGGGACAGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CATREGTGSYNEQFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	3	1	4	0	24	35	-1	39	48		TCRBV24-01,TCRBV24-or09_02												CATREGTGSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCTTACTAGCGGGAGTTGCGGTTGAGCAGTTCTTCGGGCCA	CASSLLAGVAVEQFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	3	2	9	3	7	23	34	48	37	55	TCRBV06,TCRBV10													CASSLLAGVAVEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGACGGACAGGCTACGAGCAGTACTTCGGGCCG	CASSERRTGYEQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	42	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	4	3	4	0	23	38	-1	42	49		TCRBV06-01,TCRBV06-08												CASSERRTGYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACCTAGCTTCTCGCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	21	4.7638059633776745E-5		47							TCRBJ01	TCRBJ01-02	01	0	2	7	4	11	0	18	35	-1	46	49	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02			TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCAAGATTCTGGTTAGCCGGGGGAGCAGTACTTCGGGCCG	CASSQDSG*PGEQYF	Stop	VDJ	1	21	4.7638059633776745E-5		45				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	3	7	11	0	18	35	-1	46	51	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDSG*PGEQYF+X+TCRBJ02-07		TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGGGGTTCCTACGAGCAGTACTTCGGGCCG	CASSLAGGSYEQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	42				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	9	1	1	0	1	18	-1	41	35	42	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAGGSYEQYF+X+TCRBJ02-07		TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GRGACWCRGCMMTGTATCKCTGYGCCAGCAGCTTGGCGGCAGGGAGGAAGACCCAGTACTTCGGGCCA	CASSLAAGRKTQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	9	1	6	7	1	19	33	46	40	47	TCRBV07,TCRBV23													CASSLAAGRKTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCAGGGGACTAGCGGGAGAGGACCACACCTACGAGCAGTACTTCGGGCCG	CASSRGLAGEDHTYEQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	54	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	0	2	2	2	9	19	31	47	33	56		TCRBV05-06,TCRBV05-07												CASSRGLAGEDHTYEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCCTCGACAGGGGTCGGCGCAGATACGCAGTATTTTGGCCCA	CASSSSTGVGADTQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	2	4	4	6	19	32	44	36	50	TCRBV05,TCRBV11													CASSSSTGVGADTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTCTTCTCCAGGGGGCTTTAGAGACCCAGTACTTCGGGCCA	CASSFLLQGALETQYF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	0	4	7	3	19	33	48	40	51	TCRBV05,TCRBV11													CASSFLLQGALETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTCRGCYSTGTATCTCTGTGCCAGCAGCTTGAGCCCTAAGGGGGCCGAAGCTTTCTTTGGACAA	CASSLSPKGAEAFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	0	8	7	1	19	34	48	41	49	TCRBV05,TCRBV07													CASSLSPKGAEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTAAGGCGGCTGGGGAGCTGTTTTTTGGAGAA	CASSKAAGELFF	In	VDJ	1	21	4.7638059633776745E-5	6.11462297525907E-5	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	7	5	8	4	2	23	34	42	38	44	TCRBV09,TCRBV21					01,02								CASSKAAGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCATCCGGGACTAGCGATTAGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	4.7638059633776745E-5		58	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	0	6	0	6	7	23	39	55	45	62		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGACTACCTACCGAGGGGAATGAGCAGTTCTTCGGGCCA	CASSRLPTEGNEQFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	45	TCRBV12						TCRBJ02	TCRBJ02-01	01	6	5	2	7	14	0	26	37	-1	51	56		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRLPTEGNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGGGGGAAGGTGGGGTCGGGGAGACCCAGTACTTCGGGCCA	CASSPGEGGVGETQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	2	5	1	14	26	38	45	39	59		TCRBV12-03,TCRBV12-04												CASSPGEGGVGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGCTTCAGGGGTTGGCTACGAGCAGTACTTCGGGCCG	CSAASGVGYEQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	2	3	5	4	26	34	45	39	49		TCRBV20-01,TCRBV20-or09_02												CSAASGVGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACTAGCGGCAGGAGCACAGATACGCAGTATTTTGGCCCA	CSATSGRSTDTQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	3	5	0	1	4	26	34	43	35	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSATSGRSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGACAGGGAAGGCGAGCAGTACTTCGGGCCG	CSARGDREGEQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	3	6	0	4	26	-1	48	39	52		TCRBV20-01,TCRBV20-or09_02												CSARGDREGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCTACCTTGATCAGCCCCAGCATTTTGGTGAT	CSARSYLDQPQHF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	4	9	5	2	5	26	38	43	40	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSYLDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAGGGGCGACTATGGCTACACCTTCGGTTCG	CSASRGDYGYTF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	2	3	0	2	26	-1	43	37	45		TCRBV20-01,TCRBV20-or09_02												CSASRGDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCTCCCACACTGCTCGCCGGGAGAGAGTAACGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	22	4.990653866395659E-5		56	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	8	2	7	16	7	22	33	55	49	62	TCRBV09,TCRBV12													X+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTTAGACAGGGGGCACGAGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	22	4.990653866395659E-5		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	0	8	4	4	24	38	52	42	56		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGCAGGGGAGGATCAGCCCCAGCATTTTGGTGAT	CATSDAGEDQPQHF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	42	TCRBV24						TCRBJ01	TCRBJ01-05	01	3	4	2	5	1	3	24	39	46	40	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDAGEDQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTATGGGCAGGGGTGGAGACCCAGTACTTCGGGCCA	CATSDLWAGVETQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	2	5	5	2	24	41	52	46	54		TCRBV24-01,TCRBV24-or09_02												CATSDLWAGVETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCATACAGAATCAGCCCCAGCATTTTGGTGAT	CASSIQNQPQHF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	5	4	3	0	24	35	-1	38	42		TCRBV24-01,TCRBV24-or09_02												CASSIQNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGGGACTCGTTCTCCTACGAGCAGTACTTCGGGCCG	CASRDSFSYEQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	1	10	0	0	4	24	-1	40	35	44	TCRBV06,TCRBV24					01,02								CASRDSFSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGTATGACAGGGCCACTGAAGCTTTCTTTGGACAA	CASRYDRATEAFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	3	4	4	1	24	35	46	39	47		TCRBV24-01,TCRBV24-or09_02												CASRYDRATEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCGCAGCCTAGGTCCTTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSRSLGPSSTDTQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	51	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	8	0	6	8	24	36	46	42	54		TCRBV24-01,TCRBV24-or09_02				01,02								CASSRSLGPSSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTACCCCCCTAGCGGGAAGAAGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARVPP*REEGSYNEQFF	Stop	VDJ	1	22	4.990653866395659E-5		57	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	4	3	0	7	6	24	37	53	44	59		TCRBV20-01,TCRBV20-or09_02												CSARVPP*REEGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGSGACTYGGSYSTRTATYTCTGTGCCAGCAGGCAGACGGGGGTGGACACTGAAGCTTTCTTTGGACAA	CASRQTGVDTEAFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	8	8	2	3	8	3	19	27	41	35	44	TCRBV07,TCRBV12													CASRQTGVDTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTCGGCCGTGTATGTCTGTGCCAGCAGCCCATTATCAAGCCCGACAGGGGGTTTAAGGGTTTCGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	4.990653866395659E-5		65				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	1	3	14	14	16	28	51	42	65	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03												X+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTGGCGGCAGCCCCGAACACTGAAGCTTTCTTTGGACAA	CASSLAAAPNTEAFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	45	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	3	7	5	1	1	7	18	32	37	33	44	TCRBV05,TCRBV07			TCRBD01,TCRBD02										CASSLAAAPNTEAFF+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCATTCTAGCGGGAGTTATAGCCAACTACGAGCAGTACTTCGGGCCG	CASSILAGVIANYEQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	4	2	3	3	10	18	30	43	33	53	TCRBV07,TCRBV11													CASSILAGVIANYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGGGCCCCGGCAGGGCGTACCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	22	4.990653866395659E-5		55				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	4	9	5	18	35	49	44	54	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												X+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGCCAGCGGGGATCAGCACGAGCAGTACTTCGGGCCG	CASSLASGDQHEQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	6	3	5	1	6	18	35	43	36	49	TCRBV07,TCRBV11													CASSLASGDQHEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCATCCCACCCCCGGGGGACGTAAGGGAGCAGTACTTCGGGCCG	CASIPPPGDVREQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	8	2	7	9	8	18	28	43	37	51	TCRBV07,TCRBV11													CASIPPPGDVREQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCAAGACAGGGCGCCTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPRQGAFSGANVLTF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	54	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	2	3	0	4	6	19	31	42	35	48		TCRBV05-06,TCRBV05-07												CASSPRQGAFSGANVLTF+TCRBV05-X+TCRBJ02-06	TCRBV05	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCSTSTATCTCTGTGCCAGCAGCCCGGGACAGGGGGTCTACGAGCAGTACTTCGGGCCG	CASSPGQGVYEQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	1	3	2	1	19	31	44	33	45	TCRBV05,TCRBV07													CASSPGQGVYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTCAGGGGGCCTACCCAGCGCTACGCAGTATTTTGGCCCA	CASSSGGLPSATQYF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	0	8	0	11	19	-1	40	32	51	TCRBV05,TCRBV07													CASSSGGLPSATQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGACCCGGGACCTGAGATCTCTATGGCTACACCTTCGGTTCG	CASRPGT*DLYGYTF	Stop	VDJ	1	22	4.990653866395659E-5		45	unresolved						TCRBJ01	TCRBJ01-02	01	6	0	7	4	4	9	22	33	42	37	51	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPGT*DLYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGAAGGGGTCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSVGKGSGTGELFF	In	VDJ	1	22	4.990653866395659E-5	6.405795497890455E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	5	2	4	7	5	24	36	48	43	53	TCRBV09,TCRBV21													CASSVGKGSGTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTAAGACTAGTCCCTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	4.990653866395659E-5		44	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	8	0	2	5	23	35	43	37	48	TCRBV02,TCRBV21					01,02								X+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTCCACATTACCCCTACGAGCAGTACTTCGGGCCG	CASSPHYPYEQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	6	2	2	5	26	38	43	40	48	TCRBV12,TCRBV21													CASSPHYPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGTCAGCGGGGGGAGGAACGAGCAGTACTTCGGGCCG	CASSLVSGGRNEQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	6	1	5	2	4	26	42	53	44	57		TCRBV12-03,TCRBV12-04												CASSLVSGGRNEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCTATACAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYTGNTGELFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	4	1	3	0	23	35	-1	38	43	TCRBV01,TCRBV04													CASSYTGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGACWCRGCWSYGTATCTCTGCGCCAGCAGCTTTCGGGACTAGCGGGTCCTTGCTAAGGGGGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	23	5.2175017694136434E-5		62	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	4	1	4	15	19	31	47	35	62	TCRBV01,TCRBV23					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAGGAGCGCGGGTCCCTACGAGCAGTACTTCGGGCCG	CASSQRSAGPYEQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	7	4	2	6	2	26	41	52	47	54		TCRBV03-01,TCRBV03-02				01,02								CASSQRSAGPYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCAAAAACAAAACTATGGCTACACCTTCGGTTCG	CASSQDQKQNYGYTF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	6	2	6	1	26	43	52	49	53		TCRBV03-01,TCRBV03-02												CASSQDQKQNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCCGACCGAGTTCCGATGAGCAGTTCTTCGGGCCA	CASSLRPSSDEQFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	42	TCRBV03						TCRBJ02	TCRBJ02-01	01	4	2	7	8	3	9	26	39	45	42	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRPSSDEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCTCCCGGGCCAATGAAAAACTGTTTTTTGGCAGT	CASSRANEKLFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	36	TCRBV03						TCRBJ01	TCRBJ01-04	01	8	8	0	5	4	1	26	35	43	39	44		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRANEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTGAATTATTACACCGGGGAGCTGTTTTTTGGAGAA	CSARLNYYTGELFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	42	TCRBV20						TCRBJ02	TCRBJ02-02	01	2	2	8	3	2	6	26	38	42	40	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARLNYYTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGAGACTGGAAACACCATATATTTTGGAGAG	CSARDETGNTIYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	11	2	2	1	1	26	40	44	41	45		TCRBV20-01,TCRBV20-or09_02												CSARDETGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01*02	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGGGTGGGAGGGACGCTCGAGCAGTTCTTCGGGCCA	CSARDWVGGTLEQFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	0	10	6	6	26	40	53	46	59		TCRBV20-01,TCRBV20-or09_02												CSARDWVGGTLEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGTTTGACGCTGTAGAAGCTTTCTTTGGACAA	CSARGFDAVEAFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	1	2	7	8	5	6	26	39	47	44	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGFDAVEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGGACAGGGCGAAAAACTGTTTTTTGGCAGT	CSARVGQGEKLFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	0	3	8	1	1	26	39	49	40	50		TCRBV20-01,TCRBV20-or09_02												CSARVGQGEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACTAGCGGGATTAATGAGCAGTTCTTCGGGCCA	CSARTSGINEQFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	2	3	7	0	2	26	-1	48	37	50		TCRBV20-01,TCRBV20-or09_02												CSARTSGINEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCGGGCTAGCGGGAGGTCAAAAACATTCAGTACTTCGGCGCC	CSARAG*REVKNIQYF	Stop	VDJ	1	23	5.2175017694136434E-5		48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	4	1	3	6	1	26	37	54	43	55		TCRBV20-01,TCRBV20-or09_02												CSARAG*REVKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCGACCCGTACTCTCAAGAGACCCAGTACTTCGGGCCA	CSAPDPYSQETQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	5	2	7	2	3	9	26	35	41	38	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPDPYSQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAACGGGACAGTAATCAGCCCCAGCATTTTGGTGAT	CSAERDSNQPQHF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	5	4	4	1	26	35	46	39	47		TCRBV20-01,TCRBV20-or09_02												CSAERDSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCTTGGACAGGGGGCTCCTACGAGCAGTACTTCGGGCCG	CSASWTGGSYEQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	1	0	4	0	26	35	-1	39	49		TCRBV20-01,TCRBV20-or09_02												CSASWTGGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGGTTGGCGGGAACACTGAAGCTTTCTTTGGACAA	CSGVGGNTEAFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	7	5	1	6	0	26	33	-1	39	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSGVGGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTTTGGGAGCGAACTCTACAATGAGCAGTTCTTCGGGCCA	CSFGSELYNEQFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	9	2	3	3	6	26	32	40	35	46		TCRBV20-01,TCRBV20-or09_02												CSFGSELYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGTAAGGAGGACAGGGGATCCTACGAGCAGTACTTCGGGCCG	CASKEDRGSYEQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	1	2	1	7	1	24	31	47	38	48		TCRBV24-01,TCRBV24-or09_02												CASKEDRGSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCCCGGGACCACTACAATGAGCAGTTCTTCGGGCCA	CASSSRDHYNEQFF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	42	TCRBV05						TCRBJ02	TCRBJ02-01	01	3	0	7	3	3	2	19	32	40	35	42		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRDHYNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTGGAGCACCGGGGCCGGGGCTACGAGCAGTACTTCGGGCCG	CASSLEHRGRGYEQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	48	unresolved						TCRBJ02	TCRBJ02-07	01	6	7	0	3	11	5	24	35	51	46	56	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEHRGRGYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGGCTTAGCGGACTCCTACGAGCAGTACTTCGGGCCG	CASSVGLADSYEQYF	In	VDJ	1	23	5.2175017694136434E-5	6.696968020521839E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	5	5	0	3	1	23	39	48	42	49	TCRBV09,TCRBV12					01,02								CASSVGLADSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGGCCCTCACATACCCTCAGTACCTCTGTGCCAGCAGTGAATATTCGGGGGACTACGAGCAGTACTTCGGGCCG	CASSEYSGDYEQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	42	TCRBV25			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	2	3	2	1	39	56	64	58	65		TCRBV25-01,TCRBV25-or09_02												CASSEYSGDYEQYF+TCRBV25-X+TCRBJ02-07	TCRBV25	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACAGGGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	24	5.444349672431628E-5		38	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	1	4	0	0	26	-1	-1	41	48		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCAGTCCCGGGACAGGAATCAGCCCCAGCATTTTGGTGAT	CASSQSRDRNQPQHF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	4	4	8	0	26	37	-1	45	53		TCRBV03-01,TCRBV03-02												CASSQSRDRNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACCAAGACTAGCGGGCTTTTCTCCTACGAGCAGTACTTCGGGCCG	CSATKTSGLFSYEQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	4	0	6	5	26	34	50	40	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSATKTSGLFSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCTACAGGGGTTCCAAGAGACCCAGTACTTCGGGCCA	CSALQGFQETQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	3	2	1	3	2	26	34	44	37	46		TCRBV20-01,TCRBV20-or09_02												CSALQGFQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGGGGGCGGGACCCCACAGATACGCAGTATTTTGGCCCA	CSAGGRDPTDTQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	9	0	2	0	8	26	-1	41	34	49		TCRBV20-01,TCRBV20-or09_02												CSAGGRDPTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCCCCCAAACCCCGGGTACACCTACGAGCAGTACTTCGGGCCG	CSANPPNPGYTYEQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	8	4	2	13	4	26	36	53	49	57		TCRBV20-01,TCRBV20-or09_02				01,02								CSANPPNPGYTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCATTGGAAGCGATGAAAAACTGTTTTTTGGCAGT	CSATIGSDEKLFF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	6	6	6	8	0	26	36	-1	44	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSATIGSDEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCACCGGGGAGCTGTTTTTTGGAGAA	CSARDPTGELFF	In	VJ	1	24	5.444349672431628E-5	6.988140543153224E-5	36	TCRBV20						TCRBJ02	TCRBJ02-02	01	0	0	0	4	0	3	26	-1	40	-1	43		TCRBV20-01,TCRBV20-or09_02												CSARDPTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCATCGGTTCTGCAGCCCCAGCATTTTGGTGAT	CSARASVLQPQHF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	8	5	7	3	5	26	39	45	42	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARASVLQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGATCACAGGTTGGGGGCCCGCCCAAGAGACCCAGTACTTCGGGCCA	CSARVITGWGPAQETQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	6	0	1	12	4	26	39	57	51	61		TCRBV20-01,TCRBV20-or09_02												CSARVITGWGPAQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGAGAGAGAAAAACTGTTTTTTGGCAGT	CSASEREKLFF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	3	11	2	8	1	3	26	37	41	38	44		TCRBV20-01,TCRBV20-or09_02												CSASEREKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*02	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGAGGGCAGGACCCCGGGGATTGGAGAGACCCAGTACTTCGGGCCA	CSASEGRTPGIGETQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	8	3	4	14	5	26	37	56	51	61		TCRBV20-01,TCRBV20-or09_02				01,02								CSASEGRTPGIGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTGCGGACAGGGAAGTTCGATGGCTACACCTTCGGTTCG	CASSLRTGKFDGYTF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	3	6	3	7	23	36	47	39	54	TCRBV01,TCRBV04													CASSLRTGKFDGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCACCTCCTAGCTCGCGAACAGCTCCTACGAGCAGTACTTCGGGCCG	CASSTS*LANSSYEQYF	Stop	VDJ	1	24	5.444349672431628E-5		51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	7	0	6	10	22	33	44	39	54	TCRBV12,TCRBV21					01,02								CASSTS*LANSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATCACAGGGGAATTTCTACGAGCAGTACTTCGGGCCG	CASSESQGNFYEQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	2	3	2	5	23	38	47	40	52		TCRBV06-01,TCRBV06-08												CASSESQGNFYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTGGCCCCCAAGGAGGACAGATCCGGTCGGGTACAATATTTTGGCCCA	CSARDLAPKEDRSGRVQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	57	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	1	5	15	15	16	24	38	59	53	75		TCRBV20-01,TCRBV20-or09_02												CSARDLAPKEDRSGRVQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGACGAGAGGGAACCGGAGAAAAACTGTTTTTTGGCAGT	CASRREGTGEKLFF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	6	11	0	8	4	7	18	29	38	33	45	TCRBV07,TCRBV11													CASRREGTGEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCGCTATACACGGACCAGCACCTACGAGCAGTACTTCGGGCCG	CASSRYTRTSTYEQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	48	unresolved						TCRBJ02	TCRBJ02-07	01	5	1	7	2	10	5	18	30	44	40	49	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRYTRTSTYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGTCCCCCCGGGGAACTGGGGCCCAACGTCCTGACTTTCGGGGCC	CASSPPGELGPNVLTF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	48							TCRBJ02	TCRBJ02-06	01	6	7	0	8	15	0	18	29	-1	44	49	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPGELGPNVLTF+X+TCRBJ02-06			TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCGCATGACGATAGGGCAGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSRMTIGQGSYEQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	51	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	0	15	0	19	31	-1	46	51		TCRBV05-06,TCRBV05-07												CASSRMTIGQGSYEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGARGACTCRGCYSYKTATCTYTGCGCCAGCAGCCAAGGGCGGAGCGGGTTGGGTCCCACCTACGAGCAGTACTTCGGGCCG	CASSQGRSGLGPTYEQYF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	54	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	6	4	2	9	10	19	31	46	40	56	TCRBV01,TCRBV05					01,02								CASSQGRSGLGPTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCTGCTGTGTATTTCTGTGCCAGCAGCCAACAGATGCCCACTTTACGGGACAGGAGGGGCTATGGCTACACCTTCGGTTCG	CASSQQMPTLRDRRGYGYTF	In	VDJ	1	24	5.444349672431628E-5	6.988140543153224E-5	60	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	4	4	16	5	15	30	54	46	59		TCRBV03-01,TCRBV03-02												CASSQQMPTLRDRRGYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACTCACAGGGCCAGATACGCAGTATTTTGGCCCA	CASRLTGPDTQYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	3	4	4	1	26	37	47	41	48		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRLTGPDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCAGCTTCTACATCTGCAGTGCTAGAGAGGCCGGGACTAGCGGGAGGAGACTCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAREAGTSGRRLSYNEQFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	60	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	0	1	0	4	5	15	29	48	33	53		TCRBV20-01,TCRBV20-or09_02												CSAREAGTSGRRLSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTACCCGGGACCTCGGTGACGAGCAGTTCTTCGGGCCA	CASSTRDLGDEQFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	42	unresolved						TCRBJ02	TCRBJ02-01	01	5	0	7	10	4	9	24	36	45	40	54	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTRDLGDEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGGACCAGCCCTCTTGGCTACATCTTCGGTTCG	CSAGTSPLGYIF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	0	7	16	1	18	26	34	40	35	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGTSPLGYIF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCGGACCTCAGTCGGCGAAAAACTGTTTTTTGGCAGT	CSARTSVGEKLFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	39	TCRBV20						TCRBJ01	TCRBJ01-04	01	6	1	7	8	2	10	26	34	40	36	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARTSVGEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTCACCGGGACAGGGGGCGAAGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	25	5.671197575449612E-5		52	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	0	0	4	6	3	26	36	54	42	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCCCGGACTAGCGGGAGCGGTGAGCAGTTCTTCGGGCCA	CSARDPRTSGSGEQFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	1	2	9	5	3	26	40	58	45	61		TCRBV20-01,TCRBV20-or09_02												CSARDPRTSGSGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGCGGGGGATCTAATCAAGCTTTCTTTGGACAA	CSARDSGGSNQAFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	5	2	9	0	8	26	-1	49	40	57		TCRBV20-01,TCRBV20-or09_02												CSARDSGGSNQAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTGGCCAGGGGTGGGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	25	5.671197575449612E-5		47	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	2	3	6	4	26	40	52	46	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGGTTACACAGATACGCAGTATTTTGGCCCA	CSARGGYTDTQYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	1	6	2	2	0	3	26	-1	43	39	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGGYTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAATGGGGGTTACGGCTACACCTTCGGTTCG	CSASNGGYGYTF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	3	6	1	8	4	4	26	37	46	41	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASNGGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGGGTGTGGGTCAAAAACATTCAGTACTTCGGCGCC	CSASGVWVKNIQYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	42	TCRBV20						TCRBJ02	TCRBJ02-04	01	3	6	2	3	1	7	26	37	42	38	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGVWVKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20		TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTATAACCCACGGAGGTCAGCCCCAGCATTTTGGTGAT	CSAIITHGGQPQHF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	10	1	6	11	0	26	36	-1	47	52		TCRBV20-01,TCRBV20-or09_02												CSAIITHGGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGAAAGGGACAGACCACCGGGGAGCTGTTTTTTGGAGAA	CSARKGQTTGELFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	5	4	5	2	26	35	47	40	49		TCRBV20-01,TCRBV20-or09_02												CSARKGQTTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGATGGGACTAGCGGGACCTACAATGAGCAGTTCTTCGGGCCA	CSADGTSGTYNEQFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	3	2	3	0	26	35	-1	38	51		TCRBV20-01,TCRBV20-or09_02												CSADGTSGTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGAGACCCGGTTACAATGAGCAGTTCTTCGGGCCA	CSGRPGYNEQFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	10	2	4	0	7	26	-1	37	33	44		TCRBV20-01,TCRBV20-or09_02												CSGRPGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAGGTGCCGGGGAGGGAGATACGCAGTATTTTGGCCCA	CASSLGAGEGDTQYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	9	0	5	7	0	23	38	-1	45	52	TCRBV24,TCRBV27													CASSLGAGEGDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCCGCCCGGGGCGGGAGGCCTCTACGAGCAGTACTTCGGGCCG	CASSPPGAGGLYEQYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	48				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	1	3	9	3	33	45	62	54	65	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASSPPGAGGLYEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCGTCCGGGATCCTTCCTACGAGCAGTACTTCGGGCCG	CASSPVRDPSYEQYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	8	3	1	6	4	24	36	47	42	51		TCRBV24-01,TCRBV24-or09_02												CASSPVRDPSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCCCGGGGACAGGGGATATATGGCTACACCTTCGGTTCG	CASSLSRGQGIYGYTF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	5	8	3	24	36	54	44	57	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSRGQGIYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCCGGAGGGATGGGGAGGTACAATGAGCAGTTCTTCGGGCCA	CASSPGGMGRYNEQFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	9	1	4	12	0	19	31	-1	43	49	TCRBV07,TCRBV11													CASSPGGMGRYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCGTTCCTACCTGGGAGCCCCTCCGTACGAGCAGTACTTCGGGCCG	CASSRSYLGAPPYEQYF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	9	2	4	11	8	18	30	46	41	54	TCRBV07,TCRBV11													CASSRSYLGAPPYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGCGGTACCTAGCGGGAGGAGTAACCCGTTCTTCGGGCCA	CASSAVPSGRSNPFF	In	VDJ	1	25	5.671197575449612E-5	7.279313065784608E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	1	15	7	8	24	36	54	43	62	TCRBV12,TCRBV21													CASSAVPSGRSNPFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCTCCTTGACGATTAGCGGGGACTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	26	5.898045478467597E-5		46				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	11	5	3	4	11	3	35	41	60	52	63	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												X+X+TCRBJ02-01		TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCCTCGACCTTGGCGGTGGAAACACCATATATTTTGGAGAG	CASSLDLGGGNTIYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	45				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	7	5	3	11	0	24	35	-1	46	50	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03				01,02								CASSLDLGGGNTIYF+X+TCRBJ01-03		TCRBD02-01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTCGGGGGATGGGTGATACGCAGTATTTTGGCCCA	CASSRGMGDTQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	39				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	2	6	0	6	24	-1	42	36	48	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSRGMGDTQYF+X+TCRBJ02-03		TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAATAAGGATACGCAGTATTTTGGCCCA	CASSNKDTQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	33	TCRBV03						TCRBJ02	TCRBJ02-03	01	5	5	5	6	4	0	26	38	-1	42	44		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNKDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACAGGGGGGCCGTGGAGCTTTCTTTGGACAA	CASSQGQGGRGAFF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	1	10	0	7	26	-1	51	42	58		TCRBV03-01,TCRBV03-02												CASSQGQGGRGAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAGAAAAGGGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSQGEKGLNTEAFF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	2	0	6	1	26	42	53	48	54		TCRBV03-01,TCRBV03-02												CASSQGEKGLNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGAGACGGACCTACGAGCAGTACTTCGGGCCG	CASSPRRTYEQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	39	TCRBV03						TCRBJ02	TCRBJ02-07	01	4	1	8	2	6	0	26	39	-1	45	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRRTYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGACATACGGAACACTGAAGCTTTCTTTGGACAA	CASSRDIRNTEAFF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	6	1	0	4	26	-1	45	39	49		TCRBV03-01,TCRBV03-02												CASSRDIRNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGACTGGGGCCGCGAGCAGTACTTCGGGCCG	CASSDWGREQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	7	0	6	4	2	26	38	47	42	49		TCRBV03-01,TCRBV03-02												CASSDWGREQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACATACTCGCAGGGTCTGCGTGAGACCCAGTACTTCGGGCCA	CSTYSQGLRETQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	4	3	5	9	7	26	32	46	41	53		TCRBV20-01,TCRBV20-or09_02												CSTYSQGLRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGCGGGGCTCTTTCCTACAATGAGCAGTTCTTCGGGCCA	CSASGALSYNEQFF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	3	1	1	5	26	34	42	35	47		TCRBV20-01,TCRBV20-or09_02												CSASGALSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCACTAGGGATTAGCAGGAGCTGCAGATACGCAGTATTTTGGCCCA	CSAH*GLAGAADTQYF	Stop	VDJ	1	26	5.898045478467597E-5		48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	3	8	4	2	16	26	34	41	36	57		TCRBV20-01,TCRBV20-or09_02				01,02								CSAH*GLAGAADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGGACTAGCGGGAGGGCCAGGGTGAGCAGTTCTTCGGGCCA	CSATD*REGQGEQFF	Stop	VDJ	1	26	5.898045478467597E-5		45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	1	0	9	1	6	26	36	52	37	58		TCRBV20-01,TCRBV20-or09_02												CSATD*REGQGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGCGGTACTTCCTCTGGAAACACCATATATTTTGGAGAG	CSARSGTSSGNTIYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	2	6	5	0	0	6	26	-1	43	38	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSGTSSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATCGACGGCGACTTCTCCTACGAGCAGTACTTCGGGCCG	CSARIDGDFSYEQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	2	10	0	9	1	26	38	51	47	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARIDGDFSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCAACCGGGACAGGGATCCTACGAGCAGTACTTCGGGCCG	CSARQPGQGSYEQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	1	6	1	26	37	52	43	53		TCRBV20-01,TCRBV20-or09_02												CSARQPGQGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGGGAAATCAGCCCCAGCATTTTGGTGAT	CSARGGNQPQHF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	9	1	4	0	1	26	-1	43	37	44		TCRBV20-01,TCRBV20-or09_02												CSARGGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGGACTAGCGGGAGGGTGGCAGTACTTCGGGCCG	CSAGGLAGGWQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	0	0	9	2	2	26	35	53	37	55		TCRBV20-01,TCRBV20-or09_02												CSAGGLAGGWQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGGCACTGATTAATGAAAAACTGTTTTTTGGCAGT	CASSQGALINEKLFF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	8	0	4	0	6	23	-1	43	39	49	TCRBV01,TCRBV04													CASSQGALINEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCACGTAATGAGCCAAAACATTCAGTACTTCGGCGCC	CASSHVMSQNIQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	3	6	7	5	7	1	23	37	47	44	48	TCRBV01,TCRBV04					01,02								CASSHVMSQNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGTGGGGGCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	26	5.898045478467597E-5		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	6	0	4	6	0	24	36	-1	42	48		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGACGCAGCCTTTGAGCAGTTCTTCGGGCCA	CASSLDAAFEQFF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	39	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	2	7	9	3	8	24	36	42	39	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDAAFEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAACCAACAGGGGCCTACGAGCAGTACTTCGGGCCG	CAISEPTGAYEQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	2	2	3	0	23	38	-1	41	48	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03												CAISEPTGAYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTGGCCCCCAAGGAGGACAGATCCGGTCGGGTACAGTATTTTGGCCCA	CSARDLAPKEDRSGRVQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	57	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	1	5	12	15	13	24	38	59	53	72		TCRBV20-01,TCRBV20-or09_02												CSARDLAPKEDRSGRVQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCAAGACCCTAGCGGGAGGTTCAATGAGCAGTTCTTCGGGCCA	CASSQDPSGRFNEQFF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	4	1	6	7	2	19	31	49	38	51	TCRBV05,TCRBV11													CASSQDPSGRFNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGGGACTCRGCCSTKTATCTYTRCGCCAGCAGCCGCAGGACCGGCGCTAGCACAGATACGCAGTATTTTGGCCCA	XASSRRTGASTDTQYF	In	VDJ	1	26	5.898045478467597E-5	7.570485588415992E-5	48	unresolved						TCRBJ02	TCRBJ02-03	01	4	1	7	0	4	7	19	31	39	35	46	TCRBV05,TCRBV07,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSRRTGASTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GTTTGGTGCATCCTGAAGACAGCAGCTTTACATCTGCAGTGCTTGAACTACTACCCACCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	26	5.898045478467597E-5		46	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	21	3	9	0	18	10	35	28	50	46	60		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTCCTATGGGGCCATTCCACTATGGCTACACCTTCGGTTCG	CASSPMGPFHYGYTF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	7	0	3	5	6	24	36	46	41	52	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSPMGPFHYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAAGAGCCGCTGGTCCGGCTAGCAATGAGCAGTTCTTCGGGCCA	CASSPRAAGPASNEQFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	8	6	18	0	26	39	-1	57	61		TCRBV03-01,TCRBV03-02				01,02								CASSPRAAGPASNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGACACCATCCGGGAAAACCGGGCGGGGAGCTGTTTTTTGGAGAA	CASSRHHPGKPGGELFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	8	3	7	9	8	26	39	53	48	61		TCRBV03-01,TCRBV03-02												CASSRHHPGKPGGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCCACTGGGACAGGTGAGACCCCATCCTACTTCGGGCCG	CASSPTGTGETPSYF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	13	7	13	26	37	52	44	65		TCRBV03-01,TCRBV03-02												CASSPTGTGETPSYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCTGTTCGGCAGGGCTACAATGAGCAGTTCTTCGGGCCA	CSAPVRQGYNEQFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	3	10	0	26	34	-1	44	49		TCRBV20-01,TCRBV20-or09_02												CSAPVRQGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAATTCATGGAGCGGATAAGTTACAATGAGCAGTTCTTCGGGCCA	CSAREFMERISYNEQFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	6	5	4	8	6	26	40	53	48	59		TCRBV20-01,TCRBV20-or09_02				01,02								CSAREFMERISYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGGTTTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	6.124893381485581E-5		35	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	8	5	4	0	3	26	-1	43	40	46		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTGGCGGCAGCCCTCTCCTACGAGCAGTACTTCGGGCCG	CSARDLAAALSYEQYF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	7	5	0	4	7	26	40	48	44	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLAAALSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCTGAAGCCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	27	6.124893381485581E-5		35	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	6	7	7	6	0	26	37	-1	43	46		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGGACTTTCGAGCCAAAGGCGTACCAAGAGACCCAGTACTTCGGGCCA	CSASGTFEPKAYQETQYF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	54	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	0	10	0	1	16	26	37	44	38	60		TCRBV20-01,TCRBV20-or09_02				01,02								CSASGTFEPKAYQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTTTAGCGGGAGGTCCCTCCAAGAGACCCAGTACTTCGGGCCA	CSFSGRSLQETQYF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	5	1	1	2	5	26	32	44	34	49		TCRBV20-01,TCRBV20-or09_02												CSFSGRSLQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGCGGCAACCCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQGGNPSYNEQFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	7	5	0	0	6	23	-1	43	39	49	TCRBV01,TCRBV04					01,02								CASSQGGNPSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGARGACTCRGCCCTKTATCTYTGCGCCAGCAGCCACCATATCGGGACAGTCCAAGAGACCCAGTACTTCGGGCCA	CASSHHIGTVQETQYF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	5	1	7	1	23	37	51	44	52	TCRBV04,TCRBV05													CASSHHIGTVQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCARCCAGACCTMTCTGTACYWCTGTGCCAGTCGGTTAGCGGGACGGTACACTGGGGAGCTGTTTTTTGGAGAA	CASRLAGRYTGELFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	5	3	8	5	9	22	30	43	35	52	TCRBV08,TCRBV27													CASRLAGRYTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGATGATCGGACGCCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	27	6.124893381485581E-5		50	TCRBV24						TCRBJ01	TCRBJ01-02	01	0	1	7	0	6	2	24	42	52	48	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGGGGGCCACTGAAGCTTTCTTTGGACAA	CATSGGATEAFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	36	TCRBV24						TCRBJ01	TCRBJ01-01	01	5	6	0	4	1	0	24	37	-1	38	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSGGATEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTAGGACAGCTAACTATGGTTACACCTTCGGTTCG	CASSLARTANYGYTF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	5	11	2	11	18	35	43	37	54	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLARTANYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCGGTAGCGGGAGGGTCGATGAGCAGTTCTTCGGGCCA	CASSGSGRVDEQFF	In	VDJ	1	27	6.124893381485581E-5	7.861658111047377E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	0	8	2	3	19	31	44	33	47	TCRBV05,TCRBV07													CASSGSGRVDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYGGCYSTSTATCTCTGTGCCAGCAGCTTAAAGGAACTAGCGGGAGGGCCGGGCGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	27	6.124893381485581E-5		59	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	3	0	4	6	8	19	33	52	39	60	TCRBV05,TCRBV07													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GTTTGGTGCATCCTGAGACAGCAGCTTCTACATCTGCAGTGCTTGAACTACTACCCACCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	27	6.124893381485581E-5		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	9	0	3	10	34	43	50	46	60		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACCCAGGGGGACGGTTGAAAAACTGTTTTTTGGCAGT	CASRPRGTVEKLFF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	1	7	3	5	26	37	47	40	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRPRGTVEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAAGGGAGGGGAGACCCAGTACTTCGGGCCA	CASSLKGGETQYF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	9	0	5	2	0	26	41	-1	43	50		TCRBV12-03,TCRBV12-04												CASSLKGGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGGGGTCTCTCGGGTGGGTCAGCCCCAGCATTTTGGTGAT	CASSFGVSRVGQPQHF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	3	6	0	13	26	-1	45	40	58		TCRBV12-03,TCRBV12-04												CASSFGVSRVGQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCTACGGGGCAATCGATACGCAGTATTTTGGCCCA	CASSFYGAIDTQYF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	42	TCRBV12						TCRBJ02	TCRBJ02-03	01	3	7	0	6	4	4	26	40	49	44	53		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFYGAIDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGGCCCTCACTACCTCTCAGTACCTCTGTGCCAGCAGTGAATATTCGGGGGACTACGAGCAGTACTTCGGGCCG	CASSEYSGDYEQYF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	42	TCRBV25			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	2	3	2	1	39	56	64	58	65		TCRBV25-01,TCRBV25-or09_02												CASSEYSGDYEQYF+TCRBV25-X+TCRBJ02-07	TCRBV25	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCACCCTTCGGGGGGAGGCAGGCACAGATACGCAGTATTTTGGCCCA	CASTLRGEAGTDTQYF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	48				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	8	1	1	5	6	24	34	46	39	52	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASTLRGEAGTDTQYF+X+TCRBJ02-03		TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAATGGCGGAAGGTTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	28	6.351741284503566E-5		52	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	7	5	0	3	6	26	43	50	46	56		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCGCTACGAGCAGTACTTCGGGCCG	CASSHRYEQYF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	33	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	8	6	3	1	0	26	40	-1	41	43		TCRBV03-01,TCRBV03-02				01,02								CASSHRYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGATTGGACACGAACTATGGCTACACCTTCGGTTCG	CASSRLDTNYGYTF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	6	2	4	2	26	39	48	43	50		TCRBV03-01,TCRBV03-02												CASSRLDTNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGYGACTCKGCTGTGTATYTCTGTGCCAGCAGCTGGGGGGGAGGGACAGGGAACTACGAGCAGTACTTCGGGCCG	CASSWGGGTGNYEQYF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	3	9	2	26	38	56	47	58	TCRBV03,TCRBV07													CASSWGGGTGNYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTTTTGGACTAGCGGGAGTCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSFGLAGVGTGELFF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	1	2	4	4	4	26	37	54	41	58		TCRBV03-01,TCRBV03-02												CASSFGLAGVGTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGTCAATGGGGGACAGGGTATGGAGAGACCCAGTACTTCGGGCCA	CASQWGTGYGETQYF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	9	0	3	4	7	5	26	34	50	41	55		TCRBV03-01,TCRBV03-02												CASQWGTGYGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGACGGCGGTGGGCAATGAGCAGTTCTTCGGGCCA	CSATTAVGNEQFF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	7	5	6	5	4	26	36	45	41	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSATTAVGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGCCCCGGGAATGGGCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	6.351741284503566E-5		49	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	8	3	2	4	6	26	40	49	44	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGCGGGGCACAGATACGCAGTATTTTGGCCCA	CSAPRGTDTQYF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	7	4	1	2	0	26	35	-1	37	42		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPRGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAAGCTTGAGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	28	6.351741284503566E-5		35	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	1	5	7	0	26	35	-1	42	46		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGAACCTGGAGCAGGTCGTCCCCCATGGCTACACCTTCGGTTCG	CASSQNLEQVVPHGYTF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	51	unresolved						TCRBJ01	TCRBJ01-02	01	3	4	4	6	10	9	23	37	51	47	60	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQNLEQVVPHGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAACAGGGCAGTAATGAAAAACTGTTTTTTGGCAGT	CASSEQGSNEKLFF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	3	4	2	3	22	34	42	36	45		TCRBV12-03,TCRBV12-04												CASSEQGSNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAAGGCCTGAGGTGGGCGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	28	6.351741284503566E-5		47	unresolved						TCRBJ02	TCRBJ02-02	01	5	8	0	6	13	1	22	34	51	47	52	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGGGGGGTACTACGAGCAGTACTTCGGGCCG	CATSDGGYYEQYF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	9	1	3	0	2	24	-1	45	39	47		TCRBV24-01,TCRBV24-or09_02												CATSDGGYYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCCGCGTCAGGGTTTAAACTGTTTTTTGGCAGT	CASSPASGFKLFF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	4	3	11	8	3	24	35	48	43	51		TCRBV24-01,TCRBV24-or09_02												CASSPASGFKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGTCTAAGGCGAACGAACCTACGAGCAGTACTTCGGGCCG	CASSV*GERTYEQYF	Stop	VDJ	1	28	6.351741284503566E-5		45	TCRBV24						TCRBJ02	TCRBJ02-07	01	5	5	4	2	4	8	24	37	44	41	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSV*GERTYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGTGGGGAGTCACACTGAAGCTTTCTTTGGACAA	CASSVGSHTEAFF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	2	3	2	2	24	37	44	39	46		TCRBV24-01,TCRBV24-or09_02												CASSVGSHTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCAGTTTACTTTTTGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	6.351741284503566E-5		38	unresolved			unresolved			TCRBJ02	TCRBJ02-01	01	6	3	10	7	2	6	24	36	41	38	47	TCRBV24,TCRBV28			TCRBD01,TCRBD02										X+X+TCRBJ02-01	unresolved	unresolved	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGAAGGGGCTGGAAACACCATATATTTTGGAGAG	CASSVEGAGNTIYF	In	VDJ	1	28	6.351741284503566E-5	8.152830633678761E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	5	2	2	5	0	24	36	-1	41	46	TCRBV09,TCRBV21													CASSVEGAGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATATTGTTGGCTAGCGACTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	29	6.578589187521551E-5		50	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	4	6	3	9	3	26	41	56	50	59		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAAACCCAGCGAAATCCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	29	6.578589187521551E-5		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	6	6	0	7	6	26	39	50	46	56		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGACGGGACGTCAGGTGAGCAGTTCTTCGGGCCA	CASSRDGTSGEQFF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	42	TCRBV03						TCRBJ02	TCRBJ02-01	01	4	0	7	9	0	11	26	-1	44	39	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDGTSGEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGCTAGCGGGAGAGGGAGATACGCAGTATTTTGGCCCA	CSATLAGEGDTQYF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	4	2	5	2	4	26	36	48	38	52		TCRBV20-01,TCRBV20-or09_02												CSATLAGEGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCGAATTGGTGCGAGATCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	29	6.578589187521551E-5		49	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	7	6	5	10	6	26	39	52	49	58		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTCGGACAGCCCAGGACACTGAAGCTTTCTTTGGACAA	CSAPRTAQDTEAFF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	3	4	6	26	35	45	39	51		TCRBV20-01,TCRBV20-or09_02												CSAPRTAQDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCARCCAGACMKMTCTKTACYWCTGTGCCAGCAGTCGAACGGGCCGCCTCACAGATACGCAGTATTTTGGCCCA	CASSRTGRLTDTQYF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	45	unresolved						TCRBJ02	TCRBJ02-03	01	4	8	0	2	7	5	22	32	43	39	48	TCRBV08,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTGRLTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAGTAGAACGGGGGGCCTACGGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	29	6.578589187521551E-5		52	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	2	8	1	5	6	7	23	38	51	44	58	TCRBV24,TCRBV27													X+X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCACCGCCGGGACAGCTGAAAGAAAACTGTTTTTTGGCAGT	CATAGTAERKLFF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	0	5	10	3	7	24	33	43	36	50	TCRBV24,TCRBV27													CATAGTAERKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCGAGGGCTGAATCAGCCCCAGCATTTTGGTGAT	CASSRGLNQPQHF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	7	11	0	4	2	3	24	35	42	37	45		TCRBV24-01,TCRBV24-or09_02												CASSRGLNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01*02	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCACCCCAAGGCTGGGGCCCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASTPRLGPPNTGELFF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	7	0	0	10	3	23	33	48	43	51	TCRBV06,TCRBV10													CASTPRLGPPNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGCTGACCCGTTGCTAGCGGGAGTTTACGATGAGCAGTTCTTCGGGCCA	CASSADPLLAGVYDEQFF	In	VDJ	1	29	6.578589187521551E-5	8.444003156310145E-5	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	4	2	8	11	6	23	36	57	47	63	TCRBV09,TCRBV12													CASSADPLLAGVYDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGTGCCGTACAATGAGCAGTTCTTCGGGCCA	CASSFVPYNEQFF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	39	TCRBV12						TCRBJ02	TCRBJ02-01	01	3	10	0	4	3	2	26	40	45	43	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFVPYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACAGGGAAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSQTGKGNTEAFF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	1	0	5	26	-1	47	41	52		TCRBV03-01,TCRBV03-02												CASSQTGKGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCGACTAGCGGGAGTGGAGATACGCAGTATTTTGGCCCA	CSARDPTSGSGDTQYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	2	2	5	3	3	26	40	55	43	58		TCRBV20-01,TCRBV20-or09_02												CSARDPTSGSGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATACACTCGGTGAGCAGTTCTTCGGGCCA	CATSDTLGEQFF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	36	TCRBV24						TCRBJ02	TCRBJ02-01	01	3	3	6	9	0	5	24	-1	42	39	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDTLGEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCTACAAGGGCCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	6.805437090539536E-5		41	TCRBV24						TCRBJ02	TCRBJ02-07	01	7	5	3	2	6	3	24	35	45	41	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGTCCGGGACTAGCGGGAGTTATACGCAGTATTTTGGCCCA	CASSLSSGTSGSYTQYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	51				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	0	2	7	9	2	24	36	59	45	61	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSSGTSGSYTQYF+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGAGGAGGGCCGGCCGGGGAGCTGTTTTTTGGAGAA	CASSERGGPAGELFF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	45	TCRBV06			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	10	0	6	3	4	23	38	47	41	51		TCRBV06-01,TCRBV06-08												CASSERGGPAGELFF+TCRBV06-X+TCRBJ02-02	TCRBV06	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ACGACTCGGCCSTGTATCTCTGTGCCAGCAGCTTAGGTCTAGTGGGGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	6.805437090539536E-5		41	unresolved						TCRBJ02	TCRBJ02-07	01	1	6	1	6	7	0	18	34	-1	41	46	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGCCCTGAGTATGGATACGCAGTATTTTGGCCCA	CASSLAALSMDTQYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	45							TCRBJ02	TCRBJ02-03	01	0	9	0	6	0	10	18	-1	38	35	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAALSMDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCTCCGGAGGGTATCGAGGGGAGCAGTACTTCGGGCCG	CASSSGGYRGEQYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	10	0	7	2	9	19	32	40	34	49	TCRBV07,TCRBV11													CASSSGGYRGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGCTCAGAAGCAGGGCTACACCTTCGGTTCG	CASSVAQKQGYTF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	39	unresolved			unresolved			TCRBJ01	TCRBJ01-02	01	5	5	7	8	1	10	24	36	41	37	51	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSVAQKQGYTF+X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCGTCCCTCGGAGGCTTCTCTGGAAACACCATATATTTTGGAGAG	CASSASLGGFSGNTIYF	In	VDJ	1	30	6.805437090539536E-5	8.73517567894153E-5	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	3	10	1	0	8	3	23	36	49	44	52	TCRBV09,TCRBV21													CASSASLGGFSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGGAGTAGCGGGAGTTTTGGCAATGAGCAGTTCTTCGGGCCA	CASRSSGSFGNEQFF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	2	6	3	6	26	37	49	40	55	TCRBV02,TCRBV12													CASRSSGSFGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACCCGGAATCCTATGGCTACACCTTCGGTTCG	CASSQDPESYGYTF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	42	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	1	8	4	3	3	26	43	49	46	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDPESYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCGAACTAACCTCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	31	7.032284993557519E-5		46	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	3	9	2	4	5	26	42	50	46	55		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTTTTCGGCAGGGCTGACCGGGGAGCTGTTTTTTGGAGAA	CASSPFSAGLTGELFF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	5	9	3	26	39	53	48	56		TCRBV03-01,TCRBV03-02												CASSPFSAGLTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCGGGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	31	7.032284993557519E-5		34	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	8	3	4	3	0	26	34	-1	37	42		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATTGGGACAGTTCACACCGGGGAGCTGTTTTTTGGAGAA	CSARIGTVHTGELFF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	5	3	3	3	26	38	48	41	51		TCRBV20-01,TCRBV20-or09_02												CSARIGTVHTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCGAGGCCCAGCGGACGCAGTATTTTGGCCCA	CSARPEAQRTQYF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	6	5	9	10	0	26	38	-1	48	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARPEAQRTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	31	7.032284993557519E-5		34	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	10	6	1	1	26	40	43	41	44		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCGGGAGGGGGTCGGATCCTACGAGCAGTACTTCGGGCCG	CSARREGVGSYEQYF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	0	1	0	7	26	-1	46	37	53		TCRBV20-01,TCRBV20-or09_02												CSARREGVGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTGGAGGGGGGACTTAAATGAGCAGTTCTTCGGGCCA	CSWRGDLNEQFF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	8	5	1	7	3	6	26	32	41	35	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSWRGDLNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGACCGGTGCCTACGAGCAGTACTTCGGGCCG	CASSQGTGAYEQYF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	42	unresolved						TCRBJ02	TCRBJ02-07	01	1	1	7	2	0	5	23	-1	43	39	48	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGTGAYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTAAGGCAGGCCCAAGAGACCCAGTACTTCGGGCCA	CATSDLRQAQETQYF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	4	1	4	1	24	41	49	45	50		TCRBV24-01,TCRBV24-or09_02												CATSDLRQAQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTMSCTCCCAGACATCTGTRTACTTCTGTGCCAAGGACTAAAGACGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	31	7.032284993557519E-5		41	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	1	9	0	1	4	26	33	40	34	44	TCRBV06,TCRBV10					01,02								X+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGAGGGCGGGGTACAGAGATACGCAGTATTTTGGCCCA	CASSLARAGYRDTQYF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	48				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	3	5	4	5	18	35	45	39	50	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLARAGYRDTQYF+X+TCRBJ02-03		TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GRGACWCGGCMCTSTATCTCTGYGCCAGCAGTCCTAGCGGGGGTAGCACAGATACGCAGTATTTTGGCCCA	CASSPSGGSTDTQYF	In	VDJ	1	31	7.032284993557519E-5	9.026348201572914E-5	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	2	0	0	1	20	-1	43	33	44	TCRBV05,TCRBV23													CASSPSGGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCAGACCGGGACAGATAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	31	7.032284993557519E-5		49	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	5	0	7	2	19	31	45	38	47		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGACGAAGATCGAGTCACACCGGGGAGCTGTTTTTTGGAGAA	CASRRRSSHTGELFF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	11	2	3	9	2	24	35	47	44	49	TCRBV06,TCRBV10													CASRRRSSHTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGGGTAGCGGGCGGTCCTACAATGAGCAGTTCTTCGGGCCA	CRGSGRSYNEQFF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	9	5	4	1	3	3	26	31	41	34	44		TCRBV20-01,TCRBV20-or09_02				01,02								CRGSGRSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACAGGGTGGGAAGAGACCCAGTACTTCGGGCCA	CSATGWEETQYF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	3	3	3	1	4	26	34	41	35	45		TCRBV20-01,TCRBV20-or09_02												CSATGWEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACTACCTGGGGAGAGCGGGGCGAGCAGTACTTCGGGCCG	CSATTWGERGEQYF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	6	3	6	14	0	26	34	-1	48	55		TCRBV20-01,TCRBV20-or09_02												CSATTWGERGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTACGGTCGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	32	7.259132896575504E-5		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	4	9	0	1	6	26	40	44	41	50		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCCGGGACGGACTATGGCTACACCTTCGGTTCG	CSARSGTDYGYTF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	3	0	7	3	4	2	26	37	46	41	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARSGTDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTTAGGCAGCGGGGTTACAATGAGCAGTTCTTCGGGCCA	CSAVRQRGYNEQFF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	3	4	7	1	26	35	49	42	50		TCRBV20-01,TCRBV20-or09_02												CSAVRQRGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGAAGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CSGRQGNTEAFF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	3	1	3	0	26	33	-1	36	43		TCRBV20-01,TCRBV20-or09_02												CSGRQGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTAGAGATGTCACCAACGGGAACATTCAGTACTTCGGCGCC	CSVRDVTNGNIQYF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	8	4	7	9	0	26	40	-1	49	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSVRDVTNGNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGGAGTGGGCAGGGAACACTGAAGCTTTCTTTGGACAA	CASREWAGNTEAFF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	4	4	1	8	0	22	33	-1	41	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASREWAGNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCGTTACTCGGGAGAGATCCTACAATGAGCAGTTCTTCGGGCCA	CASVTRERSYNEQFF	In	VDJ	1	32	7.259132896575504E-5	9.317520724204299E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	8	2	1	6	3	23	32	44	38	47	TCRBV09,TCRBV21													CASVTRERSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCCTCGATCGTCCCAGGGGCGGGCAGCCCCAGCATTTTGGTGAT	CASSLDRPRGGQPQHF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	2	7	12	4	26	37	55	49	59		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLDRPRGGQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGCCGGGACACAAAATGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	33	7.485980799593489E-5		53	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	6	1	3	8	26	38	47	41	55		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGTACAGACTTATGGCTACACCTTCGGTTCG	CASSQDVQTYGYTF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	42	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	3	5	5	3	3	26	43	50	46	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDVQTYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCCTCGGGGGGCGCACAGATACGCAGTATTTTGGCCCA	CASSRLGGRTDTQYF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	1	1	4	1	26	39	50	43	51		TCRBV03-01,TCRBV03-02												CASSRLGGRTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCCGGGAAGGGAGCGGGGGTAATCATGAGCAGTTCTTCGGGCCA	CASSLREGSGGNHEQFF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	6	2	8	11	5	26	39	58	50	63		TCRBV03-01,TCRBV03-02												CASSLREGSGGNHEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCCCCGGGATAGCGGGAGAAATGCATACGAGCAGTACTTCGGGCCG	CSPRDSGRNAYEQYF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	5	2	4	8	7	26	32	49	40	56		TCRBV20-01,TCRBV20-or09_02												CSPRDSGRNAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGTCCACAGATACGCAGTATTTTGGCCCA	CSASGSTDTQYF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	8	4	2	0	2	26	-1	41	37	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSASGSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGTGCCTAGCGGGGCCCAGGGGCAGTTCTTCGGGCCA	CASSLVPSGAQGQFF	In	VDJ	1	33	7.485980799593489E-5	9.608693246835683E-5	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	4	3	12	3	7	18	34	46	37	53	TCRBV07,TCRBV11													CASSLVPSGAQGQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACGGGAGTAACTACAATGAGCAGTTCTTCGGGCCA	CASSQDGSNYNEQFF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	8	2	3	0	3	26	-1	49	43	52		TCRBV03-01,TCRBV03-02												CASSQDGSNYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATAAAGATCCCATTCAAAGAAAAAACATTCAGTACTTCGGCGCC	CASSHKDPIQRKNIQYF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	51	TCRBV03						TCRBJ02	TCRBJ02-04	01	3	2	8	4	4	13	26	40	46	44	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHKDPIQRKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03		TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCAACCCAGCGGGAGGGAATGAGCAGTTCTTCGGGCCA	CSATNPAGGNEQFF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	6	0	7	7	0	26	36	-1	43	53		TCRBV20-01,TCRBV20-or09_02												CSATNPAGGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGGCAGGACAGGGATATGGCTACACCTTCGGTTCG	CSARDPAGQGYGYTF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	5	7	1	26	40	55	47	56		TCRBV20-01,TCRBV20-or09_02												CSARDPAGQGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCGTAGGGGAGCTGTTTTTTGGAGAA	CSARDLVGELFF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	4	10	8	1	4	26	40	43	41	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLVGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGATCAGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	34	7.712828702611473E-5		35	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	4	3	3	0	26	37	-1	40	44		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGAGGGGGAATAATGAGCAGTTCTTCGGGCCA	CSAGRGNNEQFF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	0	7	0	5	26	-1	42	35	47		TCRBV20-01,TCRBV20-or09_02												CSAGRGNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGCAGGGCGAGGACAAGACTATGGCTACACCTTCGGTTCG	CATSDAGRGQDYGYTF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	6	3	9	2	24	39	53	48	55		TCRBV24-01,TCRBV24-or09_02												CATSDAGRGQDYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTTCTCTTGCGCGAGCTAGCGGGAGGATTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSSLARASGRISSYNEQFF	In	VDJ	1	34	7.712828702611473E-5	9.899865769467067E-5	57	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	4	1	0	13	5	24	30	54	43	59		TCRBV20-01,TCRBV20-or09_02												CSSLARASGRISSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGTTTGGTGCCCCAACCAGACAGCTCTTACTTCTGTGCCACCCCCCATTATCCCGGTCTGTGAGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	34	7.712828702611473E-5		47	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	24	3	10	3	0	33	34	-1	31	28	64		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCGGTCCGTTAAGGGCCCAGTACTTCGGGCCA	CASSPGPLRAQYF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	39	TCRBV03						TCRBJ02	TCRBJ02-05	01	4	5	3	9	11	0	26	39	-1	50	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPLRAQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTAAACTGACAGATCCCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	35	7.939676605629458E-5		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	5	6	7	5	26	39	51	46	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAGCGGGAGACAACAATGAGCAGTTCTTCGGGCCA	CASSLAGDNNEQFF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	2	5	0	3	26	-1	48	39	51		TCRBV03-01,TCRBV03-02												CASSLAGDNNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGGACGAGAGGGACGCGCAGTATTTTGGCCCA	CSARDRDERDAQYF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	0	0	7	10	2	10	26	40	47	42	57		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDRDERDAQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTACTAGCGGGAGGCCGGGCTTCCCCAATGAGCAGTTCTTCGGGCCA	CSARGTSGRPGFPNEQFF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	3	1	6	2	11	26	39	53	41	64		TCRBV20-01,TCRBV20-or09_02												CSARGTSGRPGFPNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATACTAACTAGGATAATCTCCTCGTGGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	35	7.939676605629458E-5		52	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	3	8	8	5	15	26	38	48	43	63		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAAACTAGCGGGAGGATCACAGATACGCAGTATTTTGGCCCA	CSARETSGRITDTQYF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	3	1	2	4	2	26	37	53	41	55		TCRBV20-01,TCRBV20-or09_02												CSARETSGRITDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAGACACCTCCCGACGAGAGACCCAGTACTTCGGGCCA	CSAIDTSRRETQYF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	0	2	7	4	8	1	26	40	51	48	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAIDTSRRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTCCACTAAGAACACCGGGGAGCTGTTTTTTGGAGAA	CSSTKNTGELFF	In	VDJ	1	35	7.939676605629458E-5	1.0191038292098452E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	3	9	1	3	1	26	32	39	35	40		TCRBV20-01,TCRBV20-or09_02				01,02								CSSTKNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGACTACCACGAGCAGTACTTCGGGCCG	CASSLDYHEQYF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	36	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	3	9	5	0	2	26	-1	46	42	48		TCRBV12-03,TCRBV12-04				01,02								CASSLDYHEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCCCAGCCGGAAACACCATATATTTTGGAGAG	CASTPAGNTIYF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	36	TCRBV03						TCRBJ01	TCRBJ01-03	01	7	4	5	4	3	2	26	36	42	39	44		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPAGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGACTAGCGGGATGGGCCCGGCGTACGAGCAGTATTTCGGGCCG	CASSQGTSGMGPAYEQYF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	54	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	1	3	16	0	23	26	-1	54	42	77		TCRBV03-01,TCRBV03-02												CASSQGTSGMGPAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTCGGACTAGCGGATACAATGAGCAGTTCTTCGGGCCA	CASSLRTSGYNEQFF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	5	4	3	1	26	39	52	42	53		TCRBV03-01,TCRBV03-02				01,02								CASSLRTSGYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGAGCTCCCGCCAAGTGTACGAGCAGTACTTCGGGCCG	CSARESSRQVYEQYF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	6	7	4	1	12	26	40	44	41	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSARESSRQVYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACAGGCATGGGCAATCAGCCCCAGCATTTTGGTGAT	CSARDTGMGNQPQHF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	4	2	1	5	26	40	46	41	51		TCRBV20-01,TCRBV20-or09_02												CSARDTGMGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCCGCCACGAACACCATATATTTTGGAGAG	CSARDSATNTIYF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	39	TCRBV20						TCRBJ01	TCRBJ01-03	01	0	3	7	7	7	1	26	40	49	47	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDSATNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATCGGGCAGCTATGGCTACACCTTCGGTTCG	CASSLSGSYGYTF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	39	unresolved			unresolved			TCRBJ01	TCRBJ01-02	01	0	8	0	4	0	2	23	-1	44	40	46	TCRBV24,TCRBV27			TCRBD01,TCRBD02										CASSLSGSYGYTF+X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTACCCGCTAGCGGGGGGCGTGATGAGCAGTTCTTCGGGCCA	CASSLPASGGRDEQFF	In	VDJ	1	36	8.166524508647442E-5	1.0482210814729836E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	4	1	8	5	4	19	33	49	38	53	TCRBV05,TCRBV11													CASSLPASGGRDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAAGGGCGCCCTCCGGGACAGGGGACTCTGGAAACACCATATATTTTGGAGAG	CASSLRAPSGTGDSGNTIYF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	60	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	0	2	0	12	1	21	36	58	48	59	TCRBV24,TCRBV27													CASSLRAPSGTGDSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTTAGCGGGATAGCCATTCAGTACTTCGGCGCC	CASSLSGIAIQYF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	5	3	9	3	4	26	37	48	40	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLSGIAIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD02-01*02	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCGGACAAACAGGGCTACAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	37	8.393372411665426E-5		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	11	3	3	0	6	3	24	30	42	36	45	TCRBV06,TCRBV10													X+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGCACTGGGGAGAAGCTTTCTTTGGACAA	CASSPHWGEAFF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	36	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	0	8	8	7	0	26	39	-1	46	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPHWGEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGTCCCCTCGAAAGCTCCGGAAAGAGACCCAGTACTTCGGGCCA	CSARGSPRKLRKETQYF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	51	TCRBV20						TCRBJ02	TCRBJ02-05	01	1	1	8	3	18	0	26	39	-1	57	60		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGSPRKLRKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTGAAGGGACAGCCCAAGAGACCCAGTACTTCGGGCCA	CSAIEGTAQETQYF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	5	1	5	1	26	36	48	41	49		TCRBV20-01,TCRBV20-or09_02												CSAIEGTAQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTACCCCTGGCTAGCGGGGTTCTTGGCAATGAGCAGTTCTTCGGGCCA	CSALPLASGVLGNEQFF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	6	10	7	26	35	54	45	61		TCRBV20-01,TCRBV20-or09_02												CSALPLASGVLGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTGAATCAGATGCAGACCCAGTACTTCGGGCCA	CASSLNQMQTQYF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	5	6	6	4	24	36	45	42	49		TCRBV24-01,TCRBV24-or09_02												CASSLNQMQTQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGAGGGTGCGGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVEGAVSYNEQFF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	48	unresolved			unresolved			TCRBJ02	TCRBJ02-01	01	5	11	0	0	3	6	24	36	44	39	50	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSVEGAVSYNEQFF+X+TCRBJ02-01	unresolved	unresolved	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTTGTGRGTCTAGGAGGTTCCAGCTACGGGGAGCTGTTTTTTGGAGAA	CASSFVXLGGSSYGELFF	In	VDJ	1	37	8.393372411665426E-5	1.077338333736122E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	10	1	7	13	9	24	35	53	48	62	TCRBV12,TCRBV21													CASSFVXLGGSSYGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTCTTACCCTACGAGCAGTACTTCGGGCCG	CASSFLPYEQYF	In	VDJ	1	38	8.620220314683411E-5	1.1064555859992605E-4	36	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	3	7	2	5	0	26	38	-1	43	45		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFLPYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCCGGGACTAGCGGTTCAGATACGCAGTATTTTGGCCCA	CASSPGTSGSDTQYF	In	VDJ	1	38	8.620220314683411E-5	1.1064555859992605E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	5	4	4	2	26	37	52	41	54		TCRBV03-01,TCRBV03-02				01,02								CASSPGTSGSDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGCGGGAGTCCCGATACGCAGTATTTTGGCCCA	CSASGSPDTQYF	In	VDJ	1	38	8.620220314683411E-5	1.1064555859992605E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	2	6	1	4	26	34	43	35	47		TCRBV20-01,TCRBV20-or09_02												CSASGSPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCCAAGTGGGACACTGAAGCTTTCTTTGGACAA	CSAPKWDTEAFF	In	VDJ	1	38	8.620220314683411E-5	1.1064555859992605E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	0	9	3	8	0	26	34	-1	42	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPKWDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCGGGACCGCGTCGGGTAATCGCTACACCTTCGGTTCG	CSAIGTASGNRYTF	In	VDJ	1	38	8.620220314683411E-5	1.1064555859992605E-4	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	4	0	7	9	2	14	26	36	43	38	57		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAIGTASGNRYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCAGGTTAAATGAGGGCTACGAGCAGTACTTCGGGCCG	CSAPRLNEGYEQYF	In	VDJ	1	38	8.620220314683411E-5	1.1064555859992605E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	11	0	3	12	0	26	35	-1	47	52		TCRBV20-01,TCRBV20-or09_02												CSAPRLNEGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGTACCCTCACAGATACGCAGTATTTTGGCCCA	CSARTLTDTQYF	In	VDJ	1	38	8.620220314683411E-5	1.1064555859992605E-4	36	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	3	7	2	3	3	26	35	40	38	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARTLTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTCGACAGGTGGCATCAGCCCCAGCATTTTGGTGAT	CSALDRWHQPQHF	In	VDJ	1	38	8.620220314683411E-5	1.1064555859992605E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	4	5	3	4	26	35	44	38	48		TCRBV20-01,TCRBV20-or09_02												CSALDRWHQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCGGGTCATGGGCTACTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	38	8.620220314683411E-5		50	TCRBV24						TCRBJ02	TCRBJ02-01	01	0	8	0	6	8	4	24	42	54	50	58		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGRGACWCRGCMSTGTATCTCTRCGCCAGCAGCCAGATCGCAGGTAGTGAGACCCAGTACTTCGGGCCA	XASSQIAGSETQYF	In	VDJ	1	38	8.620220314683411E-5	1.1064555859992605E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	4	5	8	4	20	31	43	39	47	TCRBV04,TCRBV07,TCRBV17,TCRBV23													XASSQIAGSETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCSRGGGACTYRGCTGTGTATYTYTGTGCCAGCAGCTCGACAGGGTCGGAGGGCTACACCTTCGGTTCG	CASSSTGSEGYTF	In	VDJ	1	38	8.620220314683411E-5	1.1064555859992605E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	3	8	0	6	22	-1	43	36	49	TCRBV07,TCRBV12													CASSSTGSEGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTATTGGGGCACATGAACACTGAAGCTTTCTTTGGACAA	CASSLLGHMNTEAFF	In	VDJ	1	38	8.620220314683411E-5	1.1064555859992605E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	7	0	0	4	3	22	35	44	39	47	TCRBV07,TCRBV11													CASSLLGHMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGAAAGGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASRKGGQETQYF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	39	TCRBV03						TCRBJ02	TCRBJ02-05	01	6	5	1	2	3	1	26	37	46	40	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRKGGQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCGGGGCAGGGCCCGGACTAGCGGGATGGGGCGACCCAGTACTTCGGGCCA		Out	VDJ	1	39	8.847068217701396E-5		49	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	11	1	3	7	12	6	26	32	56	44	62		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGGGAGGGCCGACAGTCTACAATGAGCAGTTCTTCGGGCCA	CSATGGPTVYNEQFF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	0	3	0	8	26	-1	44	36	52		TCRBV20-01,TCRBV20-or09_02												CSATGGPTVYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGGGCTAGCGGGAGGGCGGAGCAGTTCTTCGGGCCA	CSARDWASGRAEQFF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	4	0	10	5	2	26	40	57	45	59		TCRBV20-01,TCRBV20-or09_02												CSARDWASGRAEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCGGGCACATTCAGTACTTCGGCGCC	CSARGGHIQYF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	1	7	4	8	0	1	26	-1	44	39	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGGHIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTGAGGACAGTATCTCCGAGCAGTACTTCGGGCCG	CSARGEDSISEQYF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	5	6	4	6	26	39	49	43	55		TCRBV20-01,TCRBV20-or09_02												CSARGEDSISEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGCGGGGCGGGTTGAGCAGTTCTTCGGGCCA	CSASAGRVEQFF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	3	9	1	5	26	37	44	38	49		TCRBV20-01,TCRBV20-or09_02												CSASAGRVEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGACCGATCTCTGGAAACACCATATATTTTGGAGAG	CSASGPISGNTIYF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	42	TCRBV20						TCRBJ01	TCRBJ01-03	01	3	1	7	0	1	4	26	37	42	38	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGPISGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGACCCGGGGGATAGCGGGGTTTCGTACGAGCAGTACTTCGGGCCG	CSADPGDSGVSYEQYF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	5	3	4	11	5	26	35	54	46	59		TCRBV20-01,TCRBV20-or09_02												CSADPGDSGVSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGAGGAAGCGGGCCCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAGGSGPSSYNEQFF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	6	4	0	2	5	26	39	47	41	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGGSGPSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCGGGACAGCCTACGAGCAGTACTTCGGGCCG	CSASGTAYEQYF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	2	3	0	26	35	-1	38	45		TCRBV20-01,TCRBV20-or09_02												CSASGTAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGGGATCTCCGAGGGGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	39	8.847068217701396E-5		40	TCRBV24						TCRBJ01	TCRBJ01-01	01	7	5	2	6	10	0	24	35	-1	45	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
SGACTCGGCYSTSTATCTCTGTGCCCCCCTTCCCAGGAGGGCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	39	8.847068217701396E-5		40	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	10	10	0	2	10	1	19	25	41	35	42	TCRBV05,TCRBV07													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACACAAGCGGGAGGGATACGCAGTATTTTGGCCCA	CASSQDTSGRDTQYF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	6	1	6	4	0	18	35	-1	39	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDTSGRDTQYF+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTCGGGACAGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSSGQGTGELFF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	2	5	1	0	19	32	-1	33	43	TCRBV07,TCRBV11													CASSSGQGTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAACCAGTAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLTSNSNQPQHF	In	VDJ	1	39	8.847068217701396E-5	1.1355728382623988E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	5	0	4	3	22	35	42	39	45	TCRBV07,TCRBV11													CASSLTSNSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGTGCATCCTGAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGAGACAGAATCTTCAGTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	39	8.847068217701396E-5		50	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	2	5	0	4	10	31	42	51	46	61		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGAAGGGATCAGCCCCAGCATTTTGGTGAT	CASSLRRDQPQHF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	39	TCRBV12						TCRBJ01	TCRBJ01-05	01	2	5	3	5	3	0	26	41	-1	44	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRRDQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACGGAGGGGAGACACCATATATTTTGGAGAG	CASSPRRGDTIYF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	10	0	8	3	3	26	39	48	42	51		TCRBV03-01,TCRBV03-02												CASSPRRGDTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD02-01*02	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACTCTAGAGGGGGACTACGTGGCACAGATACGCAGTATTTTGGCCCA	CSANSRGGLRGTDTQYF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	9	1	10	4	26	36	53	46	57		TCRBV20-01,TCRBV20-or09_02				01,02								CSANSRGGLRGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGCTTGGGACAGCCCCAGCATTTTGGTGAT	CSAREGLGQPQHF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	39	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	0	8	7	6	0	26	40	-1	46	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREGLGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCCTAGCGGGAGGGCCTGGTGTGCACCGGGGAGCTGTTTTTTGGAGAA	CSASP*REGLVCTGELFF	Stop	VDJ	1	40	9.073916120719381E-5		54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	4	0	4	3	9	26	37	52	40	61		TCRBV20-01,TCRBV20-or09_02												CSASP*REGLVCTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCATCCAACCCAGGGTAATAGCGCGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	40	9.073916120719381E-5		40	TCRBV20						TCRBJ01	TCRBJ01-04	01	10	4	3	8	7	9	26	30	42	37	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGACCTAAGGGAGGTCGGGGAGCTGTTTTTTGGAGAA	CASSDLREVGELFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	9	1	7	7	1	22	34	47	41	48	TCRBV02,TCRBV12													CASSDLREVGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCCACAAGTCAGGGAGACCCAGTACTTCGGGCCA	CATPQVRETQYF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	9	4	4	5	8	0	24	33	-1	41	45		TCRBV24-01,TCRBV24-or09_02												CATPQVRETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTGCTCGCTAGTCCCCACAATGAGCAGTTCTTCGGGCCA	CASSLLASPHNEQFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	8	5	7	5	24	36	47	43	52	TCRBV06,TCRBV24					01,02								CASSLLASPHNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGAGCTCTAGCGGGAGGGAAGGACAATGAGCAGTTCTTCGGGCCA	CASRALAGGKDNEQFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	0	5	4	4	23	34	50	38	54	TCRBV06,TCRBV10													CASRALAGGKDNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACCCGGCAATGAAAAACTGTTTTTTGGCAGT	CASSEPGNEKLFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	39	TCRBV06						TCRBJ01	TCRBJ01-04	01	2	9	0	5	3	0	23	38	-1	41	44		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEPGNEKLFF+TCRBV06-X+TCRBJ01-04	TCRBV06		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATCGGACTCGGCCAATGAGCAGTTCTTCGGGCCA	CASSESDSANEQFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	42	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	1	10	6	2	4	23	38	45	40	49		TCRBV06-01,TCRBV06-08				01,02								CASSESDSANEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAACGGGGCGATGAGCAGTTCTTCGGGCCA	CAISERGDEQFF	In	VDJ	1	40	9.073916120719381E-5	1.1646900905255372E-4	36							TCRBJ02	TCRBJ02-01	01	2	7	0	8	1	1	23	38	44	39	45	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISERGDEQFF+X+TCRBJ02-01			TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGGGTGGGGAGGGCAGTTCTTCGGGCCA	CASSFGWGGQFF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	36	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	9	1	12	6	0	26	40	-1	46	52		TCRBV12-03,TCRBV12-04												CASSFGWGGQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCCGGACTAGCGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASRTSGNTGELFF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	1	5	2	3	1	24	31	44	34	45	TCRBV06,TCRBV10					01,02								CASRTSGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACTCGCGGCGGGGCATTCAGTACTTCGGCGCC	CASSQDSRRGIQYF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	0	7	3	9	6	0	26	43	-1	49	55		TCRBV03-01,TCRBV03-02												CASSQDSRRGIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTAAGGACCGTATCCCCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	41	9.300764023737364E-5		38	TCRBV20						TCRBJ02	TCRBJ02-03	01	8	1	7	4	2	9	26	32	38	34	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACCTCAGGAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	41	9.300764023737364E-5		34	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	4	8	5	0	26	37	-1	42	46		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCACCAGTGAGGCGCTACACCTTCGGTTCG	CSAAPVRRYTF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	11	1	9	8	1	26	35	47	43	48		TCRBV20-01,TCRBV20-or09_02												CSAAPVRRYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGGGTATCCTGGGATACGCAGTATTTTGGCCCA	CATSDRVSWDTQYF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	8	4	6	1	8	24	38	43	39	51		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDRVSWDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCTGGGTCTTATGGTGAAAAACTGTTTTTTGGCAGT	CASSLSGSYGEKLFF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	45							TCRBJ01	TCRBJ01-04	01	6	0	9	7	6	8	24	36	45	42	53	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSGSYGEKLFF+X+TCRBJ01-04			TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTGAGTGGACCAGGGGGCAGGGCACTGAAGCTTTCTTTGGACAA	CASSFEWTRGQGTEAFF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	0	4	11	4	24	36	55	47	59		TCRBV24-01,TCRBV24-or09_02												CASSFEWTRGQGTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATTTGGTGTCAATGAGCAGTTCTTCGGGCCA	CASSEFGVNEQFF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	39	TCRBV06						TCRBJ02	TCRBJ02-01	01	2	0	10	6	3	3	23	38	43	41	46		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEFGVNEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGTACTAGCGGGCCTCTACAATGAGCAGTTCTTCGGGCCA	CASSLVLAGLYNEQFF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	48	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	3	4	3	3	3	19	33	45	36	48		TCRBV05-06,TCRBV05-07				01,02								CASSLVLAGLYNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCRGGRGACWYRGCWSKGTATYTCTGTGCCAGCAGCTTAATCTGGGGGGACCAAGAGACCCAGTACTTCGGGCCA	CASSLIWGDQETQYF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	9	1	0	6	0	22	35	-1	41	47	TCRBV07,TCRBV21													CASSLIWGDQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAACAGTTTTAGCTGGAAACACCATATATTTTGGAGAG	CASSETVLAGNTIYF	In	VDJ	1	41	9.300764023737364E-5	1.1938073427886757E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	3	5	2	0	6	23	-1	42	38	48	TCRBV02,TCRBV09													CASSETVLAGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGTGCATCCTGAAGACAGCAGCTTCTCATCTGCAGTGCTAGGGGAGACAGAATCTTCAGTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	41	9.300764023737364E-5		49	TCRBV20						TCRBJ01	TCRBJ01-01	01	19	2	5	0	19	10	32	27	51	46	61		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGTGCATCCTGAAGACAGCAGYTCTACATCTGCAGTGCTAGGGGAGACAGAATCTTCAGTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	41	9.300764023737364E-5		50	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	2	5	0	4	10	31	42	51	46	61		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGGCGGATAGCGGGAGTATCAGATACGCAGTATTTTGGCCCA	XASRRIAGVSDTQYF	In	VDJ	1	42	9.527611926755349E-5	1.222924595051814E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	5	2	4	5	3	23	34	48	39	51	TCRBV01,TCRBV17													XASRRIAGVSDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCCCCCCCTAAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	42	9.527611926755349E-5		35	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	4	9	5	5	1	26	35	43	40	44		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACCCGTTTTCGCAGGTTTGAATGAGCAGTTCTTCGGGCCA	CSAPVFAGLNEQFF	In	VDJ	1	42	9.527611926755349E-5	1.222924595051814E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	4	7	11	4	26	34	49	45	53		TCRBV20-01,TCRBV20-or09_02												CSAPVFAGLNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATGGTACAGGGGGGTCAGCCCCAGCATTTTGGTGAT	CSARDMVQGGQPQHF	In	VDJ	1	42	9.527611926755349E-5	1.222924595051814E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	1	6	6	1	26	40	54	46	55		TCRBV20-01,TCRBV20-or09_02												CSARDMVQGGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGACCAGACTAGYCGTTTCTACAATGAGCAGTTCTTCGGGCCA	CSARDDQTSRFYNEQFF	In	VDJ	1	42	9.527611926755349E-5	1.222924595051814E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	2	8	3	6	6	26	40	52	46	58		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDDQTSRFYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCCAGGGGTGGAGATTACGAGCAGTACTTCGGGCCG	CSASPRGGDYEQYF	In	VDJ	1	42	9.527611926755349E-5	1.222924595051814E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	4	3	7	26	37	46	40	53		TCRBV20-01,TCRBV20-or09_02												CSASPRGGDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACTAGCGGGAGCTTTAAACGAGCAGTACTTCGGGCCG	CASSLLAGALNEQYF	In	VDJ	1	42	9.527611926755349E-5	1.222924595051814E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	3	2	5	2	6	24	36	49	38	55		TCRBV24-01,TCRBV24-or09_02												CASSLLAGALNEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGAACAGGACAGCCCAGGGGGCTACACCTTCGGTTCG		Out	VDJ	1	42	9.527611926755349E-5		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	5	8	5	7	18	32	43	37	50	TCRBV07,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGGCATCGGGGGAGCAGTACTTCGGGCCG	CASSLAASGEQYF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	3	7	5	0	26	43	-1	48	53		TCRBV12-03,TCRBV12-04												CASSLAASGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGACTAGCAGGAGAGACCCAGTACTTCGGGCCA	CASRLAGETQYF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	3	7	4	0	3	26	-1	43	37	46		TCRBV03-01,TCRBV03-02				01,02								CASRLAGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTATAGGGGACCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	43	9.754459829773334E-5		43	TCRBV03						TCRBJ02	TCRBJ02-07	01	4	0	7	0	6	0	26	39	-1	45	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTCAGGGTCCCATTTCGTTAGACGAGCAGTACTTCGGGCCG	CASSLQGPISLDEQYF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	5	2	14	26	39	46	41	60		TCRBV03-01,TCRBV03-02												CASSLQGPISLDEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGAAGGAGACAGGGGGCCCAAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	43	9.754459829773334E-5		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	2	0	3	2	4	26	42	54	44	58		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCCCGGGACAGGGGGTTTGGGAATCGGGTGAGCAGTTCTTCGGGCCA	CASSSPGQGVWESGEQFF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	1	9	5	13	26	38	54	43	67		TCRBV03-01,TCRBV03-02												CASSSPGQGVWESGEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAAATCCCGACAGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLNPDRATGELFF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	3	4	9	1	26	38	54	47	55		TCRBV03-01,TCRBV03-02												CASSLNPDRATGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAACTCTCTAGCGGAATCCTCGAATGAGCAGTTCTTCGGGCCA	CSANSLAESSNEQFF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	5	7	7	8	26	34	48	41	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSANSLAESSNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACACAGGGGGTCGAAAGGAGTGAGCAGTTCTTCGGGCCA	CSARDTQGVERSEQFF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	1	9	3	10	26	40	51	43	61		TCRBV20-01,TCRBV20-or09_02												CSARDTQGVERSEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCGGGCACCCCCAAGAGACCCAGTACTTCGGGCCA	CASSPGHPQETQYF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	42	unresolved						TCRBJ02	TCRBJ02-05	01	5	8	0	1	3	4	18	30	37	33	41	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGHPQETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGACCAAGTGGGGGAGAGGCGGTGCCTAGCACAGATACGCAGTATTTTGGCCCA	CASRPSGGEAVPSTDTQYF	In	VDJ	1	43	9.754459829773334E-5	1.2520418473149525E-4	57	unresolved						TCRBJ02	TCRBJ02-03	01	6	6	1	0	7	13	19	30	42	37	55	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPSGGEAVPSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCAGGAGACWCRGCMMKGTATYKCTGTGCCAGCAGCTGAGACAGGGTTGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	43	9.754459829773334E-5		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	3	4	3	3	24	36	46	39	49	TCRBV07,TCRBV21													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGTGCATCCTGAAGACAGCAGCTTTACATCTGCAGTGCTAGGGGAGACAGAATCTTCAGTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	43	9.754459829773334E-5		49	TCRBV20						TCRBJ01	TCRBJ01-01	01	21	2	5	0	21	10	32	25	51	46	61		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCRGCYSTSTATYTYTGTGCCAGCATTCCCCTTTGGCGGGAGATTTCCTACGAGCAGTACTTCGGGCCG	CASIPLWREISYEQYF	In	VDJ	1	44	9.981307732791318E-5	1.281159099578091E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	12	7	2	1	15	3	26	31	53	46	56	TCRBV05,TCRBV12													CASIPLWREISYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCATGGGGTCGCACAGGGCAACTATGGCTACACCTTCGGTTCG	CASSHGVAQGNYGYTF	In	VDJ	1	44	9.981307732791318E-5	1.281159099578091E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	3	2	9	1	23	37	52	46	53	TCRBV01,TCRBV23													CASSHGVAQGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTGGGACAGGGGTGACTGAAGCTTTCTTTGGACAA	CASSQVGTGVTEAFF	In	VDJ	1	44	9.981307732791318E-5	1.281159099578091E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	2	5	2	2	26	42	54	44	56		TCRBV03-01,TCRBV03-02												CASSQVGTGVTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCCCGACAGGGGGGGTATGGCTACACCTTCGGTTCG	CSASPRQGGYGYTF	In	VDJ	1	44	9.981307732791318E-5	1.281159099578091E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	1	5	5	2	26	37	51	42	53		TCRBV20-01,TCRBV20-or09_02												CSASPRQGGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGTAAGCGTAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	44	9.981307732791318E-5		37	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	6	6	7	3	1	24	38	45	41	46		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTGGGACTAGCGGGCACAGATACGCAGTATTTTGGCCCA	CASSLGLAGTDTQYF	In	VDJ	1	44	9.981307732791318E-5	1.281159099578091E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	5	1	2	0	24	36	-1	38	49	TCRBV24,TCRBV27					01,02								CASSLGLAGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTTTAGGTATAGGGTTACGAGCAGTACTTCGGGCCG	CASSF*V*GYEQYF	Stop	VDJ	1	44	9.981307732791318E-5		42	TCRBV05						TCRBJ02	TCRBJ02-07	01	2	5	3	4	8	1	19	33	45	41	46		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSF*V*GYEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGTTAGGACAGGGCGATTGAACACTGAAGCTTTCTTTGGACAA	XASSQVRTGRLNTEAFF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	3	0	3	4	23	39	50	42	54	TCRBV01,TCRBV04													XASSQVRTGRLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGACAGGGGGTGACGAAAAACTGTTTTTTGGCAGT	CSARTGGDEKLFF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	1	8	2	4	26	34	46	36	50		TCRBV20-01,TCRBV20-or09_02												CSARTGGDEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGCGGGCTTACAACAATGAGCAGTTCTTCGGGCCA	CSARRRAYNNEQFF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	7	4	5	2	6	26	38	45	40	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARRRAYNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGTGGGGGACATACTAATGAAAAACTGTTTTTTGGCAGT	CSARSGGHTNEKLFF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	6	2	5	1	26	38	49	43	50		TCRBV20-01,TCRBV20-or09_02												CSARSGGHTNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGAGGGACTCCCCCCTACGAGCAGTACTTCGGGCCG	CSARDRGTPPYEQYF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	10	2	4	4	26	40	50	44	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDRGTPPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGTACTAGGGGCAACTATGGCTACACCTTCGGTTCG	CSARGTRGNYGYTF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	3	5	2	2	7	1	26	37	49	44	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGTRGNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAATCTAGCGGAAGGGGTAGAGACCCAGTACTTCGGGCCA	CSASNLAEGVETQYF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	4	5	4	4	7	26	37	48	41	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSASNLAEGVETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCAAAATCCCGGACGGGGGGATGGCTACACCTTCGGTTCG	CATSDQNPGRGDGYTF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	1	6	12	0	24	39	-1	51	58		TCRBV24-01,TCRBV24-or09_02												CATSDQNPGRGDGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTCCTAGCGGGAGGGCCAGTGGGTAAAGAGACCCAGTACTTCGGGCCA	CASSFLAGGPVGKETQYF	In	VDJ	2	45	1.0208155635809302E-4	1.3102763518412294E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	4	0	3	1	10	19	33	46	34	56	TCRBV05,TCRBV11													CASSFLAGGPVGKETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTCTACTAATGAAAAACTGTTTTTTGGCAGT	CASSQDSTNEKLFF	In	VDJ	2	46	1.0435003538827287E-4	1.3393936041043678E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	4	10	2	2	0	23	40	-1	42	44	TCRBV01,TCRBV04					01,02								CASSQDSTNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGGCCCTCACATCCTCTCAGTACCTCTGTGCCAGCAGTGAATATTCGGGGGACTACGAGCAGTACTTCGGGCCG	CASSEYSGDYEQYF	In	VDJ	2	46	1.0435003538827287E-4	1.3393936041043678E-4	42	TCRBV25			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	2	3	2	1	39	56	64	58	65		TCRBV25-01,TCRBV25-or09_02												CASSEYSGDYEQYF+TCRBV25-X+TCRBJ02-07	TCRBV25	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACAGAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLQNSNQPQHF	In	VDJ	2	46	1.0435003538827287E-4	1.3393936041043678E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	5	0	2	2	24	36	42	38	44		TCRBV24-01,TCRBV24-or09_02												CASSLQNSNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTTCTAGCGGGCACAGATACGCAGTATTTTGGCCCA	CASSVLAGTDTQYF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	5	1	4	0	26	37	-1	41	48		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSVLAGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCACGACGGCAGCTTAGCCAATGAGCAGTTCTTCGGGCCA	CSAHDGSLANEQFF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	5	7	6	14	0	26	34	-1	48	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAHDGSLANEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGGAGAGGTAAATGGTGGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	47	1.0661851441845271E-4		44	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	2	2	1	13	26	34	40	35	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTGTTGCTAGCGGGACCGAGACCCAGTACTTCGGGCCA	CASSVASGTETQYF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	4	3	5	4	2	22	34	47	38	49		TCRBV12-03,TCRBV12-04												CASSVASGTETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCATCGGGACAGCCAGCATGAACACTGAAGCTTTCTTTGGACAA	CASSIGTASMNTEAFF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	0	3	6	18	30	40	33	46	TCRBV07,TCRBV11													CASSIGTASMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTCCTGGACAGGGGACGTAATGAAAAACTGTTTTTTGGCAGT	CASSFLDRGRNEKLFF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	2	4	3	3	18	32	44	35	47	TCRBV07,TCRBV11													CASSFLDRGRNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCGTATACTGAATGAAAAACTGTTTTTTGGCAGT	XASSRILNEKLFF	In	VDJ	2	47	1.0661851441845271E-4	1.3685108563675063E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	3	10	5	5	1	22	34	42	39	43	TCRBV01,TCRBV07,TCRBV17					01,02								XASSRILNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGACTAGCGGGAGGCCCCTCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	47	1.0661851441845271E-4		56	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	1	1	2	2	5	25	42	58	44	63		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCGAAAAGGGTTGGGATCGATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	47	1.0661851441845271E-4		44	unresolved						TCRBJ02	TCRBJ02-01	01	5	0	8	8	11	3	24	36	51	47	54	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGGGGGGGCCTTACAATGAGCAGTTCTTCGGGCCA	CASSSGGPYNEQFF	In	VDJ	2	48	1.0888699344863256E-4	1.3976281086306447E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	0	4	0	3	26	-1	47	39	50		TCRBV12-03,TCRBV12-04												CASSSGGPYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAAATCTCGCCGGGGAGCTGTTTTTTGGAGAA	CASSQENLAGELFF	In	VDJ	2	48	1.0888699344863256E-4	1.3976281086306447E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	4	10	6	4	2	26	43	49	47	51		TCRBV03-01,TCRBV03-02				01,02								CASSQENLAGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCCCACTTCAAGCGGGGGGTATTAATGAGCAGTTCTTCGGGCCA	CSPLQAGGINEQFF	In	VDJ	2	48	1.0888699344863256E-4	1.3976281086306447E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	9	6	1	7	9	4	26	31	49	40	53		TCRBV20-01,TCRBV20-or09_02												CSPLQAGGINEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGCCAGGAGGGGCAGGGGCGAAGGGCTACACCTTCGGTTCG	CSARAPGGAGAKGYTF	In	VDJ	2	48	1.0888699344863256E-4	1.3976281086306447E-4	48	TCRBV20						TCRBJ01	TCRBJ01-02	01	1	4	2	8	12	5	26	39	57	51	62		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARAPGGAGAKGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCAAGGGGCGGGGACAGATACGCAGTATTTTGGCCCA	CSASQGAGTDTQYF	In	VDJ	2	48	1.0888699344863256E-4	1.3976281086306447E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	3	3	7	0	26	37	-1	44	50		TCRBV20-01,TCRBV20-or09_02												CSASQGAGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGCCGACATTCAGGGGAGGACTGAGCAGTTCTTCGGGCCA	CATADIQGRTEQFF	In	VDJ	2	48	1.0888699344863256E-4	1.3976281086306447E-4	42	TCRBV24						TCRBJ02	TCRBJ02-01	01	9	4	2	9	9	5	24	33	48	42	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATADIQGRTEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTCTCTACGAGCAGTACTTCGGGCCG	CSARVLYEQYF	In	VDJ	2	49	1.1115547247881241E-4	1.4267453608937832E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	4	10	3	2	0	26	39	-1	41	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVLYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTGGGGCACTTGGCAAACCGGGGAGCTGTTTTTTGGAGAA	CASSWGTWQTGELFF	In	VDJ	2	49	1.1115547247881241E-4	1.4267453608937832E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	7	0	5	0	9	18	-1	36	31	45	TCRBV07,TCRBV11													CASSWGTWQTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGACGACCAGGGGTCGATGAACACTGAAGCTTTCTTTGGACAA	CSADDQGSMNTEAFF	In	VDJ	2	50	1.1342395150899225E-4	1.4558626131569216E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	0	7	4	26	34	47	41	51		TCRBV20-01,TCRBV20-or09_02												CSADDQGSMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTAGCGGATTACAATGAGCAGTTCTTCGGGCCA	CSARLADYNEQFF	In	VDJ	2	50	1.1342395150899225E-4	1.4558626131569216E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	4	5	4	0	2	26	-1	45	38	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSARLADYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTACCACCAGAGAACACTGAGCAGTTCTTCGGGCCA	CSARVPPENTEQFF	In	VDJ	2	50	1.1342395150899225E-4	1.4558626131569216E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	1	3	6	9	12	1	26	39	54	51	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVPPENTEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAGCAGGGTTGAATGAGCAGTTCTTCGGGCCA	CSARVAGLNEQFF	In	VDJ	2	50	1.1342395150899225E-4	1.4558626131569216E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	3	7	3	3	26	39	47	42	50		TCRBV20-01,TCRBV20-or09_02												CSARVAGLNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGACCGCATTATCGACACAGATACGCAGTATTTTGGCCCA	CSASDRIIDTDTQYF	In	VDJ	2	50	1.1342395150899225E-4	1.4558626131569216E-4	45	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	2	7	2	1	11	26	37	41	38	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASDRIIDTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGAGGGACCGAGCAGTTCTTCGGGCCA	CASSLGGTEQFF	In	VDJ	2	50	1.1342395150899225E-4	1.4558626131569216E-4	36	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	10	0	10	3	3	24	36	45	39	48		TCRBV24-01,TCRBV24-or09_02												CASSLGGTEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCCTTCGGGCAGGGGGCGATACTGAAGCTTTCTTTGGACAA	CASSLRAGGDTEAFF	In	VDJ	2	50	1.1342395150899225E-4	1.4558626131569216E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	0	5	7	3	24	36	51	43	54	TCRBV02,TCRBV21													CASSLRAGGDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGCGGTCCTTGGGGCAATCAGCCCCAGCATTTTGGTGAT	CSASGPWGNQPQHF	In	VDJ	2	51	1.1569243053917209E-4	1.48497986542006E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	6	5	2	1	8	26	34	40	35	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSASGPWGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACAGGGACTCATGAAAAACTGTTTTTTGGCAGT	CSARGTGTHEKLFF	In	VDJ	2	51	1.1569243053917209E-4	1.48497986542006E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	1	3	6	0	4	26	-1	47	39	51		TCRBV20-01,TCRBV20-or09_02												CSARGTGTHEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCGCAGCGATGAGGCAGTTCTTCGGGCCA	CATSDFAAMRQFF	In	VDJ	2	51	1.1569243053917209E-4	1.48497986542006E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	6	6	12	3	5	24	41	48	44	53		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDFAAMRQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATACGGGGGTGTAGGCCAGCCCCAGCATTTTGGTGAT	CASSLYGGVGQPQHF	In	VDJ	2	51	1.1569243053917209E-4	1.48497986542006E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	8	2	7	5	7	24	36	47	41	54		TCRBV24-01,TCRBV24-or09_02												CASSLYGGVGQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCGGCGCTCCGGCCGGGAGGTTTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	51	1.1569243053917209E-4		47	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	12	8	1	1	11	2	24	30	48	41	50		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTTGGGAGGGCAGATCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGGQISGANVLTF	In	VDJ	2	51	1.1569243053917209E-4	1.48497986542006E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	3	9	0	0	0	5	18	-1	39	32	44	TCRBV07,TCRBV11													CASSLGGQISGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCCCCCTTACGGGGGGAAACACCATATATTTTGGAGAG	CASSPLTGGNTIYF	In	VDJ	2	51	1.1569243053917209E-4	1.48497986542006E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	5	8	3	4	7	0	24	36	-1	43	48	TCRBV12,TCRBV21													CASSPLTGGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCAGCTTCTACATCTGCAGTGCTAGAGATCCAGGGGGCATTGGCGGGGTAAGAACCTACAATGAGCAGTTCTTCGGGCCA	CSARDPGGIGGVRTYNEQFF	In	VDJ	2	52	1.1796090956935194E-4	1.5140971176831985E-4	60	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	0	2	2	16	15	29	39	31	55		TCRBV20-01,TCRBV20-or09_02												CSARDPGGIGGVRTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCTTAGCGGGATTCCCAATGAGCAGTTCTTCGGGCCA	CASSHLSGIPNEQFF	In	VDJ	2	52	1.1796090956935194E-4	1.5140971176831985E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	5	3	6	3	4	26	40	51	43	55		TCRBV03-01,TCRBV03-02												CASSHLSGIPNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGGGGGGGAAACAATGAGCAGTACTTCGGGCCG	CATSDRGGNNEQYF	In	VDJ	2	52	1.1796090956935194E-4	1.5140971176831985E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	0	7	1	7	24	38	47	39	54		TCRBV24-01,TCRBV24-or09_02												CATSDRGGNNEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTATGGACTAGCGACACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	52	1.1796090956935194E-4		49	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	1	6	0	2	2	24	40	51	42	53		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCCGGTTAGCGGGACGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASRLAGRYTGELFF	In	VDJ	2	53	1.2022938859953179E-4	1.543214369946337E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	5	3	3	4	4	36	45	57	49	61	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASRLAGRYTGELFF+X+TCRBJ02-02		TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGTCATAGTCATTTCTTTCTCTGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	53	1.2022938859953179E-4		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	5	8	5	5	14	26	38	46	43	60		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAAAGTAGGACAGGGGGGTACAATGAGCAGTTCTTCGGGCCA	CSAKSRTGGYNEQFF	In	VDJ	2	53	1.2022938859953179E-4	1.543214369946337E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	1	4	6	1	26	36	52	42	53		TCRBV20-01,TCRBV20-or09_02												CSAKSRTGGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCCGTCAGCGGGAGCGAGTCAGATACGCAGTATTTTGGCCCA	CSAAVSGSESDTQYF	In	VDJ	2	53	1.2022938859953179E-4	1.543214369946337E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	6	2	4	6	5	26	35	49	41	54		TCRBV20-01,TCRBV20-or09_02												CSAAVSGSESDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGACTAGCGGGAAGATACACCGGGGAGCTGTTTTTTGGAGAA	CASRLAGRYTGELFF	In	VDJ	2	53	1.2022938859953179E-4	1.543214369946337E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	3	3	3	0	4	24	-1	45	35	49		TCRBV24-01,TCRBV24-or09_02												CASRLAGRYTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGGGGCAGGACAAGTGAACACTGAAGCTTTCTTTGGACAA	CASSLGAGQVNTEAFF	In	VDJ	2	53	1.2022938859953179E-4	1.543214369946337E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	6	0	5	2	18	34	44	39	46	TCRBV05,TCRBV11													CASSLGAGQVNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCTCGCGGGAGGCCGCAGTACTTCGGGCCG	CASSSRGRPQYF	In	VDJ	2	54	1.2249786762971162E-4	1.5723316222094753E-4	36	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	7	1	9	4	2	24	36	48	40	50		TCRBV24-01,TCRBV24-or09_02												CASSSRGRPQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTATCCAGGGTCGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSLSRVVTGELFF	In	VDJ	2	54	1.2249786762971162E-4	1.5723316222094753E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	4	3	4	2	4	19	34	41	36	45	TCRBV07,TCRBV11													CASSLSRVVTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAGCGCAGATCAGGCTTTCTTTGGACAA	CASSQSADQAFF	In	VDJ	2	55	1.2476634665989147E-4	1.6014488744726138E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	6	6	11	0	8	26	-1	45	41	53		TCRBV03-01,TCRBV03-02				01,02								CASSQSADQAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCACCGTTTGGGACAGGGGCCACGAGCAGTACTTCGGGCCG	CTVWDRGHEQYF	In	VDJ	2	55	1.2476634665989147E-4	1.6014488744726138E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	0	2	5	6	2	26	30	46	36	48		TCRBV20-01,TCRBV20-or09_02												CTVWDRGHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGAGGGGAGGTCTCCTACAATGAGCAGTTCTTTGGGCCA	CSARGEVSYNEQFF	In	VDJ	2	55	1.2476634665989147E-4	1.6014488744726138E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02			6	9	1	22	5	23	26	34	45	39	68		TCRBV20-01,TCRBV20-or09_02						TCRBJ02-01,TCRBJ02-05						CSARGEVSYNEQFF+TCRBV20-X+TCRBJ02-X	TCRBV20	TCRBD02-01*02	TCRBJ02	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTCAGGACTAGCGGGAGGGAATGAGCAGTTCTTCGGGCCA	CATSDSGLAGGNEQFF	In	VDJ	2	55	1.2476634665989147E-4	1.6014488744726138E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	1	0	7	4	0	24	38	-1	42	57		TCRBV24-01,TCRBV24-or09_02												CATSDSGLAGGNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGTGGACAGGGGGCTTATCTGGAAACACCATATATTTTGGAGAG	CSAQWTGGLSGNTIYF	In	VDJ	2	56	1.2703482569007132E-4	1.6305661267357522E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	0	1	5	3	26	34	50	39	53		TCRBV20-01,TCRBV20-or09_02												CSAQWTGGLSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGRGACWYGGCWSTGTATCTCTGYGCCAGCAGCTTATTAGCGGGAGGGGAGCAGTTCTTCGGGCCA	CASSLLAGGEQFF	In	VDJ	2	56	1.2703482569007132E-4	1.6305661267357522E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	0	10	3	0	22	35	-1	38	49	TCRBV07,TCRBV23													CASSLLAGGEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGTACTCGGGCACGCTAATGAAAAACTGTTTTTTGGCAGT	CASVLGHANEKLFF	In	VDJ	2	57	1.2930330472025117E-4	1.6596833789988907E-4	42	unresolved						TCRBJ01	TCRBJ01-04	01	10	8	0	3	8	3	24	31	43	39	46	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASVLGHANEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCGAGGGACAGGGGGCTACGAGCAGTACTTCGGGCCG	CASSRGTGGYEQYF	In	VDJ	2	57	1.2930330472025117E-4	1.6596833789988907E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	1	3	3	0	24	36	-1	39	50		TCRBV24-01,TCRBV24-or09_02												CASSRGTGGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GARGACTCGGCCMTGTATCTCTGTGCCAGCAGCTTGGTCTCAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLVSGNTGELFF	In	VDJ	2	57	1.2930330472025117E-4	1.6596833789988907E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	4	1	5	0	19	33	-1	38	42	TCRBV04,TCRBV05,TCRBV11													CASSLVSGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCCCGCCGACTAGCGGGGGTACCTACGAGCAGTACTTCGGGCCG	CASSPPTSGGTYEQYF	In	VDJ	2	57	1.2930330472025117E-4	1.6596833789988907E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	2	2	2	5	2	19	31	48	36	50	TCRBV05,TCRBV07													CASSPPTSGGTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCSRGGGACTYRGCTGTGTATYTYTGTGCCAGCAGCTTAGGTTACCAGAACACCATATATTTTGGAGAG	CASSLGYQNTIYF	In	VDJ	2	57	1.2930330472025117E-4	1.6596833789988907E-4	39	unresolved			unresolved			TCRBJ01	TCRBJ01-03	01	4	4	5	7	8	0	22	35	-1	43	46	TCRBV07,TCRBV12			TCRBD01,TCRBD02										CASSLGYQNTIYF+X+TCRBJ01-03	unresolved	unresolved	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCACGCCGGGACAGAGAGTATGAACACTGAAGCTTTCTTTGGACAA	CASSHAGTESMNTEAFF	In	VDJ	2	58	1.3157178375043101E-4	1.688800631262029E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	0	7	6	26	37	51	44	57		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSHAGTESMNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCTTGGATCCGGGCACTGAAGCTTTCTTTGGACAA	CASSLALDPGTEAFF	In	VDJ	2	58	1.3157178375043101E-4	1.688800631262029E-4	45				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	4	4	8	0	18	35	-1	43	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLALDPGTEAFF+X+TCRBJ01-01		TCRBD02-01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAACTAGCGGGAGAGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	59	1.3384026278061086E-4		44	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	3	2	3	2	3	26	36	49	38	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCARCCCTAGTCTAGCGGGAGTCTACGAGCAGTACTTCGGGCCG	CASXPSLAGVYEQYF	In	VDJ	2	60	1.361087418107907E-4	1.747035135788306E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	4	2	3	8	1	26	36	54	44	55		TCRBV03-01,TCRBV03-02												CASXPSLAGVYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGCGGGATATCCCCACTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	60	1.361087418107907E-4		49	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	3	3	2	8	26	43	51	45	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGACTAGCCCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	61	1.3837722084097056E-4		43	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	7	1	0	2	26	-1	48	39	50		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCCAGGGATGAGCAGTTCTTCGGGCCA	CSASSRDEQFF	In	VDJ	2	61	1.3837722084097056E-4	1.7761523880514444E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	3	8	3	0	26	37	-1	40	45		TCRBV20-01,TCRBV20-or09_02												CSASSRDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAGGACGGATCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGRISGANVLTF	In	VDJ	2	61	1.3837722084097056E-4	1.7761523880514444E-4	48	unresolved						TCRBJ02	TCRBJ02-06	01	6	1	7	0	3	4	24	36	43	39	47	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRISGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTATGCGGGAGGACCTACCTACGAGCAGTACTTCGGGCCG	CASSYAGGPTYEQYF	In	VDJ	2	61	1.3837722084097056E-4	1.7761523880514444E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	1	2	2	5	19	32	42	34	47	TCRBV05,TCRBV11													CASSYAGGPTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GTATTTCTGTGCCAGCAGCAAATTACCCTGAGGGACTAGCGGGAGGGCCAACGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	61	1.3837722084097056E-4		65	TCRBV21			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	0	0	1	9	5	7	22	47	31	52		TCRBV21-or09_02,TCRBV21-01												X+TCRBV21-X+TCRBJ02-03	TCRBV21	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCATGGGTCCTCCATTTGCAAAGAAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	62	1.4064569987115038E-4		52	TCRBV03						TCRBJ02	TCRBJ02-04	01	5	0	9	4	2	17	26	38	43	40	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-04	TCRBV03		TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTCCGGTCTCTAGCACAGATACGCAGTATTTTGGCCCA	CSAPPVSSTDTQYF	In	VDJ	2	62	1.4064569987115038E-4	1.8052696403145828E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	8	5	0	4	5	26	35	42	39	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPPVSSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGYCACGTCTGGGGGCCCTGTCGAGCAGTACTTCGGGCCG	CASXTSGGPVEQYF	In	VDJ	2	62	1.4064569987115038E-4	1.8052696403145828E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	6	0	6	9	5	23	32	47	41	52	TCRBV06,TCRBV10													CASXTSGGPVEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGAGGGAGGGCTTACAAGAGACCCAGTACTTCGGGCCA	CASSQREGLQETQYF	In	VDJ	2	63	1.4291417890133023E-4	1.8343868925777213E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	9	0	2	2	4	23	37	46	39	50	TCRBV01,TCRBV04													CASSQREGLQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCTCGGCGTAGGGGAGACTGAAGCTTTCTTTGGACAA	CASSLGVGETEAFF	In	VDJ	2	64	1.4518265793151007E-4	1.8635041448408597E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	4	5	2	5	7	2	23	36	48	43	50	TCRBV04,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGVGETEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CTGTGTATTTCTGTGCCAGCAGCCAAGATCGGGGTGAGCAGGGGGAACCTCTGGGGCCAATGTCCTGACTTTCGGGGCC		Out	VDJ	2	64	1.4518265793151007E-4		62	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	4	1	13	10	16	11	28	45	38	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGAAGGGGCCCACAATGAGCAGTTCTTCGGGCCA	CASSVEGAHNEQFF	In	VDJ	2	64	1.4518265793151007E-4	1.8635041448408597E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	2	5	5	3	24	36	46	41	49	TCRBV09,TCRBV21													CASSVEGAHNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTCCCCCGGCAGGGGGTAAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	65	1.4745113696168992E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	1	5	8	3	24	36	51	44	54	TCRBV24,TCRBV27													X+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGAGAGGCAGGGCGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASREAGRYTGELFF	In	VDJ	2	66	1.4971961599186977E-4	1.9217386493671366E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	3	3	5	4	36	47	57	52	61	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASREAGRYTGELFF+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGGCCCTCACATACCTCTCGTACCTCTGTGCCAGCAGTGAATATTCGGGGGACTACGAGCAGTACTTCGGGCCG	CASSEYSGDYEQYF	In	VDJ	2	66	1.4971961599186977E-4	1.9217386493671366E-4	42	TCRBV25			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	2	3	2	1	39	56	64	58	65		TCRBV25-01,TCRBV25-or09_02												CASSEYSGDYEQYF+TCRBV25-X+TCRBJ02-07	TCRBV25	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGGGACTAGCGATGTGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	66	1.4971961599186977E-4		47				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	6	1	0	5	24	-1	46	37	51	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03				01,02								X+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCTCGGGGAGTACAGGTGCCGAGCAGTACTTCGGGCCG	CASSGSTGAEQYF	In	VDJ	2	66	1.4971961599186977E-4	1.9217386493671366E-4	39	TCRBV03						TCRBJ02	TCRBJ02-07	01	8	3	4	6	9	3	26	35	49	44	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGSTGAEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGAACCCCCTGGTTGGTAGCTCCGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	66	1.4971961599186977E-4		49	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	5	7	4	16	4	26	35	55	51	59		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCTCCGTTGGGACATCTAGCAATCAGCCCCAGCATTTTGGTGAT	CSVGTSSNQPQHF	In	VDJ	2	66	1.4971961599186977E-4	1.9217386493671366E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	0	6	0	6	2	26	29	41	35	43		TCRBV20-01,TCRBV20-or09_02												CSVGTSSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTGGCAAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCACCCAGTTTAGGGGGAATCAGCCCCAGCATTTTGGTGAT	CATQFRGNQPQHF	In	VDJ	2	66	1.4971961599186977E-4	1.9217386493671366E-4	39				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	5	1	4	6	0	42	51	-1	57	63	TCRBV23,TCRBV25,TCRBV27,TCRBV28	TCRBV23-or09_02,TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CATQFRGNQPQHF+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGAAGTTAAACAGGGGACATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRKLNRGHSNQPQHF	In	VDJ	2	67	1.5198809502204962E-4	1.950855901630275E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	2	0	8	3	26	37	52	45	55		TCRBV03-01,TCRBV03-02												CASRKLNRGHSNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCTTGGGTCCTTCTACGAGCAGTACTTCGGGCCG	CSLGSFYEQYF	In	VDJ	2	67	1.5198809502204962E-4	1.950855901630275E-4	33	TCRBV20						TCRBJ02	TCRBJ02-07	01	8	0	9	3	3	5	26	32	38	35	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSLGSFYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACAGATGGCTACACCTTCGGTTCG	CSARGTDGYTF	In	VDJ	2	67	1.5198809502204962E-4	1.950855901630275E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	5	6	0	0	26	-1	-1	39	45		TCRBV20-01,TCRBV20-or09_02												CSARGTDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCGCGGTGGAATCAGCCCCAGCATTTTGGTGAT	CSARARWNQPQHF	In	VDJ	2	67	1.5198809502204962E-4	1.950855901630275E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	7	5	4	3	3	26	37	44	40	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSARARWNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGTCTACCAGTTGGGGGTGAACACTGAAGCTTTCTTTGGACAA	CSARVYQLGVNTEAFF	In	VDJ	2	67	1.5198809502204962E-4	1.950855901630275E-4	48	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	6	1	0	12	0	26	37	-1	49	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVYQLGVNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTAGGACTAGCGGGAGAGAATGAGCAGTTCTTCGGGCCA	CSVGLAGENEQFF	In	VDJ	2	67	1.5198809502204962E-4	1.950855901630275E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	1	2	7	2	2	26	33	48	35	50		TCRBV20-01,TCRBV20-or09_02												CSVGLAGENEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGGGACAGGGCCAGACCACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	67	1.5198809502204962E-4		41	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	0	3	4	1	6	24	33	43	34	49		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTGAAGCGAGGCAGGGGGTTGGCTACACCTTCGGTTCG	CASSEARQGVGYTF	In	VDJ	2	67	1.5198809502204962E-4	1.950855901630275E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	1	7	4	1	23	40	51	44	52	TCRBV02,TCRBV12													CASSEARQGVGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCGCAGCGGAGCGGGGTAGTCCTTCCGATGAGCAGTTCTTCGGGCCA	CAAAERGSPSDEQFF	In	VDJ	2	68	1.5425657405222947E-4	1.9799731538934135E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	12	6	3	8	7	11	24	30	44	37	55		TCRBV24-01,TCRBV24-or09_02												CAAAERGSPSDEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAATCGACTCCTGGACGCAGATACGCAGTATTTTGGCCCA	CASNRLLDADTQYF	In	VDJ	2	68	1.5425657405222947E-4	1.9799731538934135E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	7	1	7	4	10	1	23	33	47	43	48	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNRLLDADTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCACCCCCCATTATCCCGGTCTGTGAGAAGAGACCCAGTACTTCGGGCCA	CATPHYPGL*EETQYF	Stop	VDJ	2	69	1.5652505308240931E-4		48				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	8	8	5	3	11	8	33	42	56	53	64	TCRBV23,TCRBV25,TCRBV27,TCRBV28	TCRBV23-or09_02,TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01				01,02								CATPHYPGL*EETQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTTACTTTTTCACGAAGGGGCACAGATACGCAGTATTTTGGCCCA	CASSFTFSRRGTDTQYF	In	VDJ	2	69	1.5652505308240931E-4	2.009090406156552E-4	51	unresolved						TCRBJ02	TCRBJ02-03	01	4	5	3	1	14	0	23	36	-1	50	54	TCRBV06,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFTFSRRGTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCGGGGGAACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	69	1.5652505308240931E-4		43	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	3	8	2	0	0	2	19	-1	38	32	40		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ01-03	TCRBV05	TCRBD02-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCCCCCCCGGAGTCTCGGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	71	1.6106201114276898E-4		46	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	8	4	8	16	0	24	36	-1	52	56		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGTGTAGCGGAAAAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	71	1.6106201114276898E-4		40	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	9	5	5	0	2	5	23	31	39	33	44	TCRBV02,TCRBV12					01,02								X+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCGGACAGGGATTACAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	72	1.6333049017294883E-4		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	1	3	3	1	4	24	35	44	36	48		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACGATGGGACTAGCGGCTACAATGAGCAGTTCTTCGGGCCA	CAISDDGTSGYNEQFF	In	VDJ	2	72	1.6333049017294883E-4	2.0964421629459672E-4	48				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	3	6	0	23	35	-1	41	52	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03				01,02								CAISDDGTSGYNEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCGCAGGGAGAAGGATGAAAAACTGTTTTTTGGCAGT	CASSLARREKDEKLFF	In	VDJ	2	72	1.6333049017294883E-4	2.0964421629459672E-4	48							TCRBJ01	TCRBJ01-04	01	0	4	3	6	3	6	18	35	43	38	49	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLARREKDEKLFF+X+TCRBJ01-04			TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGAACCACGAGACCGACCTCTGGAAACACCATATATTTTGGAGAG	CSARTTRPTSGNTIYF	In	VDJ	2	73	1.6559896920312868E-4	2.1255594152091057E-4	48	TCRBV20						TCRBJ01	TCRBJ01-03	01	2	2	7	0	7	4	26	38	48	45	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARTTRPTSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCTGGGACCACAAGAGACCCAGTACTTCGGGCCA	CSASLGPQETQYF	In	VDJ	2	73	1.6559896920312868E-4	2.1255594152091057E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	3	0	7	2	3	2	26	37	45	40	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASLGPQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGGGACAATTGAGCTCCTACGAGCAGTACTTCGGGCCG	CSAMGQLSSYEQYF	In	VDJ	2	73	1.6559896920312868E-4	2.1255594152091057E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	6	0	1	6	26	36	43	37	49		TCRBV20-01,TCRBV20-or09_02												CSAMGQLSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGATCACGGCGTTAGCAATCAGCCCCAGCATTTTGGTGAT	XASSQDHGVSNQPQHF	In	VDJ	2	74	1.6786744823330853E-4	2.154676667472244E-4	48	unresolved						TCRBJ01	TCRBJ01-05	01	0	9	0	0	4	2	23	40	47	44	49	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSQDHGVSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGCTTCCTAGCGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CATSDSLPSGGSTDTQYF	In	VDJ	2	74	1.6786744823330853E-4	2.154676667472244E-4	54	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	4	1	0	6	0	24	40	-1	46	57		TCRBV24-01,TCRBV24-or09_02												CATSDSLPSGGSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCGACAGGGAGCGTTCGGGGCTACACCTTCGGTTCG	CASSSTGSVRGYTF	In	VDJ	2	74	1.6786744823330853E-4	2.154676667472244E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	8	2	9	24	36	45	38	54		TCRBV24-01,TCRBV24-or09_02												CASSSTGSVRGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCAGTACCCCAGGGAGGGGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	75	1.7013592726348837E-4		47	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	0	1	6	3	24	36	49	42	52	TCRBV24,TCRBV28													X+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCCCCCGGAGTCTCGGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	75	1.7013592726348837E-4		44	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	8	4	8	14	0	24	36	-1	50	54		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGCCGGTTTAGCTTACAATGAGCAGTTCTTCGGGCCA	CASSVAGLAYNEQFF	In	VDJ	3	75	1.7013592726348837E-4	2.1837939197353825E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	7	4	1	10	24	36	41	37	51	TCRBV09,TCRBV21					01,02								CASSVAGLAYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGTGGGGGGAGTCCCAGATACGCAGTATTTTGGCCCA	CASSVVGGVPDTQYF	In	VDJ	3	76	1.7240440629366822E-4	2.212911171998521E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	9	1	4	6	5	26	37	49	43	54	TCRBV09,TCRBV12													CASSVVGGVPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGACTAGCGGGCAAGAGACCCAGTACTTCGGGCCA	CSAGTSGQETQYF	In	VDJ	3	76	1.7240440629366822E-4	2.212911171998521E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	4	2	0	0	26	-1	-1	35	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGTSGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAACTCGCATCTCGGGGTCCGGTCGGGTGGGGCTACACCTTCGGTTCG		Out	VDJ	3	77	1.7467288532384807E-4		47	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	11	8	3	8	10	13	24	31	46	41	59		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCTTGGGTCAGGGAGGAATCTACAATGAGCAGTTCTTCGGGCCA	CATLGQGGIYNEQFF	In	VDJ	3	77	1.7467288532384807E-4	2.2420284242616594E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	9	9	1	3	8	3	24	33	47	41	50		TCRBV24-01,TCRBV24-or09_02												CATLGQGGIYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTAGGGGGTTTTGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	78	1.7694136435402792E-4		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	1	0	2	5	26	37	45	39	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATCGCAGGGGGCGTTCTACGGCTACACCTTCGGTTCG	CASSLSQGAFYGYTF	In	VDJ	3	79	1.7920984338420777E-4	2.300262928787936E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	0	8	1	7	23	40	49	41	56	TCRBV24,TCRBV27													CASSLSQGAFYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGGCCCTCAATACCTCTCAGTACCTCTGTGCCAGCAGTGAATATTCGGGGGACTACGAGCAGTACTTCGGGCCG	CASSEYSGDYEQYF	In	VDJ	3	81	1.8374680144456743E-4	2.358497433314213E-4	42	TCRBV25			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	2	3	2	1	39	56	64	58	65		TCRBV25-01,TCRBV25-or09_02												CASSEYSGDYEQYF+TCRBV25-X+TCRBJ02-07	TCRBV25	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGGACTAGTTTTCCTACGAGCAGTACTTCGGGCCG	CASSQDRD*FSYEQYF	Stop	VDJ	3	81	1.8374680144456743E-4		48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	8	1	2	3	26	43	53	45	56		TCRBV03-01,TCRBV03-02				01,02								CASSQDRD*FSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCGAACTAGCGGGAGGTTCACAGATACGCAGTATTTTGGCCCA	XASSRTSGRFTDTQYF	In	VDJ	3	81	1.8374680144456743E-4	2.358497433314213E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	3	1	2	2	2	23	36	50	38	52	TCRBV04,TCRBV07,TCRBV17													XASSRTSGRFTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGCGGGAGACCCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGDPTGELFF	In	VDJ	3	81	1.8374680144456743E-4	2.358497433314213E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	5	2	4	1	4	24	36	46	37	50		TCRBV24-01,TCRBV24-or09_02												CASSLAGDPTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACAGACTAGCAATCAGCCCCAGCATTTTGGTGAT	CSARQTSNQPQHF	In	VDJ	3	82	1.8601528047474728E-4	2.3876146855773513E-4	39	TCRBV20						TCRBJ01	TCRBJ01-05	01	2	2	7	0	2	0	26	38	-1	40	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARQTSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCATGTTAGCGGGAGGGTGGTACGAGCAGTACTTCGGGCCG	CASMLAGGWYEQYF	In	VDJ	3	82	1.8601528047474728E-4	2.3876146855773513E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	11	5	0	4	6	3	24	31	48	37	51		TCRBV24-01,TCRBV24-or09_02												CASMLAGGWYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATSKCTGTGCCAGAAGCTTGGAACTAGCGGGAGGGCCAATGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	82	1.8601528047474728E-4		52	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	3	0	4	1	6	18	34	48	35	54	TCRBV05,TCRBV07													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCGTCCCGGCAGCCTCCTACGAGCAGTACTTCGGGCCG	CASVPAASYEQYF	In	VDJ	3	82	1.8601528047474728E-4	2.3876146855773513E-4	39	unresolved						TCRBJ02	TCRBJ02-07	01	8	4	5	0	7	1	23	32	42	39	43	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASVPAASYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGCCTACAGGTTCACCGGGGAGCTGTTTTTTGGAGAA	CASSLAYRFTGELFF	In	VDJ	3	83	1.8828375950492713E-4	2.4167319378404898E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	4	4	7	2	24	36	48	43	50		TCRBV24-01,TCRBV24-or09_02												CASSLAYRFTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCTTGGGAGTACGAATTTACGAGCAGTACTTCGGGCCG	CASSLGVRIYEQYF	In	VDJ	3	83	1.8828375950492713E-4	2.4167319378404898E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	9	2	4	2	8	24	36	43	38	51	TCRBV02,TCRBV21													CASSLGVRIYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAGGACCGTAGCAATCAGCCCCAGCATTTTGGTGAT	XASSQDRSNQPQHF	In	VDJ	3	84	1.9055223853510698E-4	2.445849190103628E-4	42	unresolved						TCRBJ01	TCRBJ01-05	01	3	1	7	0	0	2	23	-1	41	37	43	TCRBV01,TCRBV04,TCRBV07,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSQDRSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGTGTGACGGGGAATGAGCAGTTCTTCGGGCCA	CSASRVTGNEQFF	In	VDJ	3	84	1.9055223853510698E-4	2.445849190103628E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	3	7	8	0	26	37	-1	45	50		TCRBV20-01,TCRBV20-or09_02												CSASRVTGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCACGCAGGAAGACTCCTACGAGCAGTACTTCGGGCCG	CASTQEDSYEQYF	In	VDJ	3	84	1.9055223853510698E-4	2.445849190103628E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	4	4	0	2	4	22	32	38	34	42	TCRBV09,TCRBV12													CASTQEDSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCTGGCGCACACACACGACAATGAGCAGTTCTTCGGGCCA	CASLAHTHDNEQFF	In	VDJ	3	84	1.9055223853510698E-4	2.445849190103628E-4	42	TCRBV24						TCRBJ02	TCRBJ02-01	01	11	3	6	5	9	6	24	31	43	40	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASLAHTHDNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGCGGGAAAACCCTACAATGAGCAGTTCTTCGGGCCA	CATSEAGKPYNEQFF	In	VDJ	3	85	1.9282071756528683E-4	2.474966442366767E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	7	3	2	1	4	24	38	45	39	49		TCRBV24-01,TCRBV24-or09_02												CATSEAGKPYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCAAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCACCCTCAGCGGGACGGGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	86	1.9508919659546667E-4		43				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	6	3	2	5	4	38	48	60	53	64	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												X+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTATCGGAGGATTTGGAGATACGCAGTATTTTGGCCCA	CSIGGFGDTQYF	In	VDJ	3	88	1.9962615465582637E-4	2.562318199156182E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	10	1	5	3	6	26	32	40	35	46		TCRBV20-01,TCRBV20-or09_02												CSIGGFGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGACAGGGGGGTAGGGCCAAAAACATTCAGTACTTCGGCGCC	CSARQGGRAKNIQYF	In	VDJ	3	88	1.9962615465582637E-4	2.562318199156182E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	2	1	1	2	5	26	34	45	36	50		TCRBV20-01,TCRBV20-or09_02												CSARQGGRAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACAGGGGGCTACGAGCAGTACTTCGGGCCG	CSARGTGGYEQYF	In	VDJ	3	88	1.9962615465582637E-4	2.562318199156182E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	1	3	0	0	26	-1	-1	39	49		TCRBV20-01,TCRBV20-or09_02												CSARGTGGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTACACAACACGAAAGTGGGGACTAGCCCCACATTCAGTACTTCGGCGCC	CASSTQHESGD*PHIQYF	Stop	VDJ	3	88	1.9962615465582637E-4		54	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	6	0	7	8	16	3	24	36	61	52	64		TCRBV24-01,TCRBV24-or09_02				01,02								CASSTQHESGD*PHIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGCCGGGACAGAGTTCTATGGCTACACCTTCGGTTCG	CATSDAGTEFYGYTF	In	VDJ	3	90	2.0416311271618604E-4	2.620552703682459E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	5	4	3	4	24	39	49	42	53		TCRBV24-01,TCRBV24-or09_02												CATSDAGTEFYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCTTCTCAAATCAATGACGAGCAGTACTTCGGGCCG	CASSPSQINDEQYF	In	VDJ	3	91	2.0643159174636589E-4	2.6496699559455975E-4	42	TCRBV12						TCRBJ02	TCRBJ02-07	01	5	4	6	5	6	8	26	38	46	44	54		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSQINDEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTTAGCGGGACGAGAGACCCAGTACTTCGGGCCA	CSASLAGRETQYF	In	VDJ	3	91	2.0643159174636589E-4	2.6496699559455975E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	5	3	4	2	2	26	37	47	39	49		TCRBV20-01,TCRBV20-or09_02												CSASLAGRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTCCCGACAAAAACATTCAGTACTTCGGCGCC	CAISPDKNIQYF	In	VDJ	3	92	2.0870007077654573E-4	2.6787872082087357E-4	36	unresolved						TCRBJ02	TCRBJ02-04	01	5	2	8	3	3	0	24	36	-1	39	41	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISPDKNIQYF+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCCTCGGGAGGGCAGTAGGGAGCCCCAGTACTTCGGGCCA		Out	VDJ	3	92	2.0870007077654573E-4		47	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	8	0	9	5	11	24	36	49	41	60	TCRBV09,TCRBV21													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCTTTGGGAACTCAGAGGCTGAGCAGTTCTTCGGGCCA	CSARVFGNSEAEQFF	In	VDJ	3	93	2.1096854980672558E-4	2.7079044604718744E-4	45	TCRBV20						TCRBJ02	TCRBJ02-01	01	1	0	8	9	5	10	26	39	48	44	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVFGNSEAEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCAAAGCGGCGGGAGTTACAATGAGCAGTTCTTCGGGCCA	CASSQSGGSYNEQFF	In	VDJ	3	94	2.1323702883690543E-4	2.7370217127350126E-4	45	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	7	2	4	7	1	19	31	45	38	46		TCRBV05-06,TCRBV05-07												CASSQSGGSYNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGGGGGACGGACACCGGGGAGCTGTTTTTTGGAGAA	CATSDWGTDTGELFF	In	VDJ	3	95	2.1550550786708528E-4	2.7661389649981513E-4	45	TCRBV24						TCRBJ02	TCRBJ02-02	01	2	0	7	3	2	2	24	40	47	42	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDWGTDTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTTTGGGGCCGGGGTATGGCTACACCTTCGGTTCG	CASSLGPGYGYTF	In	VDJ	3	96	2.1777398689726513E-4	2.7952562172612894E-4	39	unresolved						TCRBJ01	TCRBJ01-02	01	3	7	0	5	0	5	22	-1	41	36	46	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPGYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAACCCTCGGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CSAQPSGSSYEQYF	In	VDJ	3	98	2.2231094495762482E-4	2.8534907217875663E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	8	3	0	7	2	26	35	47	42	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAQPSGSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCAAGGGGCCCCTACGAGCAGTACTTCGGGCCG	CASSLSRGPYEQYF	In	VDJ	3	98	2.2231094495762482E-4	2.8534907217875663E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	5	2	2	6	2	24	36	47	42	49	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSRGPYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTAGCCCGGGCCGATACCGGGGAGCTGTTTTTTGGAGAA	CASSLLARADTGELFF	In	VDJ	3	100	2.268479030179845E-4	2.911725226313843E-4	48	TCRBV24						TCRBJ02	TCRBJ02-02	01	6	8	0	5	10	4	24	36	50	46	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLARADTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGCCGGTGGGAGGGCCGATGAGCAGTTCTTCGGGCCA	CASSVAGGRADEQFF	In	VDJ	3	100	2.268479030179845E-4	2.911725226313843E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	0	8	5	3	23	39	51	44	54	TCRBV09,TCRBV12													CASSVAGGRADEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGAGAAAACGGGTCCGGGACTCGATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	101	2.2911638204816434E-4		50	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	10	3	13	4	23	34	53	47	57	TCRBV02,TCRBV09					01,02								X+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAATAGCATACTAGCGGGTGAACGCGGGGAGCTGTTTTTTGGAGAA	CSANSILAGERGELFF	In	VDJ	3	103	2.3365334010852403E-4	2.999076983103259E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	3	4	7	9	6	26	34	52	43	58		TCRBV20-01,TCRBV20-or09_02				01,02								CSANSILAGERGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACCGGGGACGGAAACCCAGTACTTCGGGCCA	CASSQPGTETQYF	In	VDJ	4	104	2.3592181913870388E-4	3.028194235366397E-4	39	TCRBV03						TCRBJ02	TCRBJ02-05	01	2	0	7	8	3	4	26	41	49	44	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQPGTETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCACCGGACAGGGGTCAACGAGCAGTACTTCGGGCCG	CSAHRTGVNEQYF	In	VDJ	4	104	2.3592181913870388E-4	3.028194235366397E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	5	5	3	26	34	48	39	51		TCRBV20-01,TCRBV20-or09_02												CSAHRTGVNEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTCGGATTCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGFANTGELFF	In	VDJ	4	104	2.3592181913870388E-4	3.028194235366397E-4	45	unresolved						TCRBJ02	TCRBJ02-02	01	4	1	8	0	2	4	23	36	41	38	45	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGFANTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCTAAGGGACTAGCGGGAGGGTGGGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	104	2.3592181913870388E-4		53	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	0	6	4	5	18	30	50	34	55	TCRBV07,TCRBV11													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCCTGAGGGGGCAGGAGAACACTGAAGCTTTCTTTGGACAA	CASLRGQENTEAFF	In	VDJ	4	106	2.4045877719906358E-4	3.086428739892674E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	5	0	1	3	4	22	31	41	34	45	TCRBV12,TCRBV21													CASLRGQENTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCGGGACTAGCGTATACGAGCAGTACTTCGGGCCG	CASSQVGTSVYEQYF	In	VDJ	4	107	2.4272725622924343E-4	3.115545992155812E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	0	6	4	2	2	26	42	54	44	56		TCRBV03-01,TCRBV03-02				01,02								CASSQVGTSVYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAAACCCGACGGCTACAATGAGCAGTTCTTCGGGCCA	CASKPDGYNEQFF	In	VDJ	4	109	2.472642142896031E-4	3.173780496682089E-4	39	unresolved						TCRBJ02	TCRBJ02-01	01	11	2	7	3	8	2	24	31	42	39	44	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKPDGYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGTTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLVATNEKLFF	In	VDJ	4	109	2.472642142896031E-4	3.173780496682089E-4	42	TCRBV24						TCRBJ01	TCRBJ01-04	01	6	0	10	0	2	3	24	36	40	38	43		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVATNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCCCTTACGAGACAGTACTTCGGGCCG	CASSLALTRQYF	In	VDJ	4	110	2.4953269331978294E-4	3.2028977489452276E-4	36	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	2	10	6	1	26	43	52	49	53		TCRBV12-03,TCRBV12-04												CASSLALTRQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCACTAGCTTCCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPLASGTGELFF	In	VDJ	4	110	2.4953269331978294E-4	3.2028977489452276E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	3	7	4	2	6	24	36	44	38	50		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPLASGTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAAGGTGGGCCCCTACGAGCAGTACTTCGGGCCG	CASSQKVGPYEQYF	In	VDJ	4	111	2.518011723499628E-4	3.232015001208366E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	8	0	2	5	1	26	41	50	46	51		TCRBV03-01,TCRBV03-02												CASSQKVGPYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAAGGCGCCTTAGCGGGAGTTACCGGGGAGCTGTTTTTTGGAGAA	CASSQEGALAGVTGELFF	In	VDJ	4	111	2.518011723499628E-4	3.232015001208366E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	5	2	5	8	2	23	40	57	48	59	TCRBV01,TCRBV04													CASSQEGALAGVTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAGAAAGGGCAGGGTAGGAACTATAGGCTACACCTTCGGTTCG		Out	VDJ	4	112	2.5406965138014264E-4		53				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	8	8	11	18	35	48	43	59	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												X+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGACTCCACAGATACGCAGTATTTTGGCCCA	CSADSTDTQYF	In	VDJ	4	114	2.5860660944050233E-4	3.3193667579977813E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	10	2	1	1	26	34	39	35	40		TCRBV20-01,TCRBV20-or09_02				01,02								CSADSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGGACAGGGTGCGGAGCTATGGCTACACCTTCGGTTCG	CASSPDRVRSYGYTF	In	VDJ	4	117	2.6541204653104185E-4	3.4067185147871964E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	4	2	7	26	38	48	40	55		TCRBV12-03,TCRBV12-04												CASSPDRVRSYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTAGGGGGGGAAAAACTGTTTTTTGGCAGT	CSARDLGGEKLFF	In	VDJ	4	117	2.6541204653104185E-4	3.4067185147871964E-4	39	TCRBV20						TCRBJ01	TCRBJ01-04	01	0	5	1	8	3	1	26	40	49	43	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLGGEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCACCAATAGTCCTAACAGCGAGCGATTATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	4	118	2.676805255612217E-4		50	TCRBV20						TCRBJ01	TCRBJ01-01	01	10	3	5	0	12	10	26	30	46	42	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCAGGGGGGCCCGGGAGGTATACGCAGTATTTTGGCCCA	CASSPGGPGRYTQYF	In	VDJ	4	118	2.676805255612217E-4	3.435835767050335E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	4	4	1	7	1	11	19	31	39	32	50	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGGPGRYTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCTAGCGGGAGAAGGCAGTATTTTGGCCCA	CSARDSSGRRQYF	In	VDJ	4	119	2.6994900459140155E-4	3.464953019313473E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	4	2	11	2	3	26	40	52	42	55		TCRBV20-01,TCRBV20-or09_02												CSARDSSGRRQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACTTCCCGAGCACAGATACGCAGTATTTTGGCCCA	CASSQDFPSTDTQYF	In	VDJ	4	120	2.722174836215814E-4	3.494070271576612E-4	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	10	0	0	5	18	-1	37	35	42	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQDFPSTDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGTACGGAATGAGCAGTTCTTCGGGCCA	CASSQEVRNEQFF	In	VDJ	4	122	2.767544416819411E-4	3.552304776102889E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	8	5	7	4	0	26	43	-1	47	50		TCRBV03-01,TCRBV03-02				01,02								CASSQEVRNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCCAGGAGGGGGGGACCCAGTACTTCGGGCCA	CASSFQEGGTQYF	In	VDJ	4	122	2.767544416819411E-4	3.552304776102889E-4	39	TCRBV24						TCRBJ02	TCRBJ02-05	01	6	5	1	7	7	1	24	36	49	43	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFQEGGTQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGGGGCCTGAACACTGAAGCTTTCTTTGGACAA	CASSGGLNTEAFF	In	VDJ	4	123	2.7902292071212094E-4	3.581422028366027E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	6	0	0	0	1	26	-1	44	38	45		TCRBV03-01,TCRBV03-02												CASSGGLNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTCTAGGGACTTACAGTACGAACTACGAGCAGTACTTCGGGCCG	CSARGLGTYSTNYEQYF	In	VDJ	4	123	2.7902292071212094E-4	3.581422028366027E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	0	10	3	5	11	26	39	50	44	61		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGLGTYSTNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTATAGCTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSASIASSYNEQFF	In	VDJ	4	124	2.8129139974230076E-4	3.6105392806291657E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	8	0	5	0	26	37	-1	42	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSASIASSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGACCCCGACTGTGACAGGGTTCAGCATGGCTACACCTTCGGTTCG		Out	VDJ	4	124	2.8129139974230076E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	2	3	6	12	6	24	31	50	43	56	TCRBV09,TCRBV21													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGATGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSVDGSNQPQHF	In	VDJ	4	127	2.8809683683284033E-4	3.697891037418581E-4	42	unresolved			unresolved			TCRBJ01	TCRBJ01-05	01	0	0	10	0	2	0	23	39	-1	41	43	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSVDGSNQPQHF+X+TCRBJ01-05	unresolved	unresolved	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCTCTTCCCGGGACAGGGGGCAGGTACTGAAGCTTTCTTTGGACAA	CASSPLFPGQGAGTEAFF	In	VDJ	4	129	2.926337948932E-4	3.7561255419448576E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	0	5	10	4	26	39	61	49	65		TCRBV03-01,TCRBV03-02												CASSPLFPGQGAGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCCGGAAACACCATATATTTTGGAGAG	CASSLAGNTIYF	In	VJ	4	130	2.9490227392337985E-4	3.7852427942079963E-4	36	TCRBV12						TCRBJ01	TCRBJ01-03	01	0	0	0	4	0	1	26	-1	43	-1	44		TCRBV12-03,TCRBV12-04												CASSLAGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCCCTACCGGGACTAGGGGGTACAATGAGCAGTTCTTCGGGCCA	CSARAPTGTRGYNEQFF	In	VDJ	4	130	2.9490227392337985E-4	3.7852427942079963E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	0	8	4	8	4	26	39	55	47	59		TCRBV20-01,TCRBV20-or09_02				01,02								CSARAPTGTRGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCCAGGTGCGGCACTGATTCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	4	130	2.9490227392337985E-4		50	TCRBV20						TCRBJ02	TCRBJ02-02	01	3	4	4	4	3	13	26	37	44	40	57		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCCCATCTGGTACTTGGGGAGAGACCCAGTACTTCGGGCCA	CASSPSGTWGETQYF	In	VDJ	4	131	2.971707529535597E-4	3.8143600464711345E-4	45	unresolved						TCRBJ02	TCRBJ02-05	01	4	6	2	4	13	0	19	31	-1	44	48	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSGTWGETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATCAAACGGGGCTCAGCCCCAGCATTTTGGTGAT	CASSLSNGAQPQHF	In	VDJ	4	133	3.0170771101391936E-4	3.8725945509974114E-4	42	TCRBV12						TCRBJ01	TCRBJ01-05	01	2	7	0	6	6	0	26	41	-1	47	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSNGAQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTGAAGCGGGCCCTGGGTTTGCGGAGACCCAGTACTTCGGGCCA	CASSLAEAGPGFAETQYF	In	VDJ	4	133	3.0170771101391936E-4	3.8725945509974114E-4	54				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	6	4	5	3	13	18	35	44	38	57	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAEAGPGFAETQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGGGGAACTAGCGGGTGCCTACGAGCAGTACTTCGGGCCG	CASGELAGAYEQYF	In	VDJ	5	134	3.0397619004409924E-4	3.90171180326055E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	10	3	4	2	7	2	24	31	47	38	49	TCRBV06,TCRBV10					01,02								CASGELAGAYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAACCTAGCGGGAGAGGGACAGATACGCAGTATTTTGGCCCA	CSAEPSGRGTDTQYF	In	VDJ	5	136	3.0851314810445893E-4	3.959946307786827E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	4	2	3	4	4	26	35	49	39	53		TCRBV20-01,TCRBV20-or09_02												CSAEPSGRGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAGGGACGCCTGGACTATGGCTACACCTTCGGTTCG	XASSQGRLDYGYTF	In	VDJ	5	136	3.0851314810445893E-4	3.959946307786827E-4	42	unresolved						TCRBJ01	TCRBJ01-02	01	3	0	7	3	0	6	22	-1	41	36	47	TCRBV01,TCRBV04,TCRBV07,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSQGRLDYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCTCTTATTGTGGACAGAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	5	137	3.1078162713463875E-4		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	5	3	13	1	24	36	55	49	56		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAAAACCGGGACAGGGGGCCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	5	140	3.175870642251783E-4		52	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	0	4	6	0	23	38	-1	44	56		TCRBV06-01,TCRBV06-08												X+TCRBV06-X+TCRBJ02-02	TCRBV06	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCTCGGTATGGGTCGGGATACGCAGTATTTTGGCCCA	CSLGMGRDTQYF	In	VDJ	5	142	3.2212402228553797E-4	4.1346498213656576E-4	36	TCRBV20						TCRBJ02	TCRBJ02-03	01	8	0	9	6	8	4	26	32	43	40	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSLGMGRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGAGGCAGGGAACGGTCGCCCCAGCATTTTGGTGAT	CSARGRERSPQHF	In	VDJ	5	143	3.2439250131571784E-4	4.163767073628796E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	3	9	1	7	26	39	45	40	52		TCRBV20-01,TCRBV20-or09_02												CSARGRERSPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCCGGTTTGTGGGAGGAGGGTCCGTACAATGAGCAGTTCTTCGGGCCA	CASSQDPGLWEEGPYNEQFF	In	VDJ	5	144	3.2666098034589766E-4	4.1928843258919344E-4	60	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	1	4	11	8	15	32	49	43	57		TCRBV03-01,TCRBV03-02												CASSQDPGLWEEGPYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCCTAGCGGGAACATTTAGCACAGATACGCAGTATTTTGGCCCA	CASLAGTFSTDTQYF	In	VDJ	5	145	3.2892945937607754E-4	4.2220015781550726E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	10	4	3	0	2	6	24	31	42	33	48	TCRBV06,TCRBV10													CASLAGTFSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAATTTGTAGGACTACCCATCCACGAGCAGTACTTCGGGCCG	CASSQFVGLPIHEQYF	In	VDJ	5	145	3.2892945937607754E-4	4.2220015781550726E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	9	5	9	7	18	30	45	39	52	TCRBV07,TCRBV11					01,02								CASSQFVGLPIHEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAAGGAGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSLRRGNTEAFF	In	VDJ	5	148	3.3573489646661705E-4	4.309353334944488E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	10	0	1	2	1	19	33	41	35	42	TCRBV05,TCRBV11													CASSLRRGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCTAATACTTGACAGGGAACGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	5	150	3.4027185452697675E-4		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	3	4	10	4	24	36	53	46	57		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCAGGGACTCTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGTLNTGELFF	In	VDJ	5	160	3.6295664482877523E-4	4.658760362102149E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	10	1	3	2	24	36	45	39	47		TCRBV24-01,TCRBV24-or09_02				01,02								CASSSGTLNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAAGATCTAGTGGACGAGCAGTACTTCGGGCCG	CSAKDLVDEQYF	In	VDJ	5	161	3.6522512385895505E-4	4.6878776143652876E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	8	5	1	3	26	40	45	41	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSAKDLVDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCACGACAGGGGAGTATCGAGTGAAGCTTTCTTTGGACAA	CASSHDRGVSSEAFF	In	VDJ	6	163	3.6976208191931474E-4	4.7461121188915645E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	7	3	9	24	36	47	39	56		TCRBV24-01,TCRBV24-or09_02												CASSHDRGVSSEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGCAACAGGGAAATCAAGAGACCCAGTACTTCGGGCCA	CASSLQQGNQETQYF	In	VDJ	6	165	3.7429903997967444E-4	4.8043466234178414E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	3	2	3	4	26	40	49	43	53		TCRBV12-03,TCRBV12-04												CASSLQQGNQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGCAGGGGGAAACATTCAGTACTTCGGCGCC	CSASAGGNIQYF	In	VDJ	6	165	3.7429903997967444E-4	4.8043466234178414E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	4	1	6	2	0	26	37	-1	39	46		TCRBV20-01,TCRBV20-or09_02												CSASAGGNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAGAATAAAGTTAACCCTACGAGCAGTACTTCGGGCCG	CSARGE*S*PYEQYF	Stop	VDJ	6	166	3.7656751900985426E-4		45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	11	2	2	0	12	26	-1	42	39	54		TCRBV20-01,TCRBV20-or09_02												CSARGE*S*PYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGAGACGAGAAGCTTTGAACACTGAAGCTTTCTTTGGACAA	CASSLRREALNTEAFF	In	VDJ	6	167	3.7883599804003414E-4	4.862581127944118E-4	48	TCRBV24						TCRBJ01	TCRBJ01-01	01	6	2	7	0	4	9	24	36	43	40	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRREALNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGCTGAGGGGTACGAGCAGTACTTCGGGCCG	CASSVAEGYEQYF	In	VDJ	6	167	3.7883599804003414E-4	4.862581127944118E-4	39	unresolved						TCRBJ02	TCRBJ02-07	01	0	5	2	4	3	0	23	39	-1	42	47	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVAEGYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTTGGGGGACGGACGACACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	6	168	3.8110447707021396E-4		49	TCRBV12						TCRBJ02	TCRBJ02-02	01	3	0	7	3	3	7	26	40	48	43	55		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCCCCCCCCGGAGTCTCGGGATGAGCAGTTCTTCGGGCCA	CASSPPPESRDEQFF	In	VDJ	6	168	3.8110447707021396E-4	4.891698380207256E-4	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	8	4	8	15	0	36	48	-1	63	67	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01				01,02								CASSPPPESRDEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAAGGGGTGGAAACACTGAAGCTTTCTTTGGACAA	CASSVRGGNTEAFF	In	VDJ	6	168	3.8110447707021396E-4	4.891698380207256E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	2	2	0	4	23	-1	43	38	47	TCRBV09,TCRBV21													CASSVRGGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAATCCGGCACAGATACGCAGTATTTTGGCCCA	CASSQESGTDTQYF	In	VDJ	6	170	3.8564143513057365E-4	4.949932884733534E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	8	6	1	3	0	26	43	-1	46	48		TCRBV03-01,TCRBV03-02				01,02								CASSQESGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTCGCCCGGGCAGTAACTCCTACGAGCAGTACTTCGGGCCG	CASSRPGSNSYEQYF	In	VDJ	6	173	3.9244687222111317E-4	5.037284641522949E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	5	8	0	0	6	5	23	34	44	40	49	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRPGSNSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAGACCAAAGCCGGGAGATCTAACTATGGCTACACCTTCGGTTCG	CASSETKAGRSNYGYTF	In	VDJ	6	173	3.9244687222111317E-4	5.037284641522949E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	8	2	0	12	2	23	34	52	46	54	TCRBV02,TCRBV09													CASSETKAGRSNYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGTTCCAGGGGTACACTGAAGCTTTCTTTGGACAA	CASRFQGYTEAFF	In	VDJ	6	176	3.9925230931165274E-4	5.124636398312364E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	3	4	1	26	37	47	41	48		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRFQGYTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GCTGGCAAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCAGGGACAGGGTGAAAAACTGTTTTTTGGCAGT	CASSQGQGEKLFF	In	VDJ	6	176	3.9925230931165274E-4	5.124636398312364E-4	39				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	3	7	2	0	42	54	-1	56	65	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASSQGQGEKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGAGGGACCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLEGPTGELFF	In	VDJ	6	178	4.0378926737201244E-4	5.182870902838641E-4	42	unresolved						TCRBJ02	TCRBJ02-02	01	0	0	7	4	0	1	18	-1	40	35	41	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGPTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCGGGACAGGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGTGGTGELFF	In	VDJ	6	179	4.0605774640219226E-4	5.211988155101779E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	4	4	1	3	18	35	44	36	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAGTGGTGELFF+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGGGTCTAACCCAGATACGCAGTATTTTGGCCCA	CASSGSNPDTQYF	In	VDJ	6	181	4.1059470446255195E-4	5.270222659628056E-4	39	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	3	4	9	4	3	3	23	36	42	39	45	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSGSNPDTQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGACCCGAGACTAGCGGGAGCAATGAGCAGTTCTTCGGGCCA	CATSDRPETSGSNEQFF	In	VDJ	6	189	4.2874253670399073E-4	5.503160677733164E-4	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	2	2	6	9	0	24	38	-1	47	59		TCRBV24-01,TCRBV24-or09_02												CATSDRPETSGSNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGCGGCCTAAGCACAGATACGCAGTATTTTGGCCCA	CSASSGLSTDTQYF	In	VDJ	6	190	4.3101101573417056E-4	5.532277929996303E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	5	5	0	0	4	26	-1	43	37	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSASSGLSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCGACAGGGAGTATTCTCGAGCAGTACTTCGGGCCG	CASSSTGSILEQYF	In	VDJ	6	191	4.332794947643504E-4	5.56139518225944E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	3	6	1	8	18	31	39	32	47	TCRBV07,TCRBV11													CASSSTGSILEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCCAGGCGGGGACTAGTGGCAATGAGCAGTTCTTCGGGCCA	CSASQAGTSGNEQFF	In	VDJ	6	192	4.3554797379453025E-4	5.590512434522579E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	8	6	9	3	26	35	52	44	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSASQAGTSGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCGGACAGGGGGATAGCTACGAGCAGTACTTCGGGCCG	CASSFGQGDSYEQYF	In	VDJ	6	192	4.3554797379453025E-4	5.590512434522579E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	1	3	3	4	24	36	49	39	53		TCRBV24-01,TCRBV24-or09_02												CASSFGQGDSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TATTTCTGTGCCAGCAGCCCCACGGAAGGCGTTGTGGGGGGAGTGGAGTCGGTTACTGAAGCTTTCTTTGGACAA	CASSPTEGVVGGVESVTEAFF	In	VDJ	7	197	4.4689036894542946E-4	5.736098695838271E-4	63	TCRBV21			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	1	5	17	13	6	18	41	35	54		TCRBV21-or09_02,TCRBV21-01												CASSPTEGVVGGVESVTEAFF+TCRBV21-X+TCRBJ01-01	TCRBV21	TCRBD02-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGTGGGAGGGGTTAGGGAGACCCAGTACTTCGGGCCA	CASSVVGGVRETQYF	In	VDJ	7	199	4.5142732700578916E-4	5.794333200364548E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	9	0	5	5	6	24	36	48	41	54	TCRBV09,TCRBV21													CASSVVGGVRETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGCCGGTAGAAAGGGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSPPVERGATDTQYF	In	VDJ	7	200	4.53695806035969E-4	5.823450452627686E-4	51	TCRBV03						TCRBJ02	TCRBJ02-03	01	4	5	1	2	11	2	26	39	56	50	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPVERGATDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATTCTCGGGACAGGGTGAAAAACTGTTTTTTGGCAGT	CASSEFSGQGEKLFF	In	VDJ	7	203	4.6050124312650855E-4	5.910802209417101E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	3	7	5	0	23	38	-1	43	52		TCRBV06-01,TCRBV06-08												CASSEFSGQGEKLFF+TCRBV06-X+TCRBJ01-04	TCRBV06	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCGTCGGGAGGGTAAACAATGAGCAGTTCTTCGGGCCA	CSARVVGRVNNEQFF	In	VDJ	7	208	4.7184363827740776E-4	6.056388470732794E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	8	0	5	4	3	26	39	51	43	54		TCRBV20-01,TCRBV20-or09_02												CSARVVGRVNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAGGGACAGGGATTCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	7	211	4.786490753679473E-4		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	3	4	2	3	26	39	50	41	53		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCGACAGGCTATTCCGCCCTTACGAGCAGTACTTCGGGCCG	CASSRDRLFRPYEQYF	In	VDJ	7	214	4.8545451245848685E-4	6.231091984311624E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	4	4	2	12	26	39	47	41	59		TCRBV03-01,TCRBV03-02												CASSRDRLFRPYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGCCGGGACAGGGGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	7	215	4.8772299148866667E-4		55	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	0	2	0	6	2	24	36	52	42	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD01-01*01	TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGAAAGGGGAGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSVGKGSGTGELFF	In	VDJ	7	215	4.8772299148866667E-4	6.260209236574763E-4	48	unresolved						TCRBJ02	TCRBJ02-02	01	0	5	2	4	3	5	23	39	47	42	52	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGKGSGTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGCGGGCCGCTACACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGRYTGELFF	In	VDJ	7	217	4.922599495490264E-4	6.31844374110104E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	5	4	3	1	5	24	36	44	37	49		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLAGRYTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGCGGCAGCTATCGACTATGGCTACACCTTCGGTTCG	CASSVAAAIDYGYTF	In	VDJ	7	220	4.990653866395659E-4	6.405795497890455E-4	45	unresolved			unresolved			TCRBJ01	TCRBJ01-02	01	0	4	5	3	3	6	23	39	45	42	51	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSVAAAIDYGYTF+X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGTACAGGAGAACACTGAAGCTTTCTTTGGACAA	CASSLVQENTEAFF	In	VDJ	8	226	5.12676260820645E-4	6.580499011469285E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	4	1	3	1	26	40	48	43	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLVQENTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCACCTAGACGGGACGGTACGGGCCACTGAAGCTTTCTTTGGACAA	CASSHLDGTVRATEAFF	In	VDJ	8	231	5.240186559715442E-4	6.726085272784978E-4	51	unresolved						TCRBJ01	TCRBJ01-01	01	3	0	7	4	7	9	23	37	49	44	58	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHLDGTVRATEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGTAGAGGTTCGGGGACGGTGGACACTGAAGCTTTCTTTGGACAA	CSGRGSGTVDTEAFF	In	VDJ	8	231	5.240186559715442E-4	6.726085272784978E-4	45	TCRBV20						TCRBJ01	TCRBJ01-01	01	1	0	7	3	5	5	26	39	49	44	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSGRGSGTVDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCTGACAGGTCCCTCCAGCACAGATACGCAGTATTTTGGCCCA	CASSLTGPSSTDTQYF	In	VDJ	8	231	5.240186559715442E-4	6.726085272784978E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	4	0	2	7	33	45	53	47	60	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASSLTGPSSTDTQYF+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGCCAGGGTGGACGAGCAGTACTTCGGGCCG	CASSQARVDEQYF	In	VDJ	8	233	5.285556140319039E-4	6.784319777311255E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	3	5	1	3	23	39	45	40	48	TCRBV01,TCRBV23													CASSQARVDEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCAGACCACCGCTGGAGCAGTTCTTCGGGCCA	CASSFRPPLEQFF	In	VDJ	8	236	5.353610511224434E-4	6.87167153410067E-4	39	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	2	7	10	4	8	24	36	43	40	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRPPLEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCGGACCTGATGACACCGGGGAGCTGTTTTTTGGAGAA	CASGPDDTGELFF	In	VDJ	8	236	5.353610511224434E-4	6.87167153410067E-4	39	unresolved						TCRBJ02	TCRBJ02-02	01	7	1	7	3	0	6	23	-1	36	32	42	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGPDDTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGAAAGGGATCTGGAAACACCATATATTTTGGAGAG	CASSVGKGSGNTIYF	In	VDJ	8	240	5.444349672431628E-4	6.988140543153224E-4	45	unresolved						TCRBJ01	TCRBJ01-03	01	5	0	8	1	8	0	24	36	-1	44	48	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGKGSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGACGGGGCAGAGTTCTACGAGCAGTACTTCGGGCCG	CSADGAEFYEQYF	In	VDJ	8	244	5.535088833638822E-4	7.104609552205778E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	5	7	0	3	3	6	26	35	43	38	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSADGAEFYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATACAGGGTTTCGAGCTTTCTTTGGACAA	CATSDTGFRAFF	In	VDJ	8	250	5.671197575449613E-4	7.279313065784608E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	3	10	0	5	24	-1	45	39	50		TCRBV24-01,TCRBV24-or09_02												CATSDTGFRAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGGAGTTGCGGGGGGTCGGACCGGGGAGCTGTTTTTTGGAGAA	CASSLGVAGGRTGELFF	In	VDJ	9	253	5.739251946355008E-4	7.366664822574024E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	7	1	5	5	4	18	34	47	39	51	TCRBV05,TCRBV11													CASSLGVAGGRTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAAAAAACAGGGGGAAGGGTGAAGCTTTCTTTGGACAA	CASSQKNRGKGEAFF	In	VDJ	9	265	6.011469429976589E-4	7.716071849731684E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	1	7	4	5	23	38	50	42	55	TCRBV01,TCRBV04													CASSQKNRGKGEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAACTACGGGGGCTCCTACGAGCAGTACTTCGGGCCG	CSASNYGGSYEQYF	In	VDJ	9	267	6.056839010580187E-4	7.774306354257961E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	2	0	6	0	26	37	-1	43	49		TCRBV20-01,TCRBV20-or09_02												CSASNYGGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCAGACAAACAGGGAAACAGCCCCAGCATTTTGGTGAT	CASSPRQTGKQPQHF	In	VDJ	10	282	6.397110865107163E-4	8.211065138205038E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	7	9	3	24	36	51	45	54		TCRBV24-01,TCRBV24-or09_02												CASSPRQTGKQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGGGAGTTCCTCCTGATCGGGAGCAGTACTTCGGGCCG	CASSLSGVPPDREQYF	In	VDJ	10	285	6.465165236012559E-4	8.298416894994453E-4	48				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	8	2	7	4	14	24	36	46	40	60	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSGVPPDREQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAAGTTGAAGGGGCATTGGGAAACACCATATATTTTGGAGAG	CASSQVEGALGNTIYF	In	VDJ	10	286	6.487850026314357E-4	8.327534147257591E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	5	2	4	8	5	18	30	43	38	48	TCRBV07,TCRBV11													CASSQVEGALGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCACTGACTAGCGGGAACCCCTGGGAGCAGTACTTCGGGCCG	CSARPLTSGNPWEQYF	In	VDJ	10	292	6.623958768125147E-4	8.502237660836423E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	2	3	7	5	8	26	38	54	43	62		TCRBV20-01,TCRBV20-or09_02												CSARPLTSGNPWEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGGAGGGGTTGTGAACACTGAAGCTTTCTTTGGACAA	CASSGGVVNTEAFF	In	VDJ	10	300	6.805437090539535E-4	8.73517567894153E-4	42	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	5	10	0	0	0	4	24	-1	42	36	46	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSGGVVNTEAFF+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTCGTTAGGGGGTTATATGAAAAACTGTTTTTTGGCAGT	CASSLVRGLYEKLFF	In	VDJ	10	303	6.873491461444931E-4	8.822527435730945E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	5	1	6	5	4	23	36	47	41	51	TCRBV01,TCRBV04													CASSLVRGLYEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGGCAACAGGGGGCGTCGTCGCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRATGGVVASSYNEQFF	In	VDJ	10	304	6.896176251746729E-4	8.851644687994084E-4	57	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	0	0	4	11	24	35	48	39	59		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRATGGVVASSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACGTCCATGGGTGGGTACGGGAACACTGAAGCTTTCTTTGGACAA	CASTSMGGYGNTEAFF	In	VDJ	11	311	7.054969783859319E-4	9.055465453836053E-4	48	TCRBV24						TCRBJ01	TCRBJ01-01	01	11	0	9	1	10	9	24	31	44	41	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTSMGGYGNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGTAGACAGGGACTATCAAGAAGCTTTCTTTGGACAA		Out	VDJ	11	316	7.168393735368311E-4		40	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	2	3	8	4	8	26	35	46	39	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGGGAACCGACTAGCGGGAAGTAGTTTCTAATGAGCAGTTCTTCGGGCCA		Out	VDJ	11	321	7.281817686877303E-4		50				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	9	2	3	7	6	10	18	26	43	32	53	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02												X+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCACCCAGCCGGGCAGGGAGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	11	325	7.372556848084497E-4		41	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	9	9	1	4	12	0	23	30	-1	42	48	TCRBV09,TCRBV21													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGTCGGGACAGGGGTCCGGCTGAAGCTTTCTTTGGACAA	CASSRRDRGPAEAFF	In	VDJ	11	328	7.440611218989891E-4	9.550458742309405E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	2	6	3	5	26	39	52	42	57		TCRBV03-01,TCRBV03-02												CASSRRDRGPAEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGCCCCCAGATGGAGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CSASPQMEYSNQPQHF	In	VDJ	11	335	7.599404751102481E-4	9.754279508151375E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	10	2	0	12	2	26	34	50	46	52		TCRBV20-01,TCRBV20-or09_02												CSASPQMEYSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
RGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGGCGCGGGGGAAGCGGGAGGTCTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	12	341	7.735513492913271E-4		59	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	6	1	0	12	3	22	38	59	50	62	TCRBV09,TCRBV21													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCCACTTAGCGGGAGGGGTCGGGGAGCTGTTTTTTGGAGAA	CSAIHLAGGVGELFF	In	VDJ	12	359	8.143839718345643E-4	0.0010453093562466697	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	5	0	7	6	2	26	36	53	42	55		TCRBV20-01,TCRBV20-or09_02												CSAIHLAGGVGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGCGGCTAGCGGGAAAGGAGACCCAGTACTTCGGGCCA	CASRRLAGKETQYF	In	VDJ	12	366	8.302633250458233E-4	0.0010656914328308665	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	4	3	5	4	3	24	35	48	39	51		TCRBV24-01,TCRBV24-or09_02												CASRRLAGKETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCTCCCCCGTGGGCCATTCAGATACGCAGTATTTTGGCCCA	CASSPVGHSDTQYF	In	VDJ	12	367	8.325318040760031E-4	0.0010686031580571804	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	11	8	0	4	10	4	24	31	45	41	49		TCRBV24-01,TCRBV24-or09_02												CASSPVGHSDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATAATAGCGGGAGGGTAAACGAGCAGTACTTCGGGCCG	CATSDNSGRVNEQYF	In	VDJ	12	368	8.348002831061829E-4	0.0010715148832834943	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	5	0	5	2	3	24	39	52	41	55		TCRBV24-01,TCRBV24-or09_02												CATSDNSGRVNEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGGCCCTAGCGGGTATACAGTTCTTCGGGCCA	CASSQALAGIQFF	In	VDJ	12	369	8.370687621363629E-4	0.0010744266085098082	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	4	13	4	4	23	37	49	41	53	TCRBV01,TCRBV04					01,02								CASSQALAGIQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCGGTCTTTCAGGGACCCAGTACTTCGGGCCA	CSARAGLSGTQYF	In	VDJ	13	378	8.574850734079815E-4	0.0011006321355466328	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	4	7	9	0	26	39	-1	48	52		TCRBV20-01,TCRBV20-or09_02												CSARAGLSGTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTGACAATCCAGCGGGAGTTGAATACGAGCAGTACTTCGGGCCG	CSVDNPAGVEYEQYF	In	VDJ	13	378	8.574850734079815E-4	0.0011006321355466328	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	6	2	4	10	5	26	33	51	43	56		TCRBV20-01,TCRBV20-or09_02												CSVDNPAGVEYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTAGGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVRGSGANVLTF	In	VDJ	13	381	8.642905104985209E-4	0.0011093673112255742	39	TCRBV20						TCRBJ02	TCRBJ02-06	01	3	0	9	0	0	0	26	-1	-1	37	40		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSVRGSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20		TCRBJ02-06*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGCCAATAGGCGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQPIGGSSYEQYF	In	VDJ	13	388	8.801698637097799E-4	0.0011297493878097713	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	2	0	8	0	26	40	-1	48	55		TCRBV03-01,TCRBV03-02												CASSQPIGGSSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGTTTTAGCGCGAGGGGTACAGATACGCAGTATTTTGGCCCA	CSARDGFSARGTDTQYF	In	VDJ	13	393	8.915122588606791E-4	0.0011443080139413404	51	TCRBV20						TCRBJ02	TCRBJ02-03	01	0	5	2	3	13	1	26	40	58	53	59		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDGFSARGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGATCCGGCGGGAGGACCTGCCGAGCAGTTCTTCGGGCCA	CASSQDPAGGPAEQFF	In	VDJ	13	395	8.960492169210387E-4	0.0011501314643939681	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	1	10	4	7	23	40	52	44	59	TCRBV04,TCRBV23													CASSQDPAGGPAEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATGGGGGGTTGGAAACACCATATATTTTGGAGAG	CSARWGVGNTIYF	In	VDJ	14	400	9.07391612071938E-4	0.0011646900905255373	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	2	9	1	3	1	1	26	38	45	39	46		TCRBV20-01,TCRBV20-or09_02												CSARWGVGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGCAAAGGGCTCGGGAAACACCATATATTTTGGAGAG	CASSVAKGSGNTIYF	In	VDJ	14	418	9.482242346151752E-4	0.0012171011445991865	45	unresolved						TCRBJ01	TCRBJ01-03	01	5	5	3	4	7	4	24	36	47	43	51	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVAKGSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCTCCCGATCTGGAGGGGACGGCTACACCTTCGGTTCG	CASSFSRSGGDGYTF	In	VDJ	15	432	9.79982941037693E-4	0.0012578652977675803	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	10	0	8	12	3	24	36	54	48	57		TCRBV24-01,TCRBV24-or09_02												CASSFSRSGGDGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*02	TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAGACATCTGTGTACTTGTGTGCCATCAGAGACAGGGTGGCGAGGAGCAAGGTTTAATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	15	435	9.867883781282327E-4		61				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	3	0	1	20	20	31	39	32	59	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												X+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAAGGGGGCGATCGAGACCCAGTACTTCGGGCCA	CASSEKGAIETQYF	In	VDJ	15	446	0.001011741647460211	0.001298629450935974	42	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	5	0	5	1	4	23	38	46	39	50		TCRBV06-01,TCRBV06-08												CASSEKGAIETQYF+TCRBV06-X+TCRBJ02-05	TCRBV06	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTAGAACCTTCCTACGAGCAGTACTTCGGGCCG	CASSLEPSYEQYF	In	VDJ	15	449	0.0010185470845507504	0.0013073646266149156	39	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	1	3	7	1	1	2	18	34	37	35	39	TCRBV07,TCRBV11			TCRBD01,TCRBD02										CASSLEPSYEQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAATAAACAATGAGCAGTTCTTCGGGCCA	CASSLINNEQFF	In	VDJ	15	450	0.0010208155635809302	0.0013102763518412295	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	9	5	1	4	26	38	41	39	45		TCRBV03-01,TCRBV03-02				01,02								CASSLINNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGTAAGATCGAGCGGGAGGACAAGAGACCCAGTACTTCGGGCCA	CSARA*DRAGGQETQYF	Stop	VDJ	15	451	0.00102308404261111		51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	6	1	2	10	1	26	39	58	49	59		TCRBV20-01,TCRBV20-or09_02												CSARA*DRAGGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGTAGGAGGGGACTAGCGGCCCCGGGGATACGAGCAGTACTTCGGGCCG		Out	VDJ	16	463	0.0010503057909732683		59	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	5	4	6	9	22	40	57	46	66		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGCCTCAGGGAACACTGAAGCTTTCTTTGGACAA	CASSLASGNTEAFF	In	VDJ	16	470	0.0010661851441845273	0.0013685108563675063	42	TCRBV24						TCRBJ01	TCRBJ01-01	01	6	4	4	1	7	0	24	36	-1	43	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLASGNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCACGGGAGTTTGGCGGGGAGCTGTTTTTTGGAGAA	CATSDPREFGGELFF	In	VDJ	16	482	0.0010934068925466853	0.0014034515590832725	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	8	2	7	3	5	24	39	48	42	53		TCRBV24-01,TCRBV24-or09_02												CATSDPREFGGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGGGGCGCCTCCAGTATTTTGGCCCA	CASSVGGRLQYF	In	VDJ	17	503	0.001141044952180462	0.0014645977888358632	36	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	5	5	1	12	2	7	24	36	44	38	51	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSVGGRLQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACGGGACTAGCGGGAGCAGATACGCAGTATTTTGGCCCA	CATGLAGADTQYF	In	VDJ	17	518	0.0011750721376331597	0.0015082736672305708	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	10	0	2	4	0	0	24	-1	-1	32	46		TCRBV24-01,TCRBV24-or09_02												CATGLAGADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACATGACAGGGACCACATTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	18	524	0.0011886830118142389		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	2	3	0	6	7	24	31	44	37	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGATGGGAGCGGGAGGGATACGCAGTATTTTGGCCCA	CASSDGSGRDTQYF	In	VDJ	19	552	0.0012522004246592745	0.0016072723249252415	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	6	1	6	5	0	23	36	-1	41	50	TCRBV09,TCRBV21													CASSDGSGRDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGAGTCGGGGTTGGGGATACGCAGTATTTTGGCCCA	CSARVGVGDTQYF	In	VDJ	19	567	0.001286227610111972	0.0016509482033199492	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	8	3	6	1	5	26	39	45	40	50		TCRBV20-01,TCRBV20-or09_02												CSARVGVGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCCTACAGTCCAGTTGGGATGAGCAGTTCTTCGGGCCA	CASLQSSWDEQFF	In	VDJ	20	595	0.0013497450229570079	0.0017324765096567367	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	3	5	8	2	10	23	32	38	34	48	TCRBV02,TCRBV09													CASLQSSWDEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGACAGCGGGAGTAGGGAGACCCAGTACTTCGGGCCA	CASSVDSGSRETQYF	In	VDJ	21	612	0.001388309166470065	0.001781975838504072	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	6	2	5	6	4	24	36	50	42	54	TCRBV09,TCRBV21													CASSVDSGSRETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTAGCGCGGATGGGGAGGCTACACCTTCGGTTCG		Out	VDJ	22	640	0.001451826579315101		40	unresolved						TCRBJ01	TCRBJ01-02	01	0	0	8	8	7	0	19	36	-1	43	47	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGACGCCTCCTACGAGCAGTACTTCGGGCCG	CASSLDASYEQYF	In	VDJ	22	644	0.0014609004954358202	0.001875151045746115	39	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	2	7	0	3	2	24	36	42	39	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDASYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCTTTTATAGCGGGAGGTCAACCGGGGAGCTGTTTTTTGGAGAA	CASSFYSGRSTGELFF	In	VDJ	22	656	0.0014881222437979783	0.001910091748461881	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	5	1	5	5	3	23	35	50	40	53	TCRBV01,TCRBV04													CASSFYSGRSTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCGGGTCAGGGGAGGGTCAGACCCAGTACTTCGGGCCA	CASGSGEGQTQYF	In	VDJ	23	688	0.0015607135727637334	0.002003266955703924	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	9	0	6	7	2	18	27	41	34	43	TCRBV07,TCRBV23													CASGSGEGQTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCTGTTAGGACAGATACGCAGTATTTTGGCCCA	CSARDPVRTDTQYF	In	VDJ	24	717	0.0016264994646389488	0.0020877069872670254	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	0	5	4	3	7	0	26	40	-1	47	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDPVRTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGGAACACGACAATGAGCAGTTCTTCGGGCCA	CSAMEHDNEQFF	In	VDJ	26	756	0.001714970146815963	0.0022012642710932655	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	4	1	8	5	1	5	26	36	40	37	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAMEHDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAATCTCAGATGGGTGGGTCGGGACAGATACGCAGTATTTTGGCCCA	CASSLISDGWVGTDTQYF	In	VDJ	27	803	0.0018215886612344156	0.002338115356730016	54	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	8	4	3	20	0	24	36	-1	56	60		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLISDGWVGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGGAGACTAACGAGCAGTACTTCGGGCCG	CASSQGETNEQYF	In	VDJ	28	824	0.0018692267208681923	0.002399261586482607	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	2	9	5	4	0	23	39	-1	43	48	TCRBV01,TCRBV04					01,02								CASSQGETNEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCTCTGGCGGGACTATCCGAATCACAGATACGCAGTATTTTGGCCCA	CASSGGTIRITDTQYF	In	VDJ	30	875	0.0019849191514073644	0.0025477595730246127	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	0	9	2	6	7	23	32	45	38	52	TCRBV02,TCRBV09					01,02								CASSGGTIRITDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCGGGACTCTTCAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	30	902	0.00204616808522222		47	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	10	2	2	5	26	39	47	41	52		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGGTGACTCCAAACGCGAGCAGTACTTCGGGCCG	CASSQEGDSKREQYF	In	VDJ	31	910	0.002064315917463659	0.0026496699559455973	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	2	10	6	4	7	26	43	51	47	58		TCRBV03-01,TCRBV03-02				01,02								CASSQEGDSKREQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCGGTTAGCGGGACGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASRLAGRYTGELFF	In	VDJ	31	912	0.0020688528755240187	0.002655493406398225	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	11	5	3	3	6	4	24	31	45	37	49		TCRBV24-01,TCRBV24-or09_02												CASRLAGRYTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTTTATCCAGCCACAGATACGCAGTATTTTGGCCCA	CASSVYPATDTQYF	In	VDJ	34	993	0.0022525996769685863	0.0028913431497296464	42	unresolved						TCRBJ02	TCRBJ02-03	01	2	4	5	2	5	1	23	37	45	42	46	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVYPATDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAAAAGGGGACAGGAGAAGGGAAACACCATATATTTTGGAGAG	CASKRGQEKGNTIYF	In	VDJ	36	1057	0.002397782334900096	0.0030776935642137324	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	0	4	4	4	5	22	32	44	36	49	TCRBV09,TCRBV12													CASKRGQEKGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGCAAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTGAATATTCGGGGGACTACGAGCAGTACTTCGGGCCG	CASSEYSGDYEQYF	In	VDJ	36	1058	0.002400050813930276	0.0030806052894400463	42	TCRBV25			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	2	3	2	1	39	56	64	58	65		TCRBV25-01,TCRBV25-or09_02												CASSEYSGDYEQYF+TCRBV25-X+TCRBJ02-07	TCRBV25	TCRBD02-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAACTTGGACAGCCCTCCTACGAGCAGTACTTCGGGCCG	CASSQLGQPSYEQYF	In	VDJ	36	1067	0.002420467125201895	0.0031068108164768707	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	5	0	3	2	23	38	47	41	49	TCRBV01,TCRBV04													CASSQLGQPSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCCAGGGATTAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	36	1071	0.002429541041322614		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	4	3	2	2	3	26	39	46	41	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTCGTTCACAGGAGCGAGTCGGAAACACCATATATTTTGGAGAG	CASSRSQERVGNTIYF	In	VDJ	41	1209	0.002742591147487433	0.0035202757986134365	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	4	4	5	8	23	35	45	40	53	TCRBV02,TCRBV12													CASSRSQERVGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGGGGACAGGCGCTTGGACGGGGAGCTGTTTTTTGGAGAA	CASGDRRLDGELFF	In	VDJ	43	1263	0.0028650890151171444	0.003677508960834384	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	11	0	4	7	3	8	24	31	42	34	50		TCRBV24-01,TCRBV24-or09_02												CASGDRRLDGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGAGAGGCAGGGCGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASREAGRYTGELFF	In	VDJ	45	1336	0.003030687984320273	0.0038900649023552946	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	4	3	3	5	4	24	35	45	40	49		TCRBV24-01,TCRBV24-or09_02												CASREAGRYTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCAGACAGGGTTTCGTCAGCCCCAGCATTTTGGTGAT	CASSQTGFRQPQHF	In	VDJ	48	1412	0.003203092390613941	0.004111356019555147	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	3	6	3	5	24	35	45	38	50		TCRBV24-01,TCRBV24-or09_02												CASSQTGFRQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGCTTCAGTCACTGAAGCTTTCTTTGGACAA	CASSVASVTEAFF	In	VDJ	52	1528	0.003466235958114803	0.004449116145807552	39	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	5	5	7	4	1	6	24	36	41	37	47	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSVASVTEAFF+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCTCCTTGACGATTAGCGGGGACTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	54	1613	0.00365905667568009		46	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	12	5	3	4	11	3	24	30	49	41	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGGGGCCCAGACCAAGAGACCCAGTACTTCGGGCCA	CASRGPDQETQYF	In	VDJ	57	1673	0.003795165417490881	0.0048713163036230595	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	8	0	0	0	4	23	-1	38	34	42	TCRBV02,TCRBV09													CASRGPDQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCAGAGGGACTAGCGGGAGACGAGCAGTACTTCGGGCCG	CASSPEGLAGDEQYF	In	VDJ	59	1744	0.00395622742863365	0.005078048794691342	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	0	2	5	0	0	23	-1	-1	40	54	TCRBV01,TCRBV04													CASSPEGLAGDEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCGACTTCTAGCGGGACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	59	1745	0.00395849590766383		40	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	11	4	3	0	5	2	26	29	43	34	45		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACCAAACCTACAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQDQTYSSYNEQFF	In	VDJ	61	1817	0.004121826397836779	0.0052906047362122535	51				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	5	0	8	0	18	35	-1	43	47	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDQTYSSYNEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACCCTCAGCGGGACGGGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	63	1865	0.004230713391285411		43	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	11	6	3	2	8	4	24	31	46	39	50		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAAGGGCTAGCGGGAGACGAGCAGTACTTCGGGCCG	CASSQEGLAGDEQYF	In	VDJ	71	2105	0.004775148358528574	0.00612918160139064	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	4	2	5	4	0	23	40	-1	44	54	TCRBV01,TCRBV04													CASSQEGLAGDEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGCCCTAATAGATAATTGAACGAGCAGTACTTCGGGCCG		Out	VDJ	74	2185	0.004956626680942961		46	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	9	5	5	12	26	38	46	43	58		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCCTGGGACTAGCGGCTCCCAATGAGCAGTTCTTCGGGCCA	CASSLGLAAPNEQFF	In	VDJ	78	2314	0.005249260475836162	0.006737732173690233	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	6	2	4	18	30	43	32	47	TCRBV07,TCRBV11					01,02								CASSLGLAAPNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGGCTGTGGGAAGAAAGACGCAGTATTTTGGCCCA	CSGAVGRKTQYF	In	VDJ	80	2369	0.005374026822496053	0.0068978770611374945	36	TCRBV20						TCRBJ02	TCRBJ02-03	01	7	0	8	9	7	6	26	33	44	40	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSGAVGRKTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCCCCCCGGAGTCTCGGGATGAGCAGTTCTTCGGGCCA	CASSPPPESRDEQFF	In	VDJ	104	3069	0.0069619621436219446	0.008936084719557185	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	8	4	8	15	0	24	36	-1	51	55		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPPPESRDEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGAACTACTACCCACCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	112	3311	0.007510934068925467		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	9	0	3	10	26	35	42	38	52		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGTAGGGACGGAGAAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	114	3378	0.007662922163947516		44	TCRBV03						TCRBJ01	TCRBJ01-04	01	5	0	7	5	4	5	26	38	47	42	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCAGGGACAGGGTGAAAAACTGTTTTTTGGCAGT	CASSQGQGEKLFF	In	VDJ	133	3927	0.008908317151516252	0.011434344963734463	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	3	7	2	0	24	36	-1	38	47		TCRBV24-01,TCRBV24-or09_02												CASSQGQGEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCCCCATTATCCCGGTCTGTGAGAAGAGACCCAGTACTTCGGGCCA	CATPHYPGL*EETQYF	Stop	VDJ	134	3960	0.008983176959512186		48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	9	8	5	3	11	8	24	33	47	44	55		TCRBV24-01,TCRBV24-or09_02				01,02								CATPHYPGL*EETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTGACAGGTCCCTCCAGCACAGATACGCAGTATTTTGGCCCA	CASSLTGPSSTDTQYF	In	VDJ	143	4240	0.009618351087962542	0.012345714959570694	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	4	0	2	7	24	36	44	38	51		TCRBV24-01,TCRBV24-or09_02												CASSLTGPSSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTCCCTGGGGAGGTTATAGTTCTGTCGGGGAGCTGTTTTTTGGAGAA	CASSPWGGYSSVGELFF	In	VDJ	153	4515	0.010242182821262	0.013146439396807002	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	9	1	7	5	12	23	35	46	40	58	TCRBV02,TCRBV09													CASSPWGGYSSVGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGTCTAGCGGAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLASSGAKNIQYF	In	VDJ	185	5475	0.012419922690234652	0.01594169561406829	48				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	4	5	0	2	0	18	35	-1	37	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLASSGAKNIQYF+X+TCRBJ02-04		TCRBD02-01	TCRBJ02-04*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAACCCACGCCCAAAACACTGAAGCTTTCTTTGGACAA	CASSVTHAQNTEAFF	In	VDJ	227	6706	0.015212420376386041	0.01952602936766063	45	unresolved						TCRBJ01	TCRBJ01-01	01	5	3	7	2	3	10	24	36	41	39	51	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVTHAQNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGAGACAGAATCTTCAGTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	245	7259	0.016466889280075496		50	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	2	5	0	4	10	26	37	46	41	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCTTGAGAGGACAGGAGGTGGGCGAAGCTTTCTTTGGACAA	CASLRGQEVGEAFF	In	VDJ	566	16748	0.03799248679745205	0.04876557409030425	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	1	4	8	6	8	23	32	45	38	53	TCRBV02,TCRBV12													CASLRGQEVGEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2058B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				15631	12177	2956	496	0	3305	2603	623	79	0	440824	343439	83377	14008	0	0.275216341	8.22336578	0.265051931	8.59186268				67052	0.201333433	0.0971118584	0.0756583139	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:32	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1103,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 566,type of chemo:carbo/taxol	0.7790288316869396	MSKCC- Snyder- P01-02		13500.0	
